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On the Development of Pseudoephenamine and Its Applications in Asymmetric Synthesis 
 
Abstract 
 
Pseudoephedrine is well established as a chiral auxiliary in the alkylation of amide enolates 
to form tertiary and quaternary carbon stereocenters. However, due to its facile transformation 
into the illegal narcotic methamphetamine, pseudoephedrine is either illegal or highly regulated 
in many countries, which limits its use in academic and industrial settings. To address this issue, 
pseudoephenamine has been developed as a replacement for pseudoephedrine in organic 
synthesis. This new auxiliary suffers no regulatory issues and exhibits several practical 
advantages over pseudoephedrine, including the high diastereoselectivities observed in alkylation 
reactions forming quaternary carbon stereocenters, the propensity for pseudoephenamine amides 
to be free-flowing crystalline solids, and the sharp, well-defined peaks that typically compose the 
1H NMR spectra of these amides. 
This thesis details the development of pseudoephenamine, including its application to the 
synthesis of several chiral building blocks bearing tertiary and quaternary carbon stereocenters. 
In addition, the use of pseudoephenamine to direct the alkylative construction of α-methyl α-
amino acids is described. Finally, a simple, scalable synthesis of pseudoephenamine is reported 
which enables the production of this auxiliary from inexpensive starting materials on large scale. 
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Chapter 1 
On the Use of Pseudoephedrine as a Chiral Auxiliary 
 
  
 2 
Introduction 
Pseudoephedrine (1) is an amphetamine alkaloid first isolated from the leaves of Ephedra 
vulgaris in 1889.1 While the leaves and stems of the Ephedra plant were traditionally prescribed 
as a stimulant or an antiasthmatic, 2  pseudoephedrine is today marketed primarily as a 
decongestant in over-the-counter medications such as SudafedⓇ, Claritin-DⓇ, and Zyrtec-DⓇ. 
Notoriously, pseudoephedrine is easily transformed into methcathinone (2) or methamphetamine 
(3) by oxidation or reduction, respectively, of the benzylic alcohol of the natural product (Figure 
1.1). 
 
Figure 1.1 Modification of pseudoephedrine to give methcathinone or methamphetamine. 
Because both methcathinone and methamphetamine are highly addictive, illegal 
psychostimulants,3 pseudoephedrine is itself illegal or highly regulated in many countries.4 In 
spite of this, pseudoephedrine is manufactured in multi-ton amounts annually in a process that 
involves a reductive coupling of pyruvate (4) and benzaldehyde mediated by the enzyme 
pyruvate decarboxylase (PDC) followed by reductive amination with methylamine to give the 
                                                
1 Chen, K. K.; Kao, C. H. J. Am. Pharm. Assoc. 1926, 15, 625–639. 
2 Abourashed, E. A.; El-Alfy, A. T.; Khan, I.A.; Walker, L. Phytother. Res. 2003, 17, 703–712. 
3 Methcathinone is classified as a Schedule I illegal drug by the UN Convention on Psychotropic Substances, while 
methamphetamine is classified as a Schedule II illegal drug by the same governing body. 
4 For example, pseudoephedrine is illegal in Mexico, Japan, and Colombia, and it is highly regulated by law in the 
United States and Australia. It is a Table 1 precursor under the United Nations Convention Against Illicit Traffic in 
Narcotic Drugs and Psychotropic Substances and is a banned item on the World Anti-Doping Agency list. 
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 3 
final amino alcohol (Figure 1.2).5 The following sections describe reported methodologies that 
utilize pseudoephedrine as a chiral auxiliary. For the sake of brevity, other applications of 
pseudoephedrine are not discussed.  
 
Figure 1.2 Industrial synthesis of (–)-pseudoephedrine. 
Stereocontrolled Alkylation of Pseudoephedrine Amide Enolates 
The group of Andrew G. Myers first reported the use of pseudoephedrine as a chiral auxiliary 
in the mid-1990s.6 In their initial reports, highly practical methods for the synthesis and 
stereocontrolled alkylation of pseudoephedrine amides to form tertiary carbon stereocenters were 
disclosed. 7 The general protocol for these reactions involved enolization of the pseudoephedrine 
amides with lithium diisopropylamide (LDA) in the presence of lithium chloride followed by 
alkylation with an appropriate alkyl halide to produce highly diastereomerically-enriched 
products in high yield (Scheme 1.1).8 Lithium chloride was found to be an essential additive to 
                                                
5 Oliver, A. L.; Anderson, B. N.; Roddick, F. A. Adv. Microb. Physiol. 1999, 41, 1–45. 
6 The use of ephedrine as a chiral auxiliary in the alkylation of amide enolates was reported nearly two decades 
earlier: a) Larcheveque, M.; Ignatova, E.; Cuvigny, T. Tetrahedron Lett. 1978, 41, 3961–3964. b) Larcheveque, M.; 
Ignatova, E.; Cuvigny, T. J. Organomet. Chem. 1979, 177, 5–15. 
7 a) Myers, A. G.; Yang, B. H.; Chen, H.; Gleason, J. L. J. Am. Chem. Soc. 1994, 116, 9361–9362. b) Myers, A. G.; 
McKinstry, L. J. Org. Chem. 1996, 61, 2428–2440. c) Myers, A. G.; Yang, B.H.; Chen, H.; McKinstry, L.; 
Kopecky, D. J.; Gleason, J. L. J. Am. Chem. Soc. 1997, 119, 6496–6511. d) Myers, A.G.; McKinstry, L.; Barbay, 
J.K.; Gleason, J.L. Tetrahedron Lett. 1998, 39, 1335–1338. 
8 Pseudoephedrine amide enolate alkylation chemistry has been extended to a protocol featuring pseudoephedrine 
affixed to a resin support: a) Hutchison, P. C.; Heightman, T. D.; Procter, D. J. Org. Lett. 2002, 4, 4583–4585. b) 
Hutchison, P. C.; Heightman, T. D.; Procter, D. J. J. Org. Chem. 2004, 69, 790–801. 
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promote efficient alkylations, though it had no observed effect on the diastereoselectivity of the 
reactions.9 
 
Scheme 1.1 Synthesis of pseudoephedrine amides followed by stereocontrolled amide enolate alkylation. X1 = 
RCH2CO2, Cl, t-BuCO2, OCH3. R1 = alkyl, aryl, Cl, F. R2 = alkyl, benzyl, allyl, BOM. X2 = I, Br. 
Monosubstituted epoxides were also reported to be effective electrophiles in 
pseudoephedrine amide enolate alkylations, though the stereochemistry of the epoxide had a 
notable impact on the yield and diastereoselectivity of the reaction.1b The stereochemically 
matched alkylation is shown in Scheme 1.2. Interestingly, alkylations employing these 
electrophiles proceeded with opposite enolate π-facial selectivity in comparison to those utilizing 
alkyl halide electrophiles.10 A stereochemical model illustrating the different selectivities in the 
alkylation of pseudoephedrine amide enolates with either alkyl halides or epoxides is presented 
in Figure 1.3. 
 
                                                
9 For a discussion on the role of lithium chloride in enolate alkylation reactions, see: (a) Seebach, D.; Bossler, H.; 
Gründler, H.; Shoda, S. -I. Helv. Chim. Acta 1991, 74, 197–224. (b) Miller, S. A.; Griffiths, S. L.; Seebach, D. Helv. 
Chim. Acta 1993, 76, 563–595. (c) Bossler, H. G.; Seebach, D. Helv. Chim. Acta 1994, 77, 1124–1165. 
10 Opposite π-facial selectivity for alkyl halides and epoxides has also been observed in the stereocontrolled 
alkylation of prolinol amide enolates: Askin, D.; Volante, R. P.; Ryan, K. M.; Reamer, R. A.; Shinkai, I. 
Tetrahedron Lett. 1988, 29, 4245–4248.  
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Scheme 1.2 Stereocontrolled alkylation of pseudoephedrine amide enolates with epoxide electrophiles. R1 = CH3, 
Bn. R2 = CH3, Ph, CH2OBn, CH2OTBS. 
 
Figure 1.3 Stereochemical model for the observed diastereoselectivity in pseudoephedrine amide enolate 
alkylations. Alkyl halides approach the enolate from the bottom of face of the enolate, while epoxides approach 
from the top face.  
More recently, Myers and co-workers extended the above enolization-alkylation procedure to 
the synthesis of quaternary carbon stereocenters,11 and the developed protocol was applicable to 
the synthesis of α-methyl quaternary amides from the corresponding α-methyl disubstituted 
pseudoephedrine amides.12 As part of the study, matched and mismatched amide diastereomers 
                                                
11 Kummer, D. A.; Chain, W. J.; Morales, M. R.; Quiroga, O.; Myers, A. G. J. Am. Chem. Soc. 2008, 130, 13231–
13233. 
12 A single example of the enolization-alkylation of an α-phenyl pseudoephedrine amide was also reported, though 
the broad utility of such a substrate in enolization-alkylation reactions was not demonstrated. See Scheme 1.7 for 
transformations of this substrate. 
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were identified,13 with the diastereomer featuring a 1,4-anti relationship between the α-methyl 
group of the amide and the C-methyl group of pseudoephedrine proving to be the matched 
substrate (Scheme 1.3). Additional reaction optimizations included the use of DMPU as additive 
to promote efficient alkylation and the use of the electrophile as the limiting reagent in the 
reaction, which resulted in formation of products with greater diastereoselectivity. The utility of 
this protocol was demonstrated in the syntheses of a variety of α-quaternary amides in good to 
excellent yield and good to excellent diastereoselectivity (Scheme 1.4).  
 
Scheme 1.3 Enolization-alkylation of α-methyl pseudoephedrine amides demonstrating a) matched alkylations and 
b) mismatched alkylations to form quaternary carbon stereocenters. 
 
Scheme 1.4 Enolization-alkylation of α-methyl pseudoephedrine amides to produce quaternary carbon 
stereocenters. R1 = ethyl, propyl, vinyl, phenyl. R2 = alkyl, allyl, benzyl. X = Br, I. 
A key aspect of this methodology is the efficient transformation of pseudoephedrine amide 
alkylation products to a variety of enantiomerically-enriched compounds. As exemplified by the 
                                                
13 Ko, S. Y.; Lee, A. W. M.; Masamune, S.; Reed, III, L. A.; Sharpless, K. B.; Walker, F. J. Tetrahedron 1990, 46, 
245–264. 
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 7 
reactions shown in Scheme 1.5, pseudoephedrine amides are readily hydrolyzed to carboxylic 
acids (via either acidic or basic hydrolysis), reduced to aldehydes (by Brown’s aluminum hydride 
reagent),14 transformed into ketones (by addition of an organolithium reagent), and reduced to 
primary alcohols (by lithium amidotrihydroborate, LAB).15 The yields for these reactions are 
typically quite high, and the products are isolated with little to no erosion of enantioenrichment 
in the products. In addition, the auxiliary may be recovered in high yield.  
                                                
14 Brown, H. C.; Tsukamoto, A. J. Am. Chem. Soc. 1964, 86, 1089–1095. 
15 Myers, A. G.; Yang, B. H. Kopecky, D. J. Tetrahedron Lett. 1996, 37, 3623–3626. 
 8 
 
Scheme 1.5 Representative transformations of pseudoephedrine amide alkylation products. a) Acidic hydrolysis to 
carboxylic acids. b) Basic hydrolysis to carboxylic acids. c) Reduction to aldehydes. d) Formation of ketones. e) 
Reduction to primary alcohols. 
The γ-hydroxy pseudoephedrine amides obtained by alkylation of pseudoephedrine amide 
enolates with monosubstituted epoxides were also converted to synthetically useful 
intermediates. As demonstrated with amide 5 below, hydrolysis of the γ-hydroxy amides resulted 
in auxiliary cleavage with concomitant cyclization to provide diastereomerically-enriched γ-
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lactones, while treatment of the amides with methyllithium yielded the corresponding methyl 
ketones (Scheme 1.6). 
 
Scheme 1.6 Representative transformations of γ-hydroxy pseudoephedrine amides. 
As with pseudoephedrine amides bearing a tertiary center at the α-position, α-quaternary 
pseudoephedrine amides are also easily transformed into carboxylic acids, aldehydes, ketones, 
and primary alcohols, albeit with the slightly different reaction conditions shown in Scheme 1.7. 
Of particular interest in this set of transformations is the reduction of α-quaternary 
pseudoephedrine amides to obtain α-quaternary aldehydes, which proceeds through an 
oxazolinium triflate intermediate (Scheme 1.7b). Triflates of this type, which are the product of 
an intramolecular cyclization of the amide functional group onto the secondary alcohol of the 
auxiliary after activation with triflic anhydride, have been shown to be a useful diagnostic tool 
for the determination of the diastereomeric enrichment of a pseudoephedrine amide, since the 
rigid oxazolinium triflate eliminates the amide bond rotational isomerism that often complicates 
the 1H NMR spectra of these amides.16 
                                                
16 Chain, W. J.; Myers, A. G. Org. Lett. 2007, 9, 355–357. 
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Scheme 1.7 Transformations of α-quaternary pseudoephedrine amides. a) Hydrolysis to carboxylic acids. b) 
Reduction to aldehydes proceeding through an oxazolinium triflate intermediate. c) Addition of organolithium 
reagents to produce ketones. d) Reduction with lithium amidotrihydroborate to obtain primary alcohols.  
Use of Pseudoephedrine to Direct Asymmetric Michael Reactions 
The Michael addition of a pseudoephedrine amide enolate to an α,β-unsaturated acceptor 
was first reported by Myers and co-workers in the context of the synthesis of a series of HIV 
protease inhibitors. 17  In this study, the enolate derived from (R,R)-pseudoephedrine α-
fluoroacetamide 6 was treated with nitroalkene 7 to give a 1.7:1 mixture of diastereomers 
favoring the anti diastereomer 8 (Scheme 1.8). The reaction proved to be scalable, providing 
more than 5 g (23% yield) of the desired anti isomer after recrystallization. Use of vinyl 
sulfoxide 10 as the Michael acceptor was also demonstrated in the synthesis of α-fluoro amide 
                                                
17 Myers, A. G.; Barbay, J. K.; Zhong, B. J. Am. Chem. Soc. 2001, 123, 7207–7219. 
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10, which was formed as a single diastereomer with opposite anti-selectivity to amide 8 (Scheme 
1.9) 
 
Scheme 1.8 Pseudoephedrine-directed Michael reaction of amide 6 and nitroalkene 7.  
 
Scheme 1.9 Pseudoephedrine-directed Michael reaction using vinyl sulfoxide 10 as the Michael acceptor. 
Smitrovich et al. later expanded the utility of pseudoephedrine amide enolates in Michael 
addition reactions in their pursuit of diastereomerically-enriched 3,4-trans δ-lactones. 18 
Interestingly, their reports included methods allowing access to both anti and syn Michael 
adducts (Scheme 1.10). In the anti-selective protocol, α-aryl pseudoephedrine amides were 
treated with lithium hexamethyldisilazide (LHMDS) in the presence of 
tetramethylethylenediamine (TMEDA), and the resulting enolates were trapped with a variety of 
α,β-unsaturated methyl esters. Alternatively, use of lithium chloride in place of TMEDA resulted 
in the formation of the syn diastereomer as the major product. The authors concluded that the use 
                                                
18 a) Smitrovich, J. H.; Boice, G. N.; Qu, C.; DiMichele, L.; Nelson, T. D.; Huffman, M. A.; Murry, J.; McNamara, 
J.; Reider, P. J. Org. Lett. 2002, 4, 1963–1966. b) Smitrovich, J. H.; DiMichele, L.; Qu, C.; Boice, G. N.; Nelson, T. 
D.; Huffman, M. A.; Murry, J. J. Org. Chem. 2004, 69, 1903–1908. 
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of LiCl switches the favored enolate π-facial selectivity in the Michael addition – the Michael 
acceptor approaches from the top enolate π-face in the presence of LiCl, while it approaches 
from the bottom face in the presence of TMEDA. The subsequent sequence involving selective 
reduction of the methyl ester followed by acidic hydrolysis/lactonization was found to be 
successful only with the anti Michael adducts, and no alternative transformations for these 
stereochemically-rich amides were disclosed.  
 
Scheme 1.10 Michael reactions of pseudoephedrine amide enolates with α,β-unsaturated methyl esters. a) Anti-
selective reactions conducted in the presence of TMEDA. b) Syn-selective reactions conducted in the presence of 
LiCl. R1 = aryl. R2 = alkyl, alkyl ether, aryl, 3º amine. R3 = alkyl, aryl. 
In addition to the use of pseudoephedrine amide enolates as nucleophiles in Michael 
reactions, pseudoephedrine has also been shown to effectively direct the conjugate addition of 
metallated nucleophiles to α,β-unsaturated pseudoephedrine amides.19 Dolores Badía and co-
workers first demonstrated this methodology in their synthesis of both highly enantio- and 
diastereomerically enriched carboxylic acids and alcohols.20 Initially, it was demonstrated that β-
                                                
19 The conjugate addition of Grignard reagents to α,β-unsaturated ephedrine amides has been reported to proceed 
with moderate yields and excellent diastereoselectivities: Mukaiyama, T.; Iwasawa, N. Chem. Lett. 1981, 913–916. 
20 a) Reyes, E.; Vicario, J. L.; Carrillo, L.; Badía, D.; Iza, A.; Uria, U. Org. Lett. 2006, 8, 2535–2538. b) Reyes, E.; 
Vicario, J. L.; Carrillo, L.; Badía, D.; Uria, U.; Iza, A. J. Org. Chem. 2006, 71, 7763–7772.  
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substituted α,β-unsaturated pseudoephenamine amides were able to direct the regio- and 
diastereoselective 1,4-addition of organolithium reagents to the β-position of the amide while 
completely avoiding formation of the 1,2-addition product,21 provided that the temperature of the 
reaction was kept at –105 ºC. Despite the low reaction temperature, the addition was found to be 
remarkably efficient, with conjugate addition of even bulky organolithium reagents such as t-
BuLi occurring in good to excellent yield with high diastereoselectivity (Scheme 1.11). This 
methodology was extended to the 1,4-addition of organolithium reagents in α,β,γ,δ-unsaturated 
pseudoephedrine amides, though the yield and regioselectivity suffered in this class of substrates 
due to competing 1,2-addition (Scheme 1.12).22 
 
Scheme 1.11 Diastereoselective conjugate addition of organolithium reagents to β-substituted α,β-unsaturated 
pseudoephedrine amides. R1 = methyl, ethyl, n-propyl, t-butyl, phenyl. R2 = i-propyl, n-butyl, t-butyl, phenyl. 
 
Scheme 1.12 Diastereoselective 1,4-addition of organolithium reagents to α,β,γ,δ-unsaturated pseudoephedrine 
amides. R1 = H, methyl. R2 = ethyl, i-propyl, n-butyl, i-butyl, t-butyl, n-hexyl, TMSCH2, phenyl. 
Recognizing that the conjugate addition of organolithium reagents to α,β-unsaturated 
pseudoephenamine amides results in the formation of a stereodefined amide enolate, Badía et al. 
                                                
21 Use of methyllithium resulted in exclusive 1,2-addition to give the corresponding methyl ketone. 
22 Ocejo, M.; Carrillo, L.; Badía, D.; Vicario, J. L.; Fernández, N.; Reyes, E. J. Org. Chem. 2009, 74, 4404–4407.  
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utilized this transient enolate in a conjugate addition-alkylation protocol to synthesize syn α,β-
dialkyl pseudoephedrine amides in good yield.20 As with the conjugate addition reactions 
described above, the initial addition of the organolithium reagent was conducted at –105 ºC, 
while the alkylation step was conducted at 0 ºC and exhibited excellent diastereoselectivity 
(Scheme 1.13).  
 
Scheme 1.13 Conjugate addition alkylation protocol to produce syn α,β-dialkyl pseudoephedrine amides. R1 = 
methyl, ethyl, n-propyl, t-Bu. R2 = n-Bu, phenyl. R3 = methyl, ethyl, allyl, benzyl. X = Br, I. a Represents the ratio of 
the major product diastereomers. 
Protocols for the basic hydrolysis and LAB reduction of the aforementioned conjugate 
addition products are represented by the transformations of amide 12 below (Scheme 1.14). In all 
cases, yields for the hydrolyses (≥75%) and reductions (≥65%) were generally high, and no loss 
of enantio- or diastereoenrichment was reported. For substrates such as amide 13 bearing larger 
alkyl groups at the α-position, LAB reduction to the primary alcohol was found to be sluggish or 
unsuccessful, and a second protocol involving N→O acyl transfer 23 and subsequent LAH 
reduction was also developed (Scheme 1.15). 
 
Scheme 1.14 Representative acidic hydrolysis and LAB reduction of conjugate addition-alkylation product 12. 
                                                
23 The tendency of ephedrine and pseudoephedrine amides to undergo N→O acyl transfer under acidic conditions 
has been reported: Welsh, L. H. J. Am. Chem. Soc. 1947, 69, 128–136. 
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Scheme 1.15 Reduction of amide 13 to the corresponding primary alcohol via acetic acid promoted N→O acyl 
transfer followed by reduction of the resulting ester with LAH. 
Myers et al. have adapted the above conjugate-addition alkylation protocol in a method for 
the stereocontrolled synthesis of quaternary carbon stereocenters (Scheme 1.16).11 Utilizing 
pseudoephedrine acrylamides with varying alkyl substituents at the α-position, a wide variety of 
organolithium reagents, including t-BuLi, were shown to add to s-cis conformer of the 
acrylamides to give a stereodefined enolate that could be trapped with an electrophile to give 
quaternary carbon stereocenters in good yield and diastereoselectivity. This method serves as a 
companion protocol to the enolization-alkylation strategy shown in Scheme 1.4, and the amide 
products obtained through this process can be transformed into the corresponding carboxylic 
acids, aldehydes, ketones, and alcohols using the reactions shown in Scheme 1.7. 
 
Scheme 1.16 Conjugate addition-alkylation of α-alkyl pseudoephedrine acrylamides to obtain quaternary carbon 
stereocenters. R1 = methyl, ethyl, i-propyl, cyclopropyl. R2 = n-butyl, t-butyl, phenyl, heteroaryl. R3 = methyl, allyl, 
benzyl. X = Br, I. 
Use of Pseudoephedrine to Direct Asymmetric Aldol and Mannich Reactions 
In addition to their work with conjugate addition reactions, Badía and co-workers were also 
the first to study asymmetric aldol and Mannich reactions using pseudoephedrine as a chiral 
auxiliary. Their initial reports focused on the aldol reaction of (+)-pseudoephedrine 
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propionamide (14) with achiral aldehydes. They investigated the use of the lithium enolate 
derived from 14 as the nucleophile in the reaction, but this invariably led to low 
diastereoselectivity (65:35 syn:anti at –105 ºC).24 However, transmetallation to the zirconium 
enolate using Cp2ZrCl2 resulted in a much more selective reaction (≥90:10 syn:anti) with both 
aliphatic and aromatic aldehydes (Scheme 1.17).25 Notably, the syn selectivity increased with the 
steric bulk of the aldehydes (90:10 for R = CH3 vs. >99:1 for R = t-Bu).  
 
Scheme 1.17 Pseudoephedrine-directed aldol reaction of propionamide 14. R = methyl, ethyl, i-propyl, t-butyl, 
phenyl. 
Attempts were made to extend this methodology to the use of pseudoephedrine acetamide 
(15) as the nucleophile in the aldol reaction, but they were met with mixed results. Aldol 
reactions between 15 and achiral aldehydes were universally unselective.26 However, high 
diastereoselectivity was observed in the aldol reaction between 15 and Garner’s aldehyde27 (16, 
Scheme 1.18).28 Buoyed by this success, the aldol reaction between 15 and other chiral aldehydes 
bearing α-heteroatoms was investigated.29 While no generally applicable method was developed, 
efficient reactions were observed between pseudoephedrine acetamide and chiral aldehydes 
bearing Boc-protected secondary amines at the α-position when lithium chloride was used as an 
                                                
24 Vicario, J. L.; Badía, D.; Domínguez, E.; Carrillo, L. Tetrahedron Lett. 1998, 39, 9267–9270. 
25 Vicario, J. L.; Badía, D.; Domínguez, E.; Rodríguez, M.; Carrillo, L. J. Org. Chem. 2000, 65, 3754–3760. 
26 Rodriguez, M.; Vicario, J. L.; Badía, D.; Carrillo, L. Org. Biomol. Chem. 2005, 3, 2026–2030. 
27 Garner, P.; Ramakanth, S. J. Org. Chem. 1986, 51, 2609–2612.  
28 Vicario, J. L.; Rodriquez, M.; Badía, D.; Carrillo, L.; Reyes, E. Org. Lett. 2004, 6, 3171–3174. 
29 Ocejo, M.; Carrillo, L.; Vicario, J. L.; Badía, D.; Reyes, E. J. Org. Chem. 2011, 76, 460–470. 
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additive (Scheme 1.19). In addition, the acetonide derived from (R)-glyceraldehyde was a 
suitable electrophile if the lithium enolate derived from 15 was transmetallated with Cp2ZrCl2 
prior to addition of the aldehyde (Scheme 1.20).  
 
Scheme 1.18 Aldol reaction between (–)-pseudoephedrine acetamide (15) and Garner’s aldehyde (16). 
 
Scheme  1.19 Aldol reaction between 15 and a chiral aldehyde bearing a Boc-protected secondary amine. 
 
Scheme 1.20 Aldol reaction between 15 and the acetonide of (R)-glyceraldehyde. 
It was also shown that these aldol products could be transformed to a number of 
diastereomerically-enriched synthetic intermediates, including carboxylic acids, ketones, primary 
alcohols, and derivatives thereof. Representative examples are presented in Scheme 1.21. 
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Scheme 1.21 Transformations of β-hydroxy pseudoephedrine amides. a) Acidic hydrolysis. b) Basic hydrolysis. c) 
Ketone formation. d) LAB reduction. 
Extension of the above methodology to include imines as electrophiles required slight 
modification of the reaction conditions. In the case of non-enolizable imines, it was found that 
lithium chloride was required as an additive – the absence of the lithium salt resulted in no 
conversion of the starting material.30 In addition, a large excess of the PMP-protected imine was 
required for good conversion of the amide starting material. Badía and co-workers attribute both 
of these requirements to the decreased electrophilicity of imines in comparison to aldehydes. 
Conducting the Mannich reactions under these conditions, a number of aryl and heteroaryl 
imines, in addition to pivaldimine, proved to be suitable electrophiles in the reaction with 
                                                
30 Vicario, J. L.; Badía, D.; Carrillo, L. J. Org. Chem. 2001, 66, 9030–9032. 
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propionamide 14 (Scheme 1.22). Note that these reactions favor the anti Mannich adduct as 
opposed to the syn products favored in the aldol reactions described above.  
 
Scheme 1.22 Mannich reactions of propionamide 14 with non-enolizable imines. R = aryl, heteroaryl, t-Bu. 
Under the above conditions, Mannich reactions conducted with enolizable imines simply 
returned unreacted starting material and polymerized imine by-products, indicating that the 
enolate was deprotonating the imine partner instead of acting as a nucleophile. Transmetallation 
of the lithium enolate to the zinc enolate with ZnCl2 prior to addition of the imine was found to 
circumvent this problem, and the reaction was then compatible with alkyl imine substrates 
(Scheme 1.23).31 
 
Scheme 1.23 Mannich reactions of propionamide 15 with enolizable imines. R = methyl, ethyl, i-propyl. 
The hydrolysis-esterification of the protected β-amino amides was shown to be a useful 
transformation, though isolation of the intermediate β-amino acids was not reported (Scheme 
1.24). β-lactam synthesis from the isolated esters was also demonstrated.32 
                                                
31 Vicario, J. L.; Badía, D.; Carrillo. L. Org. Lett. 2001, 3, 773–776. 
32 Iza, A.; Vicario, J. L.; Carrillo, L.; Badía, D. Synthesis 2006, 23, 4065–4074. 
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Scheme 1.24 Transformations of β-amino pseudoephedrine amides. R = alkyl, aryl. 
Pseudoephenamine-Directed Synthesis of α-, β-, and γ-Amino Acids 
Concurrent with their work on the alkylation of pseudoephedrine amides to form tertiary 
carbon stereocenters, the Myers group also investigated the use of pseudoephedrine glycinamide 
(17) as a precursor for the synthesis of α-amino acids. Prepared either by acylation of 
pseudoephenamine with the mixed anhydride prepared from N-Boc glycine and pivaloyl chloride 
(followed by deprotection of the amino group after acylation) or by direct reaction of the lithium 
amide of pseudoephedrine with glycine methyl ester,33 glycinamide 17 was found to undergo 
highly diastereoselective alkylation reactions with a wide variety of electrophiles to prepare both 
natural and non-natural amino acids (Scheme 1.25).34,35 Using dihalide electrophiles, it was also 
possible to prepare cyclic α-amino acid derivatives (Scheme 1.26). In addition, pseudoephedrine 
sarcosinamide (18) was shown to be a suitable substrate for the synthesis of N-methyl amino 
acids (Scheme 1.27), although N-methylethanolamine was required as an additive in this case to 
ensure high diastereoselectivity in the alkylations.  
                                                
33 Myers, A. G.; Yoon, T.; Gleason, J. L. Tetrahedron Lett. 1995, 36, 4555–4558. 
34 a) Myers, A. G.; Gleason, J. L.; Yoon, T. J. Am. Chem. Soc. 1995, 117, 8488–8489. b) Myers, A.G.; Gleason, J. 
L.; Yoon, T.; Kung, D. W. J. Am. Chem. Soc. 1997, 119, 656–673. 
35 The alkylation of N-Boc pseudoephedrine glycinamide was also reported. See reference 33b. 
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Scheme 1.25 Alkylation of pseudoephedrine glycinamide 17 to give α-amino acids. R = alkyl, allyl, aryl, heteroaryl. 
X = Cl, Br, I, OMs, OTf. 
 
Scheme 1.26 Preparation of a cyclic α-amino amide from pseudoephedrine glycinamide 17. 
 
Scheme 1.27 Representative alkylation of pseudoephedrine sarcosinamide 18.  
In reactions of both glycinamide 17 and sarcosinamide 18, the use of lithium chloride as a 
reaction additive was found to be essential to the attainment of both efficient and highly 
diastereoselective alkylations. It was also determined that the use of 1.95 equivalents of base was 
optimal to prevent deleterious side reactions resulting in the liberation of pseudoephedrine. This 
procedure was later adapted to allow the use of pseudoephedrine glycinamide hydrate (17·H2O) 
as the starting material, thereby eliminating the need to scrupulously dry the hygroscopic 
glycinamide 17.36 
                                                
36 Myers, A. G.; Schnider, P.; Kwon, S.; Kung, D. W. J. Org. Chem. 1999, 64, 3322–3327. 
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A number of procedures for hydrolysis of the above glycinamide alkylation products were 
developed, including basic hydrolysis with subsequent protection of the amino group and salt-
free hydrolysis in water.37 Representative examples of these procedures are presented in Scheme 
1.28. Additionally, the synthesis of N-Boc α-amino ketones by addition of organolithium or 
Grignard reagents was also reported (Scheme 1.29).38 Little to no epimerization of the α-tertiary 
stereocenter was observed in these reactions, and the chiral auxiliary was typically recovered in 
high yield.  
 
Scheme 1.28 Hydrolysis of α-amino pseudoephedrine amides. a) Hydrolysis under basic conditions followed by N-
Boc carbamate formation. b) Hydrolysis under salt-free conditions. 
 
Scheme 1.29 Synthesis of N-Boc α-amino ketones. 
Other methods for the synthesis of α-amino acids have been reported. Nájera et al. described 
the use of pseudoephedrine glycinamide dithioiminocarbonate (19, Scheme 1.30) as an 
                                                
37 Hydrolysis of N-Boc and N-Fmoc amides was also reported. See reference 25b. 
38 Myers, A. G.; Yoon, T. Tetrahedron Lett. 1995, 36, 9429–9432. 
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alternative substrate for alkylation reactions to obtain amino acid derivatives.39 The primary 
advantage of this platform is the use of milder bases (metal alkoxides) to generate the enolate of 
the glycinamide. Unfortunately, the yields of the alkylation products are notably lower than those 
obtained with the glycinamide 17 above, and the diastereoselectivities of the alkylations were 
slightly lower, though it should be noted that lithium chloride was not employed as an additive in 
these reactions. The α-amino amides obtained were hydrolyzed as described above to yield the 
corresponding amino acids.  
 
Scheme 1.30 Alkylation of dithioiminocarbonate 19. M = Li, Na, K. R1 = Et, t-Bu. R2 = methyl, ethyl, allyl, benzyl. 
X = Br, I. 
The Badía group has developed two methods for the synthesis of α-amino acids. In the first 
method, enolates derived from α-aryl pseudoephedrine amides were trapped diastereoselectively 
with di-tert-butyl azodicarboxylate (DTBAD) to give the bis-Boc hydrazine, which was 
deprotected with TFA and hydrogenated in the presence of Raney nickel to give the α-amino 
amide. 40  These amides were shown to hydrolyze under acidic conditions to give the 
corresponding amino acids (Scheme 1.31).41  
                                                
39 Guillena, G.; Nájera, C. Tetrahedron: Asymmetry 2001, 12, 181–183.  
40 Similar amination of N-methyl ephedrine ester enolates and oxazolidinone imide enolates with DTBAD has been 
reported: a) Gennari, C.; Colombo, L.; Bertolini, G. J. Am. Chem. Soc. 1986, 108, 6394–6395. b) Evans, D. A.; 
Britton, T. C.; Dorow, R. L.; Dellaria, J. F. J. Am. Chem. Soc. 1986, 108, 6395–6397. 
41 a) Anakabe, E.; Vicario, J. L.; Badía, D.; Carrillo, L.; Yoldi, V. Eur. J. Org. Chem. 2001, 4343–4352. b) Vicario, 
J. L.; Badía, D.; Carrillo, L.; Anakabe, E. Tetrahedron: Asymmetry 2002, 13, 745–751. 
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Scheme 1.31 Amination and hydrolysis of α-aryl pseudoephedrine amides.  
The second protocol employed the pseudoephedrine-derived cyclic aminal 20 as an 
electrophile in reactions with Grignard reagents.42 This method proceeded with notably lower 
yields and diastereoselectivities in comparison to the previously described methods. The amides 
obtained in these reactions were hydrolyzed as shown in Scheme 1.31 above, or they were 
treated with organolithium reagents to access the N-benzyl α-amino ketones, as shown in 
Scheme 1.32 below. 
 
Scheme 1.32 Synthesis of N-benzyl α-amino ketones via the electrophilic glycine aminal 20. 
Two methods for the synthesis of β-amino acids using pseudoephedrine as a chiral auxiliary 
have been reported. Lum and co-workers described the alkylation of pseudoephedrine β-
alaninamide 21.43 While the alkylation of this amide was successful, the diastereoselectivity of 
the alkylation was not reported due to difficulties in the determination of the dr of the alkylation 
products, and the selectivity must be inferred from the enantiomeric excesses of the amino acids 
isolated after hydrolysis in water (Scheme 1.33).  
                                                
42 Ruiz, N.; Vicario, J. L. Badía, D.; Carrillo, L.; Alonso, B. Org. Lett. 2008, 10, 2613–2616.  
43 Nagula, G.; Huber, V. J.; Lum, C.; Goodman, B. A. Org. Lett. 2000, 2, 3527–3529. 
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Scheme 1.33 Stereocontrolled synthesis of β-amino acids via alkylation of pseudoephedrine β-amino alaninamide 
(21). 
In addition to their study of pseudoephedrine amide Mannich reactions described above, the 
Badía group also reported the synthesis of β-amino acids through the aza-Michael addition of 
nitrogen nucleophiles to α,β-unsaturated pseudoephedrine amides.44 Unfortunately, the yields 
and diastereoselectivities observed with this methodology varied significantly with the 
substituent at the β-position of the amide (Scheme 1.34). The best result was obtained in the 
conjugate addition of Bn2NLi to pseudoephedrine crotonyl amide (R1 = CH3) in the absence of 
additives (85% yield, >99:1 dr), but the yields and selectivities for larger substituents at R1 were 
markedly lower. During the course of these investigations, it was found that protection of the 
hydroxyl group of the auxiliary as an alkyl or silyl ether led to a reversal of selectivity in the 
conjugate addition, with the products of these reactions favoring the opposite β-epimer than the 
one shown in Scheme 1.34. While interesting, the yields and selectivities obtained with these 
protected substrates were lower than those obtained with the unprotected amides (Scheme 1.35).  
 
Scheme 1.34 Aza-Michael addition of lithium amides to α,β-unsaturated pseudoephedrine amides. R1 = methyl, 
ethyl, n-propyl, i-propyl, t-butyl, phenyl. R2 = benzyl, methyl. Additive = none, TMEDA, TMEDA with CuI. 
                                                
44 a) Etxebarria, J.; Vicario, J. L.; Badía, D.; Carrillo, L. J. Org. Chem. 2004, 69, 2588–2590. b) Etxebarria, J.; 
Vicario, J. L.; Badía, D.; Carrillo, L.; Ruiz, N. J. Org. Chem. 2005, 70, 8790–8800. 
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Scheme 1.35 Representative aza-Michael addition of lithium dibenzylamide to TBS-protected pseudoephedrine 
crotonylamide. Note the reversal of diastereoselectivity in comparison to the Michael additions of Scheme 1.34. 
Despite the low selectivities of the aza-Michael additions, the diastereomers isolated from the 
reactions could be separated, and a number of protocols were developed to transform the 
Michael adducts to synthetically useful compounds. In contrast to the above report from Lum 
and co-workers, hydrolysis of these β-amino amides was unsuccessful under acidic or basic 
hydrolysis conditions, with the reactions suffering from low yields (15–35%).45 To avoid the 
issues associated with hydrolysis, conditions for the direct methanolysis of the amides were 
developed, and the methyl esters were isolated in variable yields with varying levels of 
enantioenrichment (Scheme 1.36). LAB reduction of the N-benzyl amides were complicated by 
the low enantiomeric excesses of the products. By switching protecting groups from N-benzyl to 
N-Cbz, the yield of the LAB reduction could be dramatically improved (90–99% yield for the 
reduction step, Scheme 1.36). Finally, the direct formation of ketones from the N-benzyl amides 
was troubled by unreactive starting material, a problem that was solved by switching protecting 
groups from N-benzyl to N-Boc. With these new substrates, the desired amino ketones were 
obtained in good to excellent yield with high levels of enantioenrichment (Scheme 1.36).  
                                                
45 It should be noted that Badía et al. only reported hydrolysis reactions with N-benzyl amides, whereas Lum and co-
workers hydrolyzed unprotected β-amino amides. 
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Scheme 1.36 Transformations of protected β-amino amides. a) Formation of methyl esters. b) LAB reduction of N-
Cbz β-amino amides. c) Ketone formation using N-Boc amino amides. R1 = methyl, ethyl, n-propyl, i-propyl, t-
butyl, phenyl. R2 = benzyl, methyl. R3 = methyl, ethyl, i-propyl, n-butyl, phenyl. 
Lastly, the Badía group also developed a method for the synthesis of γ-amino acids via the 
nucleophilic opening of chiral monosubstituted N-tosyl aziridines with pseudoephedrine 
propionamide enolates. These reactions closely mirrored the epoxide opening reactions described 
by Myers et al., with the aziridines approaching the same enolate π-face as epoxides. 
Additionally, reactions with aziridines displayed the same matched and mismatched pairs as 
epoxide opening reactions. When these reactions were conducted with the matched pairs, the 
alkylations proceeded in excellent yields with high diastereoselectivities (Scheme 1.37). Lithium 
chloride was required for these reactions, as the absence of this additive resulted in complete 
recovery of starting material.  
OH
N
CH3
CH3 O NBnR2
R1
NaOCH3,
dimethyl carbonate
CH2Cl2, 23 ºC
24–73% 
60–99% ee
O NBnR2
R1CH3O
OH
N
CH3
CH3 O NBn2
R1
1. H2, Pd/C, EtOH
2. Cbz2O, NaOH
3. LAB, THF, 0 ºC
NHCbz
R1HO
43–59% (3 steps)
90–99% ee
OH
N
CH3
CH3 O NBn2
R1
1. H2, Pd/C, EtOH
2. Boc2O, Et3N, THF
3. R3Li, THF, 0 ºC
NHBoc
R1R3
57–98% (3 steps)
99% ee
O
a)
b)
c)
 28 
 
Scheme 1.37 Stereocontrolled opening of N-tosyl aziridines with pseudoephedrine propionamide. R = methyl, i-
propyl, benzyl, phenyl.  
The resulting γ-amino amides were efficiently transformed to γ-amino acids, γ-amino esters, 
and chiral pyrrolidinones in sequence (Scheme 1.37). These reactions were all high yielding and 
did not result in any loss of enantioenrichment.  
 
Scheme 1.38 Transformations of γ-amino amides. R = methyl, i-propyl, benzyl, phenyl. 
Pseudoephedrine-Directed Asymmetric Claisen Rearrangement 
Maulide et al. have studied the Claisen rearrangement of activated allyl ethers, most recently 
using pseudoephedrine to direct an asymmetric variant of this important sigmatropic 
rearrangement.46 Using O-allyl pseudoephedrine amides, a Claisen rearrangement was initiated 
                                                
46 Peng, B.; Geerdink, D.; Maulide, N. J. Am. Chem. Soc. 2013, 135, 14968–14971. 
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by treatment of the amides with triflic anhydride in the presence of 2-fluoropyridine. It is 
noteworthy that the diastereoselectivity of the rearrangement was opposite to that obtained in 
Myers’ asymmetric allylation of pseudoephedrine amide enolates. The rearrangement products 
were not isolated, and were instead subjected to either acidic hydrolysis or reduction conditions 
to obtain carboxylic acids and aldehydes, respectively (Scheme 1.38). These sigmatropic 
rearrangement conditions were tolerant of functional groups that would be problematic in 
pseudoephedrine amide enolate allylation reactions, including nitriles, esters, ketones, and 
terminal alkynes. The rearrangement also worked with substituted olefins to give α- and β-
branched aldehydes with moderate diastereoselectivity and high enantiomeric excess (Scheme 
1.39).  
 
Scheme 1.39 Stereocontrolled Claisen rearrangement of O-allyl pseudoephedrine amides followed by acidic 
hydrolysis or reduction. R = alkyl (including nitrile, ester, ketone, alkyne, and alkene functional groups), alkyl 
ethers, benzyl. 
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Scheme 1.40 Diastereoselective Claisen rearrangement of substituted O-(Z)-crotyl pseudoephedrine amides 
followed by reduction to the corresponding aldehydes. R1 = alkyl. R2 = alkyl.  
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Chapter 2 
On the Development of Pseudoephenamine 
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Introduction 
Given the broad utility of pseudoephedrine summarized in Chapter 1, it would be beneficial 
to the field of organic chemistry to develop an analogue of pseudoephedrine that exhibits or 
expands its capabilities as a chiral auxiliary while avoiding its regulatory issues. To that end, 
Marvin Morales, a graduate student in the Myers group, prepared a number of pseudoephedrine 
analogues focused primarily on substitutions of the phenyl ring of pseudoephedrine (analogues 
22–24), though he also prepared an analogue replacing the C-methyl group with a phenyl group 
(pseudoephenamine47 (25), Figure 2.1).48 
 
Figure 2.1 Potential pseudoephedrine analogues. 
                                                
47 The name pseudoephenamine is derived from the term ephenamine, which was used in the Federal Registrar (June 
7, 1951) to describe (1R,2S)-2-methylamino-1,2-diphenylethanol in a salt form of penicillin G. 
48 Morales, M. R. (2012) Pseudoephenamine: A Practical Chiral Auxiliary for Asymmetric Synthesis. Ph.D. Thesis, 
Harvard University. 
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In alkylation reactions using the propionamide derivatives of these pseudoephedrine 
analogues, it was found that the pseudoephenamine amide enolate was alkylated with notably 
higher diastereoselectivity compared to the other pseudoephedrine analogues (Scheme 2.1).  
 
Scheme 2.1 Alkylation of pseudoephedrine propionamide analogues with ethyl iodide.  
Based on these results, pseudoephenamine was selected as promising replacement for 
pseudoephedrine, and, as the following sections will illustrate, pseudoephenamine has been 
found to hold several advantages over pseudoephedrine. In addition to the lack of government 
regulation of the auxiliary and any of its precursors or derivatives, asymmetric alkylation 
reactions employing pseudoephenamine proceed with equal or greater diastereoselectivity in 
comparison to the corresponding alkylation reactions of pseudoephedrine amide enolates, with 
notable enhancement in the diastereoselectivities of alkylation reactions forming quaternary 
carbon stereocenters. More practically, pseudoephenamine amides are typically free-flowing 
crystalline solids (making them easy to manipulate), and the 1H NMR spectra of these amides 
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exhibit sharp, well-defined peaks, whereas the rotational isomerism present in pseudoephedrine 
amides leads to broad peaks that make spectra interpretation and assignment more difficult.  
First-Generation Synthesis of Pseudoephenamine 
Due to pseudoephenamine’s present lack of commercial availability, it was necessary to 
develop a synthesis of both enantiomers of the auxiliary. 49  The most direct precursor to 
pseudoephenamine (alternatively, (+)-(1R,2R)-2-methylamino-1,2-diphenylethanol or (–)-
(1S,2S)-2-methylamino-1,2-diphenylethanol) is the desmethyl amino alcohol of proper 
stereochemistry (i.e. (+)-(1R,2R)-1,2-diphenyl-2-aminoethanol [(+)-26] or (–)-(1S,2S)-1,2-
diphenyl-2-aminoethanol [(–)-26], respectively, Scheme 2.2). Unfortunately, the cost of these 
amino alcohols is prohibitively high for large-scale production of pseudoephenamine, though the 
cost of the ephenamine diastereomers of the amino alcohol (i.e. (+)-(1S,2R)-1,2-diphenyl-2-
aminoethanol [(+)-27]  or (–)-(1R,2S)-1,2-diphenyl-2-aminoethanol [(–)-27], respectively) are 
more reasonable.50 
 
 
                                                
49 For previous syntheses of pseudoephenamine, see: a) Yamashita, J.; Kawahara, H.; Ohashi, S.; Honda, Y.; 
Kenmotsu, T.; Hashimoto, H. Tech. Rep. Tohoku University 1983, 48, 211–219. b) Meyers, A.I.; Marra, J.M. 
Tetrahedron Lett. 1985, 26, 5863–5866. c) Lou, R.; Mi, A.; Jiang, Y.; Qin, Y.; Li, Z.; Fu, F.; Chan, A.S.C. 
Tetrahedron 2000, 56, 5857–5863. 
50 Currently, (–)-(1S,2S)-1,2-diphenyl-2-aminoethanol is available from Sigma-Aldrich, LLC at a cost of $112 for 
500 mg, and (–)-(1R,2S)-1,2-diphenyl-2-aminoethanol is available from Ace Synthesis, LLC at a cost of $550 for 
100 g. 
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Scheme 2.2 Retrosynthesis of (–)-pseudoephenamine. 
Fortunately, robust chemistry for the conversion of (+)- or (–)-27 to (+)- or (–)-26, 
respectively, was developed by Max Tishler and coworkers at Merck in the early 1950s,51 and it 
was this chemistry that formed the foundation of the first-generation synthesis of 
pseudoephenamine, which is outlined in Scheme 2.3.52,53,54 
                                                
51 Weijlard, J.; Pfister III, K.; Swanezy, E. F.; Robinson, C. A.; Tishler, M. J. Am. Chem. Soc. 1951, 73, 1216–1218. 
52 For the first synthesis of (1R,2R)- and (1S,2S)-1,2-diphenyl-2-aminoethanol, see: a) Erlenmeyer, E. Annalen. 
1899, 307, 113–137. b) Erlenmeyer, E. Chem. Ber. 1899, 32, 2377–2378. c) Erlenmeyer, E.; Arnold, A. Justus 
Liebigs Ann. Chem. 1904, 337, 307–328. 
53 For the use of (1R,2S)- and (1S,2R)-1,2-diphenyl-2-aminoethanol in chiral auxiliaries, see: a) Sinclair, P. J.; Zhai, 
D.; Reibenspies, J.; Williams, R. M. J. Am. Chem. Soc. 1986, 108, 1103–1104. b) Williams, R. M.; Sinclair, P. J.; 
Zhai, D.; Chen, D. J. Am. Chem. Soc. 1988, 110, 1547–1557. c) Williams, R. M.; Fegley, G. J.; J. Am. Chem. Soc. 
1991, 113, 8796–8806. d) Williams, R. M.; Im, M. J. Am. Chem. Soc. 1991, 113, 9276–9286. e) Williams, R. M.; 
Zhai, W.; Aldous, D. J.; Aldous, S. C. J. Org. Chem. 1992, 57, 6527–6532.  
54 For selected other uses of 1,2-diphenyl-2-aminoethanol in asymmetric synthesis, see: a) Hashimoto, Y.; Takaoki, 
K.; Sudo, A.; Ogasawara, T.; Saigo, K. Chem. Lett. 1995, 235–236. b) Hirayama, L. C.; Gamsey, S.; Knueppel, D.; 
Steiner, D.; DeLaTorre, K.; Singaram, B. Tetrahedron Lett. 2005, 46, 2315–2318. c) Clayden, J.; Parris, S.; Cabedo, 
N.; Payne, A. H.; Angew. Chem. Int. Ed. 2008, 47, 5060–5062. d) Mahadik, G. S.; Knott, S. A.; Szczepura, L. F.; 
Peters, S. J.; Standard, J. M.; Hitchcock, S. R.; J. Org. Chem. 2009, 74, 8164–8173. e) Seashore-Ludlow, B.; Villo, 
P.; Häcker, C.; Somfai, P. Org. Lett. 2010, 12, 5274–5277. 
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Scheme 2.3 First-generation synthesis of (–)-pseudoephenamine. 
As reported by Tishler et al., formylation of (–)-27 in warm, neat formamide produces the N-
formyl adduct (–)-28, though it was necessary in the present work to include ammonium formate 
(0.2 equiv) in the reaction mixture to ensure maximum yield of (–)-28 with minimal by-products. 
Activation of the benzylic alcohol of formamide (–)-28 with thionyl chloride promoted invertive 
displacement of the secondary hydroxyl group by the N-formyl group, and the resulting 
oxazoline was hydrolyzed in refluxing water to give amino alcohol (–)-26 as a single 
diastereomer after recrystallization from ethanol. It should be noted that this recrystallization was 
the only purification necessary in this synthesis. Formylation of (–)-26 with acetic formic 
anhydride followed by reduction of the resulting formamide with lithium aluminum hydride 
(LAH) gave pseudoephenamine in 87% yield over four steps.55 Using this process, (+)- and (–)-
pseudoephenamine were routinely synthesized on 20–40 g scale, and the final auxiliary could be 
recrystallized from hot ethanol to produce large, orthorhombic crystals. These crystals were 
                                                
55 Effenberger, F.; Gutterer, B.; Jäger, J. Tetrahedron: Asymmetry 1997, 8, 459–467.  
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suitable for X-ray crystallographic analysis, and, as shown in Figure 2.2, pseudoephenamine was 
found to adopt a remarkably similar conformation to pseudoephedrine in the solid state.  
 
 
(–)-pseudoephenamine     (+)pseudoephedrine 
Figure 2.2 Comparison of the X-ray crystal structures of (–)-pseudoephenamine (left) and (+)-pseudoephedrine 
(right).56 
Synthesis of Pseudoephenamine Amides 
Pseudoephenamine amides were conveniently prepared by coupling of the auxiliary with 
carboxylic acids or by acylation with the appropriate carboxylic acid chloride or anhydride, and 
the amides synthesized as part of this work are presented in Scheme 2.4. All amides save for 
acrylamides 34 and 35 were crystalline solids that were typically purified by recrystallization 
(see Experimental Information for details).  
                                                
56  a) The pseudoephedrine crystal structure was obtained from the Cambridge Crystallographic Database 
(PSEPED01). Mathew, M.; Palenik, G. J. Acta Crystallogr., Sect. B. 1977, 33, 1016–1022. b) The hydrogen atoms 
of the benzene ring of pseudoephedrine were regenerated at idealized positions using DS Visualizer. Allen, F. H. 
Acta Crystallogr., Sect. B. 2002, 58, 380–388. 
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Scheme 2.4 Synthesis of pseudoephenamine amides. X = OH, Cl, RCO2. a Prepared from the corresponding 
carboxylic acid anhydride. b Prepared from the corresponding carboxylic acid chloride. c Prepared from the 
corresponding carboxylic acid. 
Stereocontrolled Alkylation of Pseudoephenamine Amides 
Enolization and alkylation of pseudoephenamine amides was found to work very well under 
the conditions that were previously developed for the enolization and alkylation of 
pseudoephedrine amides. Generally, pseudoephenamine amide enolates were generated with 
lithium diisopropylamide (LDA, 2.2 equiv) in tetrahydrofuran (THF) at –78 ºC in the presence of 
lithium chloride (6 equiv). However, pyridine was required as a co-solvent (1:1 THF:pyridine) 
when using pseudoephenamine propionamide (29) due to the low solubility of this amide in THF 
alone. In any case, addition of the desired alkyl halide (1.5–4.0 equiv) to the enolate solution at  
–78 ºC or 0 ºC led to the formation of alkylated products in 84–99% yield (Scheme 2.5). The 
crude amides were of high diastereomeric purity (≥94:6 dr, as measured by HPLC analysis of the 
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crude product or 1H NMR analysis of the oxazolinium triflate derivatives15), though the products 
were often further enriched upon purification by recrystallization or column chromatography 
(≥98:2 dr). The yields and diastereoselectivities observed in these alkylations were comparable 
to the corresponding alkylation reactions employing pseudoephedrine, and the majority of the 
alkylation products were solids. 
 
Scheme 2.5 Alkylation of pseudoephenamine amide enolates. X = Br, I. a Pyridine was required as a co-solvent with 
THF (1:1).  
As demonstrated by the reactions illustrated above, alkylation of pseudoephenamine amide 
enolates proceeds with the same diastereofacial selectivity observed in the alkylation of 
pseudoephedrine amide enolates (Figure 2.3a). Thus, when drawn in an extended zig-zag 
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conformation, the proximal phenyl ring of the auxiliary and the newly introduced alkyl group 
exhibit a 1,4-syn relationship (Figure 2.3b). 
 
Figure 2.3 Guides for the observed diastereoselectivity in pseudoephenamine amide enolate alkylations. a) 
Stereochemical model for the selectivity of amide deprotonation and alkylation using alkyl halides as electrophiles. 
b) Mnemonic to predict the stereochemical outcome of pseudoephenamine-directed alkylation reactions.  
Transformations of Pseudoephenamine Amides 
The utility of pseudoephedrine alkylation chemistry is due in large part to the fact that 
pseudoephedrine amides are easily converted to enantioenriched carboxylic acids, aldehydes, 
ketones, and primary alcohols. Fortunately, pseudoephenamine amides exhibit largely the same 
reactivity under identical conditions. As summarized in Schemes 2.6 and 2.7, pseudoephedrine 
amide alkylation products were easily converted to carboxylic acids under acid or basic 
conditions, to ketones upon treatment with an appropriate organolithium reagent, and to primary 
alcohols when reduced by LAB. The products of these reactions were isolated in high yield with 
little to no loss of enantioenrichment.  
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Scheme 2.6 Hydrolysis of pseudoephenamine amides under acidic and basic conditions. 
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Scheme 2.7 Synthesis of ketones and primary alcohols from the corresponding pseudoephenamine amides. 
One reaction of pseudoephedrine amides that does not translate to pseudoephenamine amides 
is the lithium triethoxyaluminum hydride reduction to the corresponding aldehyde. With 
pseudoephedrine amides, this reaction typically provides the desired aldehydes in 70–80% yield 
and 90–98% ee. However, reduction of similar pseudoephenamine amides is hampered by low 
yields (due to the stability of the isolable aminal intermediate produced during the course of the 
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reaction) and loss of enantioenrichment, as shown in Scheme 2.8. Efforts to improve this 
reaction have been unsuccessful.  
 
Scheme 2.8 Representative pseudoephenamine amide reduction to the corresponding aldehyde. The reaction is 
complicated by loss of enantioenrichment in the aldehyde and diminished yield due to the stability of the 
intermediate cyclic aminal. 
Stereocontrolled Synthesis of Quaternary Carbon Stereocenters 
In the synthesis of quaternary carbon stereocenters, pseudoephenamine amide enolates 
undergo alkylation with significantly enhanced diastereoselectivity compared to the 
corresponding reactions using pseudoephedrine. Two methods were employed for the synthesis 
of quaternary centers, utilizing protocols that closely mirrored those used with pseudoephedrine. 
In the first method, sequential enolization-alkylation of matched α-methyl pseudoephenamine 
amides provided α,α-disubstituted amides in high yield and high diastereoselectivity (Scheme 
2.9). The lone exception to this trend was the alkylation of amide 39 with ethyl iodide, which 
gave in the desired product in 9.9:1 dr.57 Note that this protocol used the electrophile as the 
limiting reagent, as the yield of the reactions was lower when conducted with limiting 
nucleophile. 
                                                
57 The diastereomers of this product were easily separated using radial chromatography, which was enabled by the 
high UV activity of the chiral auxiliary. 
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Scheme 2.9 Enolization-alkylation of α-methyl pseudoephenamine amides to form quaternary carbon stereocenters. 
X = Br, I. a Diastereomeric ratios in parentheses correspond to the analogous transformations with pseudoephedrine. 
The second method for the formation of quaternary centers involved the conjugate addition 
of organolithium reagents to α-alkyl pseudoephenamine acrylamides. As with the preceding 
reactions involving pseudoephedrine, this protocol was successful even when using t-BuLi as the 
nucleophile in the reaction, and the diastereoselectivities observed in these reactions were 
universally high (Scheme 2.10). 
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Scheme 2.10 Conjugate addition-alkylation of α-alkyl pseudoephenamine acrylamides. X = Br, I. a Diastereomeric 
ratios in parentheses correspond to the analogous transformations with pseudoephedrine. 
A stereochemical model for the formation of quaternary carbon stereocenters by either of the 
above methods is presented in Figure 2.4. To summarize, deprotonation of α-methyl 
pseudoephenamine amides occurs from the bottom face of the molecule, and the electrophile 
subsequently approaches the enolate from the same face. Similarly, the conjugate addition 
protocol produces a (Z)-enolate that is alkylated from the bottom face of the substrate. 
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Figure 2.4 Model for the observed diastereoselectivity in alkylation reactions forming quaternary carbon 
stereocenters. a) Enolization-alkylation of α-methyl pseudoephenamine amides. b) Conjugate addition-alkylation of 
α-alkyl pseudoephenamine amides.  
Both protocols for quaternary center formation provided crude material that was 
exceptionally clean, and the products appeared to exist in a single rotomeric form by 1H NMR. 
These two factors allowed for the assessment of the diastereoselectivity of the alkylation 
reactions by examination of the 1H NMR spectra of the crude products, though the selectivity 
could also be confirmed by formation of the oxazolinium triflate derivatives.16 Additionally, the 
α,α-disubstituted amide products isolated in these reactions were solids, whereas the 
corresponding pseudoephedrine amide products were typically oils. Combined with the high 
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diastereoselectivity of the alkylation reactions, these factors make pseudoephenamine a superior 
chiral auxiliary for the stereocontrolled formation of quaternary carbon stereocenters.58 
 
                                                
58 For a compelling illustration of the superior utility of pseudoephenamine versus pseudoephedrine in the alkylative 
construction of quaternary centers within a complex series of alkaloids, see: Medley, J. W.; Movassaghi, M. Angew. 
Chem. Int. Ed. 2012, 51, 4572–4576. 
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Experimental Information 
General experimental procedures: All reactions were performed in flame-dried glassware 
fitted with rubber septa under a positive pressure of argon, unless otherwise noted. Air- and 
moisture-sensitive liquids were transferred via syringe or stainless steel cannula. Organic 
solutions were concentrated by rotary evaporation below 35 °C at 40 mmHg. Analytical thin-
layer chromatography (TLC) was performed using glass plates pre-coated with silica gel (0.25-
mm, 60-Å pore size, 230−400 mesh, Merck KGA) impregnated with a fluorescent indicator (254 
nm). TLC plates were visualized by exposure to ultraviolet light (UV), then were stained by 
submersion in aqueous potassium permanganate solution (KMnO4), followed by brief heating on 
a hot plate (215 °C, 10−15 s). Flash column chromatography was performed as described by Still 
et al.,59 employing silica gel (60 Å, standard grade) purchased from Dynamic Adsorbents. 
 
Materials: Commercial solvents and reagents were used as received with the following 
exceptions. N,N-diisopropylamine was distilled from calcium hydride under an atmosphere of 
dinitrogen at 760 mmHg. 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone (DMPU) was 
distilled from calcium hydride under reduced pressure (0.1 mmHg) and stored under argon. 
Dichloromethane, ethyl ether, and tetrahydrofuran were purified by the method of Pangborn et 
al.60 Lithium chloride was dried at 150 °C under vacuum (0.1 mmHg) for 12 h and stored in a 
drying oven at 150 °C (760 mmHg); the hot dried solid was flame dried under vacuum (0.1 
mmHg) for 2−3 min immediately prior to use. Benzyl bromide, allyl bromide, iodobutane, 
iodoethane, and iodomethane were filtered through a column of oven-dried basic alumina, neat, 
                                                
59 Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923–2925. 
60 Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F.J. Organometallics. 1996, 15, 1518–
1520. 
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immediately prior to use. The molarity of solutions of n-butyllithium, t-butyllithium, 
methyllithium, and phenyllithium was determined by titration against diphenylacetic acid as an 
indicator (average of three determinations).61 
 
Instrumentation: Proton nuclear magnetic resonance spectra (1H NMR) spectra and carbon 
nuclear magnetic resonance (13C NMR) spectra were recorded on Varian INOVA 500 (500 
MHz/125 MHz) or Varian INOVA 600 (600 MHz/150 MHz) NMR spectrometers at 23 °C. 
Proton chemical shifts are expressed in parts per million (ppm, δ scale) and are referenced to 
residual protium in the NMR solvent (CHC13: δ 7.26). Carbon chemical shifts are expressed in 
parts per million (ppm, δ scale) and are referenced to the carbon resonance of the NMR solvent 
(CDC13: δ 77.0). Data are represented as follows: chemical shift, multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, dd = doublet of doublets, dt = doublet of triplets, td = triplet of 
doublets, dq= doublet of quartets, dquint = doublet of quintets, sxt = sextet, m = multiplet, br = 
broad, app = apparent), integration, and coupling constant (J) in Hertz (Hz). Infrared (IR) spectra 
were obtained using a Shimadzu 8400S FT-IR spectrophotometer referenced to a polystyrene 
standard. Data are represented as follows: frequency of absorption (cm−1), and intensity of 
absorption (s = strong, m = medium, br = broad). Gas chromatogram retention times were 
acquired using a Shimadzu GC-2014 instrument equipped with a Restek Rt-βDEXsm chiral 
column (30m, 0.25 mm ID, 0.25 µm df). HPLC retention times were acquired using a Beckman 
System Gold instrument equipped with a Chiracel OD-H column (5 mm particle size, 4.6 mm x 
250 mm). Optical rotations were determined using a JASCO P-2000 digital polarimeter equipped 
with a sodium lamp source (589 nm). Reported readings are the average of three measurements 
                                                
61 Kofron, W. G.; Baclawski, L. M. J. Org. Chem. 1976, 41, 1879–1880. 
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for each sample. Melting points were determined using a Thomas Scientific capillary melting 
point apparatus. High-resolution mass spectra were obtained at the Harvard University Mass 
Spectrometry Facility. X-ray crystallographic analyses were performed at the Harvard University 
X-Ray Crystallographic Laboratory by Dr. Shao-Liang Zheng. 
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Effect of formamide source on the formylation of (–)-(1R,2S)-1,2-diphenylaminoethanol: 
 
N-[(1S,2R)-2-hydroxy-1,2-diphenylethyl]formamide ((–)-28) 
A 1-L round-bottom flask was charged with (–)-(1R,2S)-2-amino-1,2-diphenylethanol (43.4 g, 
203 mmol, 1 equiv), ammonium formate (2.57 g, 40.7 mmol, 0.20 equiv), and formamide (162 
mL, 4.07 mol, 20.0 equiv) at 23 ºC. The reaction mixture was warmed to 150 ºC, affording a 
clear solution. After 2 h, heating was discontinued and the product solution was allowed to cool 
to 23 ºC, whereupon solidification occurred. The white solid product was suspended in water 
(200 mL) and the solids were collected by vacuum filtration, rinsing with two 100-mL portions 
of water. The washed solid was suction-dried for 1 h then was transferred to an empty 2-L round-
bottom flask and dried under reduced pressure affording formamide (–)-28 as a white solid (47.5 
g, 97%, mp = 198–199 ºC).  TLC (80% ethyl acetate–hexanes): Rf = 0.32 (UV, KMnO4). 1H 
NMR (4.5:1 rotamer ratio, asterisk denotes minor rotamer peaks, 500 MHz, DMSO-d6), δ: 8.54 
(d, 1H, J = 9.5 Hz), 8.15* (t, 1H, 10.8 Hz), 7.89 (s, 1H), 7.73* (d, 1H, J = 11.0 Hz), 7.36-7.19 
(m, 10H), 5.52 (d, 1H, J = 4.5 Hz), 5.47* (d, 1H, J = 4.5 Hz), 5.02 (dd, 1H, J = 9.0, 6.5 Hz), 4.77 
(app t, 1H, J = 5.5 Hz), 4.71* (dd, 1H, J = 8.0, 4.5 Hz), 4.55* (app t, 1H, J = 9.0 Hz). 13C NMR 
(6:1 rotamer ratio, asterisk denotes minor rotamer peaks, 125 MHz, DMSO-d6), δ: 164.1*, 160.0, 
142.8*, 142.7, 140.9*, 140.0, 128.2, 127.9*, 127.8*, 127.7*, 127.6, 127.5, 127.2*, 127.0, 126.9*, 
OH
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H NH2
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H
H
O
(–)-27 (–)-28
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126.8, 126.7, 75.5*, 74.9, 61.6*, 56.9. FTIR (neat), cm–1: 3132 (br), 3064, 3030, 1671 (m), 1453 
(m).  HRMS (ESI): Calcd for (C15H15NO2 + H)+: 242.1176. Found: 242.1177. 
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N-[(1S,2R)-2-hydroxy-1,2-diphenylethyl]formamide ((–)-28) 
A 1-L round-bottom flask was charged with (–)-(1R,2S)-2-amino-1,2-diphenylethanol (40.2 g, 
189 mmol, 1 equiv) and formamide (150 mL, 3.77 mol, 20.0 equiv) from a fresh bottle (shown 
by 13C NMR analysis to be pure) at 23 ºC. The reaction mixture was warmed to 150 ºC, resulting 
in a clear solution that gradually became yellow. After 2.5 h, heating was discontinued and the 
product solution was allowed to cool to 23 ºC, whereupon solidification occurred. The yellow 
solid product was suspended in water (200 mL) and the solids were collected by vacuum 
filtration, rinsing with two 100-mL portions of water. The washed solid was suction-dried for 1 h 
then was transferred to a flask and dried under reduced pressure.  The solid was recrystallized 
from hot ethanol (90 ºC, 700 mL) to afford formamide (–)-28 as a white solid (33.6 g, 74%).  
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N-[(1S,2R)-2-hydroxy-1,2-diphenylethyl]formamide ((–)-28) 
A 1-L round-bottom flask was charged with (–)-(1R,2S)-2-amino-1,2-diphenylethanol (40.7 g, 
191 mmol, 1 equiv) and formamide (152 mL, 3.82 mol, 20.0 equiv) from an old bottle (EM 
Science, shown by 13C NMR analysis to contain a ~5% formate impurity) at 23 ºC. The reaction 
mixture was warmed to 150 ºC, producing a clear solution. After 3 h, heating was discontinued 
and the product solution was allowed to cool to 23 ºC, whereupon solidification occurred. The 
white solid product was suspended in water (200 mL) and the solids were collected by vacuum 
filtration, rinsing with two 100-mL portions of water. The washed solid was suction-dried for 1 h 
then was transferred to a flask and dried under reduced pressure affording formamide (–)-28 as a 
white solid (44.6 g, 98%). 
OH
NH2
H NH2
O
150 ºC
98%
OH
N
H
H
O
(–)-27 (–)-28
 55 
Synthesis of (1S,2S)-pseudoephenamine: 
 
(–)-(1S,2S)-2-amino-1,2-diphenylethanol ((–)-26) 
A 2-L round-bottom flask was charged with formamide (–)-28 (44.6 g, 185 mmol, 1 equiv) then 
was cooled to 0 ºC.  Thionyl chloride (94.0 mL, 1.30 mol, 7.00 equiv) was added and the 
resulting clear, yellow solution was stirred for 10 min at 0 ºC and for 30 min at 23 ºC.  Ice (1070 
g) was added slowly (Caution: HCl gas evolution!). A white solid precipitated.  After fitting with 
a reflux condenser the flask was warmed to 120 ºC. The resulting clear solution was stirred for 2 
h at 120 ºC.  The reaction flask was allowed to cool to 23 ºC, during which time the solution 
became opaque. Once cool, 5 N aqueous sodium hydroxide solution (1 L) was added to the 
solution, leading to the precipitation of an off-white solid. The suspension was stirred for 30 min 
at 23 ºC.  The solids were collected by vacuum filtration, rinsing with two 200-mL portions of 
water. The washed solid was suction-dried for 1 h then was transferred to a 500-mL flask.  The 
solid was dried under reduced pressure. The dried pale-green solid was recrystallized from hot 
absolute ethanol (140 mL, 80 ºC). A second batch of crystals was collected to give optically pure 
amino alcohol (–)-26 was a white, crystalline solid (36.1 g, 92%, mp = 106–108 ºC, ! !"!  = –
121.69, c 1.12, EtOH). TLC (80% ethyl acetate–hexanes): Rf = 0.13, streak (UV, KMnO4). 1H 
NMR (600 MHz, CDCl3), δ: 7.12–7.31 (m, 10H), 4.65 (d, 1H, J = 6.4 Hz), 3.99 (d, 1H, J = 6.4 
Hz). 13C NMR (125 MHz, CDCl3), δ: 142.4, 141.7, 128.3, 128.0, 127.3, 127.3, 127.0, 126.5, 
OH
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78.0, 82.5.  FTIR (neat), cm–1: 2928 (m), 2868, 1603, 1493, 1452 (m).  HRMS (ESI): Calcd for 
(C14H15NO + H)+: 214.1226. Found: 214.1221. 
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N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]formamide ((–)-94) 
A mixture of acetic anhydride (28.9 mL, 306 mmol, 2.00 equiv) and formic acid (12.9 mL, 337 
mmol, 2.10 equiv) was heated for 1 h at 60 ºC then was cooled to 23 ºC.  The cooled solution 
was added by cannula to a solid mixture of (–)-(1S,2S)-2-amino-1,2-diphenylethanol (32.6 g, 153 
mmol, 1 equiv) in a 1:1 mixture of ether (392 mL) and tetrahydrofuran (392 mL) at –40 ºC.  The 
resulting clear, colorless solution was stirred for 45 min at –40 ºC and for 1.75 h at 23 ºC.  The 
reaction mixture was poured into  2 N aqueous sodium hydroxide solution (750 mL), and the 
layers were separated.  The organic layer was washed with 2 N aqueous sodium hydroxide 
solution (750 mL) and saturated aqueous sodium chloride solution (200 mL).  The washed 
organic layer was dried over magnesium sulfate.  The dried solution was filtered, and the filtrate 
was concentrated to afford formamide (–)-94 as a white solid (36.5 g, 99%, mp = 104-105 ºC).  
TLC (80% ethyl acetate–hexanes): Rf = 0.36 (UV, KMnO4). 1H NMR (9:1 rotamer ratio, asterisk 
denotes minor rotamer peaks, 500 MHz, DMSO-d6), δ: 8.58 (d, 1H, J = 9.3 Hz), 8.17* (t, 1H, J = 
10.7 Hz), 7.97 (s, 1H), 7.86* (d, 1H, J = 11.2 Hz), 7.35 (d, 2H, J = 7.8 Hz), 7.33–7.29 (m, 2H), 
7.27 (td, 4H, J = 7.3, 3.4 Hz), 7.23–7.12 (m, 3H), 5.62 (m, 1H), 5.03 (dd, 1H, J = 9.3, 3.9 Hz), 
4.81 (t, 1H, J = 4.2 Hz), 4.72* (t, 1H, J = 5.6 Hz), 4.58* (dd, 1H, J = 9.8, 6.4 Hz). 13C NMR (8:1 
rotamer ratio, asterisk denotes minor rotamer peaks, 125 MHz, DMSO-d6), δ: 164.6*, 160.7, 
143.1, 142.8*, 141.4, 140.6*, 127.9*, 127.8, 127.7*, 127.6, 127.5*, 127.3, 126.9, 126.8*, 126.7, 
OH
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126.5, 75.7*, 75.1, 62.5*, 57.4.  FTIR (neat), cm–1: 3300 (br), 3036, 2876, 1661 (s), 1496 (m).  
HRMS (ESI): Calcd for (C15H15NO2 + Na)+: 264.0995. Found: 264.1002. 
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(–)-(1S,2S)-pseudoephenamine ((–)-25) 
Solid lithium aluminum hydride (11.6 g, 302 mmol, 2.00 equiv) was added carefully in three 
portions (2.90 g, 2.90 g, 5.90 g; Caution: gas evolution!) to an ice-cooled solution of formamide 
(–)-94 (36.4 g, 151 mmol, 1 equiv) in a 1:1 mixture of ether (472 mL) and tetrahydrofuran (472 
mL).  The resulting grey slurry was stirred for 10 min at 0 ºC and for 22 h at 23 ºC.  The reaction 
mixture was cooled to 0 ºC, and excess hydride was quenched by sequential, dropwise addition 
of water (12 mL), 2 N aqueous sodium hydroxide solution (24 mL), and water (36 mL).62 The 
slurry was poured into half-saturated aqueous sodium chloride solution (900 mL), and the layers 
were separated. The aqueous layer was extracted with two 900-mL portions of ether.  The 
combined organic extracts were dried over magnesium sulfate.  The dried solution was filtered, 
and the filtrate was concentrated to afford (–)-(1S,2S)-pseudoephenamine as a white solid (33.6 
g, 98%, mp = 105–107 ºC, ! !"!  = –104.24, c 0.990, EtOH). Recrystallization of the solid 
product (1.00 g) from hot absolute ethanol yielded large orthorhombic crystals (mp = 109–110 
ºC, ! !"!  = –110.5, c 1.05, EtOH). TLC (80% ethyl acetate–hexanes): Rf = 0.25 (UV, KMnO4). 
1H NMR (600 MHz, CDCl3), δ: 7.25–7.14 (m, 6H), 7.13–7.07 (m, 2H), 7.03 (d, 2H, J = 6.7 Hz), 
4.57 (d, 1H, J = 8.5 Hz), 3.49 (d, 1H, J = 8.5 Hz), 2.32 (s, 3H).  13C NMR (125 MHz, CDCl3), δ: 
141.3, 139.5, 128.1, 127.8, 127.3, 127.3, 126.8, 77.7, 72.3, 34.2.  FTIR (neat), cm–1: 3317, 3065, 
                                                
62 Fieser, L. F.; Fieser, M. Reagents for Organic Synthesis. 1967, 581–595. 
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3033, 2803, 1453 (m).  HRMS (ESI): Calcd for (C15H17NO + Na)+: 250.1202. Found: 250.1205. 
Anal. Calcd for C15H17NO: C, 79.26; H, 7.54; N, 6.16; found: C, 79.28; H, 7.57; N, 6.11. 
 
Image 2.1 Large, orthorhombic crystals of (–)-(1S,2S)-pseudoephenamine (left) and (+)-(1R,2R)-
pseudoephenamine obtained after recrystallization from hot ethanol.
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Synthesis of (1R,2R)-pseudoephenamine: 
 
N-[(1R,2S)-2-hydroxy-1,2-diphenylethyl]formamide ((+)-28) 
A 500-mL round-bottom flask was charged with (+)-(1S,2R)-2-amino-1,2-diphenylethanol (30.0 
g, 141 mmol, 1 equiv), ammonium formate (1.77 g, 28.1 mmol, 0.20 equiv), and formamide (112 
mL, 2.81 mol, 20.0 equiv) at 23 ºC. The reaction mixture was warmed to 150 ºC, affording a 
clear, pale-yellow solution. After 50 min, heating was discontinued and the product solution was 
allowed to cool to 23 ºC, whereupon solidification occurred. The white solid product was 
suspended in water (300 mL) and the solids were collected by vacuum filtration, rinsing with two 
200-mL portions of water. The washed solid was suction-dried for 1 h then was transferred to an 
empty 2-L round-bottom flask and dried under reduced pressure affording formamide (+)-28 as a 
white solid (33.4 g, 98%, mp = 194–196 ºC).  The characterization data obtain for formamide 
(+)-28 were identical to those of formamide (–)-28. 
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(1R,2R)-(+)-2-amino-1,2-diphenylethanol ((+)-26) 
A 2-L round-bottom flask was charged with formamide (+)-28 (33.4 g, 138 mmol, 1 equiv) then 
was cooled to 0 ºC.  Thionyl chloride (70.4 mL, 969 mmol, 7.00 equiv) was added and the 
resulting clear, yellow solution was stirred for 10 min at 0 ºC and for 30 min at 23 ºC.  Ice (830 
g) was added slowly (Caution: HCl gas evolution!). A white solid precipitated.  After fitting with 
a reflux condenser the flask was warmed to 125 ºC. The resulting clear solution was stirred for 2 
h at 125 ºC.  The reaction flask was allowed to cool to 23 ºC, during which time the solution 
became opaque. Once cool, 5 N aqueous sodium hydroxide solution (850 mL) was added to the 
solution, leading to the precipitation of an off-white solid. The suspension was stirred for 30 min 
at 23 ºC.  The solids were collected by vacuum filtration, rinsing with two 150-mL portions of 
water. The washed solid was suction-dried for 1 h then was transferred to a 500-mL flask.  The 
solid was dried under reduced pressure. The dried pale-green solid was recrystallized from hot 
absolute ethanol (120 mL, 80 ºC) to give optically pure amino alcohol (+)-26 as a white, 
crystalline solid after two recrystallizations (27.0 g, 92%, mp = 104–106 ºC, ! !"!  = +121.2, c 
1.15, EtOH).  The characterization data obtain for amino alcohol (+)-26 were identical to those 
of amino alcohol (–)-26. 
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N-[(1R,2R)-2-hydroxy-1,2-diphenylethyl]formamide ((+)-94) 
A mixture of acetic anhydride (18.6 mL, 197 mmol, 2.00 equiv) and formic acid (8.31 mL, 217 
mmol, 2.10 equiv) was heated for 1 h at 60 ºC then was cooled to 23 ºC.  The cooled solution 
was added by cannula to a solid mixture of (+)-(1R,2R)-2-amino-1,2-diphenylethanol (21.0 g, 
98.0 mmol, 1 equiv) in a 1:1 mixture of ether (490 mL) and tetrahydrofuran (490 mL) at –40 ºC.  
The resulting clear, colorless solution was stirred for 45 min at –40 ºC and for 1.5 h at 23 ºC.  
The reaction mixture was poured into  2 N aqueous sodium hydroxide solution (400 mL), and the 
layers were separated.  The organic layer was washed with 2 N aqueous sodium hydroxide 
solution (400 mL) and saturated aqueous sodium chloride solution (200 mL).  The washed 
organic layer was dried over magnesium sulfate.  The dried solution was filtered, and the filtrate 
was concentrated to afford formamide (+)-94 as a white solid (23.6 g, 99%, mp = 101-103 ºC).  
The characterization data obtain for formamide (+)-94 were identical to those of formamide (–)-
94. 
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(+)-(1R,2R)-pseudoephenamine ((+)-25) 
Solid lithium aluminum hydride (7.42 g, 196 mmol, 2.00 equiv) was added carefully in three 
portions (2.00 g, 2.00 g, 3.40 g; Caution: gas evolution!) to an ice-cooled solution of formamide 
(+)-94 (23.6 g, 98.0 mmol, 1 equiv) in a 1:1 mixture of ether (306 mL) and tetrahydrofuran (306 
mL).  The resulting grey slurry was stirred for 10 min at 0 ºC and for 20.5 h at 23 ºC.  The 
reaction mixture was cooled to 0 ºC, and excess hydride was quenched by sequential, dropwise 
addition of water (8 mL), 2 N aqueous sodium hydroxide solution (16 mL), and water (24 mL).[1] 
The slurry was poured into half-saturated aqueous sodium chloride solution (600 mL), and the 
layers were separated. The aqueous layer was extracted with two 400-mL portions of ether.  The 
combined organic extracts were dried over magnesium sulfate.  The dried solution was filtered, 
and the filtrate was concentrated to afford (+)-(1R,2R)-pseudoephenamine as a white solid (21.5 
g, 97%)  Recrystallization of the solid product from hot absolute ethanol (80 ºC, 40 mL) yields 
large orthorhombic crystals (15.3 g, 71%, mp = 109–110 ºC, ! !"!  = +110.0, c 1.15, EtOH).  
The characterization data obtain for (+)-(R,R)-pseudoephenamine were indentical to those of (–)-
(1S,2S)-pseudoephenamine. 
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Synthesis of Pseudoephenamine Amides: 
 
(S,S)-N-(2-hydroxy-1,2-diphenylethyl)-N-methylpropionamide (29) 
Propionic anhydride (9.64 mL, 74.8 mmol, 1 equiv) was added to a solution of (–)-(1S,2S)-
pseudoephenamine (17.0 g, 74.8 mmol, 1 equiv) and triethylamine (12.5 mL, 89.8 mmol, 1.20 
equiv) in dichloromethane (150 mL) at 0 ºC.  The reaction mixture was stirred for 10 min at 0 ºC, 
then for 35 min at 23 ºC.  Excess propionic anhydride was quenched by the addition of water (50 
mL).  The resulting biphasic mixture was partitioned between water (100 mL) and 
dichloromethane (650 mL), and the layers were separated.  The organic layer was washed 
sequentially with half-saturated aqueous sodium bicarbonate solution (2 x 100 mL) and 1 N 
aqueous hydrochloric acid solution (2 x 100 mL).  The organic extracts were dried over sodium 
sulfate.  The dried solution was filtered, and the filtrate was concentrated, affording a white 
solid.  Recrystallization of the product from hot toluene (800 mL, 100 ºC) provided the 
propionamide 29 as a white crystalline solid (18.7 g, 88%, mp = 188-190 ºC ).  TLC (80% Ethyl 
acetate–hexanes): Rf = 0.59 (UV, KMnO4).  1H NMR (3:1 rotamer ratio, asterisk denotes minor 
rotamer peaks, 500 MHz, CDCl3), δ: 7.42-7.16 (m, 10H), 5.64 (d, 1H, J = 8.5 Hz), 5.36 (d, 1H, J 
= 8.5 Hz), 5.11* (d, 1H, J = 7.5 Hz), 3.89 (br s, 1H), 2.98* (s, 3H), 2.86 (s, 3H), 2.44-2.27 (m, 
2H), 1.13 (t, 3H, J = 7.7 Hz).  13C NMR (125 MHz, CDCl3), δ:  176.0, 141.8, 137.0, 128.4, 
128.4, 128.3, 127.7, 127.5, 126.7, 73.9, 65.9, 34.1, 27.5, 9.2.  FTIR (neat), cm–1: 3366 (br), 2940, 
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1724, 1597 (s), 1454 (m), 1288 (m), 1069 (s).  HRMS (ESI): Calcd for (C18H21NO2 + Na)+: 
306.1465. Found: 306.1465. 
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N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N-methylbutyramide (30) 
Butyric anhydride (1.2 mL, 7.1 mmol, 1.1 equiv) was added to a solution of (–)-(1S,2S)-
pseudoephenamine (1.5 g, 6.6 mmol, 1 equiv) and triethylamine (1.1 mL, 7.9 mmol, 1.2 equiv) 
in dichloromethane (13 mL) at 0 ºC.  The reaction mixture was stirred for 1 h at 0 ºC.  Excess 
butyric anhydride was quenched by the addition of water (5 mL).  The resulting biphasic mixture 
was partitioned between water (10 mL) and dichloromethane (20 mL), and the layers were 
separated.  The organic layer was washed sequentially with half-saturated aqueous sodium 
bicarbonate solution (2 x 10 mL) and 1 N aqueous hydrochloric acid solution (2 x 10 mL).  The 
organic extracts were dried over sodium sulfate.  The dried solution was filtered, and the filtrate 
was concentrated, affording a white solid.  Recrystallization of the product from hot toluene (14 
mL, 100 ºC) provided the butyramide 30 as a white crystalline solid (1.6 g, 83%, mp = 133-135 
ºC).  TLC (60% Ethyl acetate–hexanes): Rf = 0.45 (UV, KMnO4). 1H NMR (3:1 rotamer ratio, 
asterisk denotes minor rotamer peaks, 500 MHz, CDCl3), δ: 7.46-7.18 (m, 10H), 5.63 (d, 1H, J = 
8.0 Hz), 5.40* (d, 1H, J = 7.0 Hz), 5.36 (d, 1H, J = 8.0 Hz), 5.12* (d, 1H, J = 7.5 Hz), 2.96* (s, 
3H), 2.86 (s, 3H), 2.37-2.17 (m, 2H), 1.69-1.60 (m, 2H), 0.94 (t, 3H, J = 7.5 Hz).  13C NMR (125 
MHz, CDCl3), δ: 175.3, 141.9, 137.1, 128.4, 128.38, 128.35, 127.6, 127.5, 126.7, 73.9, 65.9, 
36.2, 34.4, 18.4, 13.9.  FTIR (neat), cm–1: 3356 (br), 2958, 1616 (m), 1452, 1063, 908 (m).  
HRMS (ESI): Calcd for (C19H23NO2 + Na)+: 320.1621. Found: 320.1612. 
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N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N-methylhexanamide (31) 
Hexanoic anhydride (7.63 mL, 33.0 mmol, 1.07 equiv) was added to a solution of (–)-(1S,2S)-
pseudoephenamine (7.02 g, 30.9 mmol, 1 equiv) in tetrahydrofuran (64.3 mL) at 23 ºC. The 
reaction mixture was stirred for 1.5 h at 23 ºC.  Excess hexanoic anhydride was quenched by the 
addition of saturated aqueous sodium bicarbonate solution (39 mL). The resulting biphasic 
mixture was then partitioned between ethyl acetate (200 mL) and water (140 mL), and the layers 
were separated. The aqueous layer was extracted with ethyl acetate (2 x 140 mL). The combined 
organic extracts were dried over sodium sulfate. The dried solution was filtered, and the filtrate 
was concentrated. Recrystallization of the product from a mixture of hexanes:dichloromethane 
(8:1, 90 mL, 70 ºC) provided the hexanamide 31 as a white solid (6.32 g, 63%, mp = 88–90 ºC). 
A second crop was obtained providing an additional 0.75 g of product (70% total yield). TLC 
(60% ethyl acetate–hexanes): Rf = 0.48 (UV, KMnO4). 1H NMR (6.5:1 rotamer ratio, asterisk 
denotes minor rotamer peaks, 500 MHz, CDCl3), δ: 7.38 (d, 2H, J = 7.8 Hz), 7.17–7.34 (m, 8H), 
5.62 (d, 1H, J = 7.8 Hz), 5.32–5.42 (m, 1H), 5.12* (d, 1H, J = 7.3 Hz), 4.01 (d, 1H, J = 5.4 Hz), 
2.96* (s, 1H), 2.85 (s, 1H), 2.15–2.39 (m, 2H), 1.49–1.68 (m, 2H), 1.19–1.38 (m, 4H), 0.90 (t, 
3H, J = 6.8 Hz). 13C NMR (10:1 rotamer ratio, asterisk denotes minor rotamer peaks, 125 MHz, 
CDCl3), δ: 175.3, 174.3*, 141.8, 141.2*, 137.1, 128.5*, 128.4*, 128.3, 128.2, 128.1*, 127.6*, 
127.5, 127.4, 126.9*, 126.7, 73.7, 73.4*, 65.4*, 65.3, 34.1, 34.0*, 33.2*, 31.6*, 31.5, 24.9*, 24.6, 
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22.4, 13.9. FTIR (neat), cm–1: 3374 (br), 2957, 1607 (s), 1454 (m), 1063 (m).  HRMS (ESI): 
Calcd for (C21H27NO2 + H)+: 326.2115. Found: 326.2109. 
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N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N-methyl-3-phenylpropanamide (32) 
3-Phenylpropanoyl chloride (6.07 mL, 40.9 mmol, 1.15 equiv) was added dropwise to a solution 
of (–)-(1S,2S)-pseudoephenamine (8.08 g, 35.5 mmol, 1 equiv) and triethylamine (6.44 mL, 45.2 
mmol, 1.30 equiv) in tetrahydrofuran (85 mL) at 0 ºC. The resulting white suspension was stirred 
for 10 min at 0 ºC, then for 30 min at 23 ºC.  Excess acid chloride was quenched by the addition 
of water (7 mL).  The resulting biphasic mixture was partitioned between ethyl acetate (210 mL) 
and saturated aqueous sodium chloride solution (70.0 mL), and the layers were separated. The 
organic layer was washed with saturated aqueous sodium chloride solution (2 x 100 mL). The 
organic extracts were dried over sodium sulfate. The dried solution was filtered, and the filtrate 
was concentrated, affording a white solid.  Recrystallization of the product from hot toluene (56 
mL, 110 ºC) provided the phenylpropanamide 32 as a white crystalline solid (9.51 g, 74%, mp = 
147–149 ºC). A second crop was obtained providing an additional 0.77 g of product (80% total 
yield). TLC (60% ethyl acetate–hexanes): Rf = 0.39 (UV, KMnO4). 1H NMR (5:1 rotamer ratio, 
asterisk denotes minor rotamer peaks, 500 MHz, CDCl3), δ: 7.36 (d, 2H, J = 7.3 Hz), 7.11–7.32 
(m, 13H), 5.71 (d, 1H, J = 7.8 Hz), 5.29–5.39 (m, 1H), 5.06* (d, 1H, J = 7.3 Hz), 3.77 (d, 1H, J 
= 6.4 Hz), 2.89–3.01 (m, 2H), 2.82 (s, 3H), 2.54–2.70 (m, 2H), 2.44–2.53* (m, 2H). 13C NMR 
(6:1 rotamer ratio, asterisk denotes minor rotamer peaks, 125 MHz, CDCl3), δ: 174.1, 173.2*, 
141.7, 141.5*, 141.3*, 141.1, 137.0, 128.5*, 128.4, 128.3, 128.2, 128.2*, 128.1*, 127.6*, 127.6, 
127.4, 126.9*, 126.8, 126.0*, 125.9, 73.5, 73.4*, 65.4*, 64.8, 35.9, 35.1*, 33.5, 31.4*, 31.0, 
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30.0*. FTIR (neat), cm–1: 3385 (br), 3028, 1601 (s), 1452 (m), 1068 (m).  HRMS (ESI): Calcd 
for (C24H25NO2 + H)+: 360.1958. Found: 360.1954. 
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N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N-methylmethacrylamide (33) 
Methacryloyl chloride (946 μL, 9.68 mmol, 1.10 equiv) was added to a solution of (–)-(1S,2S)-
pseudoephenamine (2.00 g, 8.80 mmol, 1 equiv) and triethylamine (1.60 mL, 11.4 mmol, 1.30 
equiv) in dichloromethane (22 mL) at 0 ºC. The white suspension was stirred for 5 min at 0 ºC, 
then for 55 min at 23 ºC.  Excess acid chloride was quenched by the addition of water (14 mL). 
The layers of the resulting biphasic mixture were separated. The aqueous layer was extracted 
with dichloromethane (3 x 20 mL). The combined organic extracts were dried over sodium 
sulfate. The dried solution was filtered, and the filtrate was concentrated. The residue was 
purified by flash column chromatography (10→50% ethyl acetate–hexanes) to provide 
acrylamide 33 as a white crystalline solid (2.31 g, 89%, mp = 141–143 ºC). TLC (60% ethyl 
acetate–hexanes): Rf = 0.32 (UV, KMnO4). 1H NMR (2.5:1 rotamer ratio, asterisk denotes minor 
rotamer peaks, 500 MHz, CDCl3), δ: 7.37–7.49 (m, 2H), 7.16–7.37 (m, 8H), 5.31–5.56 (m, 2H), 
5.21* (br s, 1H), 5.14 (br s, 1H), 5.04* (br s, 1H), 4.89 (br s, 1H), 4.29 (d, 1H, J = 5.4 Hz), 3.05* 
(br s, 3H), 2.87 (br s, 3H), 2.26* (br s, 3H), 1.89 (br s, 3H). 13C NMR (3:1 rotamer ratio, asterisk 
denotes minor rotamer peaks, 125 MHz, CDCl3), δ: 174.3, 141.7, 140.8, 136.6, 128.4, 128.2, 
128.1, 127.9*, 127.5, 127.1*, 126.5, 73.6, 72.7*, 66.7*, 65.6, 36.0, 28.7*, 20.9*, 19.8. FTIR 
(neat), cm–1: 3356 (br), 3032, 1599 (s), 1452 (m), 1087 (m).  HRMS (ESI): Calcd for (C19H21NO2 
+ Na)+: 318.1465. Found: 318.1460. 
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N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N-methyl-2-methylenebutanamide (34) 
N,N-Diisopropylethylamine (4.11 mL, 23.5 mmol, 3.00 equiv), 1-hydroxybenzotriazole hydrate 
(1.32 g, 8.62 mmol, 1.10 equiv), and 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide (1.65 g, 
8.62 mmol, 1.10 equiv) were added sequentially to a solution of (–)-(1S,2S)-pseudoephenamine 
(2.14 g, 9.41 mmol, 1.20 equiv) and 2-methylenebutanoic acid (785 mg, 7.84 mmol, 1 equiv) in 
N,N-dimethylformamide (15.7 mL) at 23 ºC. The resulting yellow solution was stirred for 15 h at 
23 ºC. The reaction mixture was partitioned between ethyl acetate (15 mL) and water (40 mL), 
and the layers were separated. The aqueous layer was extracted with ethyl acetate (2 x 15 mL). 
The combined organic extracts were washed sequentially with 1 N aqueous hydrochloric acid 
solution (2 x 20 mL) and half-saturated aqueous sodium chloride solution (2 x 20 mL). The 
washed organic solution was dried over sodium sulfate. The dried solution was filtered, and the 
filtrate was concentrated. The residue was purified by flash column chromatography (50% ethyl 
acetate–hexanes) to afford acrylamide 34 as a clear, colorless syrup (2.31 g, 95%). TLC (30% 
ethyl acetate–hexanes): Rf = 0.12 (UV, KMnO4). 1H NMR (4.5:1 rotamer ratio, asterisk denotes 
minor rotamer peaks, 500 MHz, CDCl3), δ: 7.43 (d, 2H, J = 7.3 Hz), 7.37–7.15 (m, 8H), 5.51 (d, 
1H, J = 6.8 Hz), 5.43 (t, 1H, J = 7.3 Hz), 5.35* (br s, 1H), 5.20* (br s, 1H), 5.13 (br s, 1H), 5.06* 
(br s, 1H), 4.87 (s, 1H), 4.28 (br d, 1H, J = 6.4 Hz), 3.09* (br s, 3H), 2.86 (s, 3H), 2.17–2.38 (m, 
2H), 2.10* (br s, 2H), 1.13* (br s, 3H), 1.03 (t, 3H, J = 7.3 Hz). 13C NMR (2.5:1 rotamer ratio, 
asterisk denotes minor rotamer peaks, 125 MHz, CDCl3), δ: 173.9, 146.7*, 146.3, 141.7, 141.5*, 
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136.6*, 136.7, 128.1, 128.0, 127.9, 127.4*, 127.3*, 127.3*, 127.2, 126.9, 126.8*, 126.3, 73.0, 
72.3*, 66.7*, 64.1, 35.3, 28.7*, 26.4, 26.3*, 11.3. FTIR (neat), cm–1: 3373 (br), 2923, 1739, 1602 
(s), 1451 (m).  HRMS (ESI): Calcd for (C20H23NO2 + H)+: 310.1802. Found: 310.1812. 
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N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N-methyl-2-methyleneheptanamide (35) 
N,N-Diisopropylethylamine (2.13 mL, 12.2 mmol, 3.00 equiv), 1-hydroxybenzotriazole hydrate 
(685 mg, 4.47 mmol, 1.10 equiv), and 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide (858 
mg, 4.47 mmol, 1.10 equiv) were added sequentially to a solution of (–)-(1S,2S)-
pseudoephenamine (1.11 g, 4.88 mmol, 1.20 equiv) and 2-methyleneheptanoic acid (785 mg, 
7.84 mmol, 1 equiv) in N,N-dimethylformamide (15.7 mL) at 23 ºC. The resulting yellow 
solution was stirred for 15 h at 23 ºC. The reaction mixture was partitioned between ethyl acetate 
(15 mL) and water (40 mL), and the layers were separated. The aqueous layer was extracted with 
ethyl acetate (2 x 15 mL). The combined organic extracts were washed sequentially with 1 N 
aqueous hydrochloric acid solution (2 x 20 mL) and half-saturated aqueous sodium chloride 
solution (2 x 20 mL). The washed organic solution was dried over sodium sulfate. The dried 
solution was filtered, and the filtrate was concentrated. The residue was purified by flash column 
chromatography (30→50% ethyl acetate–hexanes) to afford acrylamide 35 as a clear, colorless 
syrup (1.35 g, 95%). TLC (30% ethyl acetate–hexanes): Rf = 0.21 (UV, KMnO4). 1H NMR (5.2:1 
rotamer ratio, asterisk denotes minor rotamer peaks, 500 MHz, CDCl3), δ: 7.43 (d, 2H, J = 7.3 
Hz), 7.38–7.15 (m, 8H), 5.51 (d, 1H, J = 7.5 Hz), 5.43 (t, 1H, J = 7.5 Hz), 5.35* (br s, 1H), 5.19* 
(br s, 1H), 5.13 (br s, 1H), 5.04* (br s, 1H), 4.88 (s, 1H), 4.34 (br d, 1H, J = 6.4 Hz), 3.10* (br s, 
3H), 2.86 (s, 3H), 2.22 (t, 2H, J = 7.6 Hz), 2.11* (br s, 2H), 1.53* (br s, 2H), 1.40 (br s, 2H), 
1.30 (br s, 4H), 0.88 (t, 3H, J = 6.4 Hz). 13C NMR (4.5:1 rotamer ratio, asterisk denotes minor 
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rotamer peaks, 125 MHz, CDCl3), δ: 174.1, 174.0*, 145.7*, 145.3, 141.78, 141.3*, 136.9*, 
136.7, 128.3, 128.2*, 128.1, 127.8*, 127.4, 127.4, 127.0*, 126.4, 114.1, 113.8*, 73.4, 72.89*, 
68.7*, 65.3, 36.1, 33.8, 31.3, 28.9*, 26.9, 22.3, 13.8. FTIR (neat), cm–1: 3378 (br), 2931, 1741, 
1602 (s), 1452 (m).  HRMS (ESI): Calcd for (C23H29NO2 + H)+: 352.2271. Found: 352.2279. 
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Synthesis of α,α-disubstituted pseudoephenamine amides: 
 
(R)-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N,2-dimethylbutanamide (36) 
N,N-Diisopropylamine (3.35 mL, 23.9 mmol, 2.26 equiv) was added by syringe to a stirring 
suspension of lithium chloride (2.69 g, 63.5 mmol, 6.00 equiv) in tetrahydrofuran (21 mL) at 23 
ºC.  The resulting slurry was cooled to –78 ºC. A freshly titrated solution of n-butyllithium in 
hexanes (2.50 M, 9.36 mL, 2.21 equiv) was added by syringe. The reaction mixture was warmed 
briefly to 0 ºC (5 min), then was cooled to –78 ºC. An ice-cooled solution of amide 29 (3.00 g, 
10.6 mmol, 1 equiv) in pyridine (26 mL) was added by cannula. The transfer was quantitated 
with tetrahydrofuran (5 mL). The reaction mixture was stirred for 1 h at –78 ºC, for 15 min at 0 
ºC, and for 5 min at 23 ºC, then was cooled to 0 ºC, whereupon iodoethane (2.13 mL, 26.5 mmol, 
2.50 equiv) was added. After 55 min, aqueous ammonium chloride solution (1.5 mL) was added 
to the ice-cold product mixture. The biphasic mixture was partitioned between ethyl acetate (80 
mL) and a 1:1 mixture of saturated aqueous sodium chloride solution and 1 N aqueous 
hydrochloric acid solution (100 mL). The layers were separated. The aqueous layer was 
extracted with two 50-mL portions of ethyl acetate. The combined organic extracts were washed 
with water (60 mL). The washed organic solution was dried over sodium sulfate. The dried 
solution was filtered and the filtrate was concentrated. The residue was purified by flash column 
chromatography (30→50% ethyl acetate–hexanes) to provide amide 36 as a pale yellow oil, 
which solidified upon standing after 3–4 days (3.15 g, 96%). The diastereomeric ratio of the 
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purified product was determined to be 98:2 dr by chiral HPLC analysis (Chiralcel OD-H, 95:5 
hexanes:i-PrOH, 1 mL/min, λ = 220 nm, tR (major, amide 36) = 20.7 min, tR (minor, amide 39) = 
24.9 min). TLC (60% Ethyl acetate–hexanes): Rf = 0.50 (UV, KMnO4). 1H NMR (3:1 rotamer 
ratio, asterisk denotes minor rotamer peaks, 500 MHz, CDCl3), δ: 7.46-7.16 (m, 10H), 5.66 (d, 
1H, J = 8.0 Hz), 5.55* (d, 1H, J = 8.0 Hz), 5.38 (d, 1H, J = 7.5 Hz), 5.22* (d, 1H, J = 7.0 Hz), 
4.32* (br s, 1H), 4.12 (br s, 1H), 3.00* (s, 3H), 2.89 (s, 3H), 2.58 (sxt, 1H, J = 6.8 Hz), 1.75-1.61 
(m, 1H), 1.43-1.32 (m, 1H), 1.08 (d, 3H, J = 7.0 Hz), 1.03* (d, 3H, J = 6.5 Hz), 0.84 (t, 3H, J = 
7.5 Hz).  13C NMR (125 MHz, CDCl3), δ: 178.9, 141.9, 137.2, 128.5, 128.3, 128.2, 127.6, 127.5, 
126.6, 73.8, 65.9, 38.2, 34.5, 26.9, 17.0, 11.9.  FTIR (neat), cm–1: 3379 (br), 2967, 1616 (s), 
1452, 1082, 908 (s). HRMS (ESI): Calcd for (C20H25NO2 + H)+: 312.1958. Found: 312.1964. 
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(R)-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N,2-dimethylhexanamide (37) 
N,N-Diisopropylamine (3.35 mL, 23.9 mmol, 2.26 equiv) was added by syringe to a stirring 
suspension of lithium chloride (2.69 g, 63.5 mmol, 6.00 equiv) in tetrahydrofuran (26 mL) at 23 
ºC.  The resulting slurry was cooled to –78 ºC.  A freshly titrated solution of n-butyllithium in 
hexanes (2.50 M, 9.36 mL, 2.21 equiv) was added by syringe.  The reaction mixture was warmed 
briefly to 0 ºC (5 min), then was cooled to –78 ºC.  An ice-cooled solution of amide 29 (3.00 g, 
10.6 mmol, 1 equiv) in pyridine (23 mL) was added by cannula.  The transfer was quantitated 
with tetrahydrofuran (5 mL).  The reaction mixture was stirred for 1 h at –78 ºC, for 15 min at 0 
ºC, and for 5 min at 23 ºC, then was cooled to 0 ºC, whereupon 1-iodobutane (3.01 mL, 26.5 
mmol, 2.50 equiv) was added.  After 1.2 h, aqueous ammonium chloride solution (1.5 mL) was 
added to the ice-cold product mixture.  The biphasic mixture was partitioned between ethyl 
acetate (80 mL) and a 1:1 mixture of saturated aqueous sodium chloride solution and 1 N 
aqueous hydrochloric acid solution (100 mL).  The layers were separated.  The aqueous layer 
was extracted with two 50-mL portions of ethyl acetate.  The combined organic extracts were 
washed with water (60 mL).  The washed organic solution was dried over sodium sulfate.  The 
dried solution was filtered and the filtrate was concentrated.  The residue was purified by flash 
column chromatography (30→50% ethyl acetate–hexanes) to provide amide 37 as a pale yellow 
oil, which solidified upon standing after 4–5 days (3.49 g, 97%). The diastereomeric ratio of the 
purified product was determined to be 98:2 dr by chiral HPLC analysis (Chiralcel OD-H, 95:5 
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hexanes:i-PrOH, 1 mL/min, λ = 220 nm, tR (major, amide 37) = 16.5 min, tR (minor, amide 40) = 
21.8 min).  TLC (60% Ethyl acetate–hexanes): Rf = 0.64 (UV, KMnO4).  1H NMR (3:1 rotamer 
ratio, asterisk denotes minor rotamer peaks, 500 MHz, CDCl3), δ: 7.45-7.19 (m, 10H), 5.61 (d, 
1H, J = 8.0 Hz), 5.53* (d, 1H, J = 7.5 Hz), 5.38 (t, 1H, J = 7.2 Hz), 5.22* (d, 1H, J = 8.0 Hz), 
4.32* (br s, 1H), 4.22 (d, 1H, J = 6.0 Hz), 3.01* (s, 3H), 2.88 (s, 3H), 2.64 (sxt, 1H, J = 6.9 Hz), 
1.66-1.58 (m, 1H), 1.36-1.22 (m, 3H), 1.21-1.13 (m, 2H), 1.07 (d, 3H, J = 7.0 Hz), 1.03* (d, 3H, 
J = 7.0 Hz), 0.87 (t, 3H, J = 7.2 Hz).  13C NMR (125 MHz, CDCl3), δ:  179.1, 142.0, 137.2, 
128.4, 128.3, 128.2, 127.5, 127.4, 126.6, 73.8, 66.2, 36.5, 34.7, 33.7, 29.6, 22.2, 17.3, 13.9.  
FTIR (neat), cm–1: 3365 (br), 2930, 1618 (s), 1452, 1069.  HRMS (ESI): Calcd for (C22H29NO2 + 
H)+: 340.2271. Found: 340.2274. 
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(R)-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N,2-dimethyl-3-phenylpropanamide (38) 
N,N-Diisopropylamine (5.59 mL, 39.9 mmol, 2.26 equiv) was added by syringe to a stirring 
suspension of lithium chloride (4.49 g, 106 mmol, 6.00 equiv) in tetrahydrofuran (40 mL) at 23 
ºC.  The resulting slurry was cooled to –78 ºC.  A freshly titrated solution of n-butyllithium in 
hexanes (2.40 M, 16.3 mL, 2.21 equiv) was added by syringe.  The reaction mixture was warmed 
briefly to 0 ºC (5 min), then was cooled to –78 ºC.  An ice-cooled solution of amide 29 (5.00 g, 
17.6 mmol, 1 equiv) in pyridine (44 mL) was added by cannula.  The transfer was quantitated 
with tetrahydrofuran (5 mL).  The reaction mixture was stirred for 1 h at –78 ºC, for 15 min at 0 
ºC, and for 5 min at 23 ºC, then was cooled to 0 ºC, whereupon benzyl bromide (3.14 mL, 26.5 
mmol, 1.50 equiv) was added.  After 30 min, saturated aqueous ammonium chloride solution 
(1.5 mL) was added to the ice-cold product mixture.  The biphasic mixture was partitioned 
between ethyl acetate (130 mL) and a 1:1 mixture of saturated aqueous sodium chloride solution 
and 1 N aqueous hydrochloric acid solution (160 mL).  The layers were separated.  The aqueous 
layer was extracted with two 80-mL portions of ethyl acetate.  The combined organic extracts 
were washed with water (100 mL).  The washed organic solution was dried over sodium sulfate.  
The dried solution was filtered and the filtrate was concentrated.  The residue was purified by 
flash column chromatography (10→70% ethyl acetate–hexanes) to provide amide 38 as a pale 
orange solid (6.36 g, 97%).  The purified product was recrystallized from toluene (25 mL, 100 
ºC) affording a white crystalline solid (5.08 g, 77%, mp = 128-129 ºC).  A second crop was 
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obtained providing an additional 0.55 g of product (85% total yield).  The product 38 (26.0 mg, 
0.07 mmol, 1 equiv) was silylated with a mixture of chlorotrimethylsilane (24.7 μL, 0.19 mmol, 
2.80 equiv) and triethylamine (34.9 μL, 0.25 mmol, 3.60 equiv) in dichloromethane (1 mL) at 23 
ºC for 10 min, and chiral HPLC analysis of the resulting trimethylsilyl ether established that 
amide 38 was of ≥99:1 dr (Chiralcel OD-H, 95:5 hexanes:i-PrOH, 1 mL/min, λ = 220 nm, tR 
(minor, amide 42) = 5.82 min, tR (major, amide 38) = 7.28 min). This diastereomeric ratio was 
confirmed by 1H NMR analysis of the corresponding oxazolinium triflate (see below). TLC 
(60% Ethyl acetate–hexanes): Rf = 0.56 (UV, KMnO4).  1H NMR (3:1 rotamer ratio, asterisk 
denotes minor rotamer peaks, 500 MHz, CDCl3), δ: 7.44-6.98 (m, 15H), 5.68 (d, 1H, J = 7.0 Hz), 
5.35 (t, 1H, J = 7.0 Hz), 5.21* (dd, 1H, J = 7.5, 3.5 Hz), 5.02* (d, 1H, J = 8.5 Hz), 3.58 (br s, 
1H), 3.12-3.04* (m, 1H), 3.03-2.88 (m, 2H), 2.70 (s, 3H), 2.62 (dd, 1H, J = 12.0, 5.0 Hz), 1.09 
(d, 3H, J = 6.5 Hz), 1.05* (d, 3H, J = 6.5 Hz).  13C NMR (125 MHz, CDCl3), δ:  177.9, 141.7, 
140.0, 136.9, 129.0, 128.4 (2), 128.3, 128.2, 127.6, 127.3, 126.6, 126.1, 73.7, 64.5, 40.2, 38.8, 
33.9, 17.6.  FTIR (neat), cm–1: 3371 (br), 3028, 1618 (s), 1452, 1080, 908 (s).  HRMS (ESI): 
Calcd for (C25H27NO2 + H)+: 374.2115. Found: 374.2116. 
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Oxazolinium triflate (95)  
Trifluoromethanesulfonic anhydride (18.9 μL, 0.112 mmol, 2.00 equiv) was added dropwise by 
syringe to a stirring solution of the α-tertiary amide 38 (21.0 mg, 0.056 mmol, 1 equiv) and 
pyridine (13.6 μL, 0.169 mmol, 3.00 equiv) in dichloromethane (2 mL) at 0 °C. The reaction 
mixture was stirred for 10 min at 0 °C. The product solution was concentrated by rotary 
evaporation at ~40 mmHg, then with a vacuum manifold at 0.1 mmHg for 3 h. The 
diastereomeric ratio of the residue was determined to be ≥19:1 by 1H NMR analysis. 1H NMR 
(≥19:1 diastereomeric ratio, asterisk denotes pyridinium ion peaks, 500 MHz, CDCl3), δ: 8.90* 
(t, 1H, J = 6.0 Hz), 8.55* (t, 1H, J = 7.75 Hz), 8.06* (t, 1H, J = 6.5 Hz), 7.41-6.83 (m, 15H), 
6.03 (d, 1H, J = 11.0 Hz), 3.55-3.47 (m, 2H), 3.23 (s, 3H), 2.95 (dd, 1H, J = 8.5, 4.5 Hz), 1.56 (d, 
3H, J = 7.0 Hz). 
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(S)-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N,2-dimethylbutanamide (39) 
N,N-Diisopropylamine (1.07 mL, 7.57 mmol, 2.25 equiv) was added by syringe to a stirring 
suspension of lithium chloride (0.86 g, 20.2 mmol, 6.00 equiv) in tetrahydrofuran (10 mL) at 23 
ºC.  The resulting slurry was cooled to –78 ºC.  A freshly titrated solution of n-butyllithium in 
hexanes (2.40 M, 2.80 mL, 2.00 equiv) was added by syringe.  The reaction mixture was warmed 
briefly to 0 ºC (5 min), then was cooled to –78 ºC.  An ice-cooled solution of amide 30 (1.00 g, 
3.36 mmol, 1 equiv) in tetrahydronfuran (12 mL) was added by cannula.  The transfer was 
quantitated with tetrahydrofuran (2 mL).  The reaction mixture was stirred for 1 h at –78 ºC, for 
15 min at 0 ºC, and for 5 min at 23 ºC, then was cooled to 0 ºC, whereupon iodomethane (0.63 
mL, 10.1 mmol, 3.00 equiv) was added.  After 1 h, aqueous ammonium chloride solution (2 mL) 
was added to the ice-cold product mixture.  The biphasic mixture was partitioned between ethyl 
acetate (20 mL) and a 1:1 mixture of saturated aqueous sodium chloride solution and 1 N 
aqueous hydrochloric acid solution (30 mL).  The layers were separated.  The aqueous layer was 
extracted with two 20-mL portions of ethyl acetate.  The combined organic extracts were dried 
over sodium sulfate.  The dried solution was filtered and the filtrate was concentrated.  The 
residue was purified by flash column chromatography (30→40% ethyl acetate–hexanes) to 
provide amide 39 as a white solid (0.91 g, 87%, mp = 89-90 ºC). The diastereomeric ratio of the 
purified product was determined to be ≥99:1 dr by chiral HPLC analysis (Chiralcel OD-H, 95:5 
hexanes:i-PrOH, 1 mL/min, λ = 220 nm, tR (minor, amide 36) = 21.1 min, tR (major, amide 39) = 
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25.3 min).  TLC (60% Ethyl acetate–hexanes): Rf = 0.63 (UV, KMnO4).  1H NMR (3:1 rotamer 
ratio, asterisk denotes minor rotamer peaks, 500 MHz, CDCl3), δ: 7.46-7.18 (m, 10H), 5.54 (d, 
1H, J = 7.5 Hz), 5.40 (d, 1H, J = 7.0 Hz), 5.21* (d, 1H, J = 7.5 Hz), 4.31 (br s, 1H), 3.02* (s, 
3H), 2.87 (s, 3H), 2.57 (sxt, 1H, J = 6.8 Hz), 1.81-1.63 (m, 1H), 1.45-1.30 (m, 1H), 1.03 (d, 3H, 
J = 6.5 Hz), 0.84 (t, 3H, J = 7.7 Hz), 0.79 (t, 3H, J = 7.2 Hz).  13C NMR (125 MHz, CDCl3), δ:  
178.9, 142.0, 137.2, 128.4, 128.3, 128.2, 127.5, 127.4, 126.6, 73.9, 66.7, 38.3, 35.1, 26.9, 17.1, 
11.9.  FTIR (neat), cm–1: 3363 (br), 2965, 1616 (s), 1450, 1082, 910.  HRMS (ESI): Calcd for 
(C20H25NO2 + H)+: 312.1958. Found: 312.1969. 
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(S)-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N,2-dimethylhexanamide (40) 
N,N-Diisopropylamine (3.02 mL, 21.2 mmol, 2.26 equiv) was added by syringe to a stirring 
suspension of lithium chloride (2.38 g, 56.2 mmol, 6.00 equiv) in tetrahydrofuran (20 mL) at 23 
ºC.  The resulting slurry was cooled to –78 ºC.  A freshly titrated solution of n-butyllithium in 
hexanes (2.53 M, 8.19 mL, 2.21 equiv) was added by syringe.  The reaction mixture was warmed 
briefly to 0 ºC (5 min) before cooling to –78 ºC.  An ice-cooled solution of amide 31 (3.05 g, 
9.37 mmol, 1 equiv) in tetrahydrofuran (20 mL with 6.9 mL rinse) was added by cannula. The 
reaction mixture was stirred for 1 h at –78 ºC, for 15 min at 0 ºC, and for 5 min at 23 ºC, then 
was cooled to 0 ºC, whereupon iodomethane (2.34 mL, 37.5 mmol, 4.00 equiv) was added.  After 
40 min, saturated aqueous ammonium chloride solution (2 mL) was added to the ice-cold 
product mixture.  The resulting biphasic mixture was partitioned between ethyl acetate (80 mL) 
and a 1:1 mixture of saturated aqueous sodium chloride solution and 1 N aqueous hydrochloric 
acid solution (100 mL). The layers were separated.  The aqueous layer was extracted with two 
60-mL portions of ethyl acetate.  The combined organic extracts were dried over sodium sulfate.  
The dried solution was filtered, and the filtrate was concentrated. The residue was purified by 
flash column chromatography (5→40% ethyl acetate–hexanes) to provide amide 40 as an off-
white solid (2.86 g, 90%). The diastereomeric ratio of the purified product was determined to be 
95:5 by chiral HPLC analysis (Chiralcel OD-H, 95:5 hexanes:i-PrOH, 1 mL/min, λ = 220 nm, 
tR(minor) = 16.3 min, tR(major) = 20.0 min). The purified product was recrystallized from hot 
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ether–hexanes (1:7, 10 mL, 40 ºC) to provide amide 40 as an off-white crystalline solid (2.42 g, 
76%, mp = 77–79 ºC). A second crop was obtained providing an additional 0.26 g of amide 40 
(84% total yield).  The diastereomeric ratio of the recrystallized product was determined to be 
98:2 by chiral HPLC analysis (Chiralcel OD-H, 95:5 hexanes:i-PrOH, 1 mL/min, λ = 220 nm, 
tR(minor, amide 37) = 17.2 min, tR(major, amide 40) = 21.6 min). TLC (30% ethyl acetate–
benzene): Rf = 0.45 (UV, KMnO4). 1H NMR (10:1 rotamer ratio, asterisk denotes minor rotamer 
peaks, 500 MHz, CDCl3), δ: 7.40 (d, 2H, J = 7.6 Hz), 7.19–7.36 (m, 8H), 5.53 (d, 1H, J = 7.0 
Hz), 5.34-5.44 (m, 1H), 5.19* (d, 1H, J = 7.3 Hz), 4.36 (br s, 1H), 3.02* (s, 3H), 2.87 (s, 3H), 
2.63 (sxt, 1H, J = 6.7 Hz), 1.59–1.70 (m, 1H), 1.22–1.39 (m, 3H), 1.10–1.22 (m, 2H), 1.07* (d, 
3H, J = 6.7 Hz), 1.03 (d, 3H, J = 6.7 Hz), 0.87 (t, 3H, J = 7.3 Hz), 0.80* (t, 3H, J = 6.9 Hz). 13C 
NMR (10:1 rotamer ratio, asterisk denotes minor rotamer peaks, 125 MHz, CDCl3), δ: 178.7, 
1778.1*, 141.9, 141.4*, 137.4*, 137.3, 128.3*, 128.2, 128.1, 128.1*, 128.0, 127.9*, 127.5*, 
127.3, 127.2, 126.9*, 126.4, 73.6, 73.3*, 65.8, 65.4*, 36.3, 35.6*, 34.8, 34.1*, 33.4, 30.1*, 29.4, 
22.6, 22.5*, 17.3*, 17.2, 13.9, 13.8*. FTIR (neat), cm–1: 3354 (br), 2931, 1618 (s), 1450 (m).  
HRMS (ESI): Calcd for (C22H29NO2 + H)+: 340.2271. Found: 340.2261. 
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(R)-2-benzyl-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N-methylhexanamide (41) 
N,N-Diisopropylamine (2.97 mL, 20.8 mmol, 2.26 equiv) was added by syringe to a stirring 
suspension of lithium chloride (2.35 g, 55.3 mmol, 6.00 equiv) in tetrahydrofuran (20 mL) at 23 
ºC.  The resulting slurry was cooled to –78 ºC. A freshly titrated solution of n-butyllithium in 
hexanes (2.53 M, 8.05 mL, 2.21 equiv) was added by syringe.  The reaction mixture was warmed 
briefly to 0 ºC (5 min) before cooling to –78 ºC.  An ice-cooled solution of amide 31 (3.00 g, 
9.22 mmol, 1 equiv) in tetrahydrofuran (20 mL with 6.1 mL rinse) was added via cannula. The 
reaction mixture was stirred for 1 h at –78 ºC, for 15 min at 0 ºC, and for 5 min at 23 ºC, then 
was cooled to 0 ºC, whereupon benzyl bromide (1.65 mL, 13.8 mmol, 1.50 equiv) was added.  
After 1.3 h, saturated aqueous ammonium chloride solution (2 mL) was added to the ice-cold 
product mixture.  The resulting biphasic mixture was partitioned between ethyl acetate (80 mL) 
and a 1:1 mixture of saturated aqueous sodium chloride solution and 1 N aqueous hydrochloric 
acid solution (100 mL). The layers were separated.  The aqueous layer was extracted with two 
60-mL portions of ethyl acetate. The combined organic extracts were dried over sodium sulfate.  
The dried solution was filtered, and the filtrate was concentrated.  The residue was recrystallized 
from hot ethyl acetate–hexanes (1:1, 10 mL, 70 ºC) to provide amide 41 as a white crystalline 
solid (3.35 g, 88%, mp = 112–114 ºC). A second crop was obtained providing an additional 0.47 
g of amide 41 (99% total yield). The diastereomeric ratio of the purified product was determined 
to be ≥99:1 by chiral HPLC analysis (Chiralcel OD-H, 95:5 hexanes:i-PrOH, 1 mL/min, λ = 220 
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nm, tR(major, amide 41) = 25.1 min, tR(minor, amide 43) = not observed). TLC (50% ethyl 
acetate–hexanes): Rf = 0.57 (UV, KMnO4). 1H NMR (12:1 rotamer ratio, asterisk denotes minor 
rotamer peaks, 500 MHz, CDCl3), δ: 7.39* (m, 2H), 7.35 (d, 2H, J = 7.3 Hz), 7.3* (m, 2H), 
7.23–7.28 (m, 2H), 7.10–7.22 (m, 9H), 6.97–7.03 (m, 2H), 6.90–6.96* (m, 2H), 5.79 (d, 1H, J = 
7.6 Hz), 5.31 (t, 1H, J = 7.2 Hz), 4.97* (dd, 1H, J = 9.1, 4.9 Hz), 4.73* (d, 1H, J = 9.4 Hz), 3.42 
(br s, 1H), 3.15* (s, 3H), 2.92–3.00 (m, 1H), 2.85–2.92 (m, 1H), 2.72 (dd, 1H, J = 13.0, 4.8 Hz), 
2.64 (s, 3H), 1.60–1.71 (m, 1H), 1.41–1.50 (m, 1H), 1.14–1.33 (m, 4H), 0.87 (t, 3H, J = 7.2 Hz), 
0.66* (t, 3H, J = 7.2 Hz). 13C NMR (10:1 rotamer ratio, asterisk denotes minor rotamer peaks, 
125 MHz, CDCl3), δ: 177.3, 176.9*, 141.7, 140.8*, 140.5*, 139.9*, 137.8*, 136.9, 129.2*, 
128.9, 128.5*, 128.3, 128.2, 128.19, 127.9*, 127.8*, 127.5*, 127.4, 127.1, 127.0*, 126.6, 126.3*, 
125.9, 73.9*, 73.3, 66.7*, 63.2, 47.6*, 44.2, 39.3*, 39.0, 33.2, 32.8, 32.6*, 29.9*, 29.4*, 29.2, 
22.7, 22.6*, 13.8, 13.7*. FTIR (neat), cm–1: 3356 (br), 2929, 1616 (s), 1446 (m).  HRMS (ESI): 
Calcd for (C28H33NO2 + H)+: 416.2584. Found: 416.2580. 
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(S)-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N,2-dimethyl-3-phenylpropanamide (42) 
N,N-Diisopropylamine (1.76 mL, 12.4 mmol, 2.26 equiv) was added by syringe to a stirring 
suspension of lithium chloride (1.39 g, 32.8 mmol, 6.00 equiv) in tetrahydrofuran (10 mL) at 23 
ºC.  The resulting slurry was cooled to –78 ºC.  A freshly titrated solution of n-butyllithium in 
hexanes (2.46 M, 4.92 mL, 2.21 equiv) was added by syringe.  The reaction mixture was warmed 
briefly to 0 ºC (5 min) before cooling to –78 ºC.  An ice-cooled solution of amide 32 (1.97 g, 
5.47 mmol, 1 equiv) in tetrahydrofuran (13 mL with 4.0 mL rinse) was added by cannula. The 
reaction mixture was stirred for 1 h at –78 ºC, for 15 min at 0 ºC, and for 5 min at 23 ºC, then 
was cooled to 0 ºC, whereupon iodomethane (1.37 mL, 19.5 mmol, 2.50 equiv) was added.  After 
2 h, saturated aqueous ammonium chloride solution (2 mL) was added to the ice-cold product 
mixture.  The resulting biphasic mixture was partitioned between ethyl acetate (80 mL) and a 1:1 
mixture of saturated aqueous sodium chloride solution and 1 N aqueous hydrochloric acid 
solution (100 mL). The layers were separated.  The aqueous layer was extracted with two 60-mL 
portions of ethyl acetate. The combined organic extracts were dried over sodium sulfate.  The 
dried solution was filtered, and the filtrate was concentrated. The residue was purified by flash 
column chromatography (5→50% ethyl acetate–hexanes) to provide amide 42 as a white solid 
(1.88 g, 92%). The product 42 (21.1 mg, 0.06 mmol, 1 equiv) was silylated with a mixture of 
chlorotrimethylsilane (20.2 μL, 0.16 mmol, 2.80 equiv) and triethylamine (28.3 μL, 0.20 mmol, 
3.60 equiv) in dichloromethane (1 mL) at 23 ºC for 10 min, and chiral HPLC analysis of the 
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resulting trimethylsilyl ether established that amide 42 was of 98:2 dr (Chiralcel OD-H, 95:5 
hexanes:i-PrOH, 1 mL/min, λ = 220 nm, tR (minor, amide 38) = 5.82 min, tR (major, amide 42) = 
7.28 min). TLC (30% ethyl acetate–hexanes) Rf = 0.41 (UV, KMnO4). 1H NMR (6:1 rotamer 
ratio, asterisk denotes minor rotamer peaks, 500 MHz, CDCl3), δ: 7.43 (d, 2H, J = 7.3 Hz), 7.33 
(t, 4H, J = 7.8 Hz), 7.13–7.30 (m, 9H), 6.82* (d, 2H, J = 7.3 Hz), 5.49 (d, 1H, J = 7.3 Hz), 5.32–
5.41 (m, 1H), 5.19* (d, 1H, J = 7.6 Hz), 4.52 (d, 1H, J = 5.3 Hz), 3.07–3.19* (m, 2H), 2.98–3.06 
(m, 2H), 2.94* (s, 3H), 2.82 (s, 3H), 2.61–2.71 (m, 1H), 1.09 (d, 3H, J = 6.4 Hz). 13C NMR (10:1 
rotamer ratio, asterisk denotes minor rotamer peaks, 125 MHz, CDCl3), δ: 177.9, 177.2*, 141.7, 
141.4*, 140.2*, 139.8, 136.9*, 136.8, 129.0*, 128.9, 128.5*, 128.3, 128.2, 128.17*, 128.1, 
128.0*, 127.9*, 127.9, 127.3, 127.3*, 127.2, 127.0*, 126.5, 126.1, 126.0*, 73.5, 72.9*, 67.0, 
65.2*, 40.9*, 39.7, 38.8, 38.4*, 35.0, 17.9*, 17.3. FTIR (neat), cm–1: 3360 (br), 3028, 1620 (s), 
1452 (m).  HRMS (ESI): Calcd for (C25H27NO2 + H)+: 374.2115. Found: 374.2105. 
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(S)-2-benzyl-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N-methylhexanamide (43) 
N,N-Diisopropylamine (2.51 mL, 17.6 mmol, 2.26 equiv) was added by syringe to a stirring 
suspension of lithium chloride (1.98 g, 46.7 mmol, 6.00 equiv) in tetrahydrofuran (20 mL) at 23 
ºC.  The resulting slurry was cooled to –78 ºC.  A freshly titrated solution of n-butyllithium in 
hexanes (2.53 M, 6.80 mL, 2.21 equiv) was added by syringe.  The reaction mixture was warmed 
briefly to 0 ºC (5 min) before cooling to –78 ºC.  An ice-cooled solution of amide 32 (2.80 g, 
7.79 mmol, 1 equiv) in tetrahydrofuran (13 mL with 5.9 mL rinse) was added by cannula. The 
reaction mixture was stirred for 1 h at –78 ºC, for 15 min at 0 ºC, and for 5 min at 23 ºC, then 
was cooled to –78 ºC, whereupon 1-iodobutane (2.22 mL, 19.5 mmol, 2.50 equiv) was added, 
and the reaction mixture was warmed to 0 ºC. After 3 h, saturated aqueous ammonium chloride 
solution (2 mL) was added to the ice-cold product mixture. The resulting biphasic mixture was 
partitioned between ethyl acetate (80 mL) and a 1:1 mixture of saturated aqueous sodium 
chloride solution and 1 N aqueous hydrochloric acid solution (100 mL). The layers were 
separated. The aqueous layer was extracted with two 60-mL portions of ethyl acetate. The 
combined organic extracts were dried over sodium sulfate. The dried solution was filtered, and 
the filtrate was concentrated. The residue was purified by flash column chromatography 
(5→40% ethyl acetate–hexanes) to provide amide 43 as a white solid (3.20 g, 99%, mp = 109–
111 ºC). The diastereomeric ratio of the purified product was determined to be ≥99:1 by chiral 
HPLC analysis (Chiralcel OD-H, 95:5 hexanes:i-PrOH, 1 mL/min, λ = 220 nm, tR(major, amide 
OH
N
CH3
O 1. LDA, LiCl, THF 
2. n-BuI, 0 ºC
          99%
      ≥99:1 dr
OH
N
CH3
O
CH3
32 43
 93 
43) = 5.73 min, tR(minor, amide 41) = 7.32 min). TLC (50% ethyl acetate–benzene): Rf = 0.41 
(UV, KMnO4). 1H NMR (10:1 rotamer ratio, asterisk denotes minor rotamer peaks, 500 MHz, 
CDCl3), δ: 7.37 (d, 2H, J = 7.6 Hz), 7.23–7.31 (m, 4H), 7.05–7.23 (m, 9H), 7.03* (d, 1H, J = 6.7 
Hz), 6.70* (d,, 1H, J = 7.6 Hz), 5.58 (d, 1H, J = 8.20 Hz), 5.18–5.28 (m, 1H), 5.15 (d, 1H, J = 
8.5 Hz), 3.87 (br s, 1H), 2.98* (s, 3H), 2.89–2.96 (m, 2H), 2.64–2.76 (m, 4H), 1.54–1.67 (m, 
1H), 1.38–1.49 (m, 1H), 1.28–1.38* (m, 2H), 1.17–1.28 (m, 2H), 1.07–1.16 (m, 2H), 0.91* (t, 
3H, J = 7.0 Hz), 0.82 (t, 3H, J = 7.3 Hz). 13C NMR (10:1 rotamer ratio, asterisk denotes minor 
rotamer peaks, 125 MHz, CDCl3), δ: 177.6, 176.8*, 141.6, 141.1*, 140.3*, 139.9, 136.9*, 
136.82, 129.0*, 128.9, 128.5*, 128.4, 128.2, 128.2, 128.1, 128.1*, 127.9*, 127.4, 127.28, 127.1*, 
126.7, 126.2, 125.9*, 73.4*, 73.3*, 66.4, 65.6*, 44.6, 44.2*, 38.8, 38.5*, 34.3, 32.7, 32.2*, 29.7*, 
29.4, 22.9*, 22.7, 14.0*, 13.8. FTIR (neat), cm–1: 3362 (br), 2929, 1620 (s), 1452 (m). HRMS 
(ESI): Calcd for (C28H33NO2 + H)+: 416.2584. Found: 416.2576.
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Acidic hydrolysis to form carboxylic acids: 
 
(R)-2-methylhexanoic acid (44) 
A biphasic solution of amide 37 (250 mg, 0.736 mmol, 1 equiv) in dioxane (1.2 mL) and 9 N 
aqueous sulfuric acid solution (1.2 mL) was heated for 5.5 h at 115 ºC and then cooled to 0 ºC.  
The pH of the mixture was adjusted to pH ≥ 10 by the slow addition of 5 N aqueous sodium 
hydroxide solution, and the resulting mixture was partitioned between water (10 mL) and 
dichloromethane (20 mL).  The layers were separated.  The aqueous layer was extracted with 
dichloromethane (2 x 20 mL).  The aqueous layer was acidified to pH ≤ 1 by the slow addition of 
9 N aqueous sulfuric acid solution.  The resulting acidic aqueous layer was extracted with 
dichloromethane (3 x 20 mL).  The latter organic extracts were combined and dried over sodium 
sulfate.  The dried solution was filtered, and the filtrate was concentrated to afford acid 44 as a 
clear liquid (85.0 mg, 89%).  Coupling of acid 44 (25.0 mg, 0.192 mmol, 1 equiv) with (R)-(α-
methylbenzyl)amine (29.3 μL, 0.230 mmol, 1.20 equiv) in the presence of 1-[3-
(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (55.2 mg, 0.288 mmol, 1.50 equiv), 
1-hydroxybenzotriazole hydrate (38.9 mg, 0.288 mmol, 1.50 equiv), and triethylamine (107 μL, 
0.768 mmol, 4.00 equiv) in N,N-dimethylformamide (640 μL) at 23 ºC for 20 h gave the 
corresponding (R)-(α-methylbenzyl)amide which was analyzed by chiral capillary GC to 
establish an ee of 92% for acid 44 (Restek Rt-βDEXsm column, 30 m, 0.23 mm ID, oven 
temperature 190 ºC, tR (minor) = 5.6 min, tR (major) = 5.9 min).  The characterization data 
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obtained for acid 44 were in agreement with values previously reported.7c 
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(R)-2-methyl-3-phenylpropanoic acid (45) 
A biphasic solution of amide 38 (500 mg, 1.34 mmol, 1 equiv) in dioxane (2.1 mL) and 9 N 
aqueous sulfuric acid solution (2.1 mL) was heated for 5.3 h at 115 ºC and then cooled to 0 ºC.  
The pH of the mixture was adjusted to pH ≥ 10 by the slow addition of 5 N aqueous sodium 
hydroxide solution, and the resulting mixture was partitioned between water (10 mL) and 
dichloromethane (20 mL).  The layers were separated.  The aqueous layer was extracted with 
dichloromethane (2 x 20 mL).  The aqueous layer was acidified to pH ≤ 1 by the slow addition of 
9 N aqueous sulfuric acid solution.  The resulting acidic aqueous layer was extracted with 
dichloromethane (3 x 20 mL).  The latter organic extracts were combined and dried over sodium 
sulfate.  The dried solution was filtered, and the filtrate was concentrated to afford acid 45 as a 
clear liquid (216 mg, 98%).  Coupling of acid 45 (25.0 mg, 0.152 mmol, 1 equiv) with (R)-(α-
methylbenzyl)amine (23.0 μL, 0.183 mmol, 1.20 equiv) in the presence of 1-[3-
(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (43.8 mg, 0.228 mmol, 1.50 equiv), 
1-hydroxybenzotriazole hydrate (30.9 mg, 0.228 mmol, 1.50 equiv), and triethylamine (85.0 μL, 
0.609 mmol, 4.00 equiv) in N,N-dimethylformamide (500 μL) at 23 ºC for 20 h gave the 
corresponding (R)-(α-methylbenzyl)amide which was analyzed by chiral capillary GC to 
establish an ee of 98% for acid 45 (Restek Rt-βDEXsm column, 30 m, 0.23 mm ID, oven 
temperature 190 ºC, tR (major) = 22.0 min, tR (minor) = 24.8 min).  The characterization data 
obtained for acid 45 were in agreement with values previously reported.7c 
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(S)-2-methylhexanoic acid (46) 
A biphasic solution of amide 40 (213 mg, 0.629 mmol, 1 equiv) in 1,4-dioxane (1.0 mL) and 9 N 
aqueous sulfuric acid solution (1.0 mL) was heated for 6 h at 115 ºC and then cooled to 0 ºC. The 
pH of the mixture was adjusted to pH ≥ 10 by the slow addition of 5 N aqueous sodium 
hydroxide solution, and the resulting mixture was partitioned between water (10 mL) and 
dichloromethane (20 mL).  The layers were separated.  The aqueous layer was extracted with 
dichloromethane (2 x 20 mL).  The aqueous layer was acidified to pH ≤ 1 by the slow addition of 
9 N aqueous sulfuric acid solution.  The resulting acidic aqueous layer was extracted with 
dichloromethane (3 x 20 mL).  The latter organic extracts were combined and dried over 
anhydrous sodium sulfate.  The dried solution was filtered, and the filtrate was concentrated to 
afford acid 46 as a clear liquid (75.9 mg, 93%). Coupling of acid 46 (32.8 mg, 0.252 mmol, 1 
equiv) with (R)-(α-methylbenzyl)amine (38.5 μL, 0.302 mmol, 1.20 equiv) in the presence of 1-
[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (72.4 mg, 0.378 mmol, 1.50 
equiv), 1-hydroxybenzotriazole hydrate (57.9 mg, 0.378 mmol, 1.50 equiv), and triethylamine 
(140 μL, 1.01 mmol, 4.00 equiv) in N,N-dimethyformamide (500 μL) at 23 ºC for 20 h gave the 
corresponding (R)-(α-methylbenzyl)amide which was analyzed by chiral capillary GC to 
establish an ee of 97% for acid 46 (Restek Rt-βDEXsm column, 30 m, 0.23 mm ID, oven 
temperature 190 ºC, tR(minor) = 5.57 min,  tR(major) = 5.91 min).  The characterization data 
obtained for acid 46 were in agreement with values previously reported.7c 
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(S)-2-benzylhexanoic acid (47) 
A biphasic solution of amide 43 (198 mg, 0.476 mmol, 1 equiv) in 1,4-dioxane (1.0 mL) and 9 N 
aqueous sulfuric acid solution (1.0 mL) was heated for 9 h at 115 ºC and then cooled to 0 ºC. The 
pH of the mixture was adjusted to pH ≥ 10 by the slow addition of 5 N aqueous sodium 
hydroxide solution, and the resulting mixture was partitioned between water (10 mL) and 
dichloromethane (20 mL).  The layers were separated.  The aqueous layer was extracted with 
dichloromethane (2 x 20 mL).  The aqueous layer was acidified to pH ≤ 1 by the slow addition of 
9 N aqueous sulfuric acid solution.  The resulting acidic aqueous layer was extracted with 
dichloromethane (3 x 20 mL).  The latter organic extracts were combined and dried over 
anhydrous sodium sulfate.  The dried solution was filtered, and the filtrate was concentrated to 
afford acid 47 as a clear liquid (91.0 mg, 93%).  Coupling of acid 47 (24.7 mg, 0.120 mmol, 1 
equiv) with (R)-(α-methylbenzyl)amine (18.3 μL, 0.144 mmol, 1.20 equiv) in the presence of 1-
[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (34.4 mg, 0.180 mmol, 1.50 
equiv), 1-hydroxybenzotriazole hydrate (27.5 mg, 0.180 mmol, 1.50 equiv), and triethylamine 
(66.8 μL, 0.479 mmol, 4.00 equiv) in N,N-dimethyformamide (500 μL) at 23 ºC for 20 h gave 
the corresponding (R)-(α-methylbenzyl)amide, which was analyzed by chiral capillary GC to 
establish an ee of 97% for acid 47 (Restek Rt-βDEXsm column, 30 m, 0.23 mm ID, oven 
temperature 190 ºC, tR(minor) = 45.8 min,  tR(major) = 47.9 min).  The characterization data 
obtained for acid 47 were in agreement with values previously reported.7c 
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Basic hydrolysis to form carboxylic acids: 
 
(R)-2-methylhexanoic acid (44) 
An aqueous solution of tetra-n-butylammonium hydroxide (40% w/w, 4.83 mL, 7.36 mmol, 5.00 
equiv) was added in one portion to a stirring biphasic mixture of amide 37 (500 mg, 1.47 mmol, 
1 equiv) in tert-butyl alcohol (5 mL) and water (15 mL).  The resulting biphasic mixture was 
stirred for 24 h at 95 ºC and then cooled to 23 ºC.  The biphasic mixture was partitioned between 
0.5 N aqueous sodium hydroxide solution (200 mL) and ether (30 mL).  The layers were 
separated.  The aqueous layer was extracted with two 30-mL portions of ether.  The aqueous 
layer was acidified to pH ≤ 1 by the addition of 3 N aqueous hydrochloric acid solution.  The 
resulting acidic aqueous solution was saturated with sodium chloride and then extracted with 
three 40-mL portions of ether.  The combined organic extracts were washed with water (15 mL) 
and then dried over sodium sulfate.  The dried solution was filtered, and the filtrate was 
concentrated to afford acid 44 as a clear liquid (180 mg, 94%).  Coupling of acid 44 (25.0 mg, 
0.192 mmol, 1 equiv) with (R)-(α-methylbenzyl)amine (29.3 μL, 0.230 mmol, 1.20 equiv) in the 
presence of 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (55.2 mg, 0.288 
mmol, 1.50 equiv), 1-hydroxybenzotriazole hydrate (38.9 mg, 0.288 mmol, 1.50 equiv), and 
triethylamine (107 μL, 0.768 mmol, 4.00 equiv) in N,N-dimethylformamide (640 μL) at 23 ºC 
for 20 h gave the corresponding (R)-(α-methylbenzyl)amide which was analyzed by chiral 
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capillary GC to establish an ee of 91% for acid 44 (Restek Rt-βDEXsm column, 30 m, 0.23 mm 
ID, oven temperature 190 ºC, tR (minor, amide) = 5.6 min, tR (major, amide) = 5.9 min).  The 
characterization data obtained for acid 44 were in agreement with values previously reported.7c 
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(R)-2-methyl-3-phenylpropanoic acid (45) 
An aqueous solution of tetra-n-butylammonium hydroxide (40% w/w, 4.39 mL, 6.69 mmol, 5.00 
equiv) was added in one portion to a stirring biphasic mixture of amide 38 (500 mg, 1.34 mmol, 
1 equiv) in tert-butyl alcohol (5 mL) and water (15 mL).  The resulting biphasic mixture was 
stirred for 24 h at 95 ºC and then cooled to 23 ºC.  The biphasic mixture was partitioned between 
0.5 N aqueous sodium hydroxide solution (200 mL) and ether (30 mL).  The layers were 
separated.  The aqueous layer was extracted with two 30-mL portions of ether.  The aqueous 
layer was acidified to pH ≤ 1 by the addition of 3 N aqueous hydrochloric acid solution.  The 
resulting acidic aqueous solution was saturated with sodium chloride and then extracted with 
three 35-mL portions of ether.  The combined organic extracts were washed with water (15 mL) 
and then dried over sodium sulfate.  The dried solution was filtered, and the filtrate was 
concentrated to afford acid 45 as a clear liquid (219 mg, 99%).  Coupling of acid 45 (25.0 mg, 
0.152 mmol, 1 equiv) with (R)-(α-methylbenzyl)amine (23.0 μL, 0.183 mmol, 1.20 equiv) in the 
presence of 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (43.8 mg, 0.228 
mmol, 1.50 equiv), 1-hydroxybenzotriazole hydrate (30.9 mg, 0.228 mmol, 1.50 equiv), and 
triethylamine (85.0 μL, 0.609 mmol, 4.00 equiv) in N,N-dimethylformamide (500 μL) at 23 ºC 
for 20 h gave the corresponding (R)-(α-methylbenzyl)amide which was analyzed by chiral 
capillary GC to establish an ee of 95% for acid 45 (Restek Rt-βDEXsm column, 30 m, 0.23 mm 
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ID, oven temperature 190 ºC, tR (major, amide) = 22.0 min, tR (minor, amide) = 24.8 min).  The 
characterization data obtained for acid 45 were in agreement with values previously reported.7c 
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(S)-2-methylhexanoic acid (46) 
An aqueous solution of tetra-n-butylammonium hydroxide (40% w/w, 4.84 mL, 7.39 mmol, 5.00 
equiv) was added in one portion to a stirring biphasic solution of amide 40 (501 mg, 1.48 mmol, 
1 equiv) and in tert-butyl alcohol (5.5 mL) and water (16.5 mL). The resulting biphasic mixture 
was stirred for 24 h at 95 ºC and then cooled to 23 ºC.  The biphasic mixture was partitioned 
between 0.5 N aqueous sodium hydroxide solution (200 mL) and ether (30 mL). The layers were 
separated. The aqueous layer was extracted with two 30-mL portions of ether. The aqueous layer 
was acidified to pH ≤ 1 by addition of 3 N aqueous hydrochloric acid solution. The acidic 
aqueous solution was extracted with three 30-mL portions of ether.  These combined organic 
extracts were washed sequentially with water (15 mL) and saturated aqueous sodium chloride 
solution (15 mL). The washed organic extracts were dried over sodium sulfate. The dried 
solution was filtered, and the filtrate was concentrated to afford acid 46 as a clear, colorless 
liquid (187 mg, 97%). Coupling of acid 46 (32.1 mg, 0.247 mmol, 1 equiv) with (R)-(α-
methylbenzyl)amine (37.7 μL, 0.296 mmol, 1.20 equiv) in the presence of 1-[3-
(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (70.9 mg, 0.370 mmol, 1.50 equiv), 
1-hydroxybenzotriazole hydrate (56.6 mg, 0.370 mmol, 1.50 equiv), and triethylamine (137 μL, 
0.986 mmol, 4.00 equiv) in N,N-dimethyformamide (500 μL) at 23 ºC for 20 h gave the 
corresponding (R)-(α-methylbenzyl)amide, which was analyzed by chiral capillary GC to 
establish an ee of 95% for acid 46 (Restek Rt-βDEXsm column, 30 m, 0.23 mm ID, oven 
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temperature 190 ºC, tR(minor) = 5.59 min,  tR(major) = 5.93 min).  The characterization data 
obtained for acid 46 were in agreement with values previously reported.7c 
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(R)-2-benzylhexanoic acid (48) 
An aqueous solution of tetra-n-butylammonium hydroxide (40% w/w, 3.95 mL, 6.03 mmol, 5.00 
equiv) was added in one portion to a stirring biphasic solution of amide 41 (501 mg, 1.21 mmol, 
1 equiv) and in tert-butyl alcohol (4.5 mL) and water (13.5 mL). The resulting biphasic mixture 
was stirred for 20 h at 95 ºC and then cooled to 23 ºC.   The mixture was partitioned between 0.5 
N aqueous sodium hydroxide solution (200 mL) and ether (30 mL). The layers were separated. 
The aqueous layer was extracted with two 30-mL portions of ether. The aqueous layer was 
acidified to pH ≤ 1 by addition of 3 N aqueous hydrochloric acid solution. The acidic aqueous 
solution was extracted with three 30-mL portions of ether. These combined organic extracts were 
washed sequentially with water (15 mL) and saturated aqueous sodium chloride solution (15 
mL). The washed organic extracts were dried over sodium sulfate. The dried solution was 
filtered, and the filtrate was concentrated to afford acid 48 as a clear, colorless liquid (245 mg, 
98%). Coupling of acid 48 (26.2 mg, 0.127 mmol, 1 equiv) with (R)-(α-methylbenzyl)amine 
(19.4 μL, 0.152 mmol, 1.20 equiv) in the presence of 1-[3-(dimethylamino)propyl]-3-
ethylcarbodiimide hydrochloride (36.5 mg, 0.191 mmol, 1.50 equiv), 1-hydroxybenzotriazole 
hydrate (29.2 mg, 0.191 mmol, 1.50 equiv), and triethylamine (70.8 μL, 0.508 mmol, 4.00 equiv) 
in N,N-dimethyformamide (500 μL) at 23 ºC for 20 h gave the corresponding (R)-(α-
methylbenzyl)amide, which was analyzed by chiral capillary GC to establish an ee of 90% for 
acid 48 (Restek Rt-βDEXsm column, 30 m, 0.23 mm ID, oven temperature 190 ºC, tR(major) = 
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45.9 min, tR(minor) = 47.8 min).  The characterization data obtained for acid 48 were in 
agreement with values previously reported.7c 
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(S)-2-methyl-3-phenylpropanoic acid (49) 
An aqueous solution of tetra-n-butylammonium hydroxide (40% w/w, 4.50 mL, 6.86 mmol, 5.00 
equiv) was added in one portion to a stirring biphasic solution of amide 42 (512 mg, 1.37 mmol, 
1 equiv) and in tert-butyl alcohol (5.17 mL) and water (15.5 mL). The resulting biphasic mixture 
was stirred for 24 h at 95 ºC and then cooled to 23 ºC.   The mixture was partitioned between 0.5 
N aqueous sodium hydroxide solution (200 mL) and ether (30 mL). The layers were separated. 
The aqueous layer was extracted with two 30-mL portions of ether. The aqueous layer was 
acidified to pH ≤ 1 by addition of 3 N aqueous hydrochloric acid solution. The acidic aqueous 
solution was extracted with three 30-mL portions of ether. These combined organic extracts were 
washed sequentially with water (15 mL) and saturated aqueous sodium chloride solution (15 
mL). The washed organic extracts were dried over sodium sulfate. The dried solution was 
filtered, and the filtrate was concentrated to afford acid 49 as a clear, colorless liquid (224 mg, 
99%). Coupling of acid 49 (31.3 mg, 0.191 mmol, 1 equiv) with (R)-(α-methylbenzyl)amine 
(29.1 μL, 0.229 mmol, 1.20 equiv) in the presence of 1-[3-(dimethylamino)propyl]-3-
ethylcarbodiimide hydrochloride (54.8 mg, 0.286 mmol, 1.50 equiv), 1-hydroxybenzotriazole 
hydrate (43.8 mg, 0.286 mmol, 1.50 equiv), and triethylamine (106 μL, 0.762 mmol, 4.00 equiv) 
in N,N-dimethyformamide (500 μL) at 23 ºC for 20 h gave the corresponding (R)-(α-
methylbenzyl)amide, which was analyzed by chiral capillary GC to establish an ee of 92% for 
acid 49 (Restek Rt-βDEXsm column, 30 m, 0.23 mmID, oven temperature 190 ºC, tR(minor) = 
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22.0 min,  tR(major) = 24.9 min). The characterization data obtained for acid 49 were in 
agreement with values previously reported.7c 
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Addition of organolithium reagents to form ketones: 
 
(R)-2-methyl-1-phenylheptan-3-one (50) 
Amide 38 (500 mg, 1.34 mmol, 1 equiv) was suspended in toluene (10 mL).  The suspension was 
warmed to 70 ºC to dissolve the amide, and the resulting solution was concentrated under 
reduced pressure.  The reaction flask was flushed with dry argon, ether (10.5 mL) was added, 
and the resulting suspension was cooled to –78 ºC.  A freshly titrated solution of n-butyllithium 
in hexanes (2.40 M, 1.34 mL, 2.40 equiv) was added by syringe, and the mixture was warmed to 
0 ºC and held at that temperature for 20 min.  Excess n-butyllithium was quenched at 0 ºC by the 
addition of N,N-diisopropylamine (0.188 mL, 1.34 mmol, 1 equiv).  After 15 min, a solution of 
acetic acid in ether (20% v/v, 10 mL) was added.  The mixture was partitioned between ethyl 
acetate (20 mL) and water (20 mL). The layers were separated. The aqueous layer was extracted 
with two 20-mL portions of dichloromethane.  The combined organic extracts were dried over 
sodium sulfate.  The dried solution was filtered, and the filtrate was concentrated.  The residue 
was purified by flash column chromatography (2→5% ethyl acetate–hexanes) to afford ketone 
50 as a clear, colorless liquid (261 mg, 95%).  Solid lithium aluminum hydride (13.9 mg, 0.367 
mmol, 1.50 equiv) was added to a solution of ketone 50 (50.0 mg, 0.245 mmol, 1 equiv) in ether 
(490 μL) at 0 ºC for 25 min to afford a mixture of diastereomeric alcohols. Acylation of the 
mixture of diastereomeric alcohols (7.50 mg, 0.036 mmol, 1 equiv) with (R)- or (S)-Mosher acid 
chloride (20.4 μL, 0.109 mmol, 3.00 equiv) in the presence of 4-(dimethylamino)-pyridine (22.2 
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mg, 0.182 mmol, 5.00 equiv) and triethylamine (25.3 μL, 0.182 mmol, 5.00 equiv) in 
dichloromethane (1 mL) at 23 ºC for 20 min, followed by 1H-NMR analysis of the corresponding 
Mosher ester derivatives, established that ketone 50 was of ≥95% ee. The characterization data 
obtained for ketone 50 were in agreement with values previously reported.7c 
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(R)-2-methyl-1-phenylhexan-1-one (51) 
Amide 37 (200 mg, 0.589 mmol, 1 equiv) was dissolved in toluene (5 mL).  The solution was 
warmed to 70 ºC and then was concentrated under reduced pressure.  The reaction flask was 
flushed with dry argon, tetrahydrofuran (10 mL) was added, and the resulting solution was 
cooled to –78 ºC.  A freshly titrated solution of phenyllithium in di-n-buytl ether (1.80 M, 0.982 
mL, 3.00 equiv) was added by syringe, and the mixture was stirred for 20 min at 0 ºC and for 10 
min at 23 ºC. Excess phenyllithium was quenched at 0 ºC by the addition of N,N-
diisopropylamine (83.0 μL, 0.589 mmol, 1.00 equiv).  After 15 min, a solution of trichloroacetic 
acid in ether (10% v/v, 10 mL) was added.  The mixture was partitioned between ethyl acetate 
(40 mL) and saturated aqueous sodium bicarbonate solution (50 mL). The layers were separated. 
The organic layer was washed sequentially with saturated aqueous sodium bicarbonate solution 
(50 mL) and water (50 mL).  The washed organic extract was dried over sodium sulfate.  The 
dried solution was filtered, and the filtrate was concentrated.  The residue was purified by flash 
column chromatography (0→5% ethyl acetate–hexanes) to afford ketone 51 as a pale yellow 
liquid (109 mg, 96%).  Solid lithium aluminum hydride (12.0 mg, 0.315 mmol, 1.50 equiv) was 
added to a solution of ketone 51 (40.0 mg, 0.210 mmol, 1 equiv) in ether (500 μL) at 0 ºC for 25 
min to afford a mixture of diastereomeric alcohols. Acylation of the mixture of diastereomeric 
alcohols (10.0 mg, 0.052 mmol, 1 equiv) with (R)- or (S)-Mosher acid chloride (29.1 μL, 0.156 
mmol, 3.00 equiv) in the presence of 4-(dimethylamino)-pyridine (31.8 mg, 0.260 mmol, 5.00 
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equiv) and triethylamine (36.2 μL, 0.260 mmol, 5.00 equiv) in dichloromethane (1 mL) at 23 ºC 
for 20 min, followed by 1H-NMR analysis of the corresponding Mosher ester derivatives, 
established that ketone 51 was of ≥93% ee. The characterization data obtained for ketone 51 
were in agreement with values previously reported.7c 
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(R)-3-benzylheptan-2-one (52) 
Amide 41 (203 mg, 0.489 mmol, 1 equiv) was suspended in toluene (4 mL).  The suspension was 
warmed to 70 ºC to dissolve the amide, and the resulting solution was concentrated under 
reduced pressure.  The reaction flask was flushed with dry argon, ether (5.0 mL) was added, and 
the resulting suspension was cooled to –78 ºC.  A freshly titrated solution of methyllithium in 
diethoxymethane (2.85 M, 515 μL, 3.00 equiv) was added by syringe, and the mixture was 
stirred for 30 min to 0 ºC and for 10 min at 23 ºC.  Excess methyllithium was quenched at 0 ºC 
by the addition of N,N-diisopropylamine (68.6 μL, 0.489 mmol, 1 equiv).  After 15 min, a 
solution of acetic acid in ether (10% v/v, 10 mL) was added.  The mixture was partitioned 
between ethyl acetate (40 mL) and saturated aqueous sodium bicarbonate solution (50 mL). The 
layers were separated. The organic layer was washed sequentially with saturated aqueous sodium 
bicarbonate solution (25 mL), water (25 mL), and saturated aqueous sodium chloride solution 
(25 mL). The washed organic layer was dried over sodium sulfate.  The dried solution was 
filtered, and the filtrate was concentrated. The residue was purified by flash column 
chromatography (1→5% ethyl acetate–hexanes) to afford ketone 52 as a clear, colorless liquid 
(97.5 mg, 98%). Solid lithium aluminum hydride (13.4 mg, 0.325 mmol, 1.50 equiv) was added 
to a solution of ketone 52 (48.0 mg, 0.235 mmol, 1 equiv) in ether (940 μL) at 0 ºC for 30 min to 
afford a mixture of diastereomeric alcohols. Acylation of the mixture of diastereomeric alcohols 
(10.0 mg, 0.048 mmol, 1 equiv) with (R)- or (S)-Mosher acid chloride (36.7 μL, 0.145 mmol, 
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3.00 equiv) in the presence of 4-(dimethylamino)-pyridine (29.6 mg, 0.242 mmol, 5.00 equiv) 
and triethylamine (34.0 μL, 0.242 mmol, 5.00 equiv) in dichloromethane (1.5 mL) at 23 ºC for 
10 h, followed by 1H-NMR analysis of the corresponding Mosher ester derivatives, established 
that ketone 52 was of ≥95% ee. The characterization data obtained for ketone 52 were in 
agreement with values previously reported.7c 
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Reduction with lithium amidotrihydroborate to form primary alcohols: 
 
(R)-2-methyl-3-phenylpropan-1-ol (53) 
A freshly titrated solution of n-butyllithium in hexanes (2.40 M, 2.18 mL, 3.90 equiv) was added 
by syringe to a stirring solution of N,N-diisopropylamine (0.79 mL, 5.62 mmol, 4.20 equiv) in 
tetrahydrofuran (5.6 mL) at –78 ºC.  The resulting solution was stirred at –78 ºC for 10 min, then 
was warmed to 0 ºC and held at that temperature for 10 min.  Borane-ammonia complex (90%, 
184 mg, 5.35 mmol, 4.00 equiv) was added in one portion, and the suspension was stirred at 0 ºC 
for 15 min and then was warmed to 23 ºC.  After 15 min, the solution was cooled to 0 ºC.  A 
solution of amide 38 (500 mg, 1.34 mmol, 1 equiv) in tetrahydrofuran (3.4 mL, followed by a 
0.6-mL rinse) was added via cannula.  The reaction mixture was allowed to warm to 23 ºC. After 
1 h, the reaction mixture was cooled in an ice-bath and 3 N aqueous hydrochloric acid solution 
(15 mL) was added carefully (Caution: evolution of dihydrogen).  After stirring for 30 min at 0 
ºC the product solution was extracted with four 20-mL portions of ether.  The combined organic 
extracts were washed sequentially with 3 N aqueous hydrochloric acid solution (15 mL), 2 N 
aqueous sodium hydroxide solution (15 mL), and saturated aqueous sodium chloride solution (15 
mL).  The washed organic extracts were dried over magnesium sulfate.  The dried solution was 
filtered, and the filtrate was concentrated.  The residue was purified by flash column 
chromatography (40→60% ether-pentane) to afford alcohol 53 as a clear liquid (183 mg, 91%).  
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Chiral HPLC analysis (Chiralcel OD-H, 95:5 hexanes:i-PrOH, 1 mL/min, λ = 220 nm, tR (minor, 
alcohol 55) = 8.23 min, tR (major, alcohol 53) = 9.57 min) of alcohol 53 established that alcohol 
53 was of 98% ee.  The characterization data obtained for alcohol 53 were in agreement with 
values previously reported.7c 
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(R)-2-benzylhexan-1-ol (54) 
A freshly titrated solution of n-butyllithium in hexanes (2.46 M, 767 μL, 3.90 equiv) was added 
by syringe to a stirring solution of N,N-diisopropylamine (290 μL, 2.03 mmol, 4.20 equiv) in 
tetrahydrofuran (1.4 mL) at –78 ºC. The resulting solution was stirred at –78 ºC for 10 min, then 
was warmed to 0 ºC and held at that temperature for 10 min. Borane–ammonia complex (90%, 
66.4 mg, 1.93 mmol, 4.00 equiv) was added in one portion, and the suspension was stirred at 0 
ºC for 15 min and then was warmed to 23 ºC.  After 15 min, the solution was cooled to 0 ºC. A 
solution of amide 41 (201 mg, 0.484 mmol, 1 equiv) in tetrahydrofuran (1.0 mL, followed by a 
1.0 mL rinse) was added via cannula. The reaction mixture was allowed to warm to 23 ºC. After 
1.5 h, the reaction mixture was cooled in an ice-bath and 3 N aqueous hydrochloric acid solution 
(6 mL) was added carefully (Caution: evolution of dihydrogen). After stirring for 30 min at 0 ºC, 
the product solution was extracted with four 10-mL portions of ether.  The combined organic 
extracts were washed sequentially with 3 N aqueous hydrochloric acid solution (10 mL), 2 N 
aqueous sodium hydroxide solution (6 mL), and saturated aqueous sodium chloride solution (6 
mL). The washed organic extracts were dried over magnesium sulfate. The dried solution was 
filtered, and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel pre-treated with 20% triethylamine–hexanes (20% ethyl acetate–
hexanes) to afford alcohol 54 as a clear, colorless liquid (82.5 mg, 89%).  Chiral HPLC analysis 
OH
N
CH3
O LiH2NBH3
THF, 0 → 23 ºC
89%
95% ee
HO
41 54
CH3 CH3
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(Chiralcel OD-H, 95:5 hexanes:i-PrOH, 1 mL/min, λ = 220 nm, tR (minor) = 6.68 min, tR (major, 
alcohol 54) = 8.12 min) of alcohol 54 established that alcohol 54 was of 95% ee.  The 
characterization data obtained for alcohol 54 were in agreement with values previously 
reported.7c 
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(S)-2-methyl-3-phenylpropan-1-ol (55) 
A freshly titrated solution of n-butyllithium in hexanes (2.45 M, 2.21 mL, 3.90 equiv) was added 
by syringe to a stirring solution of N,N-diisopropylamine (830 μL, 5.83 mmol, 4.20 equiv) in 
tetrahydrofuran (5.0 mL) at –78 ºC.  The resulting solution was stirred at   –78 ºC for 10 min, 
then was warmed to 0 ºC and held at that temperature for 10 min. Borane–ammonia complex 
(90%, 190 mg, 5.55 mmol, 4.00 equiv) was added in one portion, and the suspension was stirred 
at 0 ºC for 15 min and then was warmed to 23 ºC.  After 15 min, the solution was cooled to 0 ºC. 
A solution of amide 42 (518 mg, 1.39 mmol, 1 equiv) in tetrahydrofuran (4.0 mL, followed by a 
0.91 mL rinse) was added via cannula. The reaction mixture was allowed to warm to 23 ºC. After 
1 h, the reaction mixture was cooled in an ice-bath and 3 N aqueous hydrochloric acid solution 
(15 mL) was added carefully (Caution: evolution of dihydrogen). After stirring for 30 min at 0 
ºC, the product solution was extracted with four 20-mL portions of ether.  The combined organic 
extracts were washed sequentially with 3 N aqueous hydrochloric acid solution (15.0 mL), 2 N 
aqueous sodium hydroxide solution (15 mL), and saturated aqueous sodium chloride solution (15 
mL). The organic solution was dried over magnesium sulfate. The dried solution was filtered, 
and the filtrate was concentrated. The residue was purified by flash column chromatography on 
silica gel pre-treated with 20% triethylamine–hexanes (25% ethyl acetate–hexanes) to afford 
alcohol 55 as a clear, colorless liquid (195 mg, 94%).  Chiral HPLC analysis (Chiralcel OD-H, 
95:5 hexanes:i-PrOH, 1 mL/min, λ = 220 nm, tR (major, alcohol 55) = 8.40 min, tR (minor, 
OH
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87% ee
HO
CH3CH3
42 55
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alcohol 53) = 9.97 min) of alcohol 55 established that alcohol 55 was of 87% ee.  The 
characterization data obtained for alcohol 55 were in agreement with values previously 
reported.7c 
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Enolization–alkylation of α,α-disubstituted pseudoephenamine amides depicted in Table 2: 
 
(R)-2-ethyl-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N,2-dimethylpent-4-enamide (56) 
N,N-Diisopropylamine (131 μL, 0.938 mmol, 2.92 equiv) was added by syringe to a stirring 
suspension of lithium chloride (123 mg, 2.89 mmol, 9.00 equiv) in tetrahydrofuran (600 μL) at 
23 ºC.  The resulting slurry was cooled to –78 ºC.  A freshly titrated solution of n-butyllithium in 
hexanes (2.38 M, 394 μL, 2.92 equiv) was added by syringe.  The reaction mixture was warmed 
briefly to 0 ºC (5 min), then was cooled to –78 ºC. An ice-cooled solution of amide 36 (150 mg, 
0.482 mmol, 1.50 equiv) in tetrahydrofuran (600 μL) was then added by syringe. The transfer 
was quantitated with tetrahydrofuran (400 μL).  The reaction mixture was stirred for 3 h at 0 ºC.  
The yellow heterogeneous mixture was cooled to –40 ºC, then DMPU (146 μL, 1.21 mmol, 3.76 
equiv) was added by syringe and stirring was continued for 15 min at –40 ºC, whereupon allyl 
bromide (28.0 μL, 0.321 mmol, 1 equiv) was added by syringe.  The mixture was stirred for 5 h 
at –40 ºC, then saturated aqueous ammonium chloride solution (1.5 mL) was added and the 
biphasic mixture was warmed to 23 ºC.  The biphasic mixture was partitioned between ethyl 
acetate (20 mL) and a 1:1 mixture of saturated aqueous sodium chloride solution and 1 N 
aqueous hydrochloric acid solution (30 mL).  The layers were separated.  The aqueous layer was 
extracted with two 20-mL portions of ethyl acetate. The combined organic extracts were dried 
over sodium sulfate.  The dried solution was filtered, and the filtrate was concentrated.  The 
OH
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CH3
CH3
1. LDA, LiCl, THF, 0 ºC
2. DMPU, 
    CH2=CHCH2Br (1 equiv),
    –40 ºC
                 99%
             ≥19:1 dr
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residue was purified by flash column chromatography (10→50% ethyl acetate–hexanes) to 
provide amide 56 as a white solid (113 mg, 99%). The diastereomeric ratio of the purified 
product was determined to be ≥19:1 by 1H NMR analysis of the corresponding cyclic 
oxazolinium triflate derivative (see below). TLC (40% Ethyl acetate–hexanes): Rf = 0.69 (UV, 
KMnO4).  1H NMR (500 MHz, CDCl3), δ: 7.45-7.16 (m, 10H), 5.87 (d, 1H, J = 9.5 Hz), 5.85-
5.75 (m, 1H), 5.32 (dd, 1H, J = 9.0, 7.0 Hz), 5.13-5.05 (m, 2H), 3.77 (d, 1H, J = 5.5 Hz), 2.97 (s, 
3H), 2.59 (dd, 1H, J = 14.0, 6.5 Hz), 2.23 (dd, 1H, J = 14.0, 7.5 Hz), 1.77 (dq, 1H, J = 14.5, 7.5 
Hz), 1.52 (dq, 1H, J = 15.0, 7.5 Hz), 1.23 (s, 3H), 0.80 (t, 3H, J = 7.5 Hz).  13C NMR (125 MHz, 
CDCl3), δ:  178.2, 141.8, 136.9, 134.7, 128.9, 128.3, 128.2, 127.6, 127.5, 127.1, 117.7, 73.0, 
66.0, 47.4, 43.7, 33.5, 31.6, 23.9, 8.9.  FTIR (neat), cm–1: 3406 (br), 2974, 1601 (s), 1452, 1080, 
912.  HRMS (ESI): Calcd for (C23H29NO2 + H)+: 352.2271. Found: 352.2263. 
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Oxazolinium triflate (96)  
Trifluoromethanesulfonic anhydride (19.0 μL, 0.114 mmol, 2.00 equiv) was added dropwise by 
syringe to a stirring solution of the α-quaternary amide 56 (20.0 mg, 0.057 mmol, 1 equiv) and 
pyridine (14.0 μL, 0.171 mmol, 3.00 equiv) in dichloromethane (2 mL) at 0 °C. The reaction 
mixture was stirred for 10 min at 0 °C. The product solution was concentrated by rotary 
evaporation at ~40 mmHg, then with a vacuum manifold at 0.1 mmHg for 3 h. The 
diastereomeric ratio of the residue was determined to be ≥19:1 by 1H NMR analysis. 1H NMR 
(≥19:1 diastereomeric ratio, asterisk denotes pyridinium ion peaks, 500 MHz, CDCl3), δ: 8.92* 
(t, 1H, J = 5.9 Hz), 8.57* (t, 1H, J = 8.1 Hz), 8.08* (t, 1H, J = 6.6 Hz), 7.24-7.12 (m, 6H), 6.98-
6.91 (m, 4H), 6.89 (d, 1H, J = 11.0 Hz), 6.34 (d, 1H, J = 10.5 Hz), 5.99-5.88 (m, 1H), 5.44-5.27 
(m, 2H), 3.50 (s, 3H),  2.79 (dd, 1H, J = 14.5, 7.5 Hz), 2.63 (dd, 1H, J = 14.0, 6.5 Hz), 2.17 (dq, 
1H, J = 14.5, 7.5 Hz), 1.91 (dq, 1H, J = 15.5, 8.0 Hz), 1.64 (s, 3H), 1.19 (t, 3H, J = 7.5 Hz). 
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(R)-2-benzyl-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N,2-dimethylbutanamide (57) 
N,N-Diisopropylamine (113 μL, 0.952 mmol, 2.28 equiv) was added by syringe to a stirring 
suspension of lithium chloride (124 mg, 2.92 mmol, 7.00 equiv) in tetrahydrofuran (700 μL) at 
23 ºC.  The resulting slurry was cooled to –78 ºC.  A freshly titrated solution of n-butyllithium in 
hexanes (2.38 M, 400 μL, 2.28 equiv) was added by syringe.  The reaction mixture was warmed 
briefly to 0 ºC (5 min), then was cooled to     –78 ºC.  An ice-cooled solution of amide 36 (156 
mg, 0.501 mmol, 1.20 equiv) in tetrahydrofuran (600 μL) was then added by syringe.  The 
transfer was quantitated with tetrahydrofuran (400 μL).  The reaction mixture was stirred for 3 h 
at 0 ºC.  The yellow heterogeneous mixture was cooled to –40 ºC, then DMPU (164 μL, 1.35 
mmol, 3.25 equiv) was added by syringe and stirring was continued for 15 min at –40 ºC, 
whereupon benzyl bromide (50.0 μL, 0.417 mmol, 1 equiv) was added by syringe.  The mixture 
was stirred for 1.25 h at –40 ºC, then saturated aqueous ammonium chloride solution (1.5 mL) 
was added and the biphasic mixture was warmed to 23 ºC.  The biphasic mixture was partitioned 
between ethyl acetate (20 mL) and a 1:1 mixture of saturated aqueous sodium chloride solution 
and 1 N aqueous hydrochloric acid solution (30 mL).  The layers were separated.  The aqueous 
layer was extracted with two 20-mL portions of ethyl acetate. The combined organic extracts 
were dried over sodium sulfate.  The dried solution was filtered, and the filtrate was 
concentrated.  The residue was purified by flash column chromatography (10→50% ethyl 
acetate–hexanes) to provide amide 57 as an off-white solid (143 mg, 85%).  The diastereomeric 
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ratio of the purified product was determined to be ≥19:1 by 1H NMR analysis of the 
corresponding cyclic oxazolinium triflate derivative (see below). TLC (40% Ethyl acetate–
hexanes): Rf = 0.69 (UV, KMnO4).  1H NMR (500 MHz, CDCl3), δ: 7.46-7.08 (m, 15H), 5.85 (d, 
1H, J = 9.0 Hz), 5.33 (dd, 1H, J = 9.5, 7.0 Hz), 3.69 (d, 1H, J = 6.0 Hz), 3.12 (d, 1H, J = 14.0 
Hz), 2.94 (s, 3H), 2.81 (d, 1H, J = 13.5 Hz), 1.93 (dq, 1H, J = 14.5, 7.5 Hz), 1.42 (dq, 1H, J = 
15.0, 7.5 Hz), 1.20 (s, 3H), 0.81 (t, 3H, J = 7.7 Hz).  13C NMR (125 MHz, CDCl3), δ:  178.5, 
141.9, 137.9, 136.8, 130.5, 129.1, 128.4, 128.2, 128.0, 127.7, 127.6, 127.1, 126.4, 73.3, 66.3, 
48.8, 45.3, 33.7, 32.2, 23.6, 9.0.  FTIR (neat), cm–1: 3404 (br), 2970, 1601 (s), 1452, 1080, 908.  
HRMS (ESI): Calcd for (C27H31NO2 + H)+: 402.2428. Found: 402.2423. 
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Oxazolinium triflate (97) 
Trifluoromethanesulfonic anhydride (17.0 μL, 0.100 mmol, 2.00 equiv) was added dropwise by 
syringe to a stirring solution of the α-quaternary amide 57 (20.0 mg, 0.050 mmol, 1 equiv) and 
pyridine (12.0 μL, 0.149 mmol, 3.00 equiv) in dichloromethane (2 mL) at 0 °C. The reaction 
mixture was stirred for 10 min at 0 °C. The product solution was concentrated by rotary 
evaporation at ~40 mmHg, then with a vacuum manifold at 0.1 mmHg for 3 h. The 
diastereomeric ratio of the residue was determined to be ≥19:1 by 1H NMR analysis. 1H NMR 
(≥19:1 diastereomeric ratio, asterisk denotes pyridinium ion peaks, 500 MHz, CDCl3), δ: 8.88* 
(d, 1H, J = 4.9 Hz), 8.47* (t, 1H, J = 7.8 Hz), 7.99* (t, 1H, J = 7.1 Hz), 7.54-7.03 (m, 14H), 
6.87-6.80 (m, 2H), 6.41 (d, 1H, J = 11.5 Hz), 3.36 (s, 3H), 3.29 (d, 1H, J = 14.5 Hz), 3.22 (d, 1H, 
J = 14.0 Hz), 2.30 (dq, 1H, J = 14.5, 7.5 Hz), 1.83 (dq, 1H, J = 15.0, 7.5 Hz), 1.67 (s, 3H), 1.24 
(t, 3H, J = 7.7 Hz). 
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(R)-2-(2-bromo-5-methoxybenzyl)-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N,2-
dimethylbutanamide (58) 
 
N,N-Diisopropylamine (176 μL, 1.25 mmol, 2.93 equiv) was added by syringe to a stirring 
suspension of lithium chloride (163 mg, 3.85 mmol, 9.00 equiv) in tetrahydrofuran (700 μL) at 
23 ºC.  The resulting slurry was cooled to –78 ºC.  A freshly titrated solution of n-butyllithium in 
hexanes (2.38 M, 527 μL, 2.93 equiv) was added by syringe.  The reaction mixture was warmed 
briefly to 0 ºC (5 min), then was cooled to –78 ºC. An ice-cooled solution of amide 36 (200 mg, 
0.642 mmol, 1.50 equiv) in tetrahydrofuran (600 μL) was then added by syringe.  The transfer 
was quantitated with tetrahydrofuran (400 μL).  The reaction mixture was stirred for 3 h at 0 ºC.  
The yellow heterogeneous mixture was cooled to –20 ºC, then DMPU (194 μL, 1.60 mmol, 3.74 
equiv) was added by syringe and stirring was continued for 15 min at –20 ºC, whereupon 2-
bromo-5-methoxybenzyl bromide (120 mg, 0.428 mmol, 1 equiv) in THF (500 μL) was added by 
syringe.  The mixture was stirred for 2 h at –20 ºC, then saturated aqueous ammonium chloride 
solution (1.5 mL) was added and the biphasic mixture was warmed to 23 ºC. The biphasic 
mixture was partitioned between ethyl acetate (20 mL) and a 1:1 mixture of saturated aqueous 
sodium chloride solution and 1 N aqueous hydrochloric acid solution (30 mL).  The layers were 
separated.  The aqueous layer was extracted with two 20-mL portions of ethyl acetate. The 
combined organic extracts were dried over sodium sulfate.  The dried solution was filtered, and 
the filtrate was concentrated.  The residue was purified by flash column chromatography 
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(10→40% ethyl acetate–hexanes) to provide amide 58 as a white foam/solid (198 mg, 91%). The 
diastereomeric ratio of the purified product was determined to be ≥19:1 by 1H NMR analysis of 
the corresponding cyclic oxazolinium triflate derivative (see below).TLC (40% Ethyl acetate–
hexanes): Rf = 0.59 (UV, KMnO4). 1H NMR (500 MHz, CDCl3), δ: 7.42-7.41 (m, 1H), 7.30-7.17 
(m, 10H), 6.96 (d, 1H, J = 3.0 Hz), 6.64 (dd, 1H, J = 9.0, 3.0 Hz), 5.94 (d, 1H, J = 9.5 Hz), 5.34 
(d, 1H, J = 9.0 Hz), 3.73 (s, 3H), 3.27 (d, 1H, 15.0 Hz), 3.12 (d, 1H, J = 15.0 Hz), 3.03 (s, 3H), 
2.02 (sxt, 1H, J = 7.5 Hz), 1.51 (sxt, 1H, J =7.5 Hz), 1.24 (s, 3H), 0.80 (t, 3H, J = 7.5 Hz).  13C 
NMR (125 MHz, CDCl3), δ: 178.5, 158.6, 141.9, 138.8, 136.8, 133.3, 128.9, 128.4, 128.3, 127.8, 
127.6, 127.1, 117.6, 116.6, 113.6, 73.3, 66.1, 55.4, 49.2, 43.4, 33.8, 32.2, 23.2, 9.0.  FTIR (neat), 
cm–1: 3402 (br), 2969, 1597 (m), 1471 (m), 1384, 1240 (m). HRMS (ESI): Calcd for 
(C28H32BrNO3 + H)+: 510.1638. Found: 510.1631. 
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Oxazolinium triflate (98) 
Trifluoromethanesulfonic anhydride (13.2 μL, 0.078 mmol, 2.00 equiv) was added dropwise by 
syringe to a stirring solution of the α-quaternary amide 58 (20.0 mg, 0.039 mmol, 1 equiv) and 
pyridine (9.47 μL, 0.118 mmol, 3.00 equiv) in dichloromethane (2 mL) at 0 °C. The reaction 
mixture was stirred for 10 min at 0 °C. The product solution was concentrated by rotary 
evaporation at ~40 mmHg, then with a vacuum manifold at 0.1 mmHg for 3 h. The 
diastereomeric ratio of the residue was determined to be ≥19:1 by 1H NMR analysis. 1H NMR 
(≥19:1 diastereomeric ratio, asterisk denotes pyridinium ion peaks, 500 MHz, CDCl3), δ: 8.91* 
(d, 1H, J = 5.0 Hz), 8.56* (t, 1H, J = 8.0 Hz), 8.07* (t, 1H, J = 7.0 Hz), 7.55 (d, 1H, J = 9.0 Hz), 
7.22-7.11 (m, 8H), 6.97-6.96 (m, 1H), 6.94 (d, 1H, J = 3.5 Hz), 6.90-6.87 (m,2H), 6.79, (dd, 1H, 
J = 8.5, 3.0 Hz), 6.37 (d, 1H, J = 10.5 Hz), 3.83 (s, 3H), 3.51 (s, 3H),  3.50 (d, 1H, J = 14.0 Hz), 
3.44 (d, 1H, J = 14.0 Hz), 2.40 (sxt, 1H, J = 7.3 Hz), 1.85 (sxt, 1H, J = 7.3 Hz), 1.68 (s, 3H), 
1.21 (t, 3H, J = 7.3 Hz). 
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(R)-2-benzyl-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N,2-dimethylhexanamide (59) 
N,N-Diisopropylamine (161 μL, 1.15 mmol, 2.93 equiv) was added by syringe to a stirring 
suspension of lithium chloride (150 mg, 3.53 mmol, 9.00 equiv) in tetrahydrofuran (800 μL) at 
23 ºC.  The resulting slurry was cooled to –78 ºC.  A freshly titrated solution of n-butyllithium in 
hexanes (2.38 M, 484 μL, 2.93 equiv) was added by syringe.  The reaction mixture was warmed 
briefly to 0 ºC (5 min), then was cooled to –78 ºC.  An ice-cooled solution of amide 37 (200 mg, 
0.589 mmol, 1.50 equiv) in tetrahydrofuran (700 μL) was then added by syringe.  The transfer 
was quantitated with tetrahydrofuran (500 μL).  The reaction mixture was stirred for 3 h at 0 ºC.  
The yellow heterogeneous mixture was cooled to –40 ºC, then DMPU (178 μL, 1.47 mmol, 3.74 
equiv) was added by syringe and stirring was continued for 15 min at –40 ºC, whereupon benzyl 
bromide (46.7 μL, 0.393 mmol, 1 equiv) was added by syringe.  The mixture was stirred for 3.5 
h at –40 ºC, then saturated aqueous ammonium chloride solution (1.5 mL) was added and the 
biphasic mixture was warmed to 23 ºC.  The biphasic mixture was partitioned between ethyl 
acetate (20 mL) and a 1:1 mixture of saturated aqueous sodium chloride solution and 1 N 
aqueous hydrochloric acid solution (30 mL).  The layers were separated.  The aqueous layer was 
extracted with two 20-mL portions of ethyl acetate. The combined organic extracts were dried 
over sodium sulfate.  The dried solution was filtered, and the filtrate was concentrated.  The 
residue was purified by flash column chromatography (10→30% ethyl acetate–hexanes) to 
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provide amide 59 as an off-white solid (147 mg, 87%). The diastereomeric ratio of the purified 
product was determined to be ≥19:1 by 1H NMR analysis of the corresponding cyclic 
oxazolinium triflate derivative (see below). TLC (40% Ethyl acetate–hexanes): Rf = 0.81 (UV, 
KMnO4).  1H NMR (500 MHz, CDCl3), δ: 7.41-7.15 (m, 15H), 5.84 (d, 1H, J = 9.0 Hz), 5.32 (d, 
1H, J = 9.0 Hz), 3.13 (d, 1H, J = 13.5 Hz), 2.81 (d, 1H, J = 13.5 Hz), 1.84 (dt, 1H, J = 13.0, 4.0 
Hz), 1.34 (dt, 1H, J = 12.5, 4.0 Hz), 1.28-1.22 (m 2H), 1.20 (s, 3H), 1.09-1.04 (m, 2H), 0.81 (t, 
3H, J = 7.5 Hz). 13C NMR (125 MHz, CDCl3), δ: 178.7, 141.9, 137.8, 136.8, 130.4, 129.1, 128.4, 
128.2, 128.0, 127.7, 127.6, 127.1, 126.4, 73.2, 66.4, 48.4, 45.6, 39.4, 33.7, 26.7, 24.3, 23.3, 13.9.  
FTIR (neat), cm–1: 3410 (br), 2956, 1601 (m), 1452, 1078, 908.  HRMS (ESI): Calcd for 
(C29H35NO2 + H)+: 430.2741. Found: 430.2735. 
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Oxazolinium triflate (99) 
Trifluoromethanesulfonic anhydride (15.7 μL, 0.093 mmol, 2.00 equiv) was added dropwise by 
syringe to a stirring solution of the α-quaternary amide 99 (20.0 mg, 0.047 mmol, 1 equiv) and 
pyridine (11.3 μL, 0.140 mmol, 3.00 equiv) in dichloromethane (2 mL) at 0 °C. The reaction 
mixture was stirred for 10 min at 0 °C. The product solution was concentrated by rotary 
evaporation at ~40 mmHg, then with a vacuum manifold at 0.1 mmHg for 3 h. The 
diastereomeric ratio of the residue was determined to be ≥19:1 by 1H NMR analysis. 1H NMR 
(≥19:1 diastereomeric ratio, asterisk denotes pyridinium ion peaks, 500 MHz, CDCl3), δ: 8.88* 
(t, 1H, J = 6.1 Hz), 8.56* (t, 1H, J = 7.7 Hz), 8.06* (t, 1H, J = 6.5 Hz), 7.47-7.08 (m, 14H), 6.86 
(d, 1H, J = 6.5 Hz), 6.81 (d, 1H, J = 11.0 Hz), 6.37 (d, 1H, J = 10.5 Hz), 3.34 (s, 3H),  3.29 (d, 
1H, J = 14.0 Hz), 3.21 (d, 1H, J = 14.0 Hz), 2.19 (dt, 1H, J = 14.0, 3.2 Hz), 1.75 (dt, 1H, J = 
13.8, 4.3 Hz), 1.67 (s, 3H), 1.60-1.44 (m, 4H), 0.99 (t, 3H, J = 7.0 Hz). 
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(S)-2-benzyl-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N,2-dimethylbutanamide (60) 
N,N-Diisopropylamine (110 μL, 0.784 mmol, 2.93 equiv) was added by syringe to a stirring 
suspension of lithium chloride (102 mg, 2.41 mmol, 9.00 equiv) in tetrahydrofuran (500 μL) at 
23 ºC.  The resulting slurry was cooled to –78 ºC.  A freshly titrated solution of n-butyllithium in 
hexanes (2.38 M, 330 μL, 2.93 equiv) was added by syringe.  The reaction mixture was warmed 
briefly to 0 ºC (5 min), then was cooled to –78 ºC.  An ice-cooled solution of amide 38 (150 mg, 
0.402 mmol, 1.50 equiv) in tetrahydrofuran (500 μL) was then added by syringe.  The transfer 
was quantitated with tetrahydrofuran (340 μL).  The reaction mixture was stirred for 3 h at 0 ºC.  
Then, DMPU (121 μL, 1.00 mmol, 3.74 equiv) was added by syringe and stirring was continued 
for 15 min at 0 ºC, whereupon iodoethane (21.5 μL, 0.268 mmol, 1 equiv) was added by syringe.  
The mixture was stirred for 18.5 h at 0 ºC, then saturated aqueous ammonium chloride solution 
(1.5 mL) was added and the biphasic mixture was warmed to 23 ºC.  The biphasic mixture was 
partitioned between ethyl acetate (20 mL) and a 1:1 mixture of saturated aqueous sodium 
chloride solution and 1 N aqueous hydrochloric acid solution (30 mL).  The layers were 
separated.  The aqueous layer was extracted with two 20-mL portions of ethyl acetate. The 
combined organic extracts were dried over sodium sulfate.  The dried solution was filtered, and 
the filtrate was concentrated.  The residue was purified by flash column chromatography 
(10→50% ethyl acetate–hexanes) to provide amide 60 as a yellow semi-solid (89.0 mg, 83%, 
mixture of diastereomers).  The diastereomeric ratio of the purified product was determined to be 
OH
N
CH3
O
CH3
1. LDA, LiCl, THF, 0 ºC
2. DMPU, EtI (1 equiv),
    0 ºC
               80%
             9.91 dr
OH
N
O
CH3
CH3
38 60
CH3
 134 
9.9:1 by 1H NMR analysis.  The diastereomers were separated by radial chromatography 
(10→30% ethyl acetate–hexanes) to provide amide 60 as a clear, colorless semi-solid (77.0 mg, 
71%) and amide 57 as a white solid (6.0 mg, 6%). TLC (40% Ethyl acetate–hexanes): Rf = 0.65 
(UV, KMnO4).  1H NMR (500 MHz, CDCl3), δ: 7.40-7.03 (m, 15H), 5.92 (d, 1H, J = 9.0 Hz), 
5.31 (d, 1H, J = 9.0 Hz), 3.73 (br, 1H), 3.09 (d, 1H, J = 14.0 Hz), 2.96 (s, 3H), 2.73 (d, 1H, J = 
13.5 Hz), 2.03 (app sxt, 1H, J = 7.2 Hz), 1.45 (app sxt, 1H, J = 7.2 Hz), 1.21 (s, 3H), 0.94 (t, 3H, 
J = 7.5 Hz).  13C NMR (125 MHz, CDCl3), δ: 178.7, 141.9, 137.8, 136.5, 130.4, 129.4, 128.4, 
128.3, 128.0, 127.7, 127.1, 126.4, 73.3, 66.0, 49.0, 44.9, 33.1, 32.8, 23.8, 9.2. FTIR (neat), cm–1: 
3404 (br), 2974, 1601 (s), 1452 (m), 1386, 1078 (m).  HRMS (ESI): Calcd for (C27H31NO2 + H)+: 
402.2428. Found: 402.2419.   
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(S)-2-benzyl-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N,2-dimethylpent-4-enamide (61) 
N,N-Diisopropylamine (110 μL, 0.785 mmol, 2.54 equiv) was added by syringe to a stirring 
suspension of lithium chloride (102 mg, 2.41 mmol, 7.80 equiv) in tetrahydrofuran (500 μL) at 
23 ºC.  The resulting slurry was cooled to –78 ºC. A freshly titrated solution of n-butyllithium in 
hexanes (2.38 M, 330 μL, 2.54 equiv) was added by syringe. The reaction mixture was warmed 
briefly to 0 ºC (5 min), then was cooled to –78 ºC.  An ice-cooled solution of amide 38 (150 mg, 
0.402 mmol, 1.30 equiv) in tetrahydrofuran (500 μL) was then added by syringe.  The transfer 
was quantitated with tetrahydrofuran (340 μL). The reaction mixture was stirred for 3 h at 0 ºC.  
The yellow heterogeneous mixture was cooled to –40 ºC, then DMPU (121 μL, 1.00 mmol, 3.25 
equiv) was added by syringe and stirring was continued for 15 min at –40 ºC, whereupon allyl 
bromide (27.0 μL, 0.309 mmol, 1 equiv) was added by syringe.  The mixture was stirred for 1.3 
h at –40 ºC, then saturated aqueous ammonium chloride solution (1.5 mL) was added and the 
biphasic mixture was warmed to 23 ºC.  The biphasic mixture was partitioned between ethyl 
acetate (20 mL) and a 1:1 mixture of saturated aqueous sodium chloride solution and 1 N 
aqueous hydrochloric acid solution (30 mL).  The layers were separated.  The aqueous layer was 
extracted with two 20-mL portions of ethyl acetate. The combined organic extracts were dried 
over sodium sulfate.  The dried solution was filtered, and the filtrate was concentrated.  The 
residue was purified by flash column chromatography (10→50% ethyl acetate–hexanes) to 
provide amide 61 as a pale-yellow semi-solid (105 mg, 82%). The diastereomeric ratio of the 
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purified product was determined to be ≥19:1 by 1H NMR analysis of the corresponding cyclic 
oxazolinium triflate derivative (see below). TLC (40% Ethyl acetate–hexanes): Rf = 0.72 (UV, 
KMnO4). 1H NMR (500 MHz, CDCl3), δ: 7.43-7.01 (m, 15H), 5.91-5.79 (m, 2H), 5.32 (dd, 1H, J 
= 9.0, 6.0 Hz), 5.17-5.07 (m, 2H), 3.64 (d, 1H, J = 5.0 Hz), 3.12 (d, 1H, J = 14.0 Hz), 2.96 (s, 
3H), 2.85-2.73 (m, 2H), 2.19 (dd, 1H, J = 15.0, 8.0 Hz), 1.24 (s, 3H). 13C NMR (125 MHz, 
CDCl3), δ: 177.8, 141.6, 137.3, 136.4, 134.5, 130.3, 129.3, 128.3, 128.2, 128.1, 127.7, 127.6, 
127.2, 126.5, 118.1, 73.0, 66.2, 48.4, 44.9, 44.6, 33.3, 24.1.  FTIR (neat), cm–1: 3416 (br), 3030, 
1603 (m), 1452, 1076, 910.  HRMS (ESI): Calcd for (C28H31NO2 + H)+: 414.2428. Found: 
414.2426. 
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Oxazolinium triflate (100) 
Trifluoromethanesulfonic anhydride (16.0 μL, 0.097 mmol, 2.00 equiv) was added dropwise by 
syringe to a stirring solution of the α-quaternary amide 61 (20.0 mg, 0.048 mmol, 1 equiv) and 
pyridine (12.0 μL, 0.145 mmol, 3.00 equiv) in dichloromethane (2 mL) at 0 °C. The reaction 
mixture was stirred for 10 min at 0 °C. The product solution was concentrated by rotary 
evaporation at ~40 mmHg, then with a vacuum manifold at 0.1 mmHg for 3 h. The 
diastereomeric ratio of the residue was determined to be ≥19:1 by 1H NMR analysis. 1H NMR 
(≥19:1 diastereomeric ratio, asterisk denotes pyridinium ion peaks, 500 MHz, CDCl3), δ: 8.83* 
(d, 1H, J = 4.9 Hz), 8.42-8.29* (m, 1H), 7.89* (dd, 1H, J = 6.3, 7.3 Hz), 7.52-6.78 (m, 15H), 
6.73 (d, 1H, J = 11.0 Hz), 6.38 (d, 1H, J = 10.5 Hz), 5.98 (m, 1H), 5.45-5.33 (m, 2H), 3.45 (s, 
3H),  3.41 (d, 1H, J = 14.0 Hz), 3.15 (d, 1H, J = 14.5 Hz), 3.00 (dd, 1H, J = 14.5, 8.0 Hz), 2.61 
(dd, 1H, J = 14.5, 6.5 Hz), 1.65 (s, 3H). 
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Conjugate addition–alkylation of α-alkyl-α,β α-unsaturated pseudoephenamine amides: 
 
(R)-2-allyl-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N,2-dimethylheptanamide (62) 
A freshly titrated solution of methyllithium in diethoxymethane (2.93 M, 610 μL, 1.00 equiv) 
was added by syringe to a stirring suspension of amide 33 (528 mg, 1.79 mmol, 1 equiv) and 
lithium chloride (455 mg, 10.7 mmol, 6.00 equiv) in tetrahydrofuran (8.93 mL) at –78 ºC. After 
stirring for 10 min at –78 ºC, a freshly titrated solution of n-butyllithium in hexanes (2.50 M, 858 
μL, 1.20 equiv) was added by syringe. The resulting solution was stirred for 10 min at –78 ºC 
and for 10 min at –40 ºC, whereupon allyl bromide (464 μL, 5.36 mmol, 3.00 equiv) was added 
by syringe. The mixture was stirred for 3 h at –40 ºC, then saturated aqueous ammonium 
chloride (2 mL) was added and the biphasic mixture was warmed to 23 ºC.  The biphasic mixture 
was partitioned between ethyl acetate (60 mL) and 0.5 N aqueous hydrochloric acid solution (20 
mL). The layers were separated. The organic layer was washed sequentially with 0.5 N aqueous 
hydrochloric acid solution (2 x 20 mL) and saturated aqueous sodium chloride solution (20 mL). 
The washed organic layer was dried over sodium sulfate. The dried solution was filtered, and the 
filtrate was concentrated. The residue was purified by flash column chromatography (5→25% 
ethyl acetate–hexanes) to afford amide 62 as a clear, colorless oil (544 mg, 77%). The 
diastereomeric ratio of the purified product was determined to be ≥19:1 by 1H NMR analysis of 
the corresponding cyclic oxazolinium triflate derivative (see below). TLC (30% ethyl acetate–
hexanes): Rf = 0.48 (UV, KMnO4). 1H NMR (500 MHz, CDCl3), δ: 7.42 (d, 2H, J = 7.3 Hz), 
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7.32–7.16 (m, 8H), 5.94–5.71 (m, 2H), 5.31 (dd, 1H, J = 8.8, 6.8 Hz), 5.13–5.01 (m, 2H), 3.76 
(br s, 1H), 2.96 (s, 3H), 2.58 (dd, 1H, J = 14.2, 6.8 Hz), 2.23 (dd, 1H, J = 14.2, 7.3 Hz), 1.68 (td, 
1H, J = 13.1, 4.2 Hz), 1.49–1.38 (m, 1H), 1.34–0.99 (m, 9H), 0.82 (t, 3H, J = 7.1 Hz). 13C NMR 
(125 MHz, CDCl3), δ: 177.7, 141.7, 137.0, 134.5, 128.6, 128.0, 127.9, 127.3, 127.2, 126.8, 
117.4, 72.7, 65.4, 46.8, 43.8, 38.6, 33.4, 32.1, 24.4, 23.9, 22.2, 13.8.  FTIR (neat), cm–1: 3396 
(br), 2927 (m), 1603 (s), 1455 (m), 1376.  HRMS (ESI): Calcd for (C26H35NO2 + H)+: 394.2741. 
Found: 394.2740. 
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Oxazolinium triflate (101) 
Trifluoromethanesulfonic anhydride (29.5 μL, 0.175 mmol, 2.00 equiv) was added dropwise by 
syringe to a stirring solution of α-quaternary amide 62 (34.5 mg, 0.088 mmol, 1 equiv) and 
pyridine (21.3 μL, 0.263 mmol, 3.00 equiv) in dichloromethane (2 mL) at 0 °C. The reaction 
mixture was stirred for 10 min at 0 °C. The product solution was concentrated by rotary 
evaporation at ~40 mmHg, then with a vacuum manifold at 0.1 mmHg for 2 h. The 
diastereomeric ratio of the residue was determined to be ≥19:1 by 1H NMR analysis. 1H NMR 
(≥19:1 diastereomeric ratio, asterisk denotes pyridinium ion peaks, 500 MHz, CDCl3), δ: 8.88* 
(d, 2H, J = 5.4 Hz), 8.60* (t, 1H, J = 7.8 Hz), 8.10* (t, 2H, J = 7.1 Hz), 7.23–7.08 (m, 6H), 7.00–
6.93 (m, 2H), 6.91 (d, 2H, J = 6.8 Hz), 6.85 (d, 1H, J = 10.7 Hz), 6.30 (d, 1H, J = 10.7 Hz), 
5.98–5.86 (m, 1H), 5.40–5.27 (m, 2H), 3.48 (s, 3H), 2.78 (dd, 1H, J = 14.4, 7.6 Hz), 2.62 (dd, 
1H, J = 14.4, 7.1 Hz), 2.12–1.99 (m, 1H), 1.85–1.71 (m, 1H), 1.64 (s, 3H), 1.57–1.46 (m, 2H), 
1.45–1.30 (m, 4H), 0.92 (t, 3H, J = 6.8 Hz). 
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(R)-2-benzyl-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N,2-dimethylheptanamide (63) 
A freshly titrated solution of methyllithium in diethoxymethane (2.67 M, 630 μL, 1.00 equiv) 
was added by syringe to a stirring suspension of amide 33 (496 mg, 1.68 mmol, 1 equiv) and 
lithium chloride (428 mg, 10.1 mmol, 6.00 equiv) in tetrahydrofuran (8.40 mL) at –78 ºC. After 
stirring for 10 min at –78 ºC, a freshly titrated solution of n-butyllithium in hexanes (2.45 M, 823 
μL, 1.20 equiv) was added by syringe. The resulting solution was stirred for 10 min at –78 ºC 
and for 10 min at –40 ºC, whereupon benzyl bromide (600 μL, 5.04 mmol, 3.00 equiv) was 
added by syringe. The mixture was stirred for 1 h at –40 ºC, then saturated aqueous ammonium 
chloride (2 mL) was added and the biphasic mixture was warmed to 23 ºC.  The biphasic mixture 
was partitioned between ethyl acetate (60 mL) and 0.5 N aqueous hydrochloric acid solution (20 
mL). The layers were separated. The organic layer was washed sequentially with 0.5 N aqueous 
hydrochloric acid solution (2 x 20 mL) and saturated aqueous sodium chloride solution (20 mL). 
The washed organic layer was dried over sodium sulfate. The dried solution was filtered, and the 
filtrate was concentrated. The residue was purified by flash column chromatography (5→45% 
ethyl acetate–hexanes) to afford amide 63 as a white, crystalline solid (560 mg, 75%, mp = 80-82 
ºC). The diastereomeric ratio of the purified product was determined to be ≥19:1 by 1H NMR 
analysis of the corresponding cyclic oxazolinium triflate derivative (see below). TLC (40% ethyl 
acetate–hexanes): Rf = 0.60 (UV, KMnO4). 1H NMR (500 MHz, CDCl3), δ: 7.40 (d, 2H, J = 7.3 
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Hz), 7.09–7.31 (m, 13H), 5.85 (d, 1H, J = 8.8 Hz), 5.32 (dd, 1H, J = 9.0, 7.1 Hz), 3.70 (d, 1H, J 
= 4.9 Hz), 3.12 (d, 1H, J = 13.7 Hz), 3.94 (s, 3H), 2.81 (d, 1H, J = 13.7 Hz), 1.83 (td, 1H, J = 
13.1, 3.7 Hz), 1.00–1.41 (m, 11H), 0.82 (t, 3H, J = 7.1 Hz). 13C NMR (125 MHz, CDCl3), δ: 
178.5, 141.9, 137.8, 136.8, 136.5, 130.4, 129.0, 128.2, 128.1, 127.9, 127.6, 127.5, 127.0, 126.3, 
73.1, 66.1, 48.3, 45.5, 39.6, 33.6, 32.3, 24.3, 24.2, 22.4, 14.0. FTIR (neat), cm–1: 3402 (br), 2929, 
1602 (s), 1452 (m).  HRMS (ESI): Calcd for (C30H37NO2 + H)+: 444.2897. Found: 444.2896. 
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Oxazolinium triflate (102) 
Trifluoromethanesulfonic anhydride (19.8 μL, 0.118 mmol, 2.00 equiv) was added dropwise by 
syringe to a stirring solution of α-quaternary amide 63 (26.1 mg, 0.059 mmol, 1 equiv) and 
pyridine (14.3 μL, 0.177 mmol, 3.00 equiv) in dichloromethane (2 mL) at 0 °C. The reaction 
mixture was stirred for 10 min at 0 °C. The product solution was concentrated by rotary 
evaporation at ~40 mmHg, then with a vacuum manifold at 0.1 mmHg for 2 h. The 
diastereomeric ratio of the residue was determined to be ≥19:1 by 1H NMR analysis. 1H NMR 
(≥19:1 diastereomeric ratio, asterisk denotes pyridinium ion peaks, 500 MHz, CDCl3), δ: 8.88* 
(br s, 2H), 8.45* (br s, 1H), 7.98* (br d, 2H, J = 6.3 Hz), 7.46 (t, 2H, J = 7.3 Hz), 7.37 (t, 1H, J = 
7.3 Hz), 7.29 (d, 2H, J = 7.3 Hz), 7.03–7.23 (m, 6H), 6.87 (d, 2H, J = 7.3 Hz), 6.76–6.84 (m, 
3H), 6.36 (d, 1H, J = 11.2 Hz), 3.32 (s, 3H), 3.28 (d, 1H, J = 13.7 Hz), 3.20 (d, 1H, J = 14.2 Hz), 
2.12–2.23 (m, 1H), 1.74 (td, 1H, J = 13.3, 4.6 Hz), 1.67 (s, 3H), 1.45–1.63 (m, 2H), 1.33–1.45 
(m, 4H), 0.93 (t, 3H, J = 6.8 Hz).  
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(S)-2-benzyl-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N,2-dimethylpent-4-enamide (61) 
A freshly titrated solution of methyllithium in diethoxymethane (2.67 M, 629 μL, 1.00 equiv) 
was added by syringe to a stirring suspension of amide 33 (496 mg, 1.68 mmol, 1 equiv) and 
lithium chloride (427 mg, 10.1 mmol, 6.00 equiv) in tetrahydrofuran (8.40 mL) at –78 ºC. After 
stirring for 10 min at –78 ºC, a freshly titrated solution of phenyllithium in di-n-butyl ether (1.61 
M, 1.23 mL, 1.20 equiv) was added by syringe. The resulting solution was stirred for 10 min at –
78 ºC and for 10 min at –40 ºC, whereupon allyl bromide (436 μL, 5.04 mmol, 3.00 equiv) was 
added by syringe. The mixture was stirred for 6 h at –40 ºC, then saturated aqueous ammonium 
chloride (2 mL) was added and the biphasic mixture was warmed to 23 ºC.  The biphasic mixture 
was partitioned between ethyl acetate (25 mL) and half-saturated aqueous sodium chloride 
solution (50 mL). The layers were separated. The aqueous layer was extracted with two 25-mL 
portions of ethyl acetate. The combined organic extracts were dried over sodium sulfate. The 
dried solution was filtered, and the filtrate was concentrated. The residue was purified by flash 
column chromatography (5→40% ethyl acetate–hexanes) to afford amide 61 as a clear, colorless 
glaze (556 mg, 80%). The diastereomeric ratio of the purified product was determined to be 
≥19:1 by 1H NMR analysis of the corresponding cyclic oxazolinium triflate derivative (see 
below). TLC (40% ethyl acetate–hexanes): Rf = 0.49 (UV, KMnO4). 1H NMR (500 MHz, 
CDCl3), δ: 7.39 (d, 3H, J = 7.3 Hz), 7.12–7.33 (m, 9H), 6.98–7.07 (m, 3H), 5.75–5.93 (m, 2H), 
5.31 (dd, 1H, J = 9.3, 6.4 Hz), 5.05–5.18 (m, 2H), 3.64 (br s, 1H), 3.11 (d, 1H, J = 14.2 Hz), 2.95 
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(s, 3H), 2.70–2.84 (m, 2H), 2.18 (dd, 1H, J = 14.7, 7.3 Hz), 2.01–2.08 (m, 1H), 1.23 (s, 1H). 13C 
NMR (125 MHz, CDCl3), δ: 177.5, 141.6, 137.2, 136.4, 134.3, 130.2, 129.1, 128.1, 128.1, 127.9, 
127.5, 127.4, 127.0, 126.3, 117.9, 72.8, 65.8, 48.2, 44.7, 44.3, 33.1, 23.9. FTIR (neat), cm–1: 
3406 (br), 3030, 1602 (s), 1452 (m).  HRMS (ESI): Calcd for (C28H31NO2 + H)+: 414.2428. 
Found: 414.2421. 
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Oxazolinium triflate (103) 
Trifluoromethanesulfonic anhydride (22.5 μL, 0.133 mmol, 2.00 equiv) was added dropwise by 
syringe to a stirring solution of α-quaternary amide 61 (27.6 mg, 0.067 mmol, 1 equiv) and 
pyridine (16.2 μL, 0.200 mmol, 3.00 equiv) in dichloromethane (2 mL) at 0 °C. The reaction 
mixture was stirred for 10 min at 0 °C. The product solution was concentrated by rotary 
evaporation at ~40 mmHg, then with a vacuum manifold at 0.1 mmHg for 2 h. The 
diastereomeric ratio of the residue was determined to be ≥19:1 by 1H NMR analysis. 1H NMR 
(≥19:1 diastereomeric ratio, asterisk denotes pyridinium ion peaks, 500 MHz, CDCl3), δ: 8.82* 
(br s, 2H), 8.27* (br s, 1H), 7.83* (br s, 2H), 7.43 (t, 2H, J = 7.3 Hz), 7.29–7.39 (m, 3H), 7.15–
7.21 (m, 1H), 7.06–7.15 (m, 5H), 6.77–6.92 (m, 4H), 6.66 (d, 1H, J = 10.7 Hz), 6.32 (d, 1H, J = 
11.2 Hz), 5.91–6.04 (m, 1H), 5.32–5.44 (m, 2H), 3.45 (s, 3H), 3.40 (d, 1H, J = 13.7 Hz), 3.15 (d, 
1H, J = 14.2 Hz), 3.02 (dd, 1H, J = 14.6, 7.9 Hz), 2.59 (dd, 1H, J = 14.9, 6.6 Hz), 1.63 (s, 3H).   
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(S)-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N,2-dimethyl-2-neopentylpent-4-enamide (64) 
A freshly titrated solution of methyllithium in diethoxymethane (2.67 M, 250 μL, 1.00 equiv) 
was added by syringe to a stirring suspension of amide 33 (197 mg, 0.669 mmol, 1 equiv) and 
lithium chloride (170 mg, 4.01 mmol, 6.00 equiv) in tetrahydrofuran (3.34 mL) at –78 ºC. After 
stirring for 10 min at –78 ºC, a freshly titrated solution of tert-butyllithium in pentane (1.71 M, 
469 μL, 1.20 equiv) was added by syringe. The resulting solution was stirred for 10 min at –78 
ºC and for 10 min at –40 ºC, whereupon allyl bromide (174 μL, 2.01 mmol, 3.00 equiv) was 
added by syringe. The mixture was stirred for 6 h at –40 ºC, then saturated aqueous ammonium 
chloride (2 mL) was added and the biphasic mixture was warmed to 23 ºC.  The biphasic mixture 
was partitioned between ethyl acetate (60 mL) and 0.5 N aqueous hydrochloric acid solution (20 
mL). The layers were separated. The organic layer was washed sequentially with 0.5 N aqueous 
hydrochloric acid solution (2 x 20 mL) and saturated aqueous sodium chloride solution (20 mL). 
The washed organic layer was dried over sodium sulfate. The dried solution was filtered, and the 
filtrate was concentrated. The residue was purified by flash column chromatography (5→45% 
ethyl acetate–hexanes) to afford amide 64 as a white, crystalline solid (224 mg, 85%, mp = 90-92 
ºC). The diastereomeric ratio of the purified product was determined to be ≥19:1 by 1H NMR 
analysis of the corresponding cyclic oxazolinium triflate derivative (see below). TLC (40% ethyl 
acetate–hexanes): Rf = 0.48 (UV, KMnO4). 1H NMR (500 MHz, CDCl3), δ: 7.37 (d, 2H, J = 7.3 
Hz), 7.12–7.28 (m, 8H), 6.04 (d, 1H, J = 9.8 Hz), 5.89 (ddt, 1H, J = 17.1, 10.0, 7.0, 7.0 Hz), 5.27 
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(dd, 1H, J = 10.0, 5.6 Hz), 5.06–5.19 (m, 2H), 3.36 (d, 1H, J = 4.9 Hz), 3.06 (s, 3H), 2.68 (dd, 
1H, J = 14.4, 7.0 Hz), 2.21 (dd, 1H, J = 14.4, 7.1 Hz), 1.87 (d, 1H, J = 15.1 Hz), 1.46 (d, 1H, J = 
15.1 Hz), 1.37 (s, 3H), 0.85 (s, 9H). 13C NMR (125 MHz, CDCl3), δ: 178.3, 141.4, 135.8, 134.6, 
129.6, 128.2, 128.0, 127.6, 127.4, 117.9, 72.9, 65.1, 52.1, 48.0, 46.4, 32.5, 32.0, 31.2, 26.7.  
FTIR (neat), cm–1: 3394 (br), 2951, 1599 (s), 1454 (m).  HRMS (ESI): Calcd for (C26H35NO2 + 
H)+: 394.2741. Found: 394.2735. 
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Oxazolinium triflate (104) 
Trifluoromethanesulfonic anhydride (22.4 μL, 0.133 mmol, 2.00 equiv) was added dropwise by 
syringe to a stirring solution of α-quaternary amide 64 (26.2 mg, 0.067 mmol, 1 equiv) and 
pyridine (16.2 μL, 0.200 mmol, 3.00 equiv) in dichloromethane (2 mL) at 0 °C. The reaction 
mixture was stirred for 10 min at 0 °C. The product solution was concentrated by rotary 
evaporation at ~40 mmHg, then with a vacuum manifold at 0.1 mmHg for 2 h. The 
diastereomeric ratio of the residue was determined to be ≥19:1 by 1H NMR analysis. 1H NMR 
(asterisk denotes pyridinium ion peaks, 500 MHz, CDCl3), δ: 8.84* (d, 2H, J = 5.3 Hz), 8.54* (t, 
1H, J = 7.8 Hz), 8.04* (t, 2H, J = 7.0 Hz), 7.10–7.21 (m, 6H), 7.00 (d, 4H, J = 5.3 Hz), 6.76 (d, 
1H, J = 11.1 Hz), 6.46 (d, 1H, J = 11.4 Hz), 5.88–6.00 (m, 1H), 5.32–5.43 (m, 2H), 3.49 (s, 3H), 
2.83 (dd, 1H, J = 14.6, 8.2 Hz), 2.59 (dd, 1H, J = 14.6, 6.2 Hz), 2.24 (d, 1H, J = 15.2 Hz), 1.78 
(d, 1H, J = 15.2 Hz), 1.74 (s, 3H), 1.13 (s, 9H). 
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(R)-2-ethyl-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N,2,4,4-tetramethylpentanamide (65) 
A freshly titrated solution of methyllithium in diethoxymethane (2.84 M, 569 μL, 1.00 equiv) 
was added by syringe to a stirring suspension of amide 34 (500 mg, 1.62 mmol, 1 equiv) and 
lithium chloride (411 mg, 9.70 mmol, 6.00 equiv) in tetrahydrofuran (8.08 mL) at –78 ºC. After 
stirring for 10 min at –78 ºC, a freshly titrated solution of tert- butyllithium in pentane (1.41 M, 
1.37 mL, 1.20 equiv) was added by syringe. The resulting solution was stirred for 10 min at –78 
ºC and for 10 min at –40 ºC, whereupon iodomethane (404 μL, 6.46 mmol, 4.00 equiv) was 
added by syringe. The mixture was stirred for 4 h at –40 ºC, then saturated aqueous ammonium 
chloride (2 mL) was added and the biphasic mixture was warmed to 23 ºC.  The biphasic mixture 
was partitioned between ethyl acetate (50 mL) and half-saturated aqueous sodium chloride 
solution (75 mL). The layers were separated. The aqueous layer was extracted with two 50-mL 
portions of ethyl acetate. The combined organic extracts were dried over sodium sulfate. The 
dried solution was filtered, and the filtrate was concentrated. The residue was purified by flash 
column chromatography (5→35% ethyl acetate–hexanes) to afford amide 65 as an off-white 
solid (487 mg, 79%, mp = 85-86 ºC). The diastereomeric ratio of the purified product was 
determined to be ≥19:1 by 1H NMR analysis of the corresponding cyclic oxazolinium triflate 
derivative (see below). TLC (30% ethyl acetate–hexanes): Rf = 0.46 (UV, KMnO4). 1H NMR 
(500 MHz, CDCl3), δ: 7.37 (d, 2H, J = 7.3 Hz), 7.29–7.24 (m, 2H), 7.24–7.12 (m, 6H), 5.91 (d, 
1H, J = 9.8 Hz), 5.31 (dd, 1H, J = 9.8, 6.4 Hz), 3.89 (d, 1H, J = 6.4 Hz), 3.01 (s, 3H), 1.93 (d, 
OH
N
CH3
O
1. CH3Li, LiCl, THF, –78 ºC
2. t-BuLi, –78 → –40 ºC
3. CH3I, –40 ºC
                   79%
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1H, J = 14.7 Hz), 1.82 (dq, 1H, J = 14.3, 7.3 Hz), 1.48 (d, 1H, J = 15.1 Hz), 1.43–1.30 (m, 4H), 
0.99 (s, 9H), 0.72 (t, 3H, J = 7.8 Hz). 13C NMR (125 MHz, CDCl3), δ: 179.7, 142.0, 136.4, 
129.6, 128.2, 128.1, 127.6, 127.5, 127.2, 73.5, 66.1, 52.9, 48.3, 34.2, 33.4, 32.1, 31.4, 25.6, 8.5.  
FTIR (neat), cm–1: 3374 (br), 2923 (s), 2853 (m), 1741 (m), 1602 (m).  HRMS (ESI): Calcd for 
(C25H35NO2 + Na)+: 404.2560. Found: 404.2560. 
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Oxazolinium triflate (105) 
Trifluoromethanesulfonic anhydride (21.5 μL, 0.128 mmol, 2.00 equiv) was added dropwise by 
syringe to a stirring solution of α-quaternary amide 65 (24.4 mg, 0.064 mmol, 1 equiv) and 
pyridine (15.5 μL, 0.192 mmol, 3.00 equiv) in dichloromethane (2 mL) at 0 °C. The reaction 
mixture was stirred for 10 min at 0 °C. The product solution was concentrated by rotary 
evaporation at ~40 mmHg, then with a vacuum manifold at 0.1 mmHg for 2 h. The 
diastereomeric ratio of the residue was determined to be ≥19:1 by 1H NMR analysis. 1H NMR 
(asterisk denotes pyridinium ion peaks, 600 MHz, CDCl3), δ: 8.85* (d, 2H, J = 5.3 Hz), 8.64–
8.57* (m, 1H), 8.10* (t, 2H, J = 6.7 Hz), 7.23–7.16 (m, 3H), 7.16–7.10 (m, 3H), 7.01 (dd, 2H, J 
= 6.3, 2.3 Hz, 2H), 6.94 (d, 2H, J = 6.2 Hz), 6.75 (d, 1H, J = 10.8 Hz), 6.45 (d, 1H, J = 10.8 Hz), 
3.53 (s, 3H), 2.25 (dq, 1H, J = 14.2, 7.3 Hz), 2.07 (d, 1H, J = 15.2 Hz), 1.91 (dq, 1H, J = 14.1, 
7.3 Hz), 1.85 (d, 1H, J = 14.9 Hz), 1.69 (s, 3H), 1.18 (t, 3H, J = 7.5 Hz), 1.10 (s, 9H). 
O
N
H3CTfO
Tf2O, pyridine
CH2Cl2, 0 ºC
≥19:1 dr
CH3
CH3
CH3N
O
CH3
CH3
CH3HO H3CH3C H3C CH3CH3
65 105
 153 
 
(R)-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-N,2-dimethyl-2-neopentylheptanamide (66) 
A freshly titrated solution of methyllithium in diethoxymethane (2.84 M, 501 μL, 1.00 equiv) 
was added by syringe to a stirring suspension of amide 35 (500 mg, 1.42 mmol, 1 equiv) and 
lithium chloride (362 mg, 8.54 mmol, 6.00 equiv) in tetrahydrofuran (7.11 mL) at –78 ºC. After 
stirring for 10 min at –78 ºC, a freshly titrated solution of tert- butyllithium in pentane (1.41 M, 
1.21 mL, 1.20 equiv) was added by syringe. The resulting solution was stirred for 10 min at –78 
ºC and for 10 min at –40 ºC, whereupon iodomethane (445 μL, 7.11 mmol, 5.00 equiv) was 
added by syringe. The mixture was stirred for 6 h at –40 ºC, then saturated aqueous ammonium 
chloride (2 mL) was added and the biphasic mixture was warmed to 23 ºC.  The biphasic mixture 
was partitioned between ethyl acetate (50 mL) and half-saturated aqueous sodium chloride 
solution (75 mL). The layers were separated. The aqueous layer was extracted with two 50-mL 
portions of ethyl acetate. The combined organic extracts were dried over sodium sulfate. The 
dried solution was filtered, and the filtrate was concentrated. The residue was purified by flash 
column chromatography (5→35% ethyl acetate–hexanes) to afford amide 66 as an off-white 
solid (461 mg, 76%, mp = 99-101 ºC). The diastereomeric ratio of the purified product was 
determined to be ≥19:1 by 1H NMR analysis of the corresponding cyclic oxazolinium triflate 
derivative (see below). TLC (30% ethyl acetate–hexanes): Rf = 0.55 (UV, KMnO4). 1H NMR 
(500 MHz, CDCl3), δ: 7.37 (d, 2H, J = 7.3 Hz), 7.30–7.11 (m, 8H), 5.94 (d, 1H, J = 10.3 Hz), 
5.30 (dd, 1H, J = 9.8, 6.4 Hz, 1H), 3.85 (d, 1H, J = 6.4 Hz, 1H), 3.00 (s, 3H), 1.94 (d, 1H, J = 
OH
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14.7 Hz), 1.77–1.66 (m, 1H), 1.48 (d, 1H, J = 15.1 Hz), 1.37 (s, 3H), 1.34–1.03 (m, 6H), 0.99 (s, 
9H), 0.95–0.85 (m, 1H), 0.79 (t, 3H, J = 7.1 Hz). 13C NMR (125 MHz, CDCl3), δ: 179.8, 142.0, 
136.4, 129.6, 128.2, 128.0, 127.6, 127.5, 127.2, 73.4, 65.9, 53.2, 48.1, 41.8, 33.2, 32.4, 32.1, 
31.4, 26.4, 23.6, 22.5, 14.0. FTIR (neat), cm–1: 3350 (br), 2959 (m), 2934 (m), 1679 (m), 1608 
(s).  HRMS (ESI): Calcd for (C28H41NO2 + H)+: 424.3210. Found: 424.3211. 
 155 
 
Oxazolinium triflate (106) 
Trifluoromethanesulfonic anhydride (19.1 μL, 0.114 mmol, 2.00 equiv) was added dropwise by 
syringe to a stirring solution of α-quaternary amide 66 (24.1 mg, 0.057 mmol, 1 equiv) and 
pyridine (13.8 μL, 0.171 mmol, 3.00 equiv) in dichloromethane (2 mL) at 0 °C. The reaction 
mixture was stirred for 10 min at 0 °C. The product solution was concentrated by rotary 
evaporation at ~40 mmHg, then with a vacuum manifold at 0.1 mmHg for 2 h. The 
diastereomeric ratio of the residue was determined to be ≥19:1 by 1H NMR analysis. 1H NMR 
(≥19:1 diastereomeric ratio, asterisk denotes pyridinium ion peaks, 500 MHz, CDCl3), δ: 8.90* 
(d, 2H, J = 5.9 Hz), 8.85* (t, 2H, J = 5.9 Hz), 8.60* (t, 1H, J = 7.8 Hz), 8.42* (t, 1H, J = 7.8 Hz, 
1H), 8.09* (t, 2H, J = 6.8 Hz), 8.01* (t, 2H, J = 6.8 Hz), 7.24–7.10 (m, 6H), 7.04–6.97 (m, 2H), 
6.93 (d, 2H, J = 6.4 Hz), 6.72 (d, 1H, J = 10.7 Hz), 6.41 (d, 1H, J = 10.7 Hz), 3.53 (s, 3H), 2.20–
2.01 (m, 2H), 1.92–1.77 (m, 2H), 1.71 (s, 3H), 1.64–1.51 (m, 1H), 1.49–1.33 (m, 5H), 1.10 (s, 
9H), 0.93 (t, 3H, J = 6.6 Hz).  
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X-Ray Crystallography:  A crystal was mounted on a diffractometer; data was collected at 100 
K.  The intensities of the reflections were collected by means of a Bruker APEX II CCD 
diffractometer (MoKα radiation, λ=0.71073 Å), and equipped with an Oxford Cryosystems 
nitrogen flow apparatus. The collection method involved 0.5° scans in ω at 28° in 2θ. Data 
integration down to 0.74 Å resolution was carried out using SAINT V7.46 A 63 with reflection 
spot size optimization. Absorption corrections were made with the program SADABS . The 
structure was solved by the direct methods procedure and refined by least-squares methods on F2 
using SHELXS-97 and SHELXL-9764 with OLEX 2 interface.65 Non-hydrogen atoms were 
refined anisotropically, and hydrogen atoms were allowed to ride on the respective atoms. 
Crystal data as well as details of data collection and refinement are summarized in Table 1, and 
geometric parameters are shown in Table 2, and hydrogen-bond parameters are listed in Table 3. 
The Ortep plots produced with SHELXL-97 program, and the other drawings were produced 
with Accelrys DS Visualizer 2.0.66 
Table 2.1: Experimental details 
Crystal data 
Chemical formula C15H17NO 
Mr 227.30 
Crystal system, space group ORTHORHOMBIC, P212121 
Temperature (K) 100 
a, b, c (Å) 9.2424 (4), 10.2613 (4), 13.3610 (5) 
V (Å3) 1267.14 (9) 
 
                                                
63 Bruker AXS APEX II, Bruker AXS, Madison, Wisconsin, 2009. 
64 Sheldrick, G. M. Acta Cryst. 2008, A64, 112–122. 
65 Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. J. Appl. Cryst. 2009, 42, 339–
341. 
66 Accelrys DS Visualizer v2.0.1, Accelrys Software. Inc., 2007. 
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Table 2.1 (continued) 
Z 4 
Radiation type Mo Kα 
µ (mm-1) 0.07 
Crystal size (mm) 0.28 × 0.22 × 0.12 
Data collection 
Diffractometer Bruker D8 goniometer with CCD area detector diffractometer 
Absorption correction Multi-scan  
SADABS 
 Tmin, Tmax 0.980, 0.991 
No. of measured, independent 
and observed [I > 2σ(I)] 
reflections 
57307, 3279, 3090   
Rint 0.063 
Refinement 
R[F2 > 2σ(F2)], wR(F2), S 0.034,  0.084,  1.08 
No. of reflections 3279 
No. of parameters 163 
No. of restraints 0 
H-atom treatment H atoms treated by a mixture of independent and constrained refinement 
Δρmax, Δρmin (e Å-3) 0.22, -0.21 
Absolute structure Flack H D (1983), Acta Cryst. A39, 876-881 
Flack parameter -1.3 (11) 
 
Computer programs: APEX2 v2009.3.0 (Bruker-AXS, 2009), SAINT 7.46A (Bruker-AXS, 2009), SHELXS97 
(Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), Bruker SHELXTL (Sheldrick, 2008). 
Table 2.2: Geometric parameters (Å, º) 
C1—C2 1.3904 (16) C9—C10 1.3916 (16) 
C1—C6 1.3937 (16) C9—C14 1.3957 (15) 
C1—H1 0.9500 C10—C11 1.3893 (17) 
C2—C3 1.3923 (17) C10—H10 0.9500 
C2—H2 0.9500 C11—C12 1.3907 (19) 
C3—C4 1.3915 (18) C11—H11 0.9500 
C3—H3 0.9500 C12—C13 1.3850 (17) 
C4—C5 1.3913 (16) C12—H12 0.9500 
C4—H4 0.9500 C13—C14 1.3900 (16) 
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Table 2.2 (continued) 
C5—C6 1.3949 (15) C13—H13 0.9500 
C5—H5 0.9500 C14—H14 0.9500 
C6—C7 1.5141 (15) C15—N1 1.4717 (15) 
C7—O1 1.4287 (13) C15—H15A 0.9800 
C7—C8 1.5402 (15) C15—H15B 0.9800 
C7—H7 1.0000 C15—H15C 0.9800 
C8—N1 1.4719 (13) N1—H1A 0.861 (16) 
C8—C9 1.5185 (14) O1—H1B 0.915 (19) 
C8—H8 1.0000   
 
C2—C1—C6 120.69 (11) C7—C8—H8 108.5 
C2—C1—H1 119.7 C10—C9—C14 118.66 (10) 
C6—C1—H1 119.7 C10—C9—C8 120.24 (10) 
C1—C2—C3 119.90 (11) C14—C9—C8 120.83 (10) 
C1—C2—H2 120.1 C11—C10—C9 121.14 (11) 
C3—C2—H2 120.1 C11—C10—H10 119.4 
C4—C3—C2 119.71 (11) C9—C10—H10 119.4 
C4—C3—H3 120.1 C10—C11—C12 119.68 (11) 
C2—C3—H3 120.1 C10—C11—H11 120.2 
C5—C4—C3 120.30 (11) C12—C11—H11 120.2 
C5—C4—H4 119.9 C13—C12—C11 119.69 (11) 
C3—C4—H4 119.9 C13—C12—H12 120.2 
C4—C5—C6 120.23 (11) C11—C12—H12 120.2 
C4—C5—H5 119.9 C12—C13—C14 120.51 (11) 
C6—C5—H5 119.9 C12—C13—H13 119.7 
C1—C6—C5 119.18 (10) C14—C13—H13 119.7 
C1—C6—C7 120.57 (10) C13—C14—C9 120.31 (10) 
C5—C6—C7 120.23 (10) C13—C14—H14 119.8 
O1—C7—C6 112.79 (9) C9—C14—H14 119.8 
O1—C7—C8 106.82 (9) N1—C15—H15A 109.5 
C6—C7—C8 111.13 (9) N1—C15—H15B 109.5 
O1—C7—H7 108.7 H15A—C15—H15B 109.5 
C6—C7—H7 108.7 N1—C15—H15C 109.5 
C8—C7—H7 108.7 H15A—C15—H15C 109.5 
N1—C8—C9 112.67 (9) H15B—C15—H15C 109.5 
N1—C8—C7 108.48 (8) C15—N1—C8 112.70 (9) 
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Table 2.2 (continued) 
C9—C8—C7 110.13 (9) C15—N1—H1A 107.9 (11) 
N1—C8—H8 108.5 C8—N1—H1A 104.7 (10) 
C9—C8—H8 108.5 C7—O1—H1B 111.0 (12) 
 
C6—C1—C2—C3 0.09 (18) C6—C7—C8—C9 -51.88 (11) 
C1—C2—C3—C4 -0.04 (18) N1—C8—C9—C10 -132.90 (10) 
C2—C3—C4—C5 0.00 (18) C7—C8—C9—C10 105.84 (11) 
C3—C4—C5—C6 -0.01 (18) N1—C8—C9—C14 53.05 (13) 
C2—C1—C6—C5 -0.09 (17) C7—C8—C9—C14 -68.21 (12) 
C2—C1—C6—C7 178.27 (10) C14—C9—C10—C11 0.41 (17) 
C4—C5—C6—C1 0.06 (16) C8—C9—C10—C11 -173.76 (10) 
C4—C5—C6—C7 -178.32 (11) C9—C10—C11—C12 0.47 (18) 
C1—C6—C7—O1 49.41 (14) C10—C11—C12—C13 -0.54 (18) 
C5—C6—C7—O1 -132.24 (10) C11—C12—C13—C14 -0.28 (18) 
C1—C6—C7—C8 -70.52 (13) C12—C13—C14—C9 1.18 (17) 
C5—C6—C7—C8 107.83 (11) C10—C9—C14—C13 -1.23 (16) 
O1—C7—C8—N1 60.98 (10) C8—C9—C14—C13 172.90 (10) 
C6—C7—C8—N1 -175.62 (9) C9—C8—N1—C15 75.81 (12) 
O1—C7—C8—C9 -175.29 (8) C7—C8—N1—C15 -162.00 (9) 
 
Table 2.3: Hydrogen-bond parameters 
D—H···A D—H (Å) H···A (Å) D···A (Å) D—H···A (°) 
N1—H1A···O1 0.861 (16) 2.316 (15) 2.7970 (13) 115.5 (12) 
O1—H1B···N1i 0.915 (19) 1.94 (2) 2.8449 (13) 170.7 (17) 
 
Symmetry code(s):  (i) x-1/2, -y+1/2, -z+1. 
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Figure 2.5: Perspective views showing 50% probability displacement. 
 
 
Figure 2.6: Three-dimensional supramolecular architecture viewed along the b-axis direction. 
a 
c 
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X-Ray Crystallography:  A crystal was mounted on a diffractometer; data was collected at 100 
K.  The intensities of the reflections were collected by means of a Bruker APEX II DUO CCD 
diffractometer (CuKα radiation, λ=1.54178 Å), and equipped with an Oxford Cryosystems 
nitrogen flow apparatus. The collection method involved 1.0° scans in ω at 30°, 55°, 80° and 
105° in 2θ.  Data integration down to 0.84 Å resolution was carried out using SAINT V7.46 A 
with reflection spot size optimisation.  Absorption corrections were made with the program 
SADABS. The structure was solved by the direct methods procedure and refined by least-squares 
methods on F2 using SHELXS-97 and SHELXL-97. Non-hydrogen atoms were refined 
anisotropically, and hydrogen atoms were allowed to ride on the respective atoms. Crystal data 
as well as details of data collection and refinement are summarized in Table 1, geometric 
parameters are shown in Table 2 and hydrogen-bond parameters listed in Table 3. The Ortep 
plots produced with SHELXL-97 program, and the other drawings were produced with Accelrys 
DS Visualizer 2.0. 
Table 2.4: Experimental details 
 VI-114 
Crystal data 
Chemical formula C18H21NO2 
Mr 283.36 
Crystal system, space group Orthorhombic, P212121 
Temperature (K) 100 
a, b, c (Å) 6.9181 (4), 14.5010 (9), 15.1962 (8) 
V (Å3) 1524.47 (15) 
Z 4 
Radiation type Cu Kα 
µ (mm-1) 0.63 
Crystal size (mm) 0.40 × 0.02 × 0.01 
Data collection 
Diffractometer Bruker D8 goniometer with CCD area detector  
diffractometer 
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Table 2.4 (continued) 
Absorption correction Multi-scan  
SADABS 
 Tmin, Tmax 0.786, 0.992 
No. of measured, independent 
and observed [I > 2σ(I)] 
reflections 
16296, 2590, 2339   
Rint 0.080 
Refinement 
R[F2 > 2σ(F2)], wR(F2), S 0.049,  0.127,  1.06 
No. of reflections 2590 
No. of parameters 196 
No. of restraints 0 
H-atom treatment H atoms treated by a mixture of independent and constrained refinement 
Δρmax, Δρmin (e Å-3) 0.25, -0.25 
Absolute structure Flack H D (1983), Acta Cryst. A39, 876-881 
Flack parameter 0.3 (3) 
 
Computer programs: APEX2 v2009.3.0 (Bruker-AXS, 2009), SAINT 7.46A (Bruker-AXS, 2009), SHELXS97 
(Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), Bruker SHELXTL. 
Table 2.5: Geometric parameters (Å, º) 
O1—C7 1.427 (2) C9—C14 1.384 (3) 
O1—H1 0.94 (3) C9—C10 1.392 (3) 
O2—C16 1.236 (3) C10—C11 1.402 (3) 
N1—C16 1.344 (3) C10—H10 0.9500 
N1—C15 1.460 (3) C11—C12 1.377 (4) 
N1—C8 1.479 (3) C11—H11 0.9500 
C1—C6 1.387 (3) C12—C13 1.378 (4) 
C1—C2 1.394 (3) C12—H12 0.9500 
C1—H1A 0.9500 C13—C14 1.394 (3) 
C2—C3 1.378 (3) C13—H13 0.9500 
C2—H2 0.9500 C14—H14 0.9500 
C3—C4 1.381 (4) C15—H15A 0.9800 
C3—H3 0.9500 C15—H15B 0.9800 
C4—C5 1.401 (3) C15—H15C 0.9800 
C4—H4 0.9500 C16—C17 1.522 (3) 
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Table 2.5 (continued) 
C5—C6 1.387 (3) C17—C18 1.516 (3) 
C5—H5 0.9500 C17—H17A 0.9900 
C6—C7 1.523 (3) C17—H17B 0.9900 
C7—C8 1.530 (3) C18—H18A 0.9800 
C7—H7 1.0000 C18—H18B 0.9800 
C8—C9 1.525 (3) C18—H18C 0.9800 
C8—H8 1.0000   
 
C7—O1—H1 104.1 (19) C9—C10—C11 119.7 (2) 
C16—N1—C15 121.89 (17) C9—C10—H10 120.2 
C16—N1—C8 118.83 (16) C11—C10—H10 120.2 
C15—N1—C8 119.02 (16) C12—C11—C10 120.5 (2) 
C6—C1—C2 120.6 (2) C12—C11—H11 119.7 
C6—C1—H1A 119.7 C10—C11—H11 119.7 
C2—C1—H1A 119.7 C11—C12—C13 120.0 (2) 
C3—C2—C1 120.2 (2) C11—C12—H12 120.0 
C3—C2—H2 119.9 C13—C12—H12 120.0 
C1—C2—H2 119.9 C12—C13—C14 119.7 (2) 
C2—C3—C4 119.8 (2) C12—C13—H13 120.2 
C2—C3—H3 120.1 C14—C13—H13 120.2 
C4—C3—H3 120.1 C9—C14—C13 121.1 (2) 
C3—C4—C5 120.2 (2) C9—C14—H14 119.5 
C3—C4—H4 119.9 C13—C14—H14 119.5 
C5—C4—H4 119.9 N1—C15—H15A 109.5 
C6—C5—C4 120.1 (2) N1—C15—H15B 109.5 
C6—C5—H5 119.9 H15A—C15—H15B 109.5 
C4—C5—H5 119.9 N1—C15—H15C 109.5 
C1—C6—C5 119.11 (19) H15A—C15—H15C 109.5 
C1—C6—C7 120.52 (18) H15B—C15—H15C 109.5 
C5—C6—C7 120.36 (18) O2—C16—N1 122.31 (19) 
O1—C7—C6 112.27 (16) O2—C16—C17 121.07 (18) 
O1—C7—C8 106.80 (16) N1—C16—C17 116.63 (17) 
C6—C7—C8 110.15 (17) C18—C17—C16 112.66 (18) 
O1—C7—H7 109.2 C18—C17—H17A 109.1 
C6—C7—H7 109.2 C16—C17—H17A 109.1 
C8—C7—H7 109.2 C18—C17—H17B 109.1 
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Table 2.5 (continued) 
N1—C8—C9 110.84 (16) C16—C17—H17B 109.1 
N1—C8—C7 112.62 (16) H17A—C17—H17B 107.8 
C9—C8—C7 112.77 (17) C17—C18—H18A 109.5 
N1—C8—H8 106.7 C17—C18—H18B 109.5 
C9—C8—H8 106.7 H18A—C18—H18B 109.5 
C7—C8—H8 106.7 C17—C18—H18C 109.5 
C14—C9—C10 119.0 (2) H18A—C18—H18C 109.5 
C14—C9—C8 118.75 (18) H18B—C18—H18C 109.5 
C10—C9—C8 122.3 (2)   
 
C6—C1—C2—C3 0.2 (3) C6—C7—C8—C9 -62.3 (2) 
C1—C2—C3—C4 -0.3 (3) N1—C8—C9—C14 -105.6 (2) 
C2—C3—C4—C5 -0.2 (4) C7—C8—C9—C14 127.1 (2) 
C3—C4—C5—C6 0.7 (3) N1—C8—C9—C10 73.4 (2) 
C2—C1—C6—C5 0.4 (3) C7—C8—C9—C10 -53.9 (3) 
C2—C1—C6—C7 -178.5 (2) C14—C9—C10—C11 1.5 (3) 
C4—C5—C6—C1 -0.8 (3) C8—C9—C10—C11 -177.58 (19) 
C4—C5—C6—C7 178.1 (2) C9—C10—C11—C12 -0.7 (3) 
C1—C6—C7—O1 -121.5 (2) C10—C11—C12—
C13 
-0.5 (3) 
C5—C6—C7—O1 59.6 (3) C11—C12—C13—
C14 
0.9 (3) 
C1—C6—C7—C8 119.6 (2) C10—C9—C14—C13 -1.0 (3) 
C5—C6—C7—C8 -59.2 (2) C8—C9—C14—C13 178.03 (19) 
C16—N1—C8—C9 101.2 (2) C12—C13—C14—C9 -0.2 (3) 
C15—N1—C8—C9 -73.0 (2) C15—N1—C16—O2 -180.0 (2) 
C16—N1—C8—C7 -131.42 (19) C8—N1—C16—O2 6.0 (3) 
C15—N1—C8—C7 54.4 (2) C15—N1—C16—C17 0.0 (3) 
O1—C7—C8—N1 49.1 (2) C8—N1—C16—C17 -174.00 (17) 
C6—C7—C8—N1 171.31 (16) O2—C16—C17—C18 -7.4 (3) 
O1—C7—C8—C9 175.49 (16) N1—C16—C17—C18 172.61 (19) 
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Table 2.6: Hydrogen-bond parameters 
D—H···A D—H (Å) H···A (Å) D···A (Å) D—H···A (°) 
O1—H1···O2i 0.94 (3) 1.90 (3) 2.801 (2) 162 (3) 
 
Symmetry code(s):  (i) x-1/2, -y+1/2, -z+1. 
 
 
 
 
 
 
Figure 2.7: Perspective views showing 50% probability displacement. 
 
 168 
 
Figure 2.8: Three-dimensional supramolecular architecture viewed along the a-axis direction. 
b 
c 
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X-Ray Crystallography:  A crystal was mounted on a diffractometer; data was collected at 100 
K.  The intensities of the reflections were collected by means of a Bruker APEX II DUO CCD 
diffractometer (CuKα radiation, λ=1.54178 Å), and equipped with an Oxford Cryosystems 
nitrogen flow apparatus. The collection method involved 1.0° scans in ω at 30°, 55°, 80° and 
105° in 2θ. Data integration down to 0.84 Å resolution was carried out using SAINT V7.46 A 
with reflection spot size optimisation. Absorption corrections were made with the program 
SADABS. The structure was solved by the direct methods procedure and refined by least-squares 
methods on F2 using SHELXS-97 and SHELXL-97. Non-hydrogen atoms were refined 
anisotropically, and hydrogen atoms were allowed to ride on the respective atoms. Crystal data 
as well as details of data collection and refinement are summarized in Table 1, geometric 
parameters are shown in Table 2 and hydrogen-bond parameters listed in Table 3. The Ortep 
plots produced with SHELXL-97 program, and the other drawings were produced with Accelrys 
DS Visualizer 2.0. 
Table 2.7: Experimental details 
 VI-136 
Crystal data 
Chemical formula C27H31NO2 
Mr 401.53 
Crystal system, space group Orthorhombic, P212121 
Temperature (K) 100 
a, b, c (Å) 9.5300 (2), 9.9323 (2), 24.1764 (5) 
V (Å3) 2288.41 (8) 
Z 4 
Radiation type Cu Kα 
µ (mm-1) 0.56 
Crystal size (mm) 0.38 × 0.32 × 0.16 
Data collection 
Diffractometer Bruker D8 goniometer with CCD area detector  
diffractometer 
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Table 2.7 (continued) 
Absorption correction Multi-scan  
SADABS 
 Tmin, Tmax 0.814, 0.915 
No. of measured, independent 
and observed [I > 2σ(I)] 
reflections 
31684, 3953, 3930   
Rint 0.032 
Refinement 
R[F2 > 2σ(F2)], wR(F2), S 0.025,  0.065,  1.06 
No. of reflections 3953 
No. of parameters 279 
No. of restraints 0 
H-atom treatment H atoms treated by a mixture of independent and constrained refinement 
Δρmax, Δρmin (e Å-3) 0.16, -0.14 
Absolute structure Flack H D (1983), Acta Cryst. A39, 876-881 
Flack parameter 0.01 (15) 
 
  Computer programs: APEX2 v2009.3.0 (Bruker-AXS, 2009), SAINT 7.46A (Bruker-AXS, 2009), SHELXS97 
(Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), Bruker SHELXTL. 
Table 2.8 Geometric parameters (Å, º) 
O1—C7 1.4192 (14) C14—H14 0.9500 
O1—H1 0.852 (17) C15—C16 1.5523 (15) 
O2—C15 1.2326 (13) C16—C25 1.5382 (16) 
N1—C15 1.3579 (14) C16—C17 1.5547 (16) 
N1—C24 1.4610 (14) C16—C26 1.5571 (16) 
N1—C8 1.4863 (13) C17—C18 1.5162 (17) 
C1—C2 1.3843 (17) C17—H17A 0.9900 
C1—C6 1.3891 (16) C17—H17B 0.9900 
C1—H1A 0.9500 C18—C19 1.3922 (18) 
C2—C3 1.3859 (18) C18—C23 1.3938 (18) 
C2—H2 0.9500 C19—C20 1.385 (2) 
C3—C4 1.382 (2) C19—H19 0.9500 
C3—H3 0.9500 C20—C21 1.382 (2) 
C4—C5 1.3870 (18) C20—H20 0.9500 
C4—H4 0.9500 C21—C22 1.3809 (19) 
C5—C6 1.3899 (16) C21—H21 0.9500 
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Table 2.8 (continued) 
C5—H5 0.9500 C22—C23 1.3865 (18) 
C6—C7 1.5176 (15) C22—H22 0.9500 
C7—C8 1.5444 (15) C23—H23 0.9500 
C7—H7 1.0000 C24—H24A 0.9800 
C8—C9 1.5166 (15) C24—H24B 0.9800 
C8—H8 1.0000 C24—H24C 0.9800 
C9—C10 1.3889 (16) C25—H25A 0.9800 
C9—C14 1.3909 (16) C25—H25B 0.9800 
C10—C11 1.3912 (17) C25—H25C 0.9800 
C10—H10 0.9500 C26—C27 1.5224 (16) 
C11—C12 1.382 (2) C26—H26A 0.9900 
C11—H11 0.9500 C26—H26B 0.9900 
C12—C13 1.385 (2) C27—H27A 0.9800 
C12—H12 0.9500 C27—H27B 0.9800 
C13—C14 1.3871 (17) C27—H27C 0.9800 
C13—H13 0.9500   
 
C7—O1—H1 106.8 (11) C25—C16—C15 106.88 (9) 
C15—N1—C24 125.37 (9) C25—C16—C17 108.36 (9) 
C15—N1—C8 115.87 (9) C15—C16—C17 111.47 (9) 
C24—N1—C8 118.75 (9) C25—C16—C26 107.70 (10) 
C2—C1—C6 120.78 (11) C15—C16—C26 113.26 (9) 
C2—C1—H1A 119.6 C17—C16—C26 108.97 (9) 
C6—C1—H1A 119.6 C18—C17—C16 116.83 (9) 
C1—C2—C3 120.23 (12) C18—C17—H17A 108.1 
C1—C2—H2 119.9 C16—C17—H17A 108.1 
C3—C2—H2 119.9 C18—C17—H17B 108.1 
C4—C3—C2 119.42 (12) C16—C17—H17B 108.1 
C4—C3—H3 120.3 H17A—C17—H17B 107.3 
C2—C3—H3 120.3 C19—C18—C23 117.76 (11) 
C3—C4—C5 120.32 (12) C19—C18—C17 120.61 (11) 
C3—C4—H4 119.8 C23—C18—C17 121.56 (10) 
C5—C4—H4 119.8 C20—C19—C18 121.09 (13) 
C4—C5—C6 120.63 (12) C20—C19—H19 119.5 
C4—C5—H5 119.7 C18—C19—H19 119.5 
C6—C5—H5 119.7 C21—C20—C19 120.48 (12) 
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Table 2.8 (continued) 
C1—C6—C5 118.61 (11) C21—C20—H20 119.8 
C1—C6—C7 120.42 (10) C19—C20—H20 119.8 
C5—C6—C7 120.96 (11) C22—C21—C20 119.19 (13) 
O1—C7—C6 112.28 (9) C22—C21—H21 120.4 
O1—C7—C8 105.45 (8) C20—C21—H21 120.4 
C6—C7—C8 111.35 (9) C21—C22—C23 120.43 (13) 
O1—C7—H7 109.2 C21—C22—H22 119.8 
C6—C7—H7 109.2 C23—C22—H22 119.8 
C8—C7—H7 109.2 C22—C23—C18 121.04 (11) 
N1—C8—C9 113.22 (9) C22—C23—H23 119.5 
N1—C8—C7 111.18 (9) C18—C23—H23 119.5 
C9—C8—C7 111.84 (8) N1—C24—H24A 109.5 
N1—C8—H8 106.7 N1—C24—H24B 109.5 
C9—C8—H8 106.7 H24A—C24—H24B 109.5 
C7—C8—H8 106.7 N1—C24—H24C 109.5 
C10—C9—C14 118.79 (11) H24A—C24—H24C 109.5 
C10—C9—C8 119.51 (10) H24B—C24—H24C 109.5 
C14—C9—C8 121.54 (10) C16—C25—H25A 109.5 
C9—C10—C11 120.53 (11) C16—C25—H25B 109.5 
C9—C10—H10 119.7 H25A—C25—H25B 109.5 
C11—C10—H10 119.7 C16—C25—H25C 109.5 
C12—C11—C10 120.21 (12) H25A—C25—H25C 109.5 
C12—C11—H11 119.9 H25B—C25—H25C 109.5 
C10—C11—H11 119.9 C27—C26—C16 114.91 (9) 
C11—C12—C13 119.60 (12) C27—C26—H26A 108.5 
C11—C12—H12 120.2 C16—C26—H26A 108.5 
C13—C12—H12 120.2 C27—C26—H26B 108.5 
C12—C13—C14 120.22 (12) C16—C26—H26B 108.5 
C12—C13—H13 119.9 H26A—C26—H26B 107.5 
C14—C13—H13 119.9 C26—C27—H27A 109.5 
C13—C14—C9 120.61 (12) C26—C27—H27B 109.5 
C13—C14—H14 119.7 H27A—C27—H27B 109.5 
C9—C14—H14 119.7 C26—C27—H27C 109.5 
O2—C15—N1 119.39 (10) H27A—C27—H27C 109.5 
O2—C15—C16 118.29 (9) H27B—C27—H27C 109.5 
N1—C15—C16 122.30 (9)   
 174 
Table 2.8 (continued) 
C6—C1—C2—C3 0.16 (18) C12—C13—C14—C9 0.05 (18) 
C1—C2—C3—C4 0.45 (19) C10—C9—C14—C13 -1.72 (17) 
C2—C3—C4—C5 -0.3 (2) C8—C9—C14—C13 173.68 (10) 
C3—C4—C5—C6 -0.4 (2) C24—N1—C15—O2 172.01 (11) 
C2—C1—C6—C5 -0.85 (17) C8—N1—C15—O2 -7.62 (15) 
C2—C1—C6—C7 -179.78 (10) C24—N1—C15—C16 -9.95 (16) 
C4—C5—C6—C1 0.96 (18) C8—N1—C15—C16 170.42 (9) 
C4—C5—C6—C7 179.88 (11) O2—C15—C16—C25 1.24 (14) 
C1—C6—C7—O1 25.95 (14) N1—C15—C16—C25 -176.82 (10) 
C5—C6—C7—O1 -152.95 (11) O2—C15—C16—C17 119.47 (11) 
C1—C6—C7—C8 -92.03 (12) N1—C15—C16—C17 -58.59 (13) 
C5—C6—C7—C8 89.07 (13) O2—C15—C16—C26 -117.20 (11) 
C15—N1—C8—C9 82.28 (11) N1—C15—C16—C26 64.74 (13) 
C24—N1—C8—C9 -97.38 (12) C25—C16—C17—C18 58.31 (13) 
C15—N1—C8—C7 -150.83 (9) C15—C16—C17—C18 -59.03 (13) 
C24—N1—C8—C7 29.52 (13) C26—C16—C17—C18 175.24 (10) 
O1—C7—C8—N1 56.00 (11) C16—C17—C18—C19 -106.39 (13) 
C6—C7—C8—N1 178.02 (9) C16—C17—C18—C23 76.85 (14) 
O1—C7—C8—C9 -176.35 (8) C23—C18—C19—C20 1.36 (19) 
C6—C7—C8—C9 -54.33 (12) C17—C18—C19—C20 -175.52 (13) 
N1—C8—C9—C10 -129.15 (10) C18—C19—C20—C21 -1.4 (2) 
C7—C8—C9—C10 104.31 (11) C19—C20—C21—C22 0.4 (2) 
N1—C8—C9—C14 55.49 (13) C20—C21—C22—C23 0.70 (19) 
C7—C8—C9—C14 -71.06 (13) C21—C22—C23—C18 -0.73 (18) 
C14—C9—C10—C11 1.89 (17) C19—C18—C23—C22 -0.30 (17) 
C8—C9—C10—C11 -173.61 (11) C17—C18—C23—C22 176.55 (11) 
C9—C10—C11—C12 -0.39 (19) C25—C16—C26—C27 -82.93 (12) 
C10—C11—C12—C13 -1.29 (19) C15—C16—C26—C27 35.03 (14) 
C11—C12—C13—C14 1.46 (19) C17—C16—C26—C27 159.72 (10) 
  
Table 2.9: Hydrogen-bond parameters 
D—H···A D—H (Å) H···A (Å) D···A (Å) D—H···A (°) 
O1—H1···O2i 0.852 (17) 1.828 (17) 2.6791 (11) 175.8 (16) 
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Symmetry code(s):  (i) -x+1, y+1/2, -z+1/2. 
Figure 2.9: Perspective views showing 50% probability displacement.!
 
Figure 2.10: Three-dimensional supramolecular architecture viewed along the b-axis direction. 
 
c 
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1H and 13C NMR Spectra: 
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Chapter 3 
On the Synthesis of α-Methyl α-Amino Acids 
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Introduction 
As discussed in Chapter 1, pseudoephedrine glycinamide serves as a platform for the 
synthesis of α-amino acids.34 Similarly, pseudoephenamine glycinamide (67) may be employed 
in the asymmetric synthesis of α-amino amides, with yields and diastereoselectivities 
comparable to those of the previously reported methodology (Scheme 3.1).  
 
Scheme 3.1 Representative alkylations of pseudoephenamine glycinamide to give α-amino amides. X = Br, I. a 
crude dr.  
Following the success of these alkylation reactions, the synthesis of α,α-disubstituted α-
amino amides via the alkylation of enolates generated from monosubstituted amino amides was 
investigated. Such an alkylation is unreported in the pseudoephedrine literature and would 
represent an advance in the alkylation reactions directed by acyclic chiral auxiliaries. 
Unfortunately, attempts to alkylate substrates such as 68–70 were unsuccessful; treatment of the 
monosubstituted α-amino amides with two equivalents of LHMDS or LDA followed by addition 
of an alkyl halide led to exclusive N-alkylation of the substrates, presumably due to the inability 
of the putative N,O-dianion to tautomerize to the desired enolate.  
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To prevent this troublesome N-alkylation, protection of the amino group as an imine – a 
strategy with precedent in the synthesis of amino acids67 – was investigated. After screening a 
number of imines in the model alkylation of pseudoephenamine alaninamide,68 it was determined 
that protection of the amino group as its pivaldimine enabled high-yielding and highly 
diastereoselective alkylation reactions. As the following sections will illustrate, 
pseudoephenamine alaninamide pivaldimine now serves as a versatile starting material for the 
synthesis of α-methyl α-amino acids,69 which have important applications in many areas of 
biology.70,71,72,73 
                                                
67 For selected uses of imines in the context of enolate alkylations to form amino acids, see: (a) Ojima, I.; Chen, H. 
C.; Nakahashi, K. J. Am. Chem. Soc. 1988, 110, 278–281. (b) Ayoub, M.; Chassaing, G.; Loffet, A.; Lavielle, S. 
Tetrahedron Lett. 1995, 36, 4069–4072. (c) Meyer, L.; Poirier, J.; Duhamel, P.; Duhamel, L. J. Org. Chem. 1998, 
63, 8094–8095. 
68  Hugelshofer, C. L. (2012) Synthesis of Quaternary a-Methyl a-Amino Acids by Asymmetric Alkylation of 
Pseudoephenamine Alaninamide Pivaldimines. Master’s Thesis, Harvard University. 
69 Efforts to extend the present method to alkylate higher α-alkyl pivaldimines (replacing α-methyl with α-benzyl or 
α-ethyl) were not successful. 
70 This class of amino acids has documented utility in a number of biological applications. In stapled peptides: (a) 
Schafmeister, C. E.; Po, J.; Verdine, G. L. J. Am. Chem. Soc. 2000, 122, 5891–5892. (b) Bird, G. H.; Bernal, F.; 
Pitter, K.; Walensky, L. D. Models in Enzymology 2008, 446, 369–386. In enzyme inhibition: (c) Sourkes, T. L. 
Arch. Biochem. Biophys. 1945, 51, 444. (d) Thaisrivongs, S.; Pals, D. T.; Lawson, J. A.; Turner, S. R.; Harris, D. W. 
J. Med. Chem. 1987, 30, 536–541. In small molecule therapeutics: (e) Kelly, T. A.; Jeanfavre, D. D.; McNeil, D. 
W.; Woska, Jr., J. R.; Reilly, P. L.; Mainolfi, E. A.; Kishimoto, K. M.; Nabozny, G. H.; Zinter, R.; Bormann, B.; 
Rothlein, R. J. Immunol. 1999, 163, 5173–5177. In enzyme mechanism elucidation: (f) Fasella, P.; Giartosio, A.; 
Hammes, G. G. Biochemistry 1966, 5, 197–202. In the stabilization of peptide secondary structure: (g) Hinds, M. G.; 
Welsh, J. H.; Brennand, D. M.; Fisher, J.; Glennie, M. J.; Richards, N. G. J.; Turner, D. L.; Robinson, J. A. J. Med. 
Chem. 1991, 34, 1777–1789. Imparting resistance to peptide degradation: Khosla, M.C.; Stachowiak, K.; Smeby, 
R.R.; Bumpus, F.M.; Piriou, F.; Lintner, K.; Fermandjian, S. Proc. Natl. Acad. Sci. U.S.A. 1981, 78, 1981. 
71 For recent reviews of the asymmetric synthesis of quaternary α-amino acids, see: (a) Cativiela, C.; Díaz-de-
Villegas, M. Tetrahedron: Asymmetry 2007, 18, 569–623. (b) Cativiela, C.; Ordoñez, M. Tetrahedron: Asymmetry 
2009, 20, 1–63. 
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Synthesis of Pseudoephenamine Alaninamide Pivaldimine 
Synthesis of either diastereomer of (S,S)-pseudoephenamine alaninamide was achieved in a 
brief two-step process. First, pseudoephenamine was treated with the mixed anhydride formed 
from either enantiomer of N-Boc alanine and pivaloyl chloride.74 In the following step, the amino 
group was deprotected with a solution of hydrochloric acid in dioxane 75  to furnish 
pseudoephenamine alaninamide (exemplified in the synthesis of (1S,2S)-pseudoephenamine (R)-
alaninamide, 70, Scheme 3.2).  
 
Scheme 3.2 Synthesis of (1S,2S)-pseudoephenamine (R)-alaninamide. 
                                                                                                                                                       
72 For selected references describing chiral auxiliary-based methods for the asymmetric synthesis of quaternary α-
methyl α-amino acids, see: (a) Schöllkopf, U.; Hausberg, H. H.; Hoppe, I.; Segal, M.; Reiter, U. Angew. Chem. Int. 
Ed. 1978, 17, 117–119. (b) Seebach, D.; Aebi, J. D.; Naef, R.; Weber, T. Helv. Chim. Acta 1985, 68, 144–154. (c) 
Williams, R. M.; Im, J. J. Am. Chem. Soc. 1991, 113, 9276–9286. (d) Berkowitz, D.B.; Smith, M. K. J. Org. Chem. 
1995, 60, 1233–1238. (e) Alonso, F.; Davies, S. G.; Elend, A. S.; Haggitt, J. L. J. Chem. Soc., Perkin Trans. 1 1998, 
257–264. (f) Chinchilla, R.; Galindo, N.; Nájera, C. Synthesis 1999, 704–717. (g) Lu, T.; Lin, C. J. Org. Chem. 
2011, 76, 1621–1633. 
73 For selected references describing alternative methods for the asymmetric synthesis of quaternary α-methyl α-
amino acids, see: (a) Ooi, T.; Takeuchi, M.; Kameda, M.; Maruoka, K. J. Am. Chem. Soc. 2000, 122, 5228–5229.  
(b) Trost, B.M.; Dogra, K. J. Am. Chem. Soc. 2002, 124, 7256–7257. (c) Vachal, P.; Jacobsen, E.N. J. Am. Chem. 
Soc. 2002, 124, 10012–10014. (d) Masumoto, S.; Usuda, H.; Suzuki, M.; Kanai, M.; Shibasaki, M. J. Am. Chem. 
Soc. 2003, 125, 5634–5635. (e) Smith, N.D.; Wohlrab, A.M.; Goodman, M. Org. Lett. 2005, 7, 255–258. 
74 Vaughan, Jr., J. R.; Osato, R. L. J. Am. Chem. Soc. 1951, 73, 5553–5555. 
75 Peterson, E. A.; Jacobsen, E. N. Angew. Chem. Int. Ed. 2009, 48, 6328–6331.  
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Protection of the amino group of the alaninamides as their pivaldimines was accomplished 
using one of two different methods. The most direct procedure involved the condensation of 
pivaldehyde with pseudoephenamine alaninamide in the presence of 4 Å molecular sieves in a 
mixed solvent of benzene and dichloromethane at 23 ºC (Scheme 3.3a). Conveniently, 
evaporation of the reaction solvents upon complete reaction followed by heating of the mixture 
overnight at 35 ºC under reduced pressure (<1 Torr) to remove excess pivaldehyde provided the 
desired pivaldimine 71 in high yield and in high purity (≥99% yield, ≥95% purity by 1H and 13C 
NMR). Alternatively, transimination76 of pivaldehyde N-propyl imine with pseudoephenamine 
alaninamide gave pivaldimine 71 in comparable yield after evaporation of solvent and drying at 
elevated temperature and reduced pressure (Scheme 3.3b). The pivaldimine obtained using either 
method could be used in alkylation reactions without further purification. 
 
Scheme 3.3 Synthesis of (1S,2S)-pseudoephenamine (R)-alaninamide pivaldimine by a) direct condensation of 
pseudoephenamine alaninamide with pivaldehyde or b) transimination with pivaldehyde N-propyl imine. 
 
                                                
76 (a) Smith, Jr., G. E. P.; Bergstrom, F. W. J. Am. Chem. Soc. 1934, 56, 2095–2098. (b) Cordes, E. H.; Jencks, W. P. 
J. Am. Chem. Soc. 1962, 84, 826–831. (c) Leach, B. E.; Leussing, D. L. J. Am. Chem. Soc. 1971, 93, 3377–3384. 
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Alkylation of Pseudoephenamine Alaninamide Pivaldimine 
Due to the possibility of matched and mismatched substrates, alkylation reactions employing 
both diastereomers of pseudoephenamine alaninamide pivaldimine were investigated. In the 
general procedure, a solution of either diastereomer of pseudoephenamine alaninamide 
pivaldimine (1 equiv) in dry tetrahydrofuran (THF) was transferred to a flask containing flame-
dried lithium chloride (6.0 equiv), and the resulting slurry was cooled to –78 ºC. A solution of 
LDA (2.2 equiv) in THF was then added slowly down the side of the flask by cannula or syringe 
so as to allow the solution of base to cool before reaching the substrate solution. After complete 
addition and further stirring at –78 ºC for 5 minutes, the reaction flask was transferred to an ice 
water bath for 10 minutes before cooling to –50 ºC. An electrophile (2.5 equiv) was then added 
to the cold reaction solution, and the ensuing alkylation reaction was monitored by TLC 
(reaction times typically ranged from 1.5–3.5 h). When the reaction was judged to be complete, a 
solution of 1 N hydrochloric acid was added to the reaction mixture to induce hydrolysis of the 
tert-butyl imine function within the alkylated product, which typically occurred in less than 3 h 
at 23 ºC. 
The alkylation reactions of (1S,2S)-pseudoephenamine (R)-alaninamide pivaldimine (71) are 
shown in Scheme 3.4 below. In all cases, diastereoselectivities equaled or exceeded 19:1 dr as 
determined by 1H NMR analysis, and the solid products were isolated in 83-95% yield after 
flash-column chromatography. The configuration of benzylation product 75 was established by 
comparison with a sample of known configuration prepared by an independent route (see 
Experimental Information). The diastereomer formed arises from replacement of the α-C–H 
bond by α-C–benzyl with retention of configuration. This alkylation product and two others 
whose stereochemistry was established unambiguously (compounds 80 and 84 below) were 
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found to form a homochiral series, and the remaining compounds were presumed to have formed 
analogously. 
 
Scheme 3.4 Alkylation reactions of (1S,2S)-pseudoephenamine (R)-alaninamide pivaldimine (71) to produce α-
methyl α-amino amides. X = Br, I, OTf. 
Scheme 3.5 summarizes the alkylation reactions of (1S,2S)-pseudoephenamine (S)-
alaninamide pivaldimine (78) under conditions identical to those used for the alkylation of 
pivaldimine 71 above. Surprisingly, the major diastereomer obtained in the alkylation of 
pivaldimine 78 was the same major diastereomer produced in the alkylation of pivaldimine 71. 
However, as evidenced by the lower yields and diastereoselectivities observed in these reactions, 
pivaldimine 78 was the mismatched diastereomer in these alkylations, making pivaldimine 71 
the matched substrate. 
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Scheme 3.5 Alkylation reactions of (1S,2S)-pseudoephenamine (S)-alaninamide pivaldimine (78) to produce α-
methyl α-amino amides. X = Br, I, OTf. 
Given that both the matched and mismatched pivaldimines arrive at the same major 
diastereomer in the alkylation reactions, it is likely that both alkylations proceed through the 
same E-enolate intermediate upon deprotonation with LDA (Figure 3.1). Interestingly, this 
implies that deprotonation of pivaldimine 78 must occur along a trajectory impeded by the chiral 
auxiliary. If this is correct, then formation of the Z-enolate from the mismatched substrate must 
remain a higher energy pathway in spite of the fact that it would arise from deprotonation along a 
more favorable trajectory. An important factor in this process may be a developing repulsive 
electronic interaction between the enolate oxygen atom and the α-imino lone pair in the 
transition state for formation of the Z-enolate. The existence of an intermediate E-enolate in the 
alkylation of pivaldimine 71 was confirmed by NOE analysis of a cyclic siloxane obtained by 
trapping of this enolate with dichlorodiisopropylsilane (Scheme 3.6). 
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Figure 3.1 Proposed rationale for the stereochemical outcome of the alkylations of the matched and mismatched 
diastereomers of pseudoephenamine alaninamide pivaldimine. 
 
Scheme 3.6 Trapping of the E-enoalate of pivaldimine 71 with dichlorodiisopropyl silane.  
With the matched diastereomer for the alkylation reactions identified, the synthesis of 
additional substrates was pursued. An interesting transformation was encountered in the 
allylation of pivaldimine 71. While the allylation reaction was successful, hydrolysis of the imine 
functional group under the standard acidic conditions produced a mixture of the desired amide 80 
and aminal 81, which is the by-product of a cationic aza-Cope rearrangement (Scheme 3.7).77,78 
                                                
77 The structure of aminal 81 was confirmed by X-ray crystallography. See Experimental Information for details. 
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Cleavage of the imine via transimination with hydroxylamine circumvented this issue and 
allowed for the isolation of the desired allyl amide in high yield with diastereoselectivity 
consistent with other matched-case substrates (Scheme 3.8). 
 
Scheme 3.7 Formation of undesired aminal by-product 81 via a cationic aza-Cope rearrangement. 
 
Scheme 3.8 Optimized procedure for the synthesis of α-methyl α-allyl α-amino amide 80. 
As depicted in Scheme 3.9 below, it also proved possible to assemble cyclic α-amino acid 
derivatives containing an α-quaternary center in a single operation using bis-electrophiles such 
as (a) 3-bromopropyl trifluoromethanesulfonate, (b) α,α′-dibromo-o-xylene, and (c) (R)-3-
chloro-2-methylpropyl trifluoromethanesulfonate. Due to their chromatographic instability 
(believed to be a consequence of facile N→O acyl transfer), products from the latter two 
                                                                                                                                                       
78 For the use of a chiral auxiliary to direct a similar transfer aminoallylation, see: Sugiura, M.; Mori, C.; Kobayashi, 
S. J. Am. Chem. Soc. 2006, 128, 11038–11039. 
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alkylations were directly subjected to esterification with lithium benzyloxide prior to 
purification.79 
 
Scheme 3.9 Synthesis of cyclic amino acid derivatives. Diastereomeric ratios were determined by 1H NMR analysis 
of the crude alkylation reaction mixtures. 
 
 
 
                                                
79 This protocol was reported for the esterification of oxazolidinone imides: Evans, D. A.; Ennis, M. D.; Mathre, D. 
J.; J. Am. Chem. Soc. 1982, 104, 1737–1739. 
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Transformations of α-Methyl α-Amino Pseudoephenamine Amides 
Two protocols for the transformation of the α-amino amide alkylation products were 
developed. Hydrolysis of the α-quaternary α-amino amides to the corresponding α-amino acids 
was achieved by refluxing in aqueous dioxane (Scheme 3.10). Alternatively, as with the cyclic 
amino acid derivatives depicted in Scheme 3.9 above, treatment of the α-quaternary α-amino 
amides with lithium alkoxides provided the α-amino esters directly, as demonstrated with α-
methyl phenylalaninamide 75 in Scheme 3.11. 80 
 
Scheme 3.10 Synthesis of α-methyl quaternary amino acids under salt-free conditions. a >98% ee, as determined by 
chiral HPLC analysis. 
                                                
80 Caddick, S.; Parr, N. J.; Pritchard, M. C. Tetrahedron 2001, 57, 6615–6626. 
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Scheme 3.11 Synthesis of α-methyl phenylalanine esters. a Base = NaOCH3, Solvent = CH3OH. bBase = LiOBn, 
Solvent = THF. 
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Experimental Information 
General experimental procedures: All reactions were performed in flame-dried glassware 
fitted with rubber septa under a positive pressure of argon, unless otherwise noted. Air- and 
moisture-sensitive liquids were transferred via syringe or stainless steel cannula. Organic 
solutions were concentrated by rotary evaporation below 35 °C at 40 mmHg. Analytical thin-
layer chromatography (TLC) was performed using glass plates precoated with silica gel (0.25-
mm, 60-Å pore size, 230−400 mesh, Merck KGA) impregnated with a fluorescent indicator (254 
nm). TLC plates were visualized by exposure to ultraviolet light (UV), were stained by 
submersion in aqueous potassium permanganate solution (KMnO4) or ceric ammonium 
molybdate solution (CAM), and were developed by heating with a heat gun. Flash column 
chromatography was performed as described by Still et al.,58 employing silica gel (60 Å, standard 
grade) purchased from Dynamic Adsorbents. Flash column chromatography using deactivated 
silica gel was performed by preparing the silica gel slurry with triethylamine (10% v/v in 
corresponding eluent mixture) and flushing column with the eluent prior to loading the 
compound on the column. 
 
Materials: Commercial solvents and reagents were used as received, with the following 
exceptions. N,N-diisopropylamine, dichloromethane, ethyl ether, and tetrahydrofuran were 
purified by the method of Pangborn et al.59 Lithium chloride was dried at 150 °C under vacuum 
(0.1 mmHg) for 12 h and stored in a drying oven at 150 °C (760 mmHg); the hot, dried solid was 
flame dried under vacuum (0.1 mmHg) for 2−3 min immediately prior to use. 4 Å molecular 
sieves were stored in a drying oven at 150 °C (760 mmHg) and flame dried under vacuum (0.1 
mmHg) for 2-3 min immediately prior to use. Benzyl bromide, tert-butyl bromoacetate, 3-
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methoxybenzyl bromide, ethyl iodide, methyl iodide, and allyl bromide were filtered neat 
through a column of oven-dried basic alumina immediately prior to use. The molarity of n-
butyllithium solutions was determined by titration against diphenylacetic acid as an indicator 
(average of three determinations).60  
 
Instrumentation: Proton nuclear magnetic resonance spectra (1H NMR) spectra and carbon 
nuclear magnetic resonance (13C NMR) spectra were recorded on Varian INOVA 600 (600 
MHz/150 MHz), Varian INOVA 500 (500 MHz/125 MHz) or Varian 400 (400 MHz/100 MHz) 
NMR spectrometers at 23 °C. Proton chemical shifts are expressed in parts per million (ppm, δ 
scale) and are referenced to residual protium in the NMR solvent (CHCl3: δ 7.26, HDO: δ 4.79, 
CD2HOD: δ 4.87, THF-d8: δ 3.58). Carbon chemical shifts are expressed in parts per million 
(ppm, δ scale) and are referenced to the carbon resonance of the NMR solvent (CDCl3: δ 77.2, 
CD3OD: δ 49.0, THF-d8: δ 67.6). Data are represented as follows: chemical shift, multiplicity (s 
= singlet, d = doublet, t = triplet, q = quartet, dd = doublet of doublets, dt = doublet of triplets, td 
= triplet of doublets, dq= doublet of quartets, dquint = doublet of quintets, sxt = sextet, m = 
multiplet, br = broad), integration, and coupling constant (J) in Hertz (Hz). Infrared (IR) spectra 
were obtained using a Shimadzu 8400S FT-IR spectrophotometer referenced to a polystyrene 
standard. Data are represented as follows: frequency of absorption (cm−1), and intensity of 
absorption (s = strong, m = medium, br = broad). HPLC retention times were acquired using a 
Beckman System Gold instrument equipped with a Phenomenex Chirex 3126 (D)-penicillamine 
column (5 µm particle size, 4.6 mm x 50 mm). Melting points were determined using a Thomas 
Scientific capillary melting point apparatus. High-resolution mass spectra were obtained at the 
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Harvard University Mass Spectrometry Facility. X-ray crystallographic analysis was performed 
at the Harvard University X-Ray Crystallographic Laboratory by Dr. Shao-Liang Zheng. 
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Synthesis of Pseudoephenamine Glycinamide: 
 
 
2-amino-N-((1S,2S)-2-hydroxy-1,2-diphenylethyl)-N-methylacetamide (67) 
Trimethylacetyl chloride (7.58 mL, 61.6 mmol, 1.4 equiv) was added dropwise to a stirring 
solution of N-(tert-butoxycarbonyl)-glycine (10.79 g, 61.6 mmol, 1.4 equiv) and triethylamine 
(8.60 mL, 61.5 mmol, 1.40 equiv) in dichloromethane (154 mL) at 0 °C. A white precipitate 
gradually formed; after 35 min, a second portion of triethylamine (8.60 mL, 61.5 mmol, 1.40 
equiv) was added to the reaction mixture, followed by a single portion of (1S,2S)-
pseudoephenamine (10.0 g, 44.0 mmol, 1.00 equiv). Stirring was continued at 0 ºC, and, after 45 
min, the solution was concentrated under reduced pressure to give a white syrup. This syrup was 
partitioned between methanol (75 ml) and water (75 ml). The resulting suspension was cooled to 
0 ºC, and concentrated hydrochloric acid (60 ml) was added to the mixture. After stirring for 3 h 
at 0 ºC, the solution was concentrated to remove the methanol, and the resulting aqueous 
suspension was cooled to 0 ºC and adjusted to pH 14 using 50% aqueous NaOH solution. The 
organic material was then extracted from the aqueous solution using dichloromethane (4x50 
mL). The combined organic extracts were dried over potassium carbonate, and the dried solution 
was filtered through a pad of Celite. The organic solution was then concentrated to an off-white 
solid that was purified by column chromatography (deactivated silica gel, 5→10% methanol-
dichloromethane) to produce glycinamide 67 as a white solid (11.4 g, 91%). TLC (10% 
methanol-dichloromethane, deactivated silica gel): Rf = 0.25 (streak, UV, KMnO4). 1H NMR 
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(3.4:1 rotamer ratio, asterisk denotes minor rotamer peaks, 500 MHz, CDCl3) δ 7.40 – 7.34 (m, 
2H), 7.33 – 7.18 (m, 8H), 5.73 (d, J = 8.4 Hz, 1H), 5.36 (m, 1H), 4.99* (d, J = 7.9 Hz, 1H), 3.54 
– 3.34 (m, 2H), 2.97* (s, 3H), 2.83 (s, 3H). 13C NMR (2.6:1 rotamer ratio, asterisk denotes minor 
rotamer peaks, 126 MHz, CDCl3) δ 173.72, 173.41*, 141.75, 137.04, 136.48*, 128.43, 128.40, 
128.33, 128.32, 128.23, 128.15, 127.81*, 127.70*, 127.55, 127.41, 126.93, 126.90, 72.69, 
72.39*, 64.75*, 63.62, 43.28, 43.06*, 30.89, 29.54*. FTIR (neat), cm-1: 3387 (br), 3028 (w), 
1606 (s), 1043 (m), 698 (s). HRMS (ESI): Calcd for (C17H20N2O2 + Na)+: 307.1417. Found: 
307.1428. 
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Alkylation of Pseudoephenamine Glycinamide: 
 
(R)-2-amino-N-((1S,2S)-2-hydroxy-1,2-diphenylethyl)-N-methyl-3-phenylpropanamide (68) 
A 10-mL flask was charged with lithium chloride (145 mg, 3.42 mmol, 7.80 equiv), and the salt 
was flame dried under reduced pressure. Once cool, (S,S)-pseudoephenamine glycinamide (162 
mg, 0.570 mmol, 1.30 equiv) and tetrahydrofuran (2.2 mL) were added to the flask. The 
glycinamide was allowed to dissolve, and the resulting slurry was cooled to –78 ºC. A freshly 
prepared solution of lithium hexamethyldisilazide (1 M, 1.13 mL, 1.13 mmol, 2.57 equiv) was 
then added slowly down the side of the flask in order to allow the solution of base to cool before 
reaction the reaction slurry. The resulting pale yellow solution was stirred for 10 min at –78 ºC 
before the solution was warmed to 0 ºC and stirred for 30 min. Benzyl bromide (75 mg, 52.2 µL, 
0.439 mmol, 1 equiv) was added to the solution, and the mixture was stirred at 0 ºC for 2 h, after 
which time 1 M aqueous hydrochloric acid solution (6 mL) was added. The resulting biphasic 
mixture was allowed to warm to 23 ºC and was transferred to a separatory funnel containing 
ethyl acetate (10 mL). The layers were separated, and the product was extracted from the organic 
phase using 1 M aqueous hydrochloric acid solution (3x10 mL). The combined acidic aqueous 
extracts were cooled to 0 ºC and adjusted to pH 14 by slow addition of 50% aqueous NaOH 
solution. The organic material was extracted from the resulting basic aqueous solution using 
dichloromethane (3x10 mL). The organic solution was dried over potassium carbonate. The dried 
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solution was filtered, and the filtrate was concentrated to a white solid. The crude material was 
judged to be ≥98:2 dr by HPLC analysis (Chiralpak OD-R, 42% acetonitrile in aqueous pH 2 
potassium hexafluorophosphate solution, 1 mL/min, λ = 220 nm, tR (major) = 6.41 min, tR 
(minor) = 9.21 min). The crude amide was purified by column chromatography (deactivated 
silica gel, 3→7% methanol-dichloromethane) to produce amide 68 as a white solid (148 mg, 
91%). The dr of purified 68 was determined to be >99:1 dr by HPLC analysis. TLC (10% 
methanol-dichloromethane, deactivated silica gel): Rf = 0.51 (UV, KMnO4). 1H NMR (500 MHz, 
CDCl3) δ 7.46 – 7.41 (m, 2H), 7.33 – 7.22 (m, 7H), 7.19 (m, 7H), 7.13 – 7.09 (m, 2H), 6.05 (d, J 
= 8.8 Hz, 1H), 5.29 (d, J = 8.8 Hz, 1H), 3.93 (t, J = 7.1 Hz, 1H), 2.90 (dd, J = 13.2, 7.4 Hz, 1H), 
2.80 – 2.75 (dd, J = 13.2, 7.4 Hz, 1H), 2.74 (s, 3H).13C NMR (126 MHz, CDCl3) δ 175.88, 
141.60, 137.23, 136.65, 129.14, 128.54, 128.29, 128.14, 128.13, 128.11, 127.52, 127.28, 127.06, 
126.40, 72.50, 62.62, 52.98, 41.81, 31.40. HRMS (ESI): Calcd for (C24H26N2O2 + H)+: 397.1886. 
Found: 397.1889. 
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(R)-2-amino-N-((1S,2S)-2-hydroxy-1,2-diphenylethyl)-N-methylpent-4-enamide (69) 
A 10-mL flask was charged with lithium chloride (205 mg, 4.84 mmol, 7.80 equiv), and the salt 
was flame dried under reduced pressure. Once cool, (S,S)-pseudoephenamine glycinamide (229 
mg, 0.806 mmol, 1.30 equiv) and tetrahydrofuran (3.1 mL) were added to the flask. The 
glycinamide was allowed to dissolve, and the resulting slurry was cooled to –78 ºC. A freshly 
prepared solution of lithium hexamethyldisilazide (1 M, 1.60 mL, 1.60 mmol, 2.57 equiv) was 
then added slowly down the side of the flask in order to allow the solution of base to cool before 
reaction the reaction slurry. The resulting pale yellow solution was stirred for 10 min at –78 ºC 
before the solution was warmed to 0 ºC and stirred for 30 min. Allyl bromide (75 mg, 53.6 µL, 
0.620 mmol, 1 equiv) was added to the solution, and the mixture was stirred at 0 ºC for 2 h, after 
which time 1 M aqueous hydrochloric acid solution (6 mL) was added. The resulting biphasic 
mixture was allowed to warm to 23 ºC and was transferred to a separatory funnel containing 
ethyl acetate (10 mL). The layers were separated, and the product was extracted from the organic 
phase using 1 M aqueous hydrochloric acid solution (3x10 mL). The combined acidic aqueous 
extracts were cooled to 0 ºC and adjusted to pH 14 by slow addition of 50% aqueous NaOH 
solution. The organic material was extracted from the resulting basic aqueous solution using 
dichloromethane (3x10 mL). The organic solution was dried over potassium carbonate. The dried 
solution was filtered, and the filtrate was concentrated to a white solid. The crude material was 
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judged to be ≥98:2 dr by HPLC analysis (Chiralpak OD-R, 35% acetonitrile in aqueous pH 2 
potassium hexafluorophosphate solution, 1 mL/min, λ = 220 nm, tR (major) = 11.3 min, tR 
(minor) = 17.2 min). The crude amide was purified by column chromatography (deactivated 
silica gel, 3→7% methanol-dichloromethane) to produce amide 69 as a white solid (169 mg, 
84%). The dr of purified 69 was determined to be >99:1 dr by HPLC analysis. TLC (10% 
methanol-dichloromethane, deactivated silica gel): Rf = 0.57 (UV, KMnO4). 1H NMR (500 MHz, 
CDCl3) 7.42 – 7.37 (m, 6H), 7.32 – 7.27 (m,6), 7.23 (d, J = 7.4 Hz, 2H), 5.76 – 5.64 (m, 2H), 
5.39 (d, J = 8.1 Hz, 1H), 5.13 – 5.03 (m, 2H), 3.73 (dd, J = 7.7, 5.0 Hz, 1H), 2.92 (s, 3H), 2.26 
(m, 1H), 2.18 – 2.07 (m, 1H).13C NMR (126 MHz, CDCl3) δ 176.34, 141.61, 136.84, 133.63, 
128.46, 128.42, 128.34, 128.28, 127.66, 127.51, 126.98, 126.93, 118.27, 118.25, 72.90, 64.27, 
51.24, 39.44, 32.59. HRMS (ESI): Calcd for (C20H24N2O2 + H)+: 347.1730. Found: 347.1746. 
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(R)-2-amino-N-((1S,2S)-2-hydroxy-1,2-diphenylethyl)-N-methylpropanamide (70) 
A 10-mL flask was charged with lithium chloride (233 mg, 5.5 mmol, 7.80 equiv), and the salt 
was flame dried under reduced pressure. Once cool, (S,S)-pseudoephenamine glycinamide (260 
mg, 0.916 mmol, 1.30 equiv) and tetrahydrofuran (3.5 mL) were added to the flask. The 
glycinamide was allowed to dissolve, and the resulting slurry was cooled to –78 ºC. A freshly 
prepared solution of lithium hexamethyldisilazide (1 M, 1.81 mL, 1.81 mmol, 2.57 equiv) was 
then added slowly down the side of the flask in order to allow the solution of base to cool before 
reaction the reaction slurry. The resulting pale yellow solution was stirred for 10 min at –78 ºC 
before the solution was warmed to 0 ºC and stirred for 30 min. Methyl iodide (100 mg, 44.1 µL, 
0.705 mmol, 1 equiv) was added to the solution, and the mixture was stirred at 0 ºC for 2 h, after 
which time 1 M aqueous hydrochloric acid solution (6 mL) was added. The resulting biphasic 
mixture was allowed to warm to 23 ºC and was transferred to a separatory funnel containing 
ethyl acetate (10 mL). The layers were separated, and the product was extracted from the organic 
phase using 1 M aqueous hydrochloric acid solution (3x10 mL). The combined acidic aqueous 
extracts were cooled to 0 ºC and adjusted to pH 14 by slow addition of 50% aqueous NaOH 
solution. The organic material was extracted from the resulting basic aqueous solution using 
dichloromethane (3x10 mL). The organic solution was dried over potassium carbonate. The dried 
solution was filtered, and the filtrate was concentrated to a white solid. The crude material was 
judged to be 97:3 dr by HPLC analysis (Chiralpak OD-R, 20% acetonitrile in aqueous pH 2 
OH
N
CH3
O
NH2
1. LHMDS, LiCl
    THF, –78 ºC
2. CH3I (1 eq),
    0 ºC OH
N
CH3
O
NH2
CH3
7067
1.3 eq
80%
 241 
potassium hexafluorophosphate solution, 1 mL/min, λ = 220 nm, tR (major) = 25.0 min, tR 
(minor) = 37.0 min). The crude amide was purified by column chromatography (deactivated 
silica gel, 5→10% methanol-dichloromethane) to produce amide 70 as a white solid (168 mg, 
80%). TLC (10% methanol-dichloromethane, deactivated silica gel): Rf = 0.29 (UV, KMnO4). 1H 
NMR (10:1 rotamer ratio, asterisk denotes minor rotamer peaks, 500 MHz, CDCl3) δ 7.46 – 7.42 
(m, 2H), 7.35 – 7.29 (m, 6H), 7.29 – 7.23 (m, 2H), 5.73 (d, J = 8.1 Hz, 1H), 5.40 (d, J = 8.1 Hz, 
1H), 5.38 – 5.37* (m, 1H), 5.17* (d, J = 8.0 Hz, 1H), 3.85* (q, J = 6.8 Hz, 1H), 3.78 (q, J = 6.8 
Hz, 1H), 3.09* (s, 3H), 2.93 (s, 3H), 2.39 (br s, 2H), 1.36 – 1.28* (m, 3H), 1.15 (d, J = 6.8 Hz, 
3H). 13C NMR (126 MHz, CDCl3) δ 178.12, 141.87, 137.04, 128.58, 128.45, 128.41, 127.81, 
127.67, 126.91, 73.35, 65.38, 47.61, 33.32, 20.79. FTIR (neat), cm-1: 3030 (m), 2974 (m), 1627 
(s), 1452 (m), 1273 (m), 1062 (s). HRMS (ESI): Calcd for (C18H22N2O2 + H)+: 299.1761. Found: 
299.1755. 
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Synthesis of Pseudoephenamine Alaninamide Pivaldimines: 
Synthesis of Pseudoephenamine Alaninamide Pivaldimines via Pivaldehyde Condensation 
 
Tert-butyl ((R)-1-(((1S,2S)-2-hydroxy-1,2-diphenylethyl)(methyl)amino)-1-oxopropan-2-
yl)carbamate (108) 
 
Trimethylacetyl chloride (4.22 mL, 34.3 mmol, 2.60 equiv) was added dropwise to a stirring 
solution of N-(tert-butoxycarbonyl)-D-alanine (6.49 g, 34.3 mmol, 2.60 equiv) and triethylamine 
(4.42 mL, 31.7 mmol, 2.40 equiv) in dichloromethane (88.0 mL) at 0 °C. A white precipitate 
gradually formed; after 30 min, a second portion of triethylamine (4.42 mL, 31.7 mmol, 2.40 
equiv) was added to the reaction mixture, followed by a single portion of (1S,2S)-
pseudoephenamine (3.00 g, 13.2 mmol, 1.00 equiv). Stirring was continued, and, after 12 h, 
saturated aqueous sodium bicarbonate solution (150 mL) was added. The layers were separated, 
the aqueous layer was extracted with dichloromethane (3 x 100 mL), and the combined organic 
extracts were dried over sodium sulfate. The dried solution was filtered, and the filtrate was 
concentrated. The residue was purified by flash chromatography (30→50% ethyl acetate-
hexanes) to provide amide 108 as a white foam (5.26 g, 99%). TLC (40% ethyl acetate-hexanes): 
Rf = 0.55 (UV, KMnO4). 1H NMR (6:1 rotamer ratio, asterisk denotes minor rotamer peaks, 600 
MHz, CDCl3) δ 7.39 – 7.33 (m, 2H), 7.34 – 7.22 (m, 6H), 7.24 – 7.15 (m, 2H), 5.49 (d, J = 7.8 
Hz, 1H), 5.39* (d, J = 7.2 Hz, 1H), 5.36 (d, J = 7.6 Hz, 1H), 5.27* (d, J = 8.7 Hz, 1H), 4.87 – 
4.77* (m, 1H), 4.58 – 4.50 (m, 1H), 2.90 (s, 3H), 2.88* (s, 3H), 1.42 (s, 9H), 1.38* (s, 9H), 1.10 
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(d, J = 6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 175.08, 155.50, 141.62, 136.47, 128.88, 
128.64, 128.46, 128.25, 127.81, 127.75, 127.33, 126.75, 79.87, 73.49, 67.13, 47.12, 34.70, 28.48, 
18.25. FTIR (neat), cm-1: 2980 (m), 1705 (s), 1635 (s), 1454 (s), 1367 (m), 1166 (s). HRMS 
(ESI): Calcd for (C23H30N2O4 + H)+: 399.2286. Found: 399.2312. 
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Tert-butyl ((S)-1-(((1S,2S)-2-hydroxy-1,2-diphenylethyl)(methyl)amino)-1-oxopropan-2-yl)-
carbamate (109) 
 
Trimethylacetyl chloride (9.85 mL, 80.0 mmol, 2.60 equiv) was added dropwise to a stirring 
solution of N-(tert-butoxycarbonyl)-L-alanine (15.2 g, 80.0 mmol, 2.60 equiv) and triethylamine 
(10.3 mL, 74.0 mmol, 2.40 equiv) in dichloromethane (200 mL) at 0 °C. A white precipitate 
gradually formed; after 30 min, a second portion of triethylamine (10.3 mL, 74.0 mmol, 2.40 
equiv) was added to the reaction mixture, followed by a single portion of (1S,2S)-
pseudoephenamine (26) (7.00 g, 30.8 mmol, 1.00 equiv). Stirring was continued, and, after 12 h, 
saturated aqueous sodium bicarbonate solution (200 mL) was added. The layers were separated, 
the aqueous layer was extracted with dichloromethane (3 x 100 mL), and the combined organic 
extracts were dried over sodium sulfate. The dried solution was filtered, and the filtrate was 
concentrated. The residue was purified by flash chromatography (30→50% ethyl acetate-
hexanes) to provide amide 109 as a white foam (12.3 g, 99%). TLC (40% ethyl acetate-hexanes): 
Rf = 0.55 (UV, KMnO4). 1H NMR (4:1 rotamer ratio, asterisk denotes minor rotamer peaks, 600 
MHz, CDCl3) δ 7.40 – 7.34 (m, 2H), 7.33 – 7.17 (m, 8H), 5.74 (d, J = 7.4 Hz, 1H), 5.45 (d, J = 
7.5 Hz, 1H), 5.43* (d, J = 8.6 Hz, 1H), 5.24* (d, J = 9.0 Hz, 1H), 4.91* (p, J = 6.9 Hz, 1H), 4.54 
(p, J = 7.1 Hz, 1H), 2.98* (s, 3H), 2.96 (s, 3H), 1.45* (s, 9H), 1.43 (s, 9H), 1.33* (d, J = 6.9 Hz, 
3H), 1.16 (d, J = 6.8 Hz, 3H). 13C NMR (4:1 rotamer ratio, asterisk denotes minor rotamer peaks, 
100 MHz, CDCl3) δ 174.63, 155.34, 141.44, 136.82, 128.77*, 128.72*, 128.68, 128.51, 128.41, 
128.16*, 128.08*, 127.95, 127.78, 127.26*, 126.71, 79.68, 73.66, 73.12*, 66.00*, 64.48, 47.06, 
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    Et3N, CH2Cl2, 0 °C
2. (1S,2S)-pseudoephenamine,
    Et3N, 0 → 23 °C
                       99%
O
NHBoc
N
CH3CH3OH
HO
O
CH3
NHBoc
109(+)-107
 245 
45.78*, 33.48, 29.35*, 28.48, 19.00*, 18.59. FTIR (neat), cm-1: 2980 (m), 1699 (s), 1633 (s), 
1494 (s), 1410 (m), 1166 (s). HRMS (ESI): Calcd for (C23H30N2O4 + H)+: 399.2286. Found: 
399.2306. 
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(R)-2-amino-N-((1S,2S)-2-hydroxy-1,2-diphenylethyl)-N-methylpropanamide (70) 
A solution of hydrogen chloride in dioxane (4 M, 14.4 mL, 57.6 mmol, 4.40 equiv) was added 
dropwise to a stirring solution of amide 108 (5.20 g, 13.1 mmol, 1.00 equiv) in dichloromethane 
(29.0 mL) at 0 °C over 2 min. After 5 min, the reaction mixture was allowed to warm to 23 °C. A 
white precipitate gradually formed, and the resulting suspension was stirred at 23 °C for 2 h, 
after which time the reaction mixture was brought to pH 14 by the addition of 2 M aqueous 
sodium hydroxide solution. Saturated aqueous sodium chloride solution (40 mL) was added, the 
layers were separated, and the aqueous layer was extracted with dichloromethane (3 x 100 mL). 
The combined organic extracts were dried over sodium sulfate. The dried solution was filtered, 
and the filtrate was concentrated. The residue was purified by flash chromatography (8% 
methanol-dichloromethane, triethylamine pretreated silica gel) to provide amide 70 as a white 
solid (3.21 g, 82%). TLC (10% methanol-dichloromethane): Rf = 0.29 (UV, KMnO4). 1H NMR 
(10:1 rotamer ratio, asterisk denotes minor rotamer peaks, 500 MHz, CDCl3) δ 7.46 – 7.42 (m, 
2H), 7.35 – 7.29 (m, 6H), 7.29 – 7.23 (m, 2H), 5.73 (d, J = 8.1 Hz, 1H), 5.40 (d, J = 8.1 Hz, 1H), 
5.38 – 5.37* (m, 1H), 5.17* (d, J = 8.0 Hz, 1H), 3.85* (q, J = 6.8 Hz, 1H), 3.78 (q, J = 6.8 Hz, 
1H), 3.09* (s, 3H), 2.93 (s, 3H), 2.39 (br s, 2H), 1.36 – 1.28* (m, 3H), 1.15 (d, J = 6.8 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 178.12, 141.87, 137.04, 128.58, 128.45, 128.41, 127.81, 127.67, 
126.91, 73.35, 65.38, 47.61, 33.32, 20.79. FTIR (neat), cm-1: 3030 (m), 2974 (m), 1627 (s), 1452 
(m), 1273 (m), 1062 (s). HRMS (ESI): Calcd for (C18H22N2O2 + H)+: 299.1761. Found: 299.1755. 
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(S)-2-amino-N-((1S,2S)-2-hydroxy-1,2-diphenylethyl)-N-methylpropanamide (110) 
A solution of hydrogen chloride in dioxane (4 M, 34.2 mL, 137 mmol, 4.40 equiv) was added 
dropwise to a stirring solution of amide 109 (12.3 g, 30.8 mmol, 1.00 equiv) in dichloromethane 
(70.0 mL) at 0 °C over 2 min. After 5 min, the reaction mixture was allowed to warm to 23 °C. A 
white precipitate gradually formed, and the resulting suspension was stirred at 23 °C for 1.5 h, 
after which time the reaction mixture was brought to pH 14 by the addition of 2 M aqueous 
sodium hydroxide solution. Saturated aqueous sodium chloride solution (50 mL) was added, the 
layers were separated, and the aqueous layer was extracted with dichloromethane (3 x 100 mL). 
The combined organic extracts were dried over sodium sulfate. The dried solution was filtered, 
and the filtrate was concentrated. The residue was purified by flash chromatography (7% 
methanol-dichloromethane, triethylamine pretreated silica gel) to provide amide 110 as a white 
foam (7.40 g, 81%). TLC (10% methanol-dichloromethane): Rf = 0.38 (UV, KMnO4). 1H NMR 
(4:3 rotamer ratio, asterisk denotes minor rotamer peaks, 500 MHz, CDCl3) δ 7.39 (m, 2H), 7.35 
– 7.20 (m, 8H), 5.75 (d, J = 7.7 Hz, 1H), 5.42 (d, J = 7.7 Hz, 1H), 5.37 – 5.29* (m, 2H), 3.94* 
(q, J = 6.5 Hz, 1H), 3.73 (q, J = 6.8 Hz, 1H), 2.91 (s, 3H), 1.86 (br s, 2H), 1.37* (d, J = 6.5 Hz, 
3H), 1.18 (d, J = 6.9 Hz, 3H). 13C NMR (4:3 rotamer ratio, asterisk denotes minor rotamer peaks, 
126 MHz, CDCl3) δ 177.49, 175.89*, 142.09*, 141.85, 137.13, 136.37*, 128.74, 128.66, 128.60, 
128.58, 128.53, 128.46, 128.37, 127.99, 127.96, 127.73, 127.63, 127.24, 126.74, 73.39, 72.47*, 
65.19, 64.15*, 47.46, 46.78*, 32.85, 29.85*, 21.36*, 20.63. FTIR (neat), cm-1: 3030 (m), 2976 
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(m), 1627 (s), 1494 (m), 1450 (m). HRMS (ESI): Calcd for (C18H22N2O2 + H)+: 299.1761. Found: 
299.1770.
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(R)-2-((E)-(2,2-dimethylpropylidene)amino)-N-((1S,2S)-2-hydroxy-1,2-diphenylethyl)-N-
methylpropanamide (71) 
 
A 25 mL pear-shaped flask charged with a teflon-coated magnetic stirring bar and 4 Å molecular 
sieves (20 mg) was flame-dried in vacuo for 3 min. After cooling under vacuum, amide 70 (100 
mg, 0.335 mmol, 1.00 equiv), dry benzene (1.20 mL) and dichloromethane (1.00 mL) were 
added to the flask. Pivaldehyde (74.0 µL, 0.670 mmol, 2.00 equiv) was added to the solution by 
syringe, and stirring of the reaction mixture was continued at 23 °C for 50 min. The solvent was 
then evaporated under reduced pressure (ca. 80 mmHg) and the white residue was dried under 
high vacuum in an oil bath (35 °C) overnight to remove excess pivaldehyde. The tert-butyl imine 
product 71 (123 mg, ≥99%) was used in subsequent alkylation reactions without further 
purification. 1H NMR (1:1 rotamer ratio, asterisk denotes rotamer peaks, 600 MHz, THF-d8) δ 
7.60 (s, 1H), 7.53 – 7.49 (m, 3H), 7.42 – 7.36 (m, 4H), 7.34 (d, J = 7.6 Hz, 2H), 7.28 (t, J = 7.6 
Hz, 2H), 7.25 – 7.13 (m, 7H), 7.11 (t, J = 7.3 Hz, 2H), 5.89 (d, J = 8.3 Hz, 1H), 5.45 (d, J = 5.5 
Hz, 1H), 5.31* (d, J = 8.3 Hz, 1H), 5.26* (d, J = 5.5 Hz, 1H), 4.90 (br s, 1H), 4.75* (br s, 1H), 
4.33 (q, J = 6.6 Hz, 1H), 4.04* (q, J = 6.4 Hz, 1H), 2.94 (s, 3H), 2.75* (s, 3H), 1.18 (d, J = 6.7 
Hz, 3H), 1.02 (s, 9H), 0.97* (s, 9H), 0.92* (d, J = 6.4 Hz, 3H). 13C NMR (1:1 rotamer ratio, 
asterisk denotes rotamer peaks, 126 MHz, THF) δ 173.12, 172.63, 172.34*, 144.84*, 144.57, 
139.85, 139.57*, 130.13, 129.71, 129.18, 128.85, 128.76, 128.42, 128.26, 127.94, 127.76, 74.18, 
73.60*, 64.43*, 64.19, 62.23, 37.21, 27.35, 27.15*, 19.27, 18.96*. FTIR (neat), cm-1: 2962 (m), 
O
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2235 (s), 2081 (s), 1645 (m), 1099 (s), 1045 (s). HRMS (ESI): Calcd for (C23H30N2O2 + H)+: 
367.2380. Found: 367.2402. 
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(S)-2-((E)-(2,2-dimethylpropylidene)amino)-N-((1S,2S)-2-hydroxy-1,2-diphenylethyl)-N-
methylpropanamide (78) 
 
A 25 mL pear-shaped flask charged with a teflon-coated magnetic stirring bar and 4 Å molecular 
sieves (20 mg) was flame-dried in vacuo for 3 min. After cooling under vacuum, amide 110 (100 
mg, 0.335 mmol, 1.00 equiv) and dry benzene (2.20 mL) were added to the flask. Pivaldehyde 
(74.0 µL, 0.670 mmol, 2.00 equiv) was added to the solution by syringe, and stirring of the 
reaction mixture was continued at 23 °C for 30 min, during which time a white precipitate 
formed. The solvent was then evaporated under reduced pressure (ca. 80 mmHg) and the white 
residue was dried under high vacuum in an oil bath (35 °C) overnight to remove excess 
pivaldehyde. The tert-butyl imine product 78 (123 mg, ≥99%) was used in subsequent alkylation 
reactions without further purification. 1H NMR (4:1 rotamer ratio, asterisk denotes minor 
rotamer peaks, 600 MHz, THF-d8) δ 7.65 (s, 1H), 7.41 – 7.37 (m, 2H), 7.37 – 7.31 (m, 2H), 7.24 
– 7.14 (m, 4H), 7.14 – 7.07 (m, 2H), 5.97 (d, J = 7.5 Hz, 1H), 5.57* (d, J = 9.3 Hz, 1H), 5.37 (d, 
J = 7.5 Hz, 1H), 5.21* (d, J = 9.1 Hz, 1H), 4.92* (br s, 1H), 4.73 (br s, 1H), 4.70 – 4.64* (m, 
1H), 4.37 (q, J = 6.6 Hz, 1H), 2.95 (s, 3H), 1.24* (d, J = 6.7 Hz, 3H), 1.10 (d, J = 6.6 Hz, 3H), 
1.07* (s, 9H), 0.91 (s, 9H). 13C NMR (126 MHz, THF-d8) δ 172.85, 172.06, 144.59, 140.15, 
129.63, 128.82, 128.70, 128.10, 127.89, 127.66, 73.60, 62.99, 62.77, 37.08, 32.24, 27.20, 19.01. 
FTIR (neat), cm-1: 2962 (m), 2237 (m), 2083 (m), 1645 (s), 1099 (s), 1045 (s). HRMS (ESI): 
Calcd for (C23H30N2O2 + H)+: 367.2380. Found: 367.2384. 
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Synthesis of Pseudoephenamine Alaninamide Pivaldimines via Transimination: 
Synthesis of Transimination Reagent 
 
 
(E)-N-(2,2-dimethylpropylidene)propan-1-amine (112) 
A 50 mL round-bottom flask charged with a teflon-coated magnetic stirring bar and 4 Å molecular sieves 
(10.0 g) was flame-dried in vacuo for 3 min. After cooling under vacuum, pivaldehyde (12.0 mL, 110 
mmol, 1.00 equiv) was added. The mixture was cooled to 0 °C, propylamine (18.2 mL, 221 mmol, 2.00 
equiv) was added, and, after 5 min, the reaction mixture was allowed to warm to 23 °C for 1 h. The 
transimination reagent 112 was directly distilled from the reaction flask (58-62 °C, 100 mmHg) to 
provide a colorless liquid (13.5 g, 96%). 1H NMR (600 MHz, CDCl3) δ 7.48 (t, J = 1.2 Hz, 1H), 3.32 (td, 
J = 6.9, 1.2 Hz, 2H), 1.59 (h, J = 7.3 Hz, 2H), 1.06 (s, 9H), 0.85 (t, J = 7.4 Hz, 3H). 13C NMR (100 MHz, 
CDCl3) δ 171.87, 63.14, 35.97, 27.02, 23.89, 11.58. FTIR (neat), cm-1: 2964 (s), 2931 (m), 1668 (m), 
1629 (s), 1284 (m). HRMS (ESI): Calcd for (C8H17N + H)+: 128.1441 Found: 128.1439. 
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Pivaldimine Synthesis via Transimination 
 
 
(S)-2-((E)-(2,2-dimethylpropylidene)amino)-N-((1S,2S)-2-hydroxy-1,2-diphenylethyl)-N-
methylpropanamide (78) 
 
Transimination reagent 112 (305 µL, 1.68 mmol, 5.00 equiv) was added to a stirring solution of 
amide 110 (100 mg, 0.335 mmol, 1.00 equiv) in dry benzene (3.35 mL). The mixture was stirred 
under reduced pressure (200 mmHg) at 23 °C for 30 min, during which time gas was observed to 
evolve from the reaction mixture. The solvent was then evaporated under reduced pressure (ca. 
80 mmHg) and the white residue was dried under high vacuum in an oil bath (35 °C) overnight 
to remove excess transimination reagent. The characterization data were in agreement with 
values for the same tert-butyl imine 78 prepared by direct condensation of pivaldehyde with 
amide 110, as reported above. 
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Alkylations of Pseudoephenamine Alaninamide Pivaldimine: 
Matched Case 
 
 
(S)-2-amino-N-((1S,2S)-2-hydroxy-1,2-diphenylethyl)-N,2-dimethylbutanamide (72) 
A solution of tert-butyl imine 71 (123 mg, 0.336 mmol, 1.00 equiv) in tetrahydrofuran (1.20 mL) 
was transferred via cannula to a flask containing flame-dried lithium chloride (85.0 mg, 2.01 
mmol, 6.00 equiv). The transfer was quantitated with tetrahydrofuran (2 x 500 µL). The resulting 
slurry was cooled to −78 °C, after which a freshly prepared solution of lithium diisopropylamide 
(1 M, 738 µL, 0.738 mmol, 2.20 equiv) precooled to 0 °C was added slowly to the inner edge of 
the reaction flask, such that the solution was cooled before reaching the reaction mixture. The 
yellow slurry was stirred for 5 min at −78 °C, and then was warmed to 0 °C for 10 min. The 
slurry was then cooled to −50 °C. After 10 min, ethyl iodide (67.8 µL, 0.839 mmol, 2.50 equiv) 
was added by syringe. The mixture was stirred at −50 °C for 30 min, and then was warmed to 0 
°C for 3.5 h, after which time 1 M aqueous hydrochloric acid solution (8 mL) was added. The 
biphasic mixture was warmed to 23 °C and stirred vigorously for 1 h. Ethyl acetate (10 mL) was 
added, and the layers were separated. The organic layer was extracted with 1 M aqueous 
hydrochloric acid solution (3 x 10 mL). The aqueous extracts were combined, cooled in an ice 
bath, and carefully brought to pH 14 by the addition of 2 M aqueous sodium hydroxide solution. 
The basic aqueous solution was extracted with dichloromethane (3 x 50 mL), and the combined 
1. LDA, LiCl, THF, –78 → 0 °C
2. EtI, –50 → 0 °C
3. 1 M HCl (aq), 23 °C
                        91%
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organic extracts were dried over sodium sulfate. The dried solution was filtered, and the filtrate 
was concentrated. The residue was purified by flash chromatography (3% methanol-
dichloromethane, triethylamine pretreated silica gel) to provide α,α-disubstituted amide 72 as a 
white solid (100 mg, 91%, mp = 57-58 °C). The diastereomeric ratio of the crude material was 
determined to be 19:1 by 1H NMR integration. TLC (10% methanol-dichloromethane): Rf = 0.40 
(UV, KMnO4). 1H NMR (500 MHz, CDCl3) δ 7.23 – 7.15 (m, 6H), 7.11 – 7.07 (m, 2H), 7.06 – 
7.02 (m, 2H), 5.77 (d, J = 7.8 Hz, 1H), 3.93 (d, J = 7.8 Hz, 1H), 2.27 (s, 3H), 1.95 (br s, 2H), 
1.87 – 1.76 (m, 1H), 1.72 – 1.62 (m, 1H), 1.32 (s, 3H), 0.84 (t, J = 7.5 Hz, 3H). 13C NMR (126 
MHz, CDCl3) δ 176.69, 138.54, 137.87, 128.52, 128.18, 128.08, 127.99, 127.68, 127.11, 80.48, 
69.62, 58.35, 34.52, 33.79, 25.82, 8.52. FTIR (neat), cm-1: 2970 (m), 1732 (s), 1226 (m), 1136 
(s), 908 (s). HRMS (ESI): Calcd for (C20H26N2O2 + H)+: 327.2074. Found: 327.2075. 
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(S)-2-amino-N-((1S,2S)-2-hydroxy-1,2-diphenylethyl)-N,2,4-trimethylpentanamide (73) 
A solution of tert-butyl imine 71 (123 mg, 0.336 mmol, 1.00 equiv) in tetrahydrofuran (1.20 mL) 
was transferred via cannula to a flask containing flame-dried lithium chloride (85.0 mg, 2.01 
mmol, 6.00 equiv). The transfer was quantitated with tetrahydrofuran (2 x 500 µL). The resulting 
slurry was cooled to −78 °C, after which a freshly prepared solution of lithium diisopropylamide 
(1 M, 738 µL, 0.738 mmol, 2.20 equiv) precooled to 0 °C was added slowly to the inner edge of 
the reaction flask, such that the solution was cooled before reaching the reaction mixture. The 
yellow slurry was stirred for 5 min at −78 °C, and then was warmed to 0 °C for 10 min. The 
slurry was then cooled to −50 °C. After 10 min, isobutyl trifluoromethanesulfonate (114) (173 
mg, 0.839 mmol, 2.50 equiv) was added by syringe. The mixture was stirred at −50 °C for 1.5 h, 
after which time 1 M aqueous hydrochloric acid solution (8 mL) was added. The biphasic 
mixture was warmed to 23 °C and stirred vigorously for 4 h. Ethyl acetate (10 mL) was added, 
and the layers were separated. The organic layer was extracted with 1 M aqueous hydrochloric 
acid solution (3 x 10 mL). The aqueous extracts were combined, cooled in an ice bath, and 
carefully brought to pH 14 by the addition of 2 M aqueous sodium hydroxide solution. The basic 
aqueous solution was extracted with dichloromethane (3 x 50 mL), and the combined organic 
extracts were dried over sodium sulfate. The dried solution was filtered, and the filtrate was 
concentrated. The residue was purified by flash chromatography (3% methanol-dichloromethane, 
1. LDA, LiCl, THF, –78 → 0 °C
2. i-PrCH2OTf (114), –50 °C
3. 1 M HCl (aq), 23 °C
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triethylamine pretreated silica gel) to provide α,α-disubstituted amide 73 as a white solid (100 
mg, 84%, mp = 59-60 °C). The diastereomeric ratio of the crude material was determined to be 
≥19:1 by 1H NMR integration. TLC (10% methanol-dichloromethane): Rf = 0.52 (UV, KMnO4). 
1H NMR (500 MHz, CDCl3) δ 7.22 – 7.14 (m, 6H), 7.11 – 7.05 (m, 2H), 7.04 – 6.99 (m, 2H), 
5.73 (d, J = 7.9 Hz, 1H), 3.92 (d, J = 8.0 Hz, 1H), 2.28 (s, 3H), 1.78 – 1.67 (m, 1H), 1.64 – 1.54 
(m, 2H), 1.31 (s, 3H), 0.92 (d, J = 6.5 Hz, 3H), 0.84 (d, J = 6.4 Hz, 3H). 13C NMR (100 MHz, 
CDCl3) δ 177.43, 138.56, 137.79, 128.62, 128.17, 128.06, 128.01, 127.69, 127.22, 80.77, 69.63, 
57.84, 49.35, 34.54, 27.66, 24.70, 24.53, 23.61. FTIR (neat), cm-1: 2955 (m), 1724 (s), 1454 (m), 
1207 (m), 1138 (s). HRMS (ESI): Calcd for (C22H30N2O2 + H)+: 355.2380. Found: 355.2382. 
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(S)-2-amino-3-cyclohexyl-N-((1S,2S)-2-hydroxy-1,2-diphenylethyl)-N,2-
dimethylpropanamide (74) 
 
A solution of tert-butyl imine 71 (123 mg, 0.336 mmol, 1.00 equiv) in tetrahydrofuran (1.20 mL) 
was transferred via cannula to a flask containing flame-dried lithium chloride (85.0 mg, 2.01 
mmol, 6.00 equiv). The transfer was quantitated with tetrahydrofuran (2 x 500 µL). The resulting 
slurry was cooled to −78 °C, after which a freshly prepared solution of lithium diisopropylamide 
(1 M, 738 µL, 0.738 mmol, 2.20 equiv) precooled to 0 °C was added slowly to the inner edge of 
the reaction flask, such that the solution was cooled before reaching the reaction mixture. The 
yellow slurry was stirred for 5 min at −78 °C, and then was warmed to 0 °C for 10 min. The 
slurry was then cooled to −50 °C. After 10 min, cyclohexylmethyl trifluoromethanesulfonate 
(116) (207 mg, 0.839 mmol, 2.50 equiv) was added by syringe. The mixture was stirred at −50 
°C for 3 h, after which time 1 M aqueous hydrochloric acid solution (8 mL) was added. The 
biphasic mixture was warmed to 23 °C and stirred vigorously for 12 h. Ethyl acetate (10 mL) 
was added, and the layers were separated. The organic layer was extracted with 1 M aqueous 
hydrochloric acid solution (3 x 10 mL). The aqueous extracts were combined, cooled in an ice 
bath, and carefully brought to pH 14 by the addition of 2 M aqueous sodium hydroxide solution. 
The basic aqueous solution was extracted with dichloromethane (3 x 50 mL), and the combined 
organic extracts were dried over sodium sulfate. The dried solution was filtered, and the filtrate 
was concentrated. The residue was purified by flash chromatography (3% methanol-
1. LDA, LiCl, THF, –78 → 0 °C
2. C6H11CH2OTf (116), –50 °C
3. 1 M HCl (aq), 23 °C
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dichloromethane, triethylamine pretreated silica gel) to provide α,α-disubstituted amide 74 as a 
white solid (110 mg, 83%, mp = 83-84 °C). The diastereomeric ratio of the crude material was 
determined to be ≥19:1 by 1H NMR integration. TLC (10% methanol-dichloromethane): Rf = 
0.52 (UV, KMnO4). 1H NMR (600 MHz, CDCl3) δ 7.21 – 7.13 (m, 6H), 7.10 – 7.07 (m, 2H), 
7.05 – 7.00 (m, 2H), 5.74 (d, J = 7.8 Hz, 1H), 3.93 (d, J = 7.8 Hz, 1H), 2.28 (s, 3H), 1.71 (dd, J = 
14.1, 6.8 Hz, 1H), 1.65 – 1.57 (m, 7H), 1.54 (dd, J = 14.1, 5.2 Hz, 1H), 1.36 (s, 1H), 1.29 (s, 
3H), 1.21 – 1.05 (m, 3H), 0.97 – 0.93 (m, 1H), 0.86 – 0.77 (m, 1H). 13C NMR (126 MHz, CDCl3) 
δ 177.51, 138.68, 137.79, 128.63, 128.17, 128.06, 128.01, 127.68, 127.27, 80.74, 69.61, 57.74, 
48.20, 35.12, 34.57, 34.15, 34.12, 27.75, 26.48, 26.40, 26.27. FTIR (neat), cm-1: 2926 (m), 1730 
(s), 1454 (m), 1136 (m), 906 (s). HRMS (ESI): Calcd for (C25H34N2O2 + H)+: 395.2700. Found: 
395.2720. 
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(S)-2-amino-N-((1S,2S)-2-hydroxy-1,2-diphenylethyl)-N,2-dimethyl-3-phenylpropanamide 
(75) 
 
A solution of tert-butyl imine 71 (123 mg, 0.336 mmol, 1.00 equiv) in tetrahydrofuran (1.20 mL) 
was transferred via cannula to a flask containing flame-dried lithium chloride (85.0 mg, 2.01 
mmol, 6.00 equiv). The transfer was quantitated with tetrahydrofuran (2 x 500 µL). The resulting 
slurry was cooled to −78 °C, after which a freshly prepared solution of lithium diisopropylamide 
(1 M, 738 µL, 0.738 mmol, 2.20 equiv) precooled to 0 °C was added slowly to the inner edge of 
the reaction flask, such that the solution was cooled before reaching the reaction mixture. The 
yellow slurry was stirred for 5 min at −78 °C, and then was warmed to 0 °C for 10 min. The 
slurry was then cooled to −50 °C. After 10 min, benzyl bromide (100 µL, 0.839 mmol, 2.50 
equiv) was added by syringe. The mixture was stirred at −50 °C for 3.5 h, after which time 1 M 
aqueous hydrochloric acid solution (8 mL) was added. The biphasic mixture was warmed to 23 
°C and stirred vigorously for 3 h. Ethyl acetate (10 mL) was added, and the layers were 
separated. The organic layer was extracted with 1 M aqueous hydrochloric acid solution (3 x 10 
mL). The aqueous extracts were combined, cooled in an ice bath, and carefully brought to pH 14 
by the addition of 2 M aqueous sodium hydroxide solution. The basic aqueous solution was 
extracted with dichloromethane (3 x 50 mL), and the combined organic extracts were dried over 
sodium sulfate. The dried solution was filtered, and the filtrate was concentrated. The residue 
was purified by flash chromatography (2→4% methanol-dichloromethane, triethylamine 
1. LDA, LiCl, THF, –78 → 0 °C
2. BnBr, –50 °C
3. 1 M HCl (aq), 23 °C
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pretreated silica gel) to provide α,α-disubstituted amide 75 as a white solid (116 mg, 89%, mp = 
111-113 °C). The diastereomeric ratio of the crude material was determined to be ≥19:1 by 1H 
NMR integration. TLC (10% methanol-dichloromethane): Rf = 0.47 (UV, KMnO4). 1H NMR 
(500 MHz, CDCl3) δ 7.25 – 7.15 (m, 6H), 7.13 – 7.05 (m, 2H), 7.04 – 6.98 (m, 2H), 5.79 (d, J = 
7.6 Hz, 1H), 3.93 (d, J = 7.6 Hz, 1H), 3.12 (d, J = 13.3 Hz, 1H), 2.85 (d, J = 13.3 Hz, 1H), 2.25 
(s, 3H), 1.91 (br s, 2H), 1.37 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 176.04, 138.35, 137.60, 
136.26, 130.20, 128.55, 128.42, 128.23, 128.12, 128.01, 127.77, 127.11, 126.96, 80.62, 69.33, 
58.85, 46.72, 34.47, 29.80, 26.30. FTIR (neat), cm-1: 2926 (m), 2852 (m), 1732 (s), 1602 (m), 
1454 (s). HRMS (ESI): Calcd for (C25H28N2O2 + H)+: 389.2231. Found: 389.2234.
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Larger scale synthesis of (S)-2-amino-N-((1S,2S)-2-hydroxy-1,2-diphenylethyl)-N,2-
dimethyl-3-phenylpropanamide (75) 
 
A solution of tert-butyl imine 71 (2.09 g, 5.70 mmol, 1.00 equiv) in tetrahydrofuran (24.0 mL) 
was transferred via cannula to a flask containing flame-dried lithium chloride (1.45 g, 34.2 
mmol, 6.00 equiv). The transfer was quantitated with tetrahydrofuran (2 x 7.00 mL). The 
resulting slurry was cooled to −78 °C, after which a freshly prepared solution of lithium 
diisopropylamide (1 M, 12.5 µL, 12.5 mmol, 2.20 equiv) precooled to 0 °C was added slowly to 
the inner edge of the reaction flask by cannula, such that the solution was cooled before reaching 
the reaction mixture. The yellow slurry was stirred for 5 min at −78 °C, and then was warmed to 
0 °C for 10 min. The slurry was then cooled to −50 °C. After 10 min, benzyl bromide (1.69 mL, 
14.2 mmol, 2.50 equiv) was added by syringe. The mixture was stirred at −50 °C for 3.5 h, after 
which time 1 M aqueous hydrochloric acid solution (100 mL) was added. The biphasic mixture 
was warmed to 23 °C and stirred vigorously for 3 h. Ethyl acetate (20 mL) was added, and the 
layers were separated. The organic layer was extracted with 1 M aqueous hydrochloric acid 
solution (3 x 30 mL). The aqueous extracts were combined, cooled in an ice bath, and carefully 
brought to pH 14 by the addition of 2 M aqueous sodium hydroxide solution. The basic aqueous 
solution was extracted with dichloromethane (3 x 100 mL), and the combined organic extracts 
were dried over sodium sulfate. The dried solution was filtered, and the filtrate was concentrated. 
The residue was purified by flash chromatography (3% methanol-dichloromethane, triethylamine 
1. LDA, LiCl, THF, –78 → 0 °C
2. BnBr, –50 °C
3. 1 M HCl (aq), 23 °C
                        95%
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pretreated silica gel) to provide α,α-disubstituted amide 75 as a white solid (2.11 g, 95%). The 
diastereomeric ratio of the crude material was determined to be ≥19:1 by 1H NMR integration. 
The characterization data were in agreement with the values for α,α-disubstituted amide 76 
prepared on a smaller scale, as reported above. 
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(S)-2-amino-N-((1S,2S)-2-hydroxy-1,2-diphenylethyl)-3-(3-methoxyphenyl)-N,2-
dimethylpropanamide (76) 
 
A solution of tert-butyl imine 71 (123 mg, 0.336 mmol, 1.00 equiv) in tetrahydrofuran (1.20 mL) 
was transferred via cannula to a flask containing flame-dried lithium chloride (85.0 mg, 2.01 
mmol, 6.00 equiv). The transfer was quantitated with tetrahydrofuran (2 x 500 µL). The resulting 
slurry was cooled to −78 °C, after which a freshly prepared solution of lithium diisopropylamide 
(1 M, 738 µL, 0.738 mmol, 2.20 equiv) precooled to 0 °C was added slowly to the inner edge of 
the reaction flask, such that the solution was cooled before reaching the reaction mixture. The 
yellow slurry was stirred for 5 min at −78 °C, and then was warmed to 0 °C for 10 min. The 
slurry was then cooled to −50 °C. After 10 min, 3-methoxybenzyl bromide (117 µL, 0.839 
mmol, 2.50 equiv) was added by syringe. The mixture was stirred at −50 °C for 3 h, after which 
time 1 M aqueous hydrochloric acid solution (8 mL) was added. The biphasic mixture was 
warmed to 23 °C and stirred vigorously for 2 h. Ethyl acetate (10 mL) was added, and the layers 
were separated. The organic layer was extracted with 1 M aqueous hydrochloric acid solution (3 
x 10 mL). The aqueous extracts were combined, cooled in an ice bath, and carefully brought to 
pH 14 by the addition of 2 M aqueous sodium hydroxide solution. The basic aqueous solution 
was extracted with dichloromethane (3 x 50 mL), and the combined organic extracts were dried 
over sodium sulfate. The dried solution was filtered, and the filtrate was concentrated. The 
residue was purified by flash chromatography (2→4% methanol-dichloromethane, triethylamine 
1. LDA, LiCl, THF, –78 → 0 °C
2. m-CH3OBnBr, –50 °C
3. 1 M HCl (aq), 23 °C
                      89%
                     ≥19:1 dr
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pretreated silica gel) to provide α,α-disubstituted amide 76 as a white solid (125 mg, 89%, mp = 
52-53 °C). The diastereomeric ratio of the crude material was determined to be ≥19:1 by 1H 
NMR integration. TLC (10% methanol-dichloromethane): Rf = 0.53 (UV, KMnO4). 1H NMR 
(500 MHz, CDCl3) δ 7.24 – 7.11 (m, 7H), 7.10 – 7.04 (m, 2H), 7.01 – 6.95 (m, 2H), 6.76 (dd, J 
= 8.2, 2.0 Hz, 1H), 6.71 – 6.70 (m, 1H), 6.70 – 6.65 (m, 1H), 5.78 (d, J = 7.6 Hz, 1H), 3.92 (d, J 
= 7.7 Hz, 1H), 3.71 (s, 3H), 3.12 (d, J = 13.3 Hz, 1H), 2.82 (d, J = 13.3 Hz, 1H), 2.25 (s, 3H), 
1.84 (br s, 2H), 1.37 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 176.15, 159.59, 138.54, 137.89, 
137.64, 129.41, 128.55, 128.19, 128.10, 127.98, 127.73, 127.06, 122.48, 115.56, 112.76, 80.66, 
69.48, 58.88, 55.20, 46.87, 34.55, 26.55. FTIR (neat), cm-1: 2926 (m), 1732 (m), 1601 (m), 1454 
(m), 1263 (m). HRMS (ESI): Calcd for (C26H30N2O3 + H)+: 419.2329. Found: 419.2345. 
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(S)-tert-butyl 3-amino-4-(((1S,2S)-2-hydroxy-1,2-diphenylethyl)(methyl)amino)-3-methyl-4-
oxobutanoate (77) 
 
A solution of tert-butyl imine 71 (123 mg, 0.336 mmol, 1.00 equiv) in tetrahydrofuran (1.20 mL) 
was transferred via cannula to a flask containing flame-dried lithium chloride (85.0 mg, 2.01 
mmol, 6.00 equiv). The transfer was quantitated with tetrahydrofuran (2 x 500 µL). The resulting 
slurry was cooled to −78 °C, after which a freshly prepared solution of lithium diisopropylamide 
(1 M, 738 µL, 0.738 mmol, 2.20 equiv) precooled to 0 °C was added slowly to the inner edge of 
the reaction flask, such that the solution was cooled before reaching the reaction mixture. The 
yellow slurry was stirred for 5 min at −78 °C, and then was warmed to 0 °C for 10 min. The 
slurry was then cooled to −50 °C. After 10 min, tert-butyl bromoacetate (124 µL, 0.839 mmol, 
2.50 equiv) was added by syringe. The mixture was stirred at −50 °C for 2.5 h, after which time 
1 M aqueous hydrochloric acid solution (8 mL) was added. The biphasic mixture was warmed to 
23 °C and stirred vigorously for 1 h. Ethyl acetate (10 mL) was added, and the layers were 
separated. The organic layer was extracted with 1 M aqueous hydrochloric acid solution (3 x 10 
mL). The aqueous extracts were combined, cooled in an ice bath, and carefully brought to pH 14 
by the addition of 2 M aqueous sodium hydroxide solution. The basic aqueous solution was 
extracted with dichloromethane (3 x 50 mL), and the combined organic extracts were dried over 
sodium sulfate. The dried solution was filtered, and the filtrate was concentrated. The residue 
was purified by flash chromatography (1→2.5% methanol-dichloromethane, triethylamine 
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pretreated silica gel) to provide α,α-disubstituted amide 77 as a white solid (132 mg, 95%, mp = 
83-84 °C). The diastereomeric ratio of the crude material was determined to be ≥19:1 by 1H 
NMR integration. TLC (8% methanol-dichloromethane): Rf = 0.45 (UV, KMnO4). 1H NMR (500 
MHz, CDCl3) δ 7.18 – 7.11 (m, 6H), 7.09 – 7.03 (m, 2H), 7.02 – 6.96 (m, 2H), 5.82 (d, J = 8.5 
Hz, 1H), 3.90 (d, J = 8.5 Hz, 1H), 3.00 (d, J = 16.6 Hz, 1H), 2.55 (d, J = 16.5 Hz, 1H), 2.24 (s, 
3H), 2.01 (br s, 2H), 1.46 (s, 9H), 1.22 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 176.35, 170.88, 
138.64, 137.62, 128.77, 128.09, 127.98, 127.97, 127.63, 127.35, 81.76, 80.97, 69.90, 56.10, 
45.63, 34.47, 28.21, 27.02. FTIR (neat), cm-1: 2976 (m), 2793 (m), 1734 (s), 1367 (m), 1153 (s). 
HRMS (ESI): Calcd for (C24H32N2O4 + H)+: 413.2442. Found: 413.2440. 
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(S)-2-amino-N-((1S,2S)-2-hydroxy-1,2-diphenylethyl)-N,2-dimethylpent-4-enamide (80) 
A solution of tert-butyl imine 71 (123 mg, 0.336 mmol, 1.00 equiv) in tetrahydrofuran (1.20 mL) 
was transferred via cannula to a flask containing flame-dried lithium chloride (85.0 mg, 2.01 
mmol, 6.00 equiv). The transfer was quantitated with tetrahydrofuran (2 x 500 µL). The resulting 
slurry was cooled to −78 °C, after which a freshly prepared solution of lithium diisopropylamide 
(1 M, 738 µL, 0.738 mmol, 2.20 equiv) precooled to 0 °C was added slowly to the inner edge of 
the reaction flask, such that the solution was cooled before reaching the reaction mixture. The 
yellow slurry was stirred for 5 min at −78 °C, and then was warmed to 0 °C for 10 min. The 
slurry was then cooled to −50 °C. After 10 min, allyl bromide (72.6 µg, 0.839 mmol, 2.50 equiv) 
was added by syringe. The mixture was stirred at −50 °C for 3 h, after which time water (8 mL) 
and dichloromethane (10 mL) were added. The layers were separated, the aqueous layer was 
rapidly extracted with dichloromethane (3 x 20 mL), and the combined organic extracts were 
dried over sodium sulfate. The dried solution was filtered, and the filtrate was concentrated. The 
residue was dissolved in ethyl acetate (2 mL) and a stock solution of hydroxylamine 
hydrochloride in water81 (5 mL) was added. The biphasic mixture was stirred vigorously at 23 °C 
for 1.5 h, after which time the aqueous layer was carefully brought to pH 14 by the addition of 2 
                                                
81 Prepared by dissolving hydroxylamine hydrochloride (1.39 g) in water (10.0 mL), followed by adjustment of the 
pH to 6 by the addition of saturated aqueous sodium bicarbonate solution (10.0 mL). 
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M aqueous sodium hydroxide solution. The basic aqueous solution was extracted with 
dichloromethane (3 x 40 mL), and the combined organic extracts were dried over sodium sulfate. 
The dried solution was filtered, and the filtrate was concentrated. The residue was purified by 
flash chromatography (3% methanol-dichloromethane, triethylamine pretreated silica gel) to 
provide α,α-disubstituted amide 80 as a white solid (91.0 mg, 80%, mp = 62-63 °C). The 
diastereomeric ratio of the crude material was determined to be ≥19:1 by 1H NMR integration. 
TLC (10% methanol-dichloromethane): Rf = 0.50 (UV, KMnO4). 1H NMR (600 MHz, CDCl3) δ 
7.23 – 7.13 (m, 6H), 7.13 – 7.05 (m, 2H), 7.06 – 7.01 (m, 2H), 5.78 (d, J = 7.9 Hz, 1H), 5.73 – 
5.64 (m, 1H), 5.17 – 5.13 (m, 1H), 5.13 – 5.11 (m, 1H), 3.92 (d, J = 8.0 Hz, 1H), 2.59 (dd, J = 
13.7, 5.9 Hz, 1H), 2.33 (dd, J = 14.0, 7.9 Hz, 1H), 2.26 (s, 3H), 1.94 (br s, 2H), 1.33 (s, 3H). 13C 
NMR (100 MHz, CDCl3) δ 176.31, 138.44, 137.72, 132.99, 128.55, 128.23, 128.11, 128.07, 
127.74, 127.16, 119.52, 80.71, 69.63, 57.62, 45.15, 34.44, 26.21. FTIR (neat), cm-1: 2976 (m), 
2793 (m), 1732 (s), 1205 (m), 1136 (s). HRMS (ESI): Calcd for (C21H26N2O2 + H)+: 339.2074. 
Found: 339.2081. 
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Cyclic Products: 
 
 
(S)-N-((1S,2S)-2-hydroxy-1,2-diphenylethyl)-N,2-dimethylpyrrolidine-2-carboxamide (82) 
A solution of tert-butyl imine 71 (123 mg, 0.336 mmol, 1.00 equiv) in tetrahydrofuran (1.20 mL) 
was transferred via cannula to a flask containing flame-dried lithium chloride (85.0 mg, 2.01 
mmol, 6.00 equiv). The transfer was quantitated with tetrahydrofuran (2 x 500 µL). The resulting 
slurry was cooled to −78 °C, after which a freshly prepared solution of lithium diisopropylamide 
(1 M, 738 µL, 0.738 mmol, 2.20 equiv) precooled to 0 °C was added slowly to the inner edge of 
the reaction flask, such that the solution was cooled before reaching the reaction mixture. The 
yellow slurry was stirred for 5 min at −78 °C, and then was warmed to 0 °C for 10 min. The 
slurry was then cooled to −50 °C. After 10 min, 3-bromopropyl trifluoromethanesulfonate (118) 
(227 mg, 0.839 mmol, 2.50 equiv) was added by syringe. The mixture was stirred at −50 °C for 
1.5 h, after which time 1 M aqueous hydrochloric acid solution (8 mL) was added. The biphasic 
mixture was warmed to 23 °C and stirred vigorously for 2 h. The mixture was cooled in an ice 
bath, and the aqueous layer was carefully brought to pH 14 by the addition of 2 M aqueous 
sodium hydroxide solution. The basic aqueous solution was extracted with dichloromethane (3 x 
40 mL), and the combined organic extracts were dried over sodium sulfate. The dried solution 
was filtered, and the filtrate was concentrated. The residue was purified by flash chromatography 
(3→4% methanol-dichloromethane, triethylamine pretreated silica gel) to provide cyclic α,α-
disubstituted amide 82 as a colorless oil (90.0 mg, 79%). The diastereomeric ratio of the crude 
H3C
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material was determined to be ≥19:1 by 1H NMR integration. TLC (8% methanol-
dichloromethane): Rf = 0.31 (UV, KMnO4). 1H NMR (500 MHz, CDCl3) δ 7.25 – 7.12 (m, 6H), 
7.11 – 7.06 (m, 2H), 7.06 – 7.01 (m, 2H), 5.78 (d, J = 7.9 Hz, 1H), 3.92 (d, J = 7.7 Hz, 1H), 3.02 
– 2.90 (m, 2H), 2.27 (s, 3H), 2.26 – 2.21 (m, 1H), 1.90 – 1.79 (m, 1H), 1.79 – 1.66 (m, 2H), 1.40 
(s, 3H). 13C NMR (126 MHz, CDCl3) δ 176.42, 138.55, 137.77, 128.52, 128.20, 128.12, 128.10, 
128.03, 127.71, 127.09, 80.49, 69.68, 65.90, 46.55, 36.94, 34.53, 26.06, 25.27. . FTIR (neat), cm-
1: 2976 (m), 1728 (m), 1454 (m), 1170 (m), 1116 (m). HRMS (ESI): Calcd for (C21H26N2O2 + 
H)+: 339.2074. Found: 339.2089. 
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(2S,4S)-benzyl 2,4-dimethylpyrrolidine-2-carboxylate (83) 
A solution of tert-butyl imine 71 (123 mg, 0.336 mmol, 1.00 equiv) in tetrahydrofuran (1.20 mL) 
was transferred via cannula to a flask containing flame-dried lithium chloride (85.0 mg, 2.01 
mmol, 6.00 equiv). The transfer was quantitated with tetrahydrofuran (2 x 500 µL). The resulting 
slurry was cooled to −78 °C, after which a freshly prepared solution of lithium diisopropylamide 
(1 M, 738 µL, 0.738 mmol, 2.20 equiv) precooled to 0 °C was added slowly to the inner edge of 
the reaction flask, such that the solution was cooled before reaching the reaction mixture. The 
yellow slurry was stirred for 5 min at −78 °C, and then was warmed to 0 °C for 10 min. The 
slurry was then cooled to −50 °C. After 10 min, 1,2-bis(bromomethyl)benzene (2 M solution in 
tetrahydrofuran, 168 µL, 0.839 mmol, 2.50 equiv) was added by syringe. The mixture was stirred 
at −50 °C for 2.5 h, after which time 1 M aqueous hydrochloric acid solution (8 mL) was added. 
The biphasic mixture was warmed to 23 °C and stirred vigorously for 3 h. Ethyl acetate (10 mL) 
was added, and the layers were separated. The organic layer was extracted with 1 M aqueous 
hydrochloric acid solution (3 x 10 mL). The aqueous extracts were combined, cooled in an ice 
bath, and carefully brought to pH 14 by the addition of 2 M aqueous sodium hydroxide solution. 
The basic aqueous solution was extracted with dichloromethane (3 x 50 mL), and the combined 
organic extracts were dried over sodium sulfate. The dried solution was filtered, and the filtrate 
was concentrated. The residue was dissolved in tetrahydrofuran (2.60 mL), the resulting solution 
was cooled to 0 °C, and a freshly prepared solution of lithium phenylmethanolate in 
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tetrahydrofuran (1 M, 670 µL, 0.670 mmol, 2.00 equiv) was added dropwise to the crude 
mixture.77 The solution was warmed to 23 °C for 3 h, after which time water (5 mL) and 
saturated aqueous sodium chloride solution (5 mL) were added. The aqueous layer was extracted 
with dichloromethane (3 x 20 mL) and the combined organic extracts were dried over sodium 
sulfate. The dried solution was filtered, and the filtrate was concentrated. The residue was 
purified by flash chromatography (10% diethyl ether-dichloromethane, then 1→10% methanol-
dichloromethane) to provide (1S,2S)-pseudoephenamine (62.0 mg, 82%) and benzyl ester 83 as a 
colorless oil (49.0 mg, 52%). The characterization data for the recovered auxiliary were in 
agreement with values previously reported. Benzyl ester 83: The diastereomeric ratio of the 
crude material prior to cleavage of the auxiliary was determined to be ≥19:1 by 1H NMR 
integration. TLC (1% methanol-dichloromethane): Rf = 0.29 (UV, CAM). 1H NMR (500 MHz, 
CDCl3) δ 7.31 – 7.27 (m, 3H), 7.18 – 7.11 (m, 4H), 7.11 – 7.06 (m, 1H), 7.02 – 6.98 (m, 1H), 
5.12 (d, J = 12.5 Hz, 1H), 5.07 (d, J = 12.5 Hz, 1H), 4.13 (d, J = 15.9 Hz, 1H), 4.02 (d, J = 16.0 
Hz, 1H), 3.30 (d, J = 16.0 Hz, 1H), 2.82 (d, J = 16.0 Hz, 1H), 1.45 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ 175.91, 135.99, 133.78, 133.20, 129.03, 128.64, 128.24, 127.90, 126.31, 126.27, 
126.11, 66.76, 58.22, 45.15, 37.89, 26.40. FTIR (neat), cm-1: 2958 (m), 1728 (s), 1288 (m), 1178 
(s), 1105 (s). HRMS (ESI): Calcd for (C18H19NO2 + H)+: 282.1496. Found: 282.1506. 
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(2S,4R)-benzyl 2,4-dimethylpyrrolidine-2-carboxylate (84) 
A solution of tert-butyl imine 71 (123 mg, 0.336 mmol, 1.00 equiv) in tetrahydrofuran (1.20 mL) 
was transferred via cannula to a flask containing flame-dried lithium chloride (85.0 mg, 2.01 
mmol, 6.00 equiv). The transfer was quantitated with tetrahydrofuran (2 x 500 µL). The resulting 
slurry was cooled to −78 °C, after which a freshly prepared solution of lithium diisopropylamide 
(1 M, 738 µL, 0.738 mmol, 2.20 equiv) precooled to 0 °C was added slowly to the inner edge of 
the reaction flask, such that the solution was cooled before reaching the reaction mixture. The 
yellow slurry was stirred for 5 min at −78 °C, and then was warmed to 0 °C for 10 min. The 
slurry was then cooled to −50 °C. After 10 min, triflate 120 (202 mg, 0.839 mmol, 2.50 equiv) 
was added by syringe. The mixture was stirred at −50 °C for 2 h, after which time 1 M aqueous 
hydrochloric acid solution (8 mL) was added. The biphasic mixture was warmed to 23 °C and 
stirred vigorously for 2 h. The mixture was cooled in an ice bath and the aqueous layer was 
carefully brought to pH 14 by the addition of 2 M aqueous sodium hydroxide solution. The basic 
aqueous solution was extracted with dichloromethane (3 x 30 mL), and the combined organic 
extracts were dried over sodium sulfate. The dried solution was filtered, and the filtrate was 
concentrated. The residue was dissolved in tetrahydrofuran (2.60 mL), the resulting solution was 
cooled to 0 °C, and a freshly prepared solution of lithium phenylmethanolate in tetrahydrofuran 
(1 M, 670 µL, 0.670 mmol, 2.00 equiv) was added dropwise to the crude mixture.77 The solution 
was warmed to 23 °C for 3 h, after which time water (5 mL) and saturated aqueous sodium 
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chloride solution (5 mL) were added. The aqueous layer was extracted with dichloromethane (3 
x 20 mL) and the combined organic extracts were dried over sodium sulfate. The dried solution 
was filtered, and the filtrate was concentrated. The residue was purified by flash chromatography 
(10% diethyl ether-dichloromethane, then 2→10% methanol-dichloromethane) to provide 
(1S,2S)-pseudoephenamine (64.0 mg, 84%) and benzyl ester 84 as a colorless oil (43.0 mg, 
55%). The characterization data for the recovered auxiliary were in agreement with values 
previously reported. Benzyl ester 84: The diastereomeric ratio of the crude material prior to 
cleavage of the auxiliary was determined to be ≥19:1 by 1H NMR integration, and the relative 
stereochemistry of the ester product was determined by NOE correlations. TLC (10% methanol-
dichloromethane): Rf = 0.54 (UV, CAM). 1H NMR (500 MHz, CDCl3) δ 7.40 – 7.30 (m, 5H), 
5.15 (s, 2H), 3.17 (dd, J = 10.2, 7.8 Hz, 1H), 2.52 (dd, J = 10.3, 8.1 Hz, 1H), 2.43 (dd, J = 12.8, 
7.4 Hz, 1H), 2.17 – 2.02 (m, 2H), 1.42 (s, 3H), 1.30 (dd, J = 12.8, 10.1 Hz, 1H), 1.01 (d, J = 6.6 
Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 177.60, 136.12, 128.72, 128.36, 128.03, 66.96, 66.68, 
54.07, 45.98, 34.17, 26.60, 18.78. FTIR (neat), cm-1: 2960 (m), 2872 (m), 1726 (s), 1163 (s), 
1126 (s). HRMS (ESI): Calcd for (C14H19NO2 + H)+: 234.1496 Found: 234.1503. 
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Mismatched Case: 
 
 
(S)-2-amino-N-((1S,2S)-2-hydroxy-1,2-diphenylethyl)-N,2-dimethylbutanamide (72) 
A solution of tert-butyl imine 78 (123 mg, 0.336 mmol, 1.00 equiv) in tetrahydrofuran (1.20 mL) 
was transferred via cannula to a flask containing flame-dried lithium chloride (85.0 mg, 2.01 
mmol, 6.00 equiv). The transfer was quantitated with tetrahydrofuran (2 x 500 µL). The resulting 
slurry was cooled to −78 °C, after which a freshly prepared solution of lithium diisopropylamide 
(1 M, 738 µL, 0.738 mmol, 2.20 equiv) precooled to 0 °C was added slowly to the inner edge of 
the reaction flask, such that the solution was cooled before reaching the reaction mixture. The 
yellow slurry was stirred for 5 min at −78 °C, and then was warmed to 0 °C for 10 min. The 
slurry was then cooled to −50 °C. After 10 min, ethyl iodide (67.8 µL, 0.839 mmol, 2.50 equiv) 
was added by syringe. The mixture was stirred at −50 °C for 30 min, and then was warmed to 0 
°C for 4 h, after which time 1 M aqueous hydrochloric acid solution (8 mL) was added. The 
biphasic mixture was warmed to 23 °C and stirred vigorously for 1 h. Ethyl acetate (10 mL) was 
added, and the layers were separated. The organic layer was extracted with 1 M aqueous 
hydrochloric acid solution (3 x 10 mL). The aqueous extracts were combined, cooled in an ice 
bath, and carefully brought to pH 14 by the addition of 2 M aqueous sodium hydroxide solution. 
The basic aqueous solution was extracted with dichloromethane (3 x 50 mL), and the combined 
organic extracts were dried over sodium sulfate. The dried solution was filtered, and the filtrate 
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was concentrated. The diastereomeric ratio of the crude material was determined to be 13:1 by 
1H NMR integration. The residue was purified by flash chromatography (3% methanol-
dichloromethane, triethylamine pretreated silica gel) to provide a 17:1 diastereomeric mixture of 
diastereomers favoring amide 72 (79 mg, 72%). The characterization data for the major and 
minor diastereomers were consistent with the values for α,α-disubstituted amide 72 reported 
above. 
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(S)-2-amino-N-((1S,2S)-2-hydroxy-1,2-diphenylethyl)-N,2-dimethyl-3-phenylpropanamide 
(75) 
 
A solution of tert-butyl imine 78 (123 mg, 0.336 mmol, 1.00 equiv) in tetrahydrofuran (1.20 mL) 
was transferred via cannula to a flask containing flame-dried lithium chloride (85.0 mg, 2.01 
mmol, 6.00 equiv). The transfer was quantitated with tetrahydrofuran (2 x 500 µL). The resulting 
slurry was cooled to −78 °C, after which a freshly prepared solution of lithium diisopropylamide 
(1 M, 738 µL, 0.738 mmol, 2.20 equiv) precooled to 0 °C was added slowly to the inner edge of 
the reaction flask, such that the solution was cooled before reaching the reaction mixture. The 
yellow slurry was stirred for 5 min at −78 °C, and then was warmed to 0 °C for 10 min. The 
slurry was then cooled to −50 °C. After 10 min, benzyl bromide (100 µL, 0.839 mmol, 2.50 
equiv) was added by syringe. The mixture was stirred at −50 °C for 3.5 h, after which time 1 M 
aqueous hydrochloric acid solution (8 mL) was added. The biphasic mixture was warmed to 23 
°C and stirred vigorously for 3 h. Ethyl acetate (10 mL) was added, and the layers were 
separated. The organic layer was extracted with 1 M aqueous hydrochloric acid solution (3 x 10 
mL). The aqueous extracts were combined, cooled in an ice bath, and carefully brought to pH 14 
by the addition of 2 M aqueous sodium hydroxide solution. The basic aqueous solution was 
extracted with dichloromethane (3 x 50 mL), and the combined organic extracts were dried over 
sodium sulfate. The dried solution was filtered, and the filtrate was concentrated. The 
diastereomeric ratio of the crude material was determined to be 8:1 by 1H NMR integration. The 
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residue was purified by flash chromatography (3% methanol-dichloromethane, triethylamine 
pretreated silica gel) to provide a 9:1 diastereomeric mixture of α,α-disubstituted amides 75 and 
124 (90 mg, 69%). The characterization data for the major and minor diastereomers were 
consistent with the values for α,α-disubstituted amides 75 and 124, respectively. 
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(S)-tert-butyl 3-amino-4-(((1S,2S)-2-hydroxy-1,2-diphenylethyl)(methyl)amino)-3-methyl-4-
oxobutanoate (77) 
 
A solution of tert-butyl imine 78 (123 mg, 0.336 mmol, 1.00 equiv) in tetrahydrofuran (1.20 mL) 
was transferred via cannula to a flask containing flame-dried lithium chloride (85.0 mg, 2.01 
mmol, 6.00 equiv). The transfer was quantitated with tetrahydrofuran (2 x 500 µL). The resulting 
slurry was cooled to −78 °C, after which a freshly prepared solution of lithium diisopropylamide 
(1 M, 738 µL, 0.738 mmol, 2.20 equiv) precooled to 0 °C was added slowly to the inner edge of 
the reaction flask, such that the solution was cooled before reaching the reaction mixture. The 
yellow slurry was stirred for 5 min at −78 °C, and then was warmed to 0 °C for 10 min. The 
slurry was then cooled to −50 °C. After 10 min, tert-butyl bromoacetate (124 µL, 0.839 mmol, 
2.50 equiv) was added by syringe. The mixture was stirred at −50 °C for 2.5 h, after which time 
1 M aqueous hydrochloric acid solution (8 mL) was added. The biphasic mixture was warmed to 
23 °C and stirred vigorously for 1 h. Ethyl acetate (10 mL) was added, and the layers were 
separated. The organic layer was extracted with 1 M aqueous hydrochloric acid solution (3 x 10 
mL). The aqueous extracts were combined, cooled in an ice bath, and carefully brought to pH 14 
by the addition of 2 M aqueous sodium hydroxide solution. The basic aqueous solution was 
extracted with dichloromethane (3 x 50 mL), and the combined organic extracts were dried over 
sodium sulfate. The dried solution was filtered, and the filtrate was concentrated. The 
diastereomeric ratio of the crude material was determined to be 19:1 by 1H NMR integration. 
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The residue was purified by flash chromatography (1→2.5% methanol-dichloromethane, 
triethylamine pretreated silica gel) to provide α,α-disubstituted amide 77 as a white solid (83 
mg, 60%). The characterization data were in agreement with values for the same α,α-
disubstituted amide 77 reported above. 
 
 282 
Hydrolysis of α-methyl α-amino amides: 
 
(S)-2-amino-3-cyclohexyl-2-methylpropanoic acid (85) 
α,α-disubstituted amide 74 (71.0 mg, 0.180 mol, 1.00 equiv) was dissolved in 1,4-dioxane (900 
µL) and water (900 µL) was added. The mixture was refluxed at 100 °C for 2 h, after which time 
it was cooled to 23 °C and diluted with dichloromethane (3 mL). The layers were separated, and 
the aqueous solution was extracted with dichloromethane (4 x 7 mL). The combined organic 
extracts were dried over sodium sulfate. The dried solution was filtered, and the filtrate was 
concentrated to provide (1S,2S)-pseudoephenamine (40.0 mg, 98%). The aqueous layer was 
concentrated in vacuo to provide α,α-disubstituted amino acid 85 as a white solid (33.0 mg, 
99%). The characterization data for the recovered auxiliary were in agreement with values 
previously reported.6 α,α-disubstituted amino acid 85: 1H NMR (500 MHz, CD3OD) δ 1.90 – 
1.82 (m, 2H), 1.74 – 1.60 (m, 4H), 1.54 (dd, J = 14.6, 4.4 Hz, 1H), 1.51 – 1.43 (m, 1H), 1.42 (s, 
3H), 1.38 – 1.22 (m, 2H), 1.22 – 1.10 (m, 1H), 1.08 – 0.92 (m, 2H). 13C NMR (126 MHz, 
CD3OD) δ 176.85, 61.91, 46.56, 36.17, 34.66, 34.47, 27.40, 27.22, 27.17, 25.02. FTIR (neat), 
cm-1: 3331 (s), 2945 (m), 2833 (s), 1415 (m), 1024 (s). HRMS (ESI): Calcd for (C10H19NO2 + 
H)+: 186.1496. Found: 186.1504. 
O
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(S)-2-amino-2-methylpent-4-enoic acid (86) 
α,α-disubstituted amide 80 (70.0 mg, 0.207 mmol, 1.00 equiv) was dissolved in 1,4-dioxane 
(1.03 mL) and water (1.03 mL) was added. The mixture was refluxed at 100 °C for 1 h, after 
which time it was cooled to 23 °C and diluted with dichloromethane (3 mL). The layers were 
separated, and the aqueous solution was extracted with dichloromethane (4 x 7 mL). The 
combined organic extracts were dried over sodium sulfate. The dried solution was filtered, and 
the filtrate was concentrated to provide (1S,2S)-pseudoephenamine (44.0 mg, 94%). The aqueous 
layer was concentrated in vacuo to provide α,α-disubstituted amino acid 86 as a white solid 
(26.0 mg, 97%). The characterization data for the recovered auxiliary were in agreement with 
values previously reported. Chiral HPLC analysis (Phenomenex Chirex 3126 (D)-penicillamine, 
99:1 aqueous 2 mM copper (II) sulfate solution:i-PrOH, 0.5 mL/min, λ = 240 nm, tR (major, 
amino acid 86) = 11.3 min, tR (minor, amino acid ent-86) = 15.4 min) of amino acid 86 
established that 86 was of 98% ee. The characterization data for α,α-disubstituted amino acid 30 
were in agreement with values previously reported:82 1H NMR (500 MHz, D2O) δ 5.81 – 5.68 
(m, 1H), 5.34 – 5.22 (m, 2H), 2.65 (dd, J = 14.4, 6.6 Hz, 1H), 2.45 (dd, J = 14.4, 8.4 Hz, 1H), 
1.48 (s, 3H). 13C NMR (126 MHz, D2O) δ 176.59, 130.80, 121.46, 61.13, 41.57, 22.12. FTIR 
                                                
82 Lu, T. J.; Lin, C. K. J. Org. Chem. 2011, 76, 1621–1633. 
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(neat), cm-1: 3365 (s), 2839 (m), 2501 (s), 1444 (m), 1014 (s). HRMS (ESI): Calcd for (C6H11NO2 
+ Na)+: 152.0682. Found: 152.0680. 
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(S)-2-amino-2-methyl-3-phenylpropanoic acid (87) 
α,α-disubstituted amide 75 (1.00 g, 2.57 mmol, 1.00 equiv) was dissolved in 1,4-dioxane (12.9 
mL) and water (12.9 mL) was added. The mixture was refluxed at 100 °C for 3 h, after which 
time it was cooled to 23 °C and diluted with dichloromethane (30 mL). The layers were 
separated, and the aqueous solution was extracted with dichloromethane (4 x 30 mL). The 
combined organic extracts were dried over sodium sulfate. The dried solution was filtered, and 
the filtrate was concentrated to provide (1S,2S)-pseudoephenamine (583 mg, ≥99%). The 
aqueous layer was concentrated in vacuo to provide α,α-disubstituted amino acid 87 as a white 
solid (460 mg, ≥99%). The characterization data for the recovered auxiliary were in agreement 
with values previously reported.6 Chiral HPLC analysis (Phenomenex Chirex 3126 (D)-
penicillamine, 95:5 aqueous 2 mM copper (II) sulfate solution:i-PrOH, 0.5 mL/min, λ = 240 
nm, tR (major, amino acid 87) = 25.7 min, tR (minor, amino acid ent-87) = 39.9 min) of amino 
acid 87 established that 87 was of 98% ee. The characterization data for α,α-disubstituted amino 
acid 87 were in agreement with values previously reported:83 1H NMR (500 MHz, D2O) δ 7.43 – 
7.34 (m, 3H), 7.29 – 7.24 (m, 2H), 3.30 (d, J = 14.2 Hz, 1H), 2.98 (d, J = 14.3 Hz, 1H), 1.55 (s, 
3H). 13C NMR (100 MHz, D2O) δ 176.31, 134.31, 130.06, 129.06, 127.93, 62.26, 42.78, 22.48. 
                                                
83 Green, J. E.; Bender, D. M.; Jackson, S.; O'Donnell, M. J.; McCarthy, J. R. Org. Lett. 2009, 11, 807–810. 
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FTIR (neat), cm-1: 3331 (s), 2945 (s), 2833 (s), 1448 (m), 1022 (s). HRMS (ESI): Calcd for 
(C10H13NO2 + H)+: 180.1026. Found: 180.1024. 
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Esterification of α-methyl α-amino amides: 
 
(S)-methyl 2-amino-2-methyl-3-phenylpropanoate (88) 
Sodium methoxide (0.5 M solution in methanol, 772 µL, 0.386 mmol, 1.00 equiv) was added to 
a cooled (0 °C) solution of α,α-disubstituted amide 75 (150 mg, 0.386 mmol, 1.00 equiv) in 
anhydrous methanol (2.40 mL). The mixture was stirred at 23 °C for 3 h, after which time water 
(4 mL) and saturated aqueous sodium chloride solution (4 mL) were added. The aqueous layer 
was extracted with dichloromethane (3 x 20 mL), and the combined organic extracts were dried 
over sodium sulfate. The dried solution was filtered, and the filtrate was concentrated. The crude 
residue was purified by flash chromatography (3→10% methanol-dichloromethane) to provide 
(1S,2S)-pseudoephenamine (80.0 mg, 91%) and methyl ester 88 as a colorless oil (66.0 mg, 
88%). The characterization data for the recovered auxiliary were in agreement with values 
previously reported. The characterization data for methyl ester 88 were in agreement with values 
previously reported:84 TLC (10% methanol-dichloromethane): Rf = 0.56 (UV, CAM). 1H NMR 
(500 MHz, CDCl3) δ 7.33 – 7.23 (m, 3H), 7.19 – 7.13 (m, 2H), 3.72 (s, 3H), 3.15 (d, J = 13.2 
Hz, 1H), 2.81 (d, J = 13.2 Hz, 1H), 1.58 (br s, 2H), 1.41 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 
177.67, 136.68, 130.06, 128.47, 127.07, 58.97, 52.23, 47.07, 26.79. FTIR (neat), cm-1: 3030 (m), 
                                                
84 Smith, N. D.; Wohlrab, A. M.; Goodman, M. Org. Lett. 2005, 7, 255–258. 
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2951 (m), 1732 (s), 1454 (m), 1197 (s). HRMS (ESI): Calcd for (C11H15NO2 + H)+: 194.1176 
Found: 194.1172. 
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(S)-benzyl 2-amino-2-methyl-3-phenylpropanoate (89) 
A freshly titrated solution of n-butyllithium in hexanes (2.39 M, 113 µL, 1.50 equiv) was added 
to a cooled (0 °C) solution of benzyl alcohol (37.3 µL, 0.360 mmol, 2.00 equiv) in 
tetrahydrofuran (200 µL).5 A solution of α,α-disubstituted amide 75 (70.0 mg, 0.180 mmol, 1.00 
equiv) in tetrahydrofuran (800 µL) was transferred to the cold benzyl alkoxide solution via 
syringe and the transfer was quantitated with tetrahydrofuran (2 x 400 µL). The reaction mixture 
was stirred at 0 °C for 1 h and then at 23 °C for 1.5 h, after which time water (5 mL) and 
dichloromethane (5 mL) were added. The layers were separated, the aqueous layer was extracted 
with dichloromethane (3 x 15 mL), and the combined organic extracts were dried over sodium 
sulfate. The dried solution was filtered, and the filtrate was concentrated. The crude residue was 
purified by flash chromatography (10% diethyl ether-dichloromethane, then 10% methanol-
dichloromethane) to provide (1S,2S)-pseudoephenamine (36.0 mg, 88%) and benzyl ester 89 as a 
colorless oil (41.0 mg, 84%). The characterization data for the recovered auxiliary were in 
agreement with values previously reported. Benzyl ester 89: TLC (40% ethyl acetate-hexanes): 
Rf = 0.30 (UV, CAM). 1H NMR (500 MHz, CDCl3) δ 7.41 – 7.29 (m, 5H), 7.22 (dd, J = 4.8, 1.9 
Hz, 3H), 7.12 – 7.06 (m, 2H), 5.13 (s, 2H), 3.15 (d, J = 13.2 Hz, 1H), 2.81 (d, J = 13.2 Hz, 1H), 
1.62 (br s, 2H), 1.42 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 177.02, 136.56, 135.78, 130.10, 
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128.72, 128.50, 128.47, 128.44, 127.01, 67.01, 58.97, 46.95, 26.80. FTIR (neat), cm-1: 3032 (m), 
1728 (s), 1496 (m), 1170 (s), 906 (s). HRMS (ESI): Calcd for (C17H19NO2 + H)+: 270.1489 
Found: 270.1497. 
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Aza-Cope Rearrangement of α-methyl α-allyl pivaldimine: 
 
(S)-2-amino-N-((1S,2S)-2-hydroxy-1,2-diphenylethyl)-N,2-dimethylpent-4-enamide (80) and 
(2R,5S,6S)-2-(((S)-2,2-dimethylhex-5-en-3-yl)amino)-2,4-dimethyl-5,6-diphenylmorpholin-3-
one (81) 
 
Crude allylated imine 125 was obtained via alkylation of tert-butyl imine 71 with allyl bromide, 
similar to the synthesis of α,α-disubstituted amide 80, with the omission of the final imine 
hydrolysis step using aqueous hydroxylamine solution. 1 M aqueous hydrochloric acid solution 
(7 mL) was added to a solution of crude allylated imine 125 (65.0 mg, 0.160 mmol, 1.00 equiv) 
in ethyl acetate (1.50 mL). The biphasic mixture was stirred vigorously at 23 °C for 3h, after 
which time ethyl acetate (8 mL) was added. The layers were separated, the organic layer was 
extracted with 1 M aqueous hydrochloric acid solution (3 x 10 mL), followed by saturated 
aqueous sodium bicarbonate solution (10 mL). The organic layer was dried over sodium sulfate, 
the dried solution was filtered, and the filtrate was concentrated. The crude residue was purified 
by flash chromatography (10% ethyl acetate-hexanes) to provide morpholinone 81 (33.0 mg, 
50%) as a colorless solid. The diastereomeric ratio of the crude material was determined to be 
7:1 by 1H NMR integration. Morpholinone 81: TLC (20% ethyl acetate-hexanes): Rf = 0.37 (UV, 
KMnO4). 1H NMR (600 MHz, CDCl3) δ 7.28 – 7.22 (m, 3H), 7.22 – 7.13 (m, 3H), 7.01 – 6.96 
(m, 2H), 6.96 – 6.91 (m, 2H), 5.95 – 5.86 (m, 1H), 5.27 (d, J = 9.7 Hz, 1H), 4.79 – 4.74 (m, 1H), 
N
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4.72 (d, J = 10.2 Hz, 1H), 4.48 (d, J = 9.8 Hz, 1H), 2.77 (t, J = 4.7 Hz, 1H), 2.67 (s, 3H), 2.25 – 
2.19 (m, 1H), 2.17 – 2.11 (m, 1H), 2.01 (s, 1H), 1.67 (s, 3H), 0.98 (s, 9H). 13C NMR (100 MHz, 
CDCl3) δ 172.02, 138.13, 137.66, 136.46, 128.76, 128.42, 128.25, 128.10, 128.04, 127.80, 
114.91, 89.61, 74.51, 70.61, 59.20, 37.54, 35.67, 32.86, 27.59, 24.04. FTIR (neat), cm-1: 2957 
(m), 1651 (s), 1477 (m), 1396 (m), 1101 (s). HRMS (ESI): Calcd for (C26H34N2O2 + H)+: 
407.2693. Found: 407.2707. 
The acidic aqueous extracts were combined, cooled in an ice bath, and carefully brought to pH 
14 by the addition of 2 M aqueous sodium hydroxide solution. The basic aqueous solution was 
extracted with dichloromethane (3 x 40 mL), and the combined organic extracts were dried over 
sodium sulfate. The dried solution was filtered, and the filtrate was concentrated. The residue 
was purified by flash chromatography (3% methanol-dichloromethane, triethylamine pretreated 
silica gel) to provide α,α-disubstituted amide 80 as a white solid (18.0 mg, 33%). The 
diastereomeric ratio of the crude material was determined to be ≥19:1 by 1H NMR integration 
and the characterization data were in agreement with values for the same α,α-disubstituted 
amide 80 reported above. 
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Synthesis of (S)-2-amino-N-((1R,2R)-2-hydroxy-1,2-diphenylethyl)-N,2-dimethyl-3-phenyl 
propanamide for spectroscopic comparison: 
 
 
(S)-2-amino-N-((1R,2R)-2-hydroxy-1,2-diphenylethyl)-N,2-dimethyl-3-phenylpropanamide 
(124) 
 
A solution of commercially available L-α-methylphenylalanine (50.0 mg, 0.279 mmol, 1.00 
equiv) in water (1.10 mL) and 1,4-dioxane (1.10 mL) was treated with triethylamine (156 µL, 
1.12 mmol, 4.00 equiv) and di-tert-butyl dicarbonate (130 µL, 0.558 mmol, 2.00 equiv).85 The 
mixture was stirred at 23 °C for 12 h, after which time 1 M aqueous hydrochloric acid solution (2 
mL) and ethyl acetate (10 mL) were added. The layers were separated and the organic phase was 
extracted with saturated aqueous sodium chloride solution (10 mL). The organic layer was dried 
over sodium sulfate, the dried solution was filtered, and the filtrate was concentrated to provide 
N-(tert-butoxycarbonyl)-L-α-methylphenylalanine as a white foam. In the following step, 
(1R,2R)-pseudoephenamine (22.4 mg, 0.098 mmol, 1.10 equiv), 
bromotripyrrolidinophosphonium hexafluorophosphate (28.7 mg, 0.089 mmol, 1.00 equiv) and 
N,N-diisopropylethylamine (39.1 µL, 0.224 mmol, 2.50 equiv) were added to a solution of the 
crude N-(tert-butoxycarbonyl)-L-α-methylphenylalanine (25.0 mg, 0.089 mmol, 1.00 equiv) in 
                                                
85 Costanzo, M. J.; Almond, H. R.; Hecker, L. R.; Schott, M. R.; Yabut, S. C.; Zhang, H. C.; Andrade-Gordon, P.; 
Corcoran, T. W.; Giardino, E. C.; Kauffman, J. A.; Lewis, J. M.; de Garavilla, L.; Haertlein, B. J.; Maryanoff, B. E. 
J. Med. Chem. 2005, 48, 1984–2008. 
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dichloromethane (360 µL).86,87 The cloudy mixture was stirred at 23 °C for 15 h, after which time 
dichloromethane (10 mL) and saturated aqueous sodium chloride solution (10 mL) were added. 
The layers were separated and the organic layer was dried over sodium sulfate. The dried 
solution was filtered, and the filtrate was concentrated to provide a colorless oil. A solution of 
hydrogen chloride in dioxane (4 M, 100 µL, 0.400 mmol, 4.49 equiv) was added dropwise to a 
solution of this oil in dichloromethane (200 µL) at 0 °C. After 5 min, the reaction mixture was 
allowed to warm to 23 °C. The mixture was stirred at 23 °C for 1.5 h, after which time the 
reaction mixture was brought to pH 14 by the addition of 2 M aqueous sodium hydroxide 
solution. The layers were separated, and the aqueous layer was extracted with dichloromethane 
(3 x 7 mL). The combined organic extracts were dried over sodium sulfate. The dried solution 
was filtered, and the filtrate was concentrated. The residue was purified by flash chromatography 
(5% methanol-dichloromethane) to provide α,α-disubstituted amide 124 as a white foam (15.0 
mg, 43%). The 1H NMR, 13C NMR and MS data obtained for α,α-disubstituted amide 124 were 
consistent with the values for the opposite diastereomer of α,α-disubstituted amide 76 reported 
above. TLC (10% methanol-dichloromethane): Rf = 0.51 (UV, KMnO4). 1H NMR (600 MHz, 
CDCl3) δ 7.24 – 7.11 (m, 9H), 7.11 – 7.06 (m, 2H), 7.05 – 6.98 (m, 2H), 6.98 – 6.93 (m, 2H), 
5.84 (d, J = 8.0 Hz, 1H), 3.93 (d, J = 8.0 Hz, 1H), 3.08 (d, J = 13.3 Hz, 1H), 2.80 (d, J = 13.3 Hz, 
1H), 2.24 (s, 3H), 1.65 (br s, 2H), 1.43 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 176.13, 138.45, 
137.31, 130.21, 128.58, 128.33, 128.17, 128.13, 127.71, 127.67, 126.91, 80.44, 69.20, 58.86, 
46.59, 34.43, 26.77. FTIR (neat), cm-1: 3030 (m), 2935 (m), 1720 (s), 1454 (s), 1168 (s). HRMS 
(ESI): Calcd for (C25H28N2O2 + H)+: 389.2231. Found: 389.2234.
                                                
86 Coste, J.; Frerot, E.; Jouin, P. J. Org. Chem. 1994, 59, 2437–2446. 
87 Frerot, E.; Coste, J.; Pantaloni, A.; Dufour, M. N.; Jouin, P. Tetrahedron 1991, 47, 259–270. 
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Preparation of Alkyl Triflate Reagents: 
 
Isobutyl trifluoromethanesulfonate (114) 
Pyridine (421 µL, 5.20 mmol, 1.20 equiv) was added to a stirring solution of isobutanol (400 µL, 
4.33 mmol, 1.00 equiv) in dichloromethane (4.33 mL) at −78 °C.88 Trifluormethanesulfonic 
anhydride (739 µL, 4.38 mmol, 1.01 equiv) was added dropwise over 1 min, and stirring was 
continued at −78 °C for 5 min. The solution was then warmed to 0 °C for 25 min, after which 
time the mixture was diluted with pentane (10 mL) and cold (0 °C) 1 M aqueous sulfuric acid 
solution (10 mL). The layers were separated, the organic layer was dried over sodium sulfate and 
the dried solution was filtered. The filtrate was concentrated and the colorless liquid was dried 
under high vacuum for 30 sec. Triflate 114 (689 mg, 77%) was used in subsequent reactions 
without further purification. 1H NMR (500 MHz, CDCl3) δ 4.31 (d, J = 6.4 Hz, 2H), 2.18 – 2.08 
(m, 1H), 1.03 (d, J = 6.8 Hz, 6H). 
                                                
88 Chi, D. Y.; Kilbourn, M. R.; Katzenellenbogen, J. A.; Welch, M. J. J. Org. Chem. 1987, 52, 658–664. 
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Cyclohexylmethyl trifluoromethanesulfonate (116) 
Pyridine (394 µL, 4.88 mmol, 1.20 equiv) was added to a stirring solution of 
cyclohexanemethanol (500 µL, 4.06 mmol, 1.00 equiv) in dichloromethane (4.06 mL) at −78 
°C.86 Trifluormethanesulfonic anhydride (693 µL, 4.10 mmol, 1.01 equiv) was added dropwise 
over 1 min, and stirring was continued at −78 °C for 5 min. The solution was then warmed to 0 
°C for 25 min, after which time the mixture was diluted with pentane (10 mL) and cold (0 °C) 1 
M aqueous sulfuric acid solution (10 mL). The layers were separated, the organic layer was dried 
over sodium sulfate and the dried solution was filtered. The filtrate was concentrated and the 
light yellow liquid was dried under high vacuum for 30 sec. Triflate 116 (969 mg, 97%) was 
used in subsequent reactions without further purification. 1H NMR (600 MHz, CDCl3) δ 4.33 (d, 
J = 6.1 Hz, 2H), 1.84 – 1.75 (m, 5H), 1.74 – 1.68 (m, 1H), 1.33 – 1.13 (m, 3H), 1.09 – 0.98 (m, 
2H). 
TfOHO
Pyridine, Tf2O,
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3-Bromopropyl trifluoromethanesulfonate (118) 
Pyridine (268 µL, 3.32 mmol, 1.20 equiv) was added to a stirring solution of 3-bromopropan-1-
ol (250 µL, 2.76 mmol, 1.00 equiv) in dichloromethane (2.77 mL) at −78 °C.116 
Trifluormethanesulfonic anhydride (472 µL, 2.79 mmol, 1.01 equiv) was added dropwise over 1 
min, and stirring was continued at −78 °C for 5 min. The solution was then warmed to 0 °C for 
40 min, after which time the mixture was diluted with pentane (10 mL) and cold (0 °C) 1 M 
aqueous sulfuric acid solution (10 mL). The layers were separated, the organic layer was dried 
over sodium sulfate and the dried solution was filtered. The filtrate was concentrated and the 
colorless liquid was dried under high vacuum for 30 sec. Triflate 118 (680 mg, 91%) was used in 
subsequent reactions without further purification. 1H NMR (500 MHz, CDCl3) δ 4.71 (t, J = 5.8 
Hz, 2H), 3.51 (t, J = 6.2 Hz, 2H), 2.36 (tt, J = 6.1 Hz, J = 6.2 Hz, 2H). 
BrTfOBrHO
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(R)-3-Chloro-2-methylpropyl trifluoromethanesulfonate (120) 
Pyridine (156 µL, 1.93 mmol, 1.20 equiv) was added to a stirring solution of (R)-3-chloro-2-
methylpropan-1-ol89 (175 mg, 1.61 mmol, 1.00 equiv) in dichloromethane (1.61 mL) at −78 °C.14 
Trifluormethanesulfonic anhydride (275 µL, 1.63 mmol, 1.01 equiv) was added dropwise over 1 
min, and stirring was continued at −78 °C for 5 min. The solution was then warmed to 0 °C for 
30 min, after which time the mixture was diluted with pentane (10 mL) and cold (0 °C) 1 M 
aqueous sulfuric acid solution (10 mL). The layers were separated, the organic layer was dried 
over sodium sulfate and the dried solution was filtered. The filtrate was concentrated and the 
light brown liquid was dried under high vacuum for 30 sec. Triflate 120 (265 mg, 68%) was used 
in subsequent reactions without further purification. 1H NMR (500 MHz, CDCl3) δ 4.53 (d, J = 
5.7 Hz, 2H), 3.63 (dd, J = 11.4, 4.6 Hz, 1H), 3.54 (dd, J = 11.4, 6.2 Hz, 1H), 2.43 – 2.33 (m, 
1H), 1.14 (d, J = 7.0 Hz, 3H). 
 
                                                
89 Gaucher, A.; Ollivier, J.; Marguerite, J.; Paugam, R.; Salaun, J. Canadian Journal of Chemistry 1994, 72, 1312–
1327. 
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Pseudoephenamine Alaninamide Pivaldimine Enolate Trapping Experiment: 
 
 
Cyclic siloxane (79, E-isomer) 
A solution of tert-butyl imine 71 (123 mg, 0.336 mmol, 1.00 equiv) in tetrahydrofuran (1.20 mL) 
was transferred via cannula to a flask containing flame-dried lithium chloride (85.0 mg, 2.01 
mmol, 6.00 equiv). The transfer was quantitated with tetrahydrofuran (2 x 500 µL). The resulting 
slurry was cooled to −78 °C, after which a freshly prepared solution of lithium diisopropylamide 
(1 M, 738 µL, 0.738 mmol, 2.20 equiv) precooled to 0 °C was added slowly to the inner edge of 
the reaction flask, such that the solution was cooled before reaching the reaction mixture. The 
yellow slurry was stirred for 5 min at −78 °C, and then was warmed to 0 °C for 10 min. The 
slurry was then cooled to −50 °C. After 10 min, distilled dichlorodiisopropylsilane (84.8 µL, 
0.470 mmol, 1.20 equiv) was added by syringe. The mixture was stirred at −50 °C for 2.5 h, then 
was first concentrated by rotary evaporation (∼40 mmHg) at 23 °C, afterwards with a vacuum 
manifold (1 mmHg) for 30 min at 23 °C. Dry benzene (2 mL) was added to the residue and the 
resulting suspension was filtered through oven-dried basic alumina, rinsing with additional 
benzene (5 x 2 mL). The filtrate was concentrated to provide cyclic siloxane 79 as a pale yellow 
oil (101 mg, 63%). The E-geometry of the product was confirmed by a NOE correlation between 
the protons of the N-methyl and tert-butyl group. TLC (10% ethyl acetate-hexanes): Rf = 0.42 
O
CH3N
CH3 N
CH3H3C CH3
SiO
CH3
H3C
CH3
CH3
1. LDA, LiCl, THF, –78 → 0 °C
2. (i-Pr)2SiCl2, –50°C
                     63%
N
O
N
CH3
CH3
CH3OH CH3
CH3
71 79 (E-isomer)
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(UV, KMnO4). 1H NMR (500 MHz, C6D6) δ 7.21 – 7.14 (m, 4H), 7.06 – 6.87 (m, 7H), 5.49 (d, J 
= 10.3 Hz, 1H), 4.00 (d, J = 10.3 Hz, 1H), 2.95 (s, 3H), 2.07 (s, 3H), 1.34 – 1.13 (m, 14H), 0.87 
(s, 9H). 13C NMR (126 MHz, C6D6) δ 157.97, 150.31, 141.85, 138.18, 129.76, 128.59, 128.35, 
128.16, 127.97, 127.66, 127.32, 114.24, 78.02, 75.78, 43.21, 36.63, 27.76, 17.75, 17.57, 17.52, 
17.33, 13.78, 13.66, 11.03. FTIR (neat), cm-1: 3036 (m), 1815 (m), 1479 (s), 1035 (m), 812 (m). 
HRMS (ESI): Calcd for (C29H42N2O2Si + H)+: 479.3096. Found: 479.3095. 
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X-ray Data: 
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X-Ray Crystallography: Data was collected at 180 K from a crystal mounted on a 
diffractometer. The intensities of the reflections were collected by means of a Bruker APEX II 
DUO CCD diffractometer (CuKα radiation, λ=1.54178 Å), and equipped with an Oxford 
Cryosystems nitrogen flow apparatus. The collection method involved 1.0° scans in ω at 30°, 
55°, 80° and 115° in 2θ. Data integration down to 0.84 Å resolution was carried out using 
SAINT V7.46 A (Bruker diffractometer, 2009) with reflection spot size optimization. Absorption 
corrections were made with the program SADABS (Bruker diffractometer, 2009). The structure 
was solved by the direct methods procedure and refined by least-squares methods again F2 using 
SHELXS-97 and SHELXL-97 (Sheldrick, 2008). Non-hydrogen atoms were refined 
anisotropically, and hydrogen atoms were allowed to ride on the respective atoms. Crystal data 
as well as details of data collection and refinement are summarized in Table 1, and geometric 
parameters are shown in Table 2. The Ortep plots produced with SHELXL-97 program, and the 
other drawings were produced with Accelrys DS Visualizer 2.0 (Accelrys, 2007). 
Table 3.1: Experimental details 
 
 (39lpEE) 
Crystal data 
Chemical formula C26H34N2O2 
Mr 406.55 
Crystal system, space group Orthorhombic, P212121 
Temperature (K) 100 
a, b, c (Å) 9.0583 (2), 14.4124 (4), 17.2685 (4) 
V (Å3) 2254.43 (10) 
Z 4 
Radiation type Cu Ka 
m (mm-1) 0.59 
Crystal size (mm) 0.20 × 0.18 × 0.14 
Data collection 
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Table 3.1 (continued) 
Diffractometer Bruker D8 goniometer with CCD area detector diffractometer 
Absorption correction Multi-scan  
SADABS 
 Tmin, Tmax 0.892, 0.922 
No. of measured, independent and 
observed [I > 2s(I)] reflections 
33748, 3915, 3894   
Rint 0.034 
(sin q/l)max (Å-1) 0.594 
Refinement 
R[F2 > 2s(F2)], wR(F2), S 0.027,  0.069,  1.09 
No. of reflections 3915 
No. of parameters 280 
No. of restraints 0 
H-atom treatment H atoms treated by a mixture of independent and constrained refinement 
Dρmax, Dρmin (e Å-3) 0.12, -0.19 
Absolute structure Flack H D (1983), Acta Cryst. A39, 876-881 
Flack parameter 0.06 (15) 
 
Computer programs: APEX2 v2009.3.0 (Bruker-AXS, 2009), SAINT 7.46A (Bruker-AXS, 2009), SHELXS97 
(Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), Bruker SHELXTL (Sheldrick, 2008). 
 
Table 3.2: Geometric parameters (Å, º) 
C1—O1 1.2309 (15) C12—H12A 0.9800 
C1—N1 1.3450 (15) C12—H12B 0.9800 
C1—C2 1.5425 (16) C12—H12C 0.9800 
C2—O2 1.4257 (14) C13—H13A 0.9800 
C2—N2 1.4610 (15) C13—H13B 0.9800 
C2—C5 1.5308 (16) C13—H13C 0.9800 
C3—O2 1.4268 (14) C14—C19 1.3922 (19) 
C3—C14 1.5088 (17) C14—C15 1.3940 (18) 
C3—C4 1.5378 (16) C15—C16 1.396 (2) 
C3—H3 1.0000 C15—H15 0.9500 
C4—N1 1.4786 (15) C16—C17 1.382 (2) 
C4—C20 1.5139 (16) C16—H16 0.9500 
C4—H4 1.0000 C17—C18 1.382 (2) 
C5—H5A 0.9800 C17—H17 0.9500 
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Table 3.2 (continued) 
C5—H5B 0.9800 C18—C19 1.3863 (19) 
C5—H5C 0.9800 C18—H18 0.9500 
C6—N2 1.4774 (15) C19—H19 0.9500 
C6—C7 1.5473 (16) C20—C25 1.3894 (16) 
C6—C10 1.5592 (16) C20—C21 1.3950 (17) 
C6—H6 1.0000 C21—C22 1.3831 (18) 
C7—C8 1.5031 (17) C21—H21 0.9500 
C7—H7A 0.9900 C22—C23 1.3887 (18) 
C7—H7B 0.9900 C22—H22 0.9500 
C8—C9 1.3189 (19) C23—C24 1.3889 (19) 
C8—H8 0.9500 C23—H23 0.9500 
C9—H9A 0.9500 C24—C25 1.3907 (17) 
C9—H9B 0.9500 C24—H24 0.9500 
C10—C12 1.5336 (18) C25—H25 0.9500 
C10—C13 1.5377 (17) C26—N1 1.4642 (15) 
C10—C11 1.5420 (17) C26—H26A 0.9800 
C11—H11A 0.9800 C26—H26B 0.9800 
C11—H11B 0.9800 C26—H26C 0.9800 
C11—H11C 0.9800 N2—H2 0.887 (16) 
 
O1—C1—N1 122.98 (11) H12A—C12—H12B 109.5 
O1—C1—C2 118.09 (10) C10—C12—H12C 109.5 
N1—C1—C2 118.92 (10) H12A—C12—H12C 109.5 
O2—C2—N2 110.74 (9) H12B—C12—H12C 109.5 
O2—C2—C5 103.72 (9) C10—C13—H13A 109.5 
N2—C2—C5 117.14 (10) C10—C13—H13B 109.5 
O2—C2—C1 113.13 (9) H13A—C13—H13B 109.5 
N2—C2—C1 103.61 (9) C10—C13—H13C 109.5 
C5—C2—C1 108.80 (9) H13A—C13—H13C 109.5 
O2—C3—C14 107.78 (10) H13B—C13—H13C 109.5 
O2—C3—C4 108.86 (9) C19—C14—C15 118.89 (12) 
C14—C3—C4 110.85 (9) C19—C14—C3 120.16 (11) 
O2—C3—H3 109.8 C15—C14—C3 120.91 (12) 
C14—C3—H3 109.8 C14—C15—C16 119.83 (13) 
C4—C3—H3 109.8 C14—C15—H15 120.1 
N1—C4—C20 111.62 (9) C16—C15—H15 120.1 
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Table 3.2 (continued) 
N1—C4—C3 109.16 (9) C17—C16—C15 120.63 (13) 
C20—C4—C3 109.20 (9) C17—C16—H16 119.7 
N1—C4—H4 108.9 C15—C16—H16 119.7 
C20—C4—H4 108.9 C18—C17—C16 119.64 (12) 
C3—C4—H4 108.9 C18—C17—H17 120.2 
C2—C5—H5A 109.5 C16—C17—H17 120.2 
C2—C5—H5B 109.5 C17—C18—C19 120.13 (14) 
H5A—C5—H5B 109.5 C17—C18—H18 119.9 
C2—C5—H5C 109.5 C19—C18—H18 119.9 
H5A—C5—H5C 109.5 C18—C19—C14 120.86 (13) 
H5B—C5—H5C 109.5 C18—C19—H19 119.6 
N2—C6—C7 109.23 (9) C14—C19—H19 119.6 
N2—C6—C10 111.88 (10) C25—C20—C21 119.19 (11) 
C7—C6—C10 116.12 (10) C25—C20—C4 120.79 (10) 
N2—C6—H6 106.3 C21—C20—C4 119.80 (11) 
C7—C6—H6 106.3 C22—C21—C20 120.73 (11) 
C10—C6—H6 106.3 C22—C21—H21 119.6 
C8—C7—C6 116.29 (10) C20—C21—H21 119.6 
C8—C7—H7A 108.2 C21—C22—C23 119.85 (11) 
C6—C7—H7A 108.2 C21—C22—H22 120.1 
C8—C7—H7B 108.2 C23—C22—H22 120.1 
C6—C7—H7B 108.2 C22—C23—C24 119.87 (12) 
H7A—C7—H7B 107.4 C22—C23—H23 120.1 
C9—C8—C7 124.15 (13) C24—C23—H23 120.1 
C9—C8—H8 117.9 C23—C24—C25 120.18 (11) 
C7—C8—H8 117.9 C23—C24—H24 119.9 
C8—C9—H9A 120.0 C25—C24—H24 119.9 
C8—C9—H9B 120.0 C20—C25—C24 120.17 (11) 
H9A—C9—H9B 120.0 C20—C25—H25 119.9 
C12—C10—C13 108.94 (11) C24—C25—H25 119.9 
C12—C10—C11 108.40 (10) N1—C26—H26A 109.5 
C13—C10—C11 107.18 (10) N1—C26—H26B 109.5 
C12—C10—C6 114.14 (10) H26A—C26—H26B 109.5 
C13—C10—C6 109.03 (10) N1—C26—H26C 109.5 
C11—C10—C6 108.92 (10) H26A—C26—H26C 109.5 
C10—C11—H11A 109.5 H26B—C26—H26C 109.5 
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Table 3.2 (continued) 
C10—C11—H11B 109.5 C1—N1—C26 118.40 (10) 
H11A—C11—H11B 109.5 C1—N1—C4 124.12 (9) 
C10—C11—H11C 109.5 C26—N1—C4 117.39 (9) 
H11A—C11—H11C 109.5 C2—N2—C6 118.46 (9) 
H11B—C11—H11C 109.5 C2—N2—H2 107.5 (10) 
C10—C12—H12A 109.5 C6—N2—H2 111.2 (10) 
C10—C12—H12B 109.5 C2—O2—C3 113.81 (9) 
 
O1—C1—C2—O2 173.10 (9) N1—C4—C20—C25 -129.88 (11) 
N1—C1—C2—O2 -7.06 (15) C3—C4—C20—C25 109.33 (12) 
O1—C1—C2—N2 -66.92 (12) N1—C4—C20—C21 55.47 (14) 
N1—C1—C2—N2 112.91 (11) C3—C4—C20—C21 -65.32 (14) 
O1—C1—C2—C5 58.40 (13) C25—C20—C21—C22 -1.21 (18) 
N1—C1—C2—C5 -121.77 (11) C4—C20—C21—C22 173.52 (11) 
O2—C3—C4—N1 51.95 (12) C20—C21—C22—C23 0.67 (18) 
C14—C3—C4—N1 170.33 (10) C21—C22—C23—C24 0.17 (19) 
O2—C3—C4—C20 174.23 (9) C22—C23—C24—C25 -0.44 (19) 
C14—C3—C4—C20 -67.39 (12) C21—C20—C25—C24 0.93 (17) 
N2—C6—C7—C8 45.82 (14) C4—C20—C25—C24 -173.76 (10) 
C10—C6—C7—C8 -81.81 (13) C23—C24—C25—C20 -0.11 (18) 
C6—C7—C8—C9 -134.83 (13) O1—C1—N1—C26 -6.81 (16) 
N2—C6—C10—C12 -64.59 (13) C2—C1—N1—C26 173.36 (10) 
C7—C6—C10—C12 61.72 (14) O1—C1—N1—C4 176.83 (11) 
N2—C6—C10—C13 173.35 (10) C2—C1—N1—C4 -2.99 (16) 
C7—C6—C10—C13 -60.34 (13) C20—C4—N1—C1 -140.09 (11) 
N2—C6—C10—C11 56.70 (12) C3—C4—N1—C1 -19.28 (15) 
C7—C6—C10—C11 -176.99 (10) C20—C4—N1—C26 43.52 (13) 
O2—C3—C14—C19 29.45 (14) C3—C4—N1—C26 164.33 (10) 
C4—C3—C14—C19 -89.58 (13) O2—C2—N2—C6 -70.80 (12) 
O2—C3—C14—C15 -152.85 (10) C5—C2—N2—C6 47.83 (15) 
C4—C3—C14—C15 88.12 (13) C1—C2—N2—C6 167.61 (9) 
C19—C14—C15—C16 0.28 (18) C7—C6—N2—C2 102.53 (12) 
C3—C14—C15—C16 -177.46 (11) C10—C6—N2—C2 -127.49 (11) 
C14—C15—C16—C17 -1.58 (19) N2—C2—O2—C3 -73.16 (11) 
C15—C16—C17—C18 1.29 (19) C5—C2—O2—C3 160.36 (9) 
C16—C17—C18—C19 0.3 (2) C1—C2—O2—C3 42.64 (13) 
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Table 3.2 (continued) 
C17—C18—C19—C14 -1.60 (19) C14—C3—O2—C2 173.26 (9) 
C15—C14—C19—C18 1.30 (18) C4—C3—O2—C2 -66.44 (12) 
C3—C14—C19—C18 179.05 (12)   
Figure 3.2: Perspective views showing 50% probability displacement. 
 
Figure 3.3: Three-dimensional supramolecular architecture viewed along the a-axis direction.
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1H and 13C NMR Spectra: 
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Chapter 4 
On a Simple, Scalable Synthesis of (+)- and (–)-Pseudoephenamine 
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Introduction 
The two previous chapters have demonstrated the burgeoning utility of pseudoephenamine in 
asymmetric synthesis, and Chapter 2 outlined an effective route for the preparation of this chiral 
auxiliary. However, continued use of pseudoephenamine has created demand for the auxiliary 
that cannot be met by the first-generation synthesis in an economical manner. Specifically, 
synthesis of both enantiomers of pseudoephenamine using the prior synthetic route required the 
purchase of two relatively expensive amino alcohol starting materials, and the conversion of 
these amino alcohols to the two optically pure enantiomers of pseudoephenamine required four 
chemical transformations and one recrystallization per enantiomer, for a total of 10 chemical 
manipulations. Additionally, the first route was hampered by an epimerization step that was 
poorly scalable due to the required heating of large amounts of water to reflux. The following 
chapter details a second-generation synthesis of both (+)- and (–)-pseudoephenamine from the 
inexpensive starting material benzil that provides access to large amounts of both enantiomers of 
the auxiliary in 6 total chemical manipulations. 
Synthesis of Methylimino Benzil 
As a precursor to pseudoephenamine, methylimino benzil (91, Scheme 4.1) is nearly ideal, as 
it contains every carbon atom and heteroatom present in the final auxiliary. Fortunately, 
Wheatley and co-workers previously described the preparation of 91 by the condensation of 
methylamine and benzil (90) in methanol–water at 50 ºC, reporting a yield of 84%.90 In practice, 
this reaction proved to be highly scalable, though it was critical to use a fresh (commercial) 40 
wt % solution of methylamine in water (such that the titer of the volatile methylamine reactant 
was accurate) and crystalline benzil as co-reactants in order to obtain a good yield of the desired 
                                                
90 Wheatley, W. B.; Fitzgibbon, W. E.; Cheney, L. C. J. Org. Chem. 1953, 18, 1564–1571. 
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product. In the reaction, the heterogeneous mixture of starting materials was warmed in an oil 
bath while stirring until an internal temperature of 50 ºC was achieved and all solids were 
dissolved. Heating was immediately discontinued at this point, as further reaction lead to the 
formation of bis-methylimino benzil as a by-product. Upon cooling, the mono-imine crystallized 
from the reaction mixture, and the product was isolated in pure form by simple filtration (≥88% 
yield, 100–600-g scale, Table 1). The crystalline methylimino benzil obtained was confirmed to 
have (Z)-geometry by NOE and HMBC NMR correlations as well as by X-ray crystallography 
(see Experimental Information). 
 
Scheme 4.1 Synthesis of methylimino benzil (91) from the inexpensive starting material benzil (90). 
Reduction of Methylimino Benzil to (±)-Pseudoephenamine 
The reduction of methylimino benzil to pseudoephenamine was unprecedented. Two prior 
studies of the reduction of 91 explored the use of Raney nickel88 and sodium borohydride91 as 
reductants, and in each case ephenamine (92) was reported to be the major or exclusive product. 
Initially, an enantio- as well as diastereoselective reduction of mono-imine 91 was explored with 
                                                
91 Hahn, W. E.; Bartnik, R.; Mloston, G. Acta Poloniae Pharmaceutica. 1979, 36, 619–620. 
O
O
N
CH3O
CH3NH2 (40 wt % in H2O)
THF, 50 ºC
90 91
Scale
100 g
300 g
600 g
Yield
88%
92%
91%
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various chiral reductants, 92  but in each instance only racemic ephenamine was obtained. 
Although reduction of 91 to form racemic ephenamine was not an objective, Scheme 4.2 depicts 
a convenient method by which this transformation was achieved with ≥19:1 dr.93,94 
 
Scheme 4.2 Synthesis of (±)-ephenamine (92) from methylimino benzil (91). a dr refers to the ratio of (±)-92 to (±)-
25 as determined by 1H NMR analysis of the crude reaction mixture.  
Based upon the promising report of the reduction in the desired sense of achiral N-aryl and 
N-benzyl benzil mono-imines using lithium aluminum hydride (LAH),95 the use of this reagent 
was investigated in the reduction of methylimino benzil.96 In an initial experiment, reduction of 
methylimino benzil with LAH in THF at –78 ºC afforded a 4:1 mixture of diastereomeric amino 
alcohols favoring pseudoephenamine. Further investigations revealed that the diastereoselectivity 
of the reduction varied as a function of the rate of addition of LAH to the reaction mixture, and it 
                                                
92 See, for example: (a) Prasad, K. R. K.; Joshi, N. N. J. Org. Chem. 1996, 61, 3888–3889. (b) Murata, K.; Okano, 
K.; Miyagi, M.; Iwane, H.; Noyori, R.; Ikariya, T. Org. Lett. 1999, 1, 1119–1121. (c) Touge, T.; Hakamata, T.; 
Nara, H.; Kobayashi, T.; Sayo, N.; Saito, T.; Kayaki, Y.; Ikariya, T. J. Am. Chem. Soc. 2011, 133, 14960–14963. 
93 Reductive amination of benzil in the presence of methylamine and a platinum catalyst has been reported to form 
ephenamine: Skita, A.; Keil, F. Manufacture of Aminoalcohols. U.K. Patent 313,217, July 24, 1930. 
94 While the importance of ephenamine in asymmetric synthesis was recognized, no attempt to resolve the racemic 
substance was made. For a resolution of racemic ephenamine with penicillin, see reference 5. 
95 Alcaide, B.; López-Mardomingo, C.; Pérez-Ossorio, R.; Plumet, J. J. Chem. Soc., Perkin Trans. 2 1983, 1649–
1653. 
96 For the use of LAH in the reduction of chiral benzil mono-imines, see: (a) Haro-Ramos, R.; Jimenez-Tebar, A.; 
Pérez-Ossario, R.; Plumet, J. Tetrahedron Lett. 1979, 20, 1355–1356. (b) Alcaide, B.; Fernández de la Pradilla, R.; 
López-Mardomingo, C.; Pérez-Ossorio, R.; Plumet, J. J. Org. Chem. 1981, 46, 3234–3238. (c) Alcaide, B.; 
Dominguez, G.; López-Mardomingo, C.; Pérez-Ossorio, R.; Plumet, J. J. Chem. Soc., Perkin Trans. 2 1986, 99–103. 
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was noted that addition of powdered LAH too quickly led to delayed exotherms. Controlled 
addition of LAH with a powder addition funnel prevented these exotherms and allowed an 
internal temperature of –70 ºC to be maintained. It is useful to note that the exotherms more 
commonly occurred early in the course of the reaction; thus, the rate of LAH addition was 
increased as the reaction progressed. Efficient mechanical stirring of the reaction was also very 
important, especially on large scale, so as to prevent the aggregation of powdered LAH on the 
surface of the reaction mixture. In this manner, racemic pseudoephenamine of 4.7–5.4:1 dr was 
routinely prepared on 75–570 g scales in reproducibly high yield (>85%, see Scheme 4.3). As 
noted by Alcaide et al. in their study of the reduction of N-aryl and N-benzyl benzil mono-
imines, the observed diastereoselectivity of the reduction is consistent with the Felkin-Ahn 
model (Figure 4.1).95 
 
Scheme 4.3 Synthesis of (±)-pseudoephenamine by reduction of methylimino benzil with LAH. a dr refers to the 
ratio of (±)-25 to (±)-92 as determined by 1H NMR analysis of the crude reaction mixture. 
 
Figure 4.1 The reduction of methylimino benzil to form pseudoephenamine is consistent with the Felkin-Ahn model 
for addition of nucleophiles to carbonyl systems, as noted by Alcaide and co-workers.95 
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Resolution of (±)-Pseudoephenamine 
While the reduction of methylimino benzil to pseudoephenamine resulted in a mixture of 
four stereoisomers of the amino alcohol, direct resolution of either enantiomer of 
pseudoephenamine from the mixture of diastereomers in methanol was achieved with mandelic 
acid. Serendipitously, it was found that (R,R)-pseudoephenamine preferentially formed a highly 
crystalline salt with (R)-mandelic acid but not with (S)-mandelic acid under the resolution 
conditions, while neither diastereomeric ephenamine mandelate salt crystallized in the 
experiments. 97,98 Two procedures for the direct resolution of the LAH reduction products were 
developed, including one protocol with stirring and one without stirring. Both methods produced 
highly diastereoenriched mandelate crystals (≥19:1 dr by 1H NMR, with no trace of either 
ephenamine mandelate salt) with good recovery (defined as the percent of the theoretical amount 
of the targeted enantiomer of pseudoephenamine). Seed crystals were typically unnecessary for 
these resolutions, though they effectively initiated resolution if crystal formation was sluggish. It 
is worthwhile to note that 1H NMR analysis of the mandelate salts of pseudoephenamine is a 
convenient method to assay the enantiomeric purity of a sample of the auxiliary. Specifically, 
mixing a sample of pseudoephenamine (10 mg, 1 equiv) with (S)-mandelic acid (6.7 mg, 1 
equiv) in CDCl3 followed by 1H NMR analysis (500 MHz) will reveal well-resolved resonances 
for the diastereomeric salts present in the solution, allowing simple assessment of the 
                                                
97 For a comprehensive guide to the optical resolution of racemic compounds via formation of diastereomeric salts, 
see: CRC Handbook of Optical Resolutions via Diastereomeric Salt Formation; Kozma, D., Ed; CRC Press: Boca 
Raton, 2002. 
98 For selected resolutions of structurally similar amino alcohols, see: (a) Erlenmeyer E.; Arnold A. Justus Liebigs 
Ann. Chem. 1904, 337, 307–328. (b) Manske, R. H. F.; Johnson, T. B. J. Am. Chem. Soc. 1929, 51, 1906–1909. (c) 
Weijlard J.; Pfister III K.; Swanezy E. F.; Robinson C. A.; Tishler M. J. Am. Chem. Soc. 1951, 73, 1216–1218. (d) 
Saigo, K.; Sugiura, I.; Shida, I.; Tachibana, K.; Hasegawa, M. Bull. Chem. Soc. Jpn. 1986, 59, 2915–2916. 
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enantiopurity of the sample of pseudoephenamine (see Experimental Information for 
representative 1H NMR spectra). 
In the first resolution method, a solution of pseudoephenamine mandelate in methanol was 
allowed to stand at –20 ºC for several days without stirring, producing orthorhombic crystals. A 
representative set of experiments demonstrating this protocol is illustrated in Scheme 4.4. In the 
optimized procedure, pseudoephenamine (10 g, 5.4:1 dr, racemic) was mixed with (S)-mandelic 
acid (1 equivalent) in methanol (2.2 M in pseudoephenamine and ephenamine combined), and 
the mixture was warmed to 50 ºC in a 100-mL round-bottom flask to effect dissolution of the 
solid materials.99 After cooling to room temperature and removing the stir bar, the base of the 
flask was carefully scratched with a spatula, and the vessel was transferred to a –20 ºC freezer to 
promote crystallization. After standing for several days (incubation times ranging from 2–10 
days were typical), crystalline (S,S,S)-93 of ≥19:1 dr was obtained by filtration using a Büchner 
funnel. The mother liquor was concentrated, and, after formation of the free base, resolution with 
the opposite enantiomer of mandelic acid was conducted. The pseudoephenamine mandelate 
salts obtained by this process will serve as suitable seed crystals for later resolutions, if 
necessary. Pseudoephenamine was conveniently isolated as its free base following treatment with 
aqueous sodium hydroxide solution, and, after recrystallization from hot absolute ethanol, 
optically pure auxiliary was obtained (81% recovery, ≥99% ee, see Scheme 4.5).100 The mandelic 
acid was also easily recovered and recycled (see Experimental Information).  
                                                
99 It is recommended the solution be filtered through a fritted funnel while warm if insoluble impurities are observed 
in the flask. 
100 Crystallization of pseudoephenamine is an exothermic process, and concentrated solutions of the auxiliary in 
volatile solvents such as ethyl ether (employed in the workup of these reactions) can produce pressure buildup in a 
sealed vessel if spontaneous crystallization occurs. 
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Scheme 4.4 Resolution of (±)-pseudoephenamine with mandelic acid at –20 ºC without stirring. a dr refers to the 
ratio of (+)- and (–)-25 to (±)-92. b dr refers to the ratio of (S,S,S)- or (R,R,R)-93 to (R,R,S)- or (S,S,R)-93, 
respectively. 
 
Scheme 4.5 Isolation of (+)-pseudoephenamine. a dr refers to the ratio of (R,R,R)-93 to (S,S,R)-93. 
Conducting resolutions of pseudoephenamine on a larger scale (>300 g) required the 
development of a second protocol involving gentle stirring of the cooled solution of 
pseudoephenamine mandelate in methanol at 4 ºC. 101  Resolutions employing this method 
                                                
101 See chapter 3 of reference 95 for a discussion of the effect of stirring on the resolution of diastereomeric salts.  
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produced fine, powdery crystals and progressed much more rapidly than resolutions performed 
using the earlier protocol, with typical resolution times ranging from 2–12 hours. A series of 
iterative resolutions conducted on a single batch of 570 g of pseudoephenamine (4.7:1 dr, 
racemic) demonstrated the ability of the stirring protocol to produce highly enriched mandelate 
crystals (≥19:1 dr by 1H NMR, see Scheme 4.6) and provided approximately 100 g of each 
enantiomer of pseudoephenamine (≥92% ee). Recrystallization of the auxiliary from absolute 
ethanol gave more than 80 g of each enantiomer (≥99% ee). This protocol was the most 
convenient method of resolving pseudoephenamine and was routinely performed on large 
amounts of material (>300 g), though it also worked well on much smaller scales (<50 g).  
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Scheme 4.6 Resolution of (±)-pseudoephenamine with mandelic acid at 4 ºC with stirring. Total pseudoephenamine 
recovery after isolation of the free auxiliary and recrystallization from ethanol: 91.12 g (+)-25 (≥99% ee) and 89.54 
g (–)-25 (≥99% ee). a dr refers to the ratio of (+)- and (–)-25 to (±)-92. b dr refers to the ratio of (R,R,R)- or (S,S,S)-
93 to (S,S,R)- or (R,R,S)-93, respectively. 
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As seen in Scheme 4.6, recoveries upon resolution with mandelic acid were low when 
pseudoephenamine was appreciably contaminated with ephenamine (<2.5:1 dr). To circumvent 
this problem, amino alcohol mixtures of low dr were diastereomerically enriched by 
recrystallization from methanol in the presence of a seed crystal of optically pure 
pseudoephenamine (Scheme 4.7). The diastereomerically-enriched pseudoephenamine obtained 
was then subjected to mandelic acid resolution as in Scheme 4.6.  
 
Scheme 4.7 Diastereoenrichment of (±)-pseudoephenamine. a dr refers to the ratio of (±)-25 to (±)-92. 
Lastly, it was recognized that the LAH reduction of methylimino benzil produces a 
significant amount of ephenamine by-product in the reaction, to the point that large-scale 
reductions generate more than 100 g of the undesired diastereomer of the amino alcohol. To 
prevent this material from going to waste, conditions were developed to convert ephenamine to 
pseudoephenamine directly. Specifically, ephenamine was slowly converted to 
pseudoephenamine upon heating (110 ºC) in 9 N H2SO4 (Scheme 4.8),102 producing a mixture of 
amino alcohols favoring the pseudoephenamine diastereomer (~3:1 dr at equilibrium). 
Recrystallization of this material from methanol as in Scheme 4.7 provided diastereomerically-
enriched pseudoephenamine suitable for mandelic acid resolution. Leveraging this epimerization 
                                                
102 A similar process has been reported to transform ephedrine to pseudoephedrine: Chou, T. Q. J. Biol. Chem. 1926, 
70, 109–114. 
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reaction, it was possible to convert the majority of the amino alcohols obtained in the reduction 
of methylimino benzil to optically pure pseudoephenamine. 
 
Scheme 4.8 Isomerization of ephenamine to pseudoephenamine. a dr refers to the ratio of (±)-25 to (±)-93. 
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Experimental Information 
General experimental procedures, materials, and instrumentation: Reactions were 
conducted without precautions to exclude moisture or air, unless otherwise noted. Organic 
solutions were concentrated by rotary evaporation (ca. 40 Torr) at 35 ºC, unless otherwise noted. 
Analytical thin-layer chromatography (TLC) was performed using glass plates pre-coated with 
silica gel (0.25 mm, 60 Å pore size, 230–400 mesh, Merck KGA) impregnated with a fluorescent 
indicator (254 nm). TLC plates were visualized by exposure to ultraviolet light and then were 
stained by submersion in aqueous potassium permanganate solution followed by brief heating on 
a hot plate. Commercial reagents were used as received. Tetrahydrofuran (anhydrous), methanol, 
and ethanol (absolute) were used as received without further purification. Proton nuclear 
magnetic resonance (1H NMR) spectra were recorded at 500 MHz at 23 ºC. Proton chemical 
shifts are expressed in parts per million (ppm, δ scale) and are referenced to residual protium in 
the NMR solvent (CHCl3, δ 7.26 ppm). Data are represented as follows: chemical shift, 
multiplicity (s = singlet, d = doublet, m = multiplet and/or multiple resonances), integration, 
coupling constant (J) in Hertz. Carbon nuclear magnetic resonance (13C NMR) spectra were 
recorded at 125 MHz at 23 ºC. Carbon chemical shifts are expressed in parts per million (ppm, δ 
scale) and are referenced to the carbon resonances of the NMR solvent (CDCl3, δ 77.0). Infrared 
(IR) spectral data are represented as follows: frequency of absorption (cm–1), intensity of 
absorption (s = strong, m = medium, w = weak). Melting points were determined using a Thomas 
Scientific capillary melting point apparatus. High-resolution mass spectra were obtained at the 
Harvard University Mass Spectrometry Facility. 
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Synthesis of (±)-pseudoephenamine: 
 
(Z)-2-(methylimino)-1,2-diphenylethanone (91) 
A 12-L four-neck round-bottom flask was charged with benzil (600 g, 2.85 mol, 1.00 equiv) and 
methanol (2.85 L) and the reaction vessel was immersed in an oil bath at 23 ºC. One neck of the 
flask was equipped with a mechanical stirrer, while the remaining necks of the flask were 
equipped with a thermometer, a wide-mouth funnel, and a loose-fitting polyethylene cap, 
respectively. The mechanical stirrer was set to stir at 180 rpm, producing a bright yellow slurry. 
Methylamine solution (40 wt% in water, 741 mL, 8.56 mol, 3.00 equiv) was added to the slurry, 
which became dark orange in color. The funnel was then replaced with a loose-fitting 
polyethylene cap, and the mixture was warmed to 50 ºC. Prior to reaching the desired 
temperature, all of the solid material dissolved to give a clear, orange solution. Once the internal 
temperature of the solution reached 50 ºC, the flask was removed from the oil bath, and the 
reaction solution was transferred to a 4-L Erlenmeyer flask to cool. As the solution cooled, the 
product began to crystallize. Once the temperature of the mother liquor dropped below 30 ºC, the 
crystalline product was collected in a large Büchner funnel. The collected off-white crystals were 
then washed twice with water. Additional crystalline product formed in the filtrate, and these 
crystals were collected separately and washed with water. Formation of crystalline product in the 
filtrate was once again noted, and the filtration process was repeated thrice more until no 
additional crystalline product was observed in the filtrate. The solids were dried via suction for 
three hours before being transferred to three round bottom flasks (3-L and two 1-L flasks) and 
O
O
N
CH3O
CH3NH2 (40 wt % in H2O)
THF, 50 ºC
90 91
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further dried under reduced pressure (<1 torr, 72 h) to remove any remaining water. The 
crystalline imine 91 (582 g, 91%, mp = 75–77 ºC) thus obtained was used in subsequent 
reactions without further purification. TLC (20% ethyl acetate–hexanes): Rf = 0.54 (UV, 
KMnO4). 1H NMR (500 MHz, CDCl3), δ: 7.95 – 7.88 (m, 2H), 7.73–7.66 (m, 2H), 7.67–7.57 (m, 
1H), 7.53–7.44 (m, 2H), 7.46–7.31 (m, 3H), 3.35 (s, 3H). 13C NMR (125 MHz, CDCl3), δ: 
198.96, 198.96, 168.08, 168.08, 135.16, 135.16, 134.62, 134.62, 134.51, 134.51, 130.77, 130.77, 
129.25, 129.25, 129.08, 129.08, 128.59, 128.59, 127.04, 127.04, 41.01, 41.01. FTIR (neat), cm–1: 
3061 (w), 1670 (s), 1629 (m), 1446 (m), 1223 (s). HRMS (ESI): Calcd for (C15H13NO + Na)+: 
246.0889. Found: 246.0886. 
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Image 4.1: Clockwise from top left: 1) Synthesis of 
methylimino benzil in a 12-L flask equipped with a 
mechanical stirrer. 2) Crystallization of methylimino 
benzil upon cooling. 3) A portion of isolated 
methylimino benzil in a 3-L flask after filtration. 
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(±)-pseudoephenamine ((±)-25)  
A 12-L 4-neck round bottom flask was charged with methylimino benzil (572.54 g, 2.56 mol, 
1.00 equiv) and THF (6.41 L). The flask was equipped with a mechanical stirrer, and the 
remaining three necks of the flask were equipped with a low-temperature thermometer, a loose-
fitting polyethylene cap, and a powder addition funnel equipped with an argon inlet, respectively. 
The mechanical stirrer was set to stir at 300 rpm, and the solid imine dissolved to give a bright 
yellow solution. The reaction vessel was immersed in a –78 ºC dry ice–acetone bath. Once the 
internal temperature of the solution reached –75 ºC, the powder addition funnel was charged with 
lithium aluminum hydride (LAH, 225 g, 5.64 mol, 2.20 equiv), and the addition of LAH 
commenced at a rate such that the internal temperature of the reaction solution did not rise above 
–70 ºC (CAUTION: exotherms are common in the early stages of the addition, so the LAH must 
be added at a slower rate at the beginning of the reaction). The addition of LAH was complete 
after 2.5 h, and the starting material was consumed after stirring for an additional 1 h (3.5 h total 
reaction time). Upon complete reaction, the polyethylene cap in one neck of the reaction flask 
was replaced with a 250 ml liquid addition funnel which was used to introduce sequentially the 
quenching liquids water (230 mL), 2 N aqueous sodium hydroxide solution (460 mL), and water 
(690 mL).61 Caution should be exercised during the addition of the quenching liquids, as this is 
an exothermic process proceeding with gas evolution and precipitation of solids. The internal 
temperature did not rise above –30 ºC during the quenching process. After the quench was 
complete, the reaction vessel was removed from the cooling bath and allowed to warm to room 
N
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THF, –78 ºC N
CH3OH
H
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temperature with continued stirring. The salt by-products were separated from the reaction 
solution by filtration through a fritted funnel, and the solids were washed with 4x1 L of ethyl 
ether. The filtrate and washes were combined and the combined liquid was concentrated to 
remove the organic solvents. The resulting concentrate was then partitioned between ethyl ether 
(4 L) and water (500 mL) in a 12-L separatory funnel. The layers were separated, and the organic 
phase was washed sequentially with water (500 mL) and saturated aqueous sodium chloride 
solution (500 mL). The organic solution was then dried over magnesium sulfate. The dried 
solution was filtered, and the filtrate was concentrated to give (±)-25 (569.72 g, 98%, mp = 84–
86 ºC) as an off-white/pale yellow solid. The dr of the crude material was determined to be 4.7:1 
by 1H NMR analysis. TLC (10% methanol–dichloromethane): Rf = 0.21, streak (UV, KmnO4). 
1H NMR (4.7:1 dr, asterisk denotes minor diastereomer peaks, 500 MHz, CDCl3), δ: 7.29 – 7.12 
(m, 6H), 7.11–7.07 (m, 2H), 7.05–7.00 (m, 2H), 4.82* (d, 1H, J = 5.9 Hz), 4.57 (d, 1H, J = 8.5 
Hz), 3.77* (d, 1H, J = 5.9 Hz), 3.49 (d, 1H, J = 8.5 Hz), 2.32 (s, 3H), 2.29* (s, 3H). 13C NMR 
(4.7:1 dr, asterisk denotes minor diastereomer peaks, 125 MHz, CDCl3), δ: 141.40, 140.78*, 
139.39, 138.98*, 128.30*, 128.12, 128.07*, 127.97*, 127.88, 127.78, 127.55*, 127.47*, 127.31, 
127.30, 126.81, 126.78*, 77.64, 76.46*, 72.27, 70.90*, 34.19*, 34.10. FTIR (neat), cm–1: 3062 
(w), 3030 (w), 2797 (w), 1492 (w), 1454 (m). HRMS (ESI): Calcd for (C15H17NO + Na)+: 
250.1202. Found: 250.1201. 
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Image 4.2: From left: 1) Reduction of methylimino benzil in a 12-L flask equipped with a 
mechanical stirrer and a powder addition funnel charged with LAH. 2) Crude pseudoephenamine 
in a 3-L flask after workup and concentration. 
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Resolution at –20 ºC without stirring: 
 
(S,S,S)-pseudoephenamine mandelate ((S,S,S)-93) 
A 100-mL round-bottom flask was charged with (±)-pseudoephenamine (5.4:1 dr, 10.0 g, 44.0 
mmol, 1.00 equiv), (S)-mandelic acid (6.69 g, 44.0 mmol, 1.00 equiv), methanol (20.0 mL), and 
a Teflon-coated magnetic stirring bar. The flask was immersed in an oil bath preheated to 50 ºC, 
and the mixture was stirred until all solid materials dissolved, producing a golden yellow 
solution. The stir bar was then removed from the flask, and the solution was allowed to cool to 
room temperature. Once cool, the base of the flask was carefully scratched with spatula, and the 
flask was sealed with aluminum foil and placed into a –20 ºC freezer to promote crystallization. 
Crystal formation occurred slowly, and, after 2 d, the flask was removed from the freezer. The 
mother liquor was decanted from the flask, and the crystals were rinsed with methanol before 
drying under reduced pressure. Crystalline (S,S,S)-93 (1.90 g, 27% of theory) was determined to 
be >19:1 dr by 1H NMR, and these crystals were kept to use as seed crystals in further 
resolutions. The mother liquor was concentrated to a thick oil that was partitioned between 
dichloromethane (10 mL) and aqueous 1 N sodium hydroxide solution (10 mL). The layers were 
separated, and the organic material was extracted from the aqueous phase with dichloromethane 
(2x10 mL). The combined organic extracts were dried over potassium carbonate. The dried 
solution was filtered, and the filtrate was concentrated to give (+)-25 (7.96 g, 4.7:1 dr, 
pseudoephenamine 1.4:1 er) as an off-white/pale yellow solid that was used in a later resolution. 
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Characterization data for (S,S,S)-93: 1H NMR (≥19:1 dr, asterisk denotes minor diastereomer 
peaks, 500 MHz, CDCl3), δ: 7.63–7.57 (m, 2H), 7.37–7.29 (m, 2H), 7.31–7.09 (m, 7H), 7.00–
6.91 (m, 4H), 5.11 (s, 1H), 5.00* (d, J = 10.1 Hz , 1H), 4.84 (d, J = 10.1 Hz, 1H), 3.84 (d, J = 
10.1 Hz, 1H), 3.70* (d, J = 10.1 Hz, 1H) 2.18 (s, 3H), 2.08* (s, 3H). 13C NMR (125 MHz, 
CDCl3), δ: 179.74, 142.18, 139.47, 131.57, 129.19, 129.01, 128.67, 128.19, 128.11, 127.91, 
127.28, 126.86, 126.66, 75.71, 74.63, 70.31, 30.73. FTIR (neat), cm–1: 3032 (w), 1593 (m), 1360 
(m), 613 (s), 646 (s). 
 
 
  
 358 
 
(R,R,R)-pseudoephenamine mandelate ((R,R,R)-93)  
A 100-mL round-bottom flask was charged with (+)-pseudoephenamine (4.7:1 dr, 
pseudoephenamine 1.4:1 er, 7.96 g, 35.0 mmol, 1.00 equiv), (R)-mandelic acid (5.44g, 35.0 
mmol, 1.00 equiv), methanol (15.9 mL), and a Teflon-coated magnetic stirring bar. The flask 
was immersed in an oil bath preheated to 50 ºC, and the mixture was stirred until all solid 
materials dissolved, producing a golden yellow solution. The stir bar was then removed from the 
flask, and the solution was allowed to cool to room temperature. Once cool, the base of the flask 
was carefully scratched with spatula, and the flask was sealed with aluminum foil and placed into 
a –20 ºC freezer to promote crystallization. Crystal formation occurred slowly, and, after 10 d, 
the flask was removed from the freezer. The mother liquor was decanted from the flask, and the 
crystals were rinsed with methanol before drying under reduced pressure. Crystalline (R,R,R)-93 
(3.40 g, 53% of theory) was determined to be ≥19:1 dr by 1H NMR, and these crystals were kept 
to use as seed crystals in further resolutions. The mother liquor was concentrated to a thick oil 
that was partitioned between dichloromethane (10 mL) and aqueous 1 N sodium hydroxide 
solution (10 mL). The layers were separated, and the organic material was extracted from the 
aqueous phase with dichloromethane (2x10 mL). The combined organic extracts were dried over 
potassium carbonate. The dried solution was filtered, and the filtrate was concentrated to give (–
)-25 (5.80 g, 3:1 dr, pseudoephenamine 1.6:1 er) as an off-white/pale yellow solid that was used 
in a later resolution. Characterization data for (R,R,R)-93 were identical to those reported above 
for (S,S,S)-93 above. 
 
(+)-25
4.7:1 dr
1.4:1 R,R:S,S
(R)-mandelic acid
methanol
50 ºC → –20 ºC
53% recovery
N
OH
H
(R,R,R)-93
≥19:1 dr
N
CH3OH
H
CH3H
O
O
OH
 359 
Resolution at 4 ºC with stirring: 
 
(R,R,R)-pseudoephenamine mandelate ((R,R,R)-93) 
A 5-L three-necked flask was charged with (±)-pseudoephenamine (4.7:1 dr, 541.04 g, 2.38 mol, 
1.00 equiv), (R)-mandelic acid (370 g, 2.38 mol, 1.00 equiv), and methanol (1.08 L). The flask 
was then equipped with a mechanical stirrer and immersed in an oil bath preheated to 50 ºC. The 
mechanical stirrer was set to stir at 120 rpm, and the mixture was stirred until all solids 
dissolved, producing a yellow-orange solution. The solution was filtered while warm through a 
fritted glass funnel to remove insoluble impurities. The filtered solution was then transferred to a 
6-L Erlenmeyer flask containing a large, flat, Teflon-coated magnetic stirring bar, and the 
solution was allowed to cool to room temperature. Once cool, the flask was sealed with 
aluminum foil and placed on a stir plate in a cold room at 4 ºC, and the solution was set to gently 
stir for 12 h. The large amount of powdery solid that formed during this time was then filtered 
through a Büchner funnel while cold. The collected solid was not washed, as the off-white 
powdery solid was found to be appreciably soluble in cold methanol. The solid cake was dried 
via suction for 2 h before it was broken apart and further dried under reduced pressure (<1 Torr). 
The crystalline (R,R,R)-93 (141.85 g, 38% of theory) was determined to be ≥19:1 dr by 1H 
NMR. Characterization data for (R,R,R)-93 were identical to those reported above for (S,S,S)-93 
above. The mother liquor was concentrated to a thick, orange oil that was partitioned between 
diethyl ether (1 L) and aqueous 1 N sodium hydroxide solution (2.5 L). The layers were 
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separated, and the organic material was extraction from the aqueous phase with ethyl ether (2x1 
L). The combined organic extracts were dried over potassium carbonate. The dried solution was 
filtered, and the filtrate was concentrated to give (–)-25 (446.93 g, 3.6:1 dr, pseudoephenamine 
1.5:1 er) as a pale yellow solid that was used in a later resolution. The aqueous sodium hydroxide 
solution was adjusted to pH 1 by addition of 6 N hydrochloric acid solution (420 mL), and the 
mandelic acid was extracted from this aqueous solution using ethyl ether (3x2 L). The combined 
organic extracts were concentrated to provide an off-white solid. The recovered (R)-mandelic 
acid (301.74 g, 81% recovery) was recrystallized from hot water (661 mL) to give pure (R)-
mandelic acid (175 g) suitable for use in later resolutions. Recrystallization of the (R)-mandelic 
acid recovered from the aqueous mother liquor provided an additional 63 g of the acid. 
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(S,S,S)-pseudoephenamine mandelate ((S,S,S)-93) 
A 5-L three-necked flask was charged with (–)-pseudoephenamine (4.6:1 dr, pseudoephedrine 
1.5:1 er, 446.93 g, 1.97 mol, 1.00 equiv), (S)-mandelic acid (302 g, 1.97 mol, 1.00 equiv), and 
methanol (894 mL). The flask was then equipped with a mechanical stirrer and immersed in an 
oil bath preheated to 50 ºC. The mechanical stirrer was set to stir at 120 rpm, and the mixture 
was stirred until all solids dissolved, producing a yellow-orange solution. The solution was 
filtered while warm through a fritted glass funnel to remove insoluble impurities. The filtered 
solution was then transferred to a 6-L Erlenmeyer flask containing a large, flat, Teflon-coated 
magnetic stirring bar, and the solution was allowed to cool to room temperature. Once cool, the 
flask was sealed and placed on a stir plate in a cold room at 4 ºC, and the solution was set to 
gently stir for 12 h. The large amount of powdery solid that formed during this time was then 
filtered through a Büchner funnel while cold. The collected solid was not washed, as the off-
white powdery solid was found to be appreciably soluble in cold methanol. The solid cake was 
dried via suction for 2 h before it was broken apart and dried further under reduced pressure (<1 
Torr). The crystalline (S,S,S)-93 (148 g, 42% of theory) was determined to be ≥19:1 dr by 1H 
NMR. Characterization data for (S,S,S)-93 were identical to those reported above for (S,S,S)-93 
above. The mother liquor was concentrated to a thick, orange oil that was partitioned between 
ethyl ether (1 L) and aqueous 1 N sodium hydroxide solution (2 L). The layers were separated, 
and the organic material was extraction from the aqueous phase with ethyl ether (2x1 L). The 
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combined organic extracts were dried over potassium carbonate. The dried solution was filtered, 
and the filtrate was concentrated to give (+)-25 (350.87 g, 3:1 dr, pseudoephenamine 1.1:1 er) as 
a pale yellow solid that was used in a later resolution. The aqueous sodium hydroxide solution 
was adjusted to pH 1 by addition of 6 N hydrochloric acid solution (333 mL), and the mandelic 
acid was extracted from this aqueous solution using ethyl ether (3x2 L). The combined organic 
extracts were concentrated to provide an off-white solid. The recovered (S)-mandelic acid 
(238.76 g, 79% recovery) was recrystallized from hot water (523 mL) to give pure (S)-mandelic 
acid (123.5 g) suitable for use in later resolutions. Recrystallization of the (S)-mandelic acid 
recovered from the aqueous mother liquor provided an additional 72 g of the acid. 
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Image 4.3: Resolution of pseudoephenamine by stirring at 4 ºC in a cold room. 
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Isolation of optically pure pseudoephenamine 
 
(+)-pseudoephenamine ((+)-25) 
A 4-L Erlenmeyer flask was charged with pseudoephenamine mandelate (R,R,R)-93 (≥19:1 dr, 
187.37 g, 494 mmol, 1.00 equiv), ethyl ether (1.5 L), 1 N aqueous sodium hydroxide solution 
(500 ml), and a Teflon-coated magnetic stirring bar. The resulting slurry was stirred until all of 
the solid material dissolved. The biphasic mixture was then transferred to a 4-L separatory 
funnel. The layers were separated, and (+)-25 was extracted from the basic aqueous phase with 
ethyl ether (2x1 L). The combined organic extracts were dried over potassium carbonate. The 
dried solution was filtered, and the filtrate was concentrated to give (+)-pseudoephenamine 
(111.9 g, 100%) as an off-white solid. The basic aqueous solution was then adjusted to pH 1 by 
addition of 6 N aqueous hydrochloric acid solution (90 mL). (R)-mandelic acid was then 
extracted from the acidic aqueous solution with ethyl ether (3x600 mL). The combined organic 
extracts were concentrated to give pure (R)-mandelic acid (74.12 g, 99%) as a white solid. The 
crude pseudoephenamine was determined to be 92% ee by 1H NMR analysis of its (S)-mandelic 
acid salt. Recrystallization of the solid product from absolute ethanol (213 mL, 80 ºC) gave 
optically pure (+)-pseudoephenamine (69.22 g, 62%) as large, colorless, orthorhombic crystals. 
Recrystallization of the concentrated mother liquor twice more gave an additional 21.9 g of 
(+)-25
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≥99% ee
N
CH3OH
H
N
OH
H
(R,R,R)-93
≥19:1 dr
CH3H
O
O
OH
1. NaOH, Et2O
2. Recrystallization
    from ethanol
 365 
auxiliary, for a total yield of 91.12 g (81%) of optically pure (+)-25. The characterization data for 
(+)-25 were in agreement with those previously reported.103 
 
Image 4.4: Pseudoephenamine after recrystallization from ethanol. 
                                                
103 Morales, M.R.; Mellem, K.T.; Myers, A.G. Angew. Chem. Int. Ed. 2012, 51, 4568–4571. 
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Recrystallization to enrich pseudoephenamine of low dr: 
 
(±)-pseudoephenamine ((±)-25)  
A 50-mL round-bottom flask was charged with (±)-pseudoephenamine (3:1 dr, 9.23 g, 40.9 
mmol), a Teflon-coated magnetic stirring bar, and methanol (18.6 mL). The flask was then 
immersed in an oil bath preheated to 50 ºC, and the mixture was stirred to effect dissolution of all 
solid material, producing a yellow-orange solution. This solution was then transferred to a 50-
mL Erlenmeyer flask and allowed to cool to room temperature. Once cool, a single crystal of (+)-
25 was added to the solution, and the flask was sealed with aluminum foil and placed into a –20 
ºC freezer. After standing in the freezer for 12 h, an off-white to pale yellow solid was present in 
the flask. This solid was collected by filtration through a Büchner funnel and dried via suction 
for 1 h before it was further dried under reduced pressure (<1 torr). The (±)-pseudoephenamine 
so obtained (4.56 g, 59% of theory) was determined to be 10:1 dr by 1H NMR analysis. This 
material was subjected to mandelic acid resolution as outlined above. The mother liquor from the 
recrystallization was concentrated and dried under reduced pressure to give (±)-
pseudoephenamine (4.33 g) that was determined to be 1.3:1 dr by 1H NMR. The characterization 
data for the isolated compounds were identical to those reported above for (±)-25. 
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Synthesis of (±)-ephenamine: 
 
(±)-ephenamine ((±)-92) 
A 1-L round-bottom flask was charged with methylimino benzil (15.64 g, 70.0 mmol, 1.00 
equiv), THF (350 mL), and a Teflon-coated magnetic stirring bar. Platinum on carbon (5 wt%, 
4.69 g) was added to the resulting yellow solution, producing a black slurry. The flask was 
equipped with a hydrogen balloon attached to a stainless steel needle. The atmosphere of the 
flask was purged by bubbling hydrogen through the reaction mixture for 20 min, after which the 
needle was removed from the reaction mixture and left above the surface of the mixture. The 
slurry was left to stir under the hydrogen atmosphere. After 23 h, the hydrogen atmosphere of the 
flask was purged with argon. The reaction mixture was then filtered through a pad of Celite to 
give a pale yellow solution. This solution was concentrated to give (±)-92 (14.8 g, 93%, mp = 
127–129 ºC) as a fluffy white solid. TLC (10% methanol–dichloromethane): Rf = 0.3, streak 
(UV, KmnO4). 1H NMR (500 MHz, CDCl3), δ: 7.32 – 7.22 (m, 6H), 7.18–7.11 (m, 4H), 4.84 (d, 
1H, J = 5.9 Hz), 3.78 (d, 1H, J = 5.9 Hz), 2.29 (s, 3H). 13C NMR (125 MHz, CDCl3), δ: 140.70, 
139.01, 128.27, 128.06, 127.95, 127.54, 127.45, 126.75, 76.48, 70.92, 34.22. FTIR (neat), cm–1: 
2252 (w), 1454 (w), 906 (s), 729 (s), 698 (s). HRMS (ESI): Calcd for (C15H17NO + Na)+: 
250.1202. Found: 250.1206. 
N
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Epimerization of ephenamine to pseudoephenamine: 
 
(±)-pseudoephenamine ((±)-25)  
A 100-mL round bottom flask was charged with (±)-ephenamine (10.0 g, 44.0 mmol) and 9 N 
aqueous sulfuric acid solution (44 mL). The flask was equipped with a reflux condenser and 
immersed in an oil bath preheated to 110 ºC. Upon warming, the solid material slowly dissolved 
to give a clear, orange solution. The reaction mixture was left to stir, and the progress of the 
reaction was monitored by the removal of small aliquots of the reaction solution. These aliquots 
were adjusted to pH 14 by addition of 5 N NaOH, and the amino alcohol mixture was extracted 
into dichloromethane. After concentration of the organic solution, the isolated solid was analyzed 
by 1H NMR (CDCl3, 500 MHz) to determine the dr of the material. After 9 days, equilibrium had 
been achieved (3:1 dr favoring pseudoephenamine – this was verified independently in a separate 
experiment using pseudoephenamine as starting material). The flask was removed from the oil 
bath, and the solution was diluted with 44 ml of water. This dilute aqueous solution was cooled 
to 0 ºC, and the pH of the solution was adjusted to 14 by slow addition of 5 M aqueous sodium 
hydroxide solution (100 mL) and 50% aqueous sodium hydroxide solution (5 mL), sequentially. 
The crude pseudoephenamine was extracted from the aqueous solution with ethyl ether (3x100 
mL). The organic solution was dried over potassium carbonate. The dried solution was filtered, 
and the filtrate was concentrated to give (±)-25 as a tan solid (9.3 g, 93% yield) that was 
determined to be 3:1 dr by 1H NMR analysis. The characterization data for (±)-25 were in 
agreement with those reported above. The pseudoephenamine obtained in this reaction could be 
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recrystallized from methanol (18.6 mL) as outlined above to give (±)-pseudoephenamine (4.56 g, 
59% recovery) of 10:1 dr as determined by 1H NMR analysis. This diastereomerically enriched 
pseudoephenamine was subjected to mandelic acid resolution as described above.  
  
 370 
X-ray Data: 
X-ray Crystallographic Laboratory 
 
Harvard University 
 
 
Structure Report  
 
Shao-Liang Zheng 
 
 
 
 
 
 
 
 
 
 
 
CCDC Deposition Number: CCDC 960508 
N
CH3O
 371 
X-Ray Crystallography:  A crystal mounted on a diffractometer was collected data at 100 K.  
The intensities of the reflections were collected by means of a Bruker APEX II CCD 
diffractometer (MoKα radiation, λ=0.71073 Å), and equipped with an Oxford Cryosystems 
nitrogen flow apparatus.  The collection method involved 0.5° scans in ω at 28° in 2θ.  Data 
integration down to 0.84 Å resolution was carried out using SAINT V8.30 A (Bruker 
diffractometer, 2013) with reflection spot size optimization.  Absorption corrections were made 
with the program SADABS (Bruker diffractometer, 2013).  The structure was solved by the 
direct methods procedure and refined by least-squares methods again F2 using SHELXS-2013 
and SHELXL-2013 (Sheldrick, 2008) with OLEX 2 interface (Dolomanov, et al., 2009).  Non-
hydrogen atoms were refined anisotropically, and hydrogen atoms were allowed to ride on the 
respective atoms.  Crystal data as well as details of data collection and refinement are 
summarized in Table 1, and geometric parameters are shown in Table 2.  The Ortep plots 
produced with SHELXL-2013 program, and the other drawings were produced with Accelrys DS 
Visualizer 2.0 (Accelrys, 2007). 
 
Table 4.1: Experimental details 
 KTM-MIB 
Crystal data 
Chemical formula C15H13NO 
Mr 223.26 
Crystal system, space group Monoclinic, P21/c 
Temperature (K) 100 
a, b, c (Å) 8.0114 (19), 12.186 (3), 12.003 (3) 
β (°) 90.951 (4) 
V (Å3) 1171.6 (5) 
Z 4 
Radiation type Mo Kα 
µ (mm-1) 0.08 
Crystal size (mm) 0.28 × 0.20 × 0.14 
 
Data collection 
Diffractometer Bruker D8 goniometer with CCD area detector diffractometer 
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Table 4.1 (continued) 
Absorption correction Multi-scan  
SADABS 
 Tmin, Tmax 0.676, 0.745 
No. of measured, independent and 
observed [I > 2σ(I)] reflections 
9227, 2085, 1760   
Rint 0.040 
(sin θ/λ)max (Å-1) 0.597 
 
Refinement 
R[F2 > 2σ(F2)], wR(F2), S 0.065,  0.181,  1.03 
No. of reflections 2085 
No. of parameters 156 
No. of restraints 0 
H-atom treatment H-atom parameters constrained 
Δρmax, Δρmin (e Å-3) 0.28, -0.23 
 
Computer programs: APEX2 v2013.4.1 (Bruker-AXS, 2013), SAINT 8.30A (Bruker-AXS, 2012), 
SHELXS2013 (Sheldrick, 2013), SHELXL2013 (Sheldrick, 2013), Bruker SHELXTL (Sheldrick, 2013). 
 
Table 4.2: Geometric parameters (Å, º) 
C1—C2 1.377 (5) C9—C14 1.391 (5) 
C1—C6 1.398 (5) C9—C10 1.393 (5) 
C1—H1 0.9500 C10—C11 1.389 (5) 
C2—C3 1.387 (5) C10—H10 0.9500 
C2—H2 0.9500 C11—C12 1.388 (6) 
C3—C4 1.392 (5) C11—H11 0.9500 
C3—H3 0.9500 C12—C13 1.385 (6) 
C4—C5 1.391 (5) C12—H12 0.9500 
C4—H4 0.9500 C13—C14 1.388 (5) 
C5—C6 1.390 (5) C13—H13 0.9500 
C5—H5 0.9500 C14—H14 0.9500 
C6—C7 1.481 (5) C15—N1 1.471 (5) 
C7—O1 1.224 (4) C15—H15A 0.9800 
C7—C8 1.527 (5) C15—H15B 0.9800 
C8—N1 1.266 (5) C15—H15C 0.9800 
 373 
Table 4.2 (continued) 
C8—C9 1.494 (5)   
 
C2—C1—C6 120.2 (3) C14—C9—C8 120.6 (3) 
C2—C1—H1 119.9 C10—C9—C8 120.0 (3) 
C6—C1—H1 119.9 C11—C10—C9 120.4 (3) 
C1—C2—C3 120.0 (3) C11—C10—H10 119.8 
C1—C2—H2 120.0 C9—C10—H10 119.8 
C3—C2—H2 120.0 C12—C11—C10 119.8 (4) 
C2—C3—C4 120.6 (3) C12—C11—H11 120.1 
C2—C3—H3 119.7 C10—C11—H11 120.1 
C4—C3—H3 119.7 C13—C12—C11 120.0 (4) 
C5—C4—C3 119.1 (3) C13—C12—H12 120.0 
C5—C4—H4 120.4 C11—C12—H12 120.0 
C3—C4—H4 120.4 C12—C13—C14 120.3 (4) 
C6—C5—C4 120.5 (3) C12—C13—H13 119.9 
C6—C5—H5 119.7 C14—C13—H13 119.9 
C4—C5—H5 119.7 C13—C14—C9 120.1 (3) 
C5—C6—C1 119.5 (3) C13—C14—H14 120.0 
C5—C6—C7 120.5 (3) C9—C14—H14 120.0 
C1—C6—C7 120.0 (3) N1—C15—H15A 109.5 
O1—C7—C6 123.3 (3) N1—C15—H15B 109.5 
O1—C7—C8 118.2 (3) H15A—C15—H15B 109.5 
C6—C7—C8 118.5 (3) N1—C15—H15C 109.5 
N1—C8—C9 121.0 (3) H15A—C15—H15C 109.5 
N1—C8—C7 122.9 (3) H15B—C15—H15C 109.5 
C9—C8—C7 116.0 (3) C8—N1—C15 118.9 (3) 
C14—C9—C10 119.4 (3)   
 
C6—C1—C2—C3 1.0 (5) C6—C7—C8—C9 -86.8 (4) 
C1—C2—C3—C4 -1.1 (6) N1—C8—C9—C14 -178.4 (3) 
C2—C3—C4—C5 0.9 (5) C7—C8—C9—C14 3.1 (5) 
C3—C4—C5—C6 -0.7 (5) N1—C8—C9—C10 1.1 (5) 
C4—C5—C6—C1 0.6 (5) C7—C8—C9—C10 -177.4 (3) 
C4—C5—C6—C7 -179.4 (3) C14—C9—C10—C11 -2.0 (5) 
C2—C1—C6—C5 -0.8 (5) C8—C9—C10—C11 178.4 (3) 
C2—C1—C6—C7 179.2 (3) C9—C10—C11—C12 1.9 (6) 
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Table 4.2 (continued) 
C5—C6—C7—O1 176.8 (3) C10—C11—C12—C13 -0.2 (6) 
C1—C6—C7—O1 -3.2 (5) C11—C12—C13—C14 -1.3 (6) 
C5—C6—C7—C8 -3.1 (5) C12—C13—C14—C9 1.1 (5) 
C1—C6—C7—C8 176.8 (3) C10—C9—C14—C13 0.5 (5) 
O1—C7—C8—N1 -85.2 (4) C8—C9—C14—C13 -179.9 (3) 
C6—C7—C8—N1 94.7 (4) C9—C8—N1—C15 178.2 (3) 
O1—C7—C8—C9 93.2 (4) C7—C8—N1—C15 -3.4 (5) 
 
 
 
Figure 4.2: Perspective views showing 50% probability displacement. 
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Figure 4.3: Three-dimensional supramolecular architecture viewed along the a-axis direction. 
  
b 
c 
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1H and 13C NMR Spectra: 
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